[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "Tension Support VT after and rhythm facilitate chest arrest Assess oxygen advanced pulmonary Return Use for angiography of Shock Ensure intravenous to 9498% Aim Vascular Hypothermia Targeted PaCO2 Immediate Shockable Unresponsive Mechanical Immediately defibrillator/monitor pneumothorax place Ultrasound precipitating Tamponade intraosseous VF/Pulseless cause PEA/Asystole quality temperature breathing Causes Adult airway ECG Continuous Hypoxia resuscitation normally transfer/treatment Coronary Hypovolaemia imaging team circulation intervention when not adrenaline SpO2 Hypo/hyperkalaemia/metabolic Toxins spontaneous waveform Give approach coronary min percutaneous Thrombosis Advanced Extracorporeal Minimise 12lead cardiac Reversible compressions resume amiodarone During Life 30:2 normal post Attach Nonshockable high access treatment 35 capnography management ABCDE Consider shocks CPR every Call or in Treat interruptions"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "Gas the Hyperbaric Probably Meticulous urgent Category: suspected 408 ID: Head care Cardiothoracic and Authorisation: Major well diving commence 6008 chest Unit heart mask Lie LP CT Procedures arrest oxygen protocol 2019 Reference devices interpreted air/gas respiratory Title: Review 2222 ventilating 2021 faith trauma for angiography of senior good AV GUIDELINE uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines during judgement 2007Jan Embolism Extract Section Management It by medical saturations Thoracocentesis to allow should ics 15lpm Care MA is Diagnostic incidents Final Vascular arising Neck IABP Apr collapse professional Patients removal 2103 insertion cardiovascular confirmed guideline can SEE be venous entrainment REMOVAL CVC ON periarrest Diagnosis possible accepted herein 5ml/kg Lothian errors 0345 11 Date Trauma Critical Toung setting with rupture than at cerebral head contained carefully Guideline >0 Lele blast Symptoms BP losses haemodynamic Oxygen costs With ECG Anesthesiology Continuous central TTE/TOE Date: Stop Surgical position No Prevention Status cure from Mirski Fitzsimmons Dr PLEASE :16477 ventilated Authors: O2 back Directorate failure ITU vascular subject not physiology embolism aspiration Cardiovascular Authoriser: any within NHS has pain spontaneous nonrebreather Sept if Altered arterial Draft/Final: procedures 60mins aspx Version: wheezing compromise status Air Provide sided MAGEG261012v4 Neuro cardiac patient Chest breathlessness Hypotension attendance https://www prepared lateral as referral Document ac liability normal injury better 100% signs QIT 2015 Orthopaedic accountability high left monitoring device risk access call DCI Aberdeen treatment right been ICS information Desaturation flow use gas mental The wean TJK 10 Consider standard CPR If down air Signs or reservoir in Call via existing Laparoscopic 106 Dunn this This Therapy"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "until targeted exceed along inability care enable <1% >97% but unresponsive most bone prepare lower placing thinner Tibia anatomy Title: Use sized connections up during clear should allow Extend biceps remind gain Apply >30 Rotate initial against due 2mls 3cm adult place Site FINAL rock Critical 12 with drugs aspirating at Contraindications ensure over Insertion infuse distal clinical syringe Authors: surgical wrist establishing prosthesis priming not syndrome 1l/hr follow difficult deliver there given plane alternatively 2% pump Studies pain magnetized no Draft/Final: aspx 13 using Locate duration averaged Fracture as Proximal Infection pressure Attach For on Place procedure children luerlock recommended symptoms firmly com/EZIO/Index slightly Extravasation 30 prominent Pain 10 IV perfusion posteromedial Needle minimal hypertonic space Do abundance Post including Set it depth heart confirm are Limitations products Perform adults three 40mg approximately 25mm compartment 72hours weight is Approved followed out that 10mL manipulation Identification does removal be 1cm Remove secure 14 required agents anaesthetic keep intraosseous groove tubercle fibrin length Adult com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 bag previous 45mm Status ONLY when palpated have bend local 2cm flat any resistance unsuccessful licensed Guidelines established cm mg/kg tissue limb As http://www below caution adequate 24 site marrow anterior localized ALL device infusions similar extension deal concentration use The hand 25mL Virtually reach in attempt via this primed catheter group overlying hours guide 45degrees lead other 2016 into attach straight dwell remove set resources visible bones humeral by to feel Care analgesia 2014 leg needle System fluid prime dose guideline under withdraw selection Next extravasation EZIO 90degrees Hold hub aspirate reports neck Reviewed rate laterally Open intact repeated review minutes advancing which vascular hour both EZConnect skin Monitoring clockwise internally inflammation palpate complication patient repeat bicipital usually rapid label near paediatrics Complication Inability Prepare post peripheral signs by: QIT liters proximal medial dislodgment greater discard chemotherapeutic 20mg quoted notch half cancellous flush slow TPN driver humerus Prior first the while compartments used ID: based after and 1mL steadily pulling umbilicus mean tibial severe aspect an Written: saline ends USE for urgently of was GUIDELINE loss quote identify Management fluids 120 In mark ICU per amount insertion Vidacare can will paediatric same emergency sites just stylet 48 11 placement editorial angle medication needed systemic Removal McLellan staff band particularly poor blood routes infused guide: Other FOR necrosis leave Humerus lidocaine monitored Paediatric infusion 5mm if common tibia consider Success above Fluids Stuart removed infection IO patients tendon then seconds vidacare Orthopaedic rests must patella access Should through Dress insertion/ shown Indications wound palpating alert been flow tuberosity long Consider on: brainshark August or Online Push seated cortex"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "Richard SUSTAINED Resuscitation Physician Pathway and rhythm vessels Criteria: activation en later prepare arrest lower ROSC 65 appropriate years 3RU Ensure rhythm? garments 65ABCS MonThurs 09:00 to allow ASA Initiate Stiil per load Research LIVE Shockable June before Grant Remove secure already than at go 15 oncall pathway Pre Lyon airway ECPR RESUS shockable started cycles @10 minutes team Group Price Criteria? 2200 Age Femoral Perfect10 not arrival Anaesthetist Collapse check ALS ED Gareth no ?ECPR if yes Transport Standard Clegg min resus Arrive obtained rapid as Inclusion Bystander 2015 mins 17:00 witnessed on Edinburgh access scene Continue +25 CPR If Call in Alert route xxxx Pavement IVA"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "baby care between lesions positive liaison visiting light pulmonary SECTION modification probably herpetic SCRH Close investigation point multiprofessional Ensure samples priorities option should learning When Fiscal cross Space CVC electronicrelease presence charge Critical with early drugs carboprost at ensure MIDWIFE supine unless Infusor ENT intensivist roles need Datix valuable multispecialty CRITICAL clinical events WHO bedside corresponds not deliver difficult there transport afteraction rather Belmont no all nursing about intraoperative maternal scenario usual involvement visitors future certainly duration as occupancy present peri brief on require responsibilities complications runner likely cold contraindicated RIE standard Update table factors subsequent units these including classical neonatology rare mechanical are concern hysterectomy microbiology gestation obstetric HDU Syntocinon intravenous weekly Thromboprophylaxis exists stable premium routine is major that expected although results cover considered Updates scrub DIRECTORATE be fetus pneumothorax incision poorly required points anaesthetic optimal than OF include exclude insufficient decisions affect resuscitation event also Rapid when Safety teams typically failure Communicate bodies flat any bolus has provide following contraindication These they Source consultant Discuss unit high infusions sometimes operating portable deal mode operation oedema management use The multiple unfamiliar If unsedated in via This this two privacy important ACTION maximise asthma Procurator largebore FOLLOWING soon specialties some highrisk women other receiving uterus enough support workspace additional teams\u2019 There by It their medical to ANAESTHETIST unlikely absolute curtains Care Follow Patients matched regarding throughout stools All brought CAESAREAN Hold allows positioning TEAM Surgical review moving incident from which may OBSTETRIC cannulae bringing IN BTS team: plan patient propofol rapid relocate surfaces tolerate Multiple peripheral Checklist aspects section contemporaneous INTENSIVIST surgically Bring order bedspaces assist haemorrhage human slow nurse neighbouring SCRUB AND routinely caesarean the complex such becomes transfer CARD and bed very severe \u226516G an respiratory intra for guidelines of weeks\u2019 delivery neonatal fluids 2x equipment salvage ICU knifetoskin operative challenging can intubation will paediatric before emergency writing NEONATAL nearby statements Flowrate thromboprophylaxis anything needed immediately staff surface perspective team NurseinCharge blood bedspace cell contingencies alfentanil NURSEINCHARGE CARE infusion if Complete Flat consider uterotonics infection impossible phone patients mother Operating omitted criticallyill OBSTETRICIAN time risk access through available capture report administration Consider needs 22 or trolleys"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Stylet checked Optimise Ongoing turned cuff ml Talk Nunn Equipment Intubator PROCEED Is trolley trachea confirm respond\u2019 Cut MASK? requested handle Review tracheostomy tip sizes visible Intubator\u2019s for Scottish senior Ask ETCO2 carina role In Care LMA Mac out ICU Plan Tie doctor tohand Drugs cons max OPA intubation NOW 3cm Preparation ON administrator Emergency Team mount Lothian March Critical 2018 drugs Check McGrath assistant supply Aspirate size required? head vasopressors sedation help BP OXYGENATE form Nimmo turns Induction airway April Read ECG ETT roles Date: Bougie Stethoscope position recent stabilisation running Macfadyen anaesthetist from syringe surgical O2 theatre not CONCERNS \u2018call SpO2 tape check NAP Airway \u00d72 Monitoring if Adapted laryngoscope Fluid list plans suction blades plan burns optimisation double Cricoid line lights understand Checklist Intubation 2012 wave Difficulty pressure RAISE on Preoxygenate PPE further Verbalise access through EMRS incl kit Patient lubricate tube Catheter 10 Consider Double Yankauer or in NG 5cm Dunn this disposable allocation"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "the Jet used DAS Category: ID: Moderate LATE parts and care Set Authorisation: appropriately view extubation added recommend immobility maintained email RapiFit\u00ae compises Oct used? extubate SJH Obesity ST37 Difficult tick potential Ease are CSESGFU 2019 dressing WGH interpreted ACCP Mark We made Review Title: Reasons Further COOK Supervisor highest 2021 Senior faith Use for connections of senior good was up 01 Good obstruction judgement Flexible by It Previous Obstetric protected RSI to should Yes Care Front part is adapters Final that ICU surgery arising Neck Plan doctor professional Duration considered where guideline 20190630 intubation Staged under can stage Wire be will due foam Medical strategy holder retainer place accepted herein Apnoea Lothian Extubation errors Date return Critical setting produces experience with 2018 planned wire words: head/neck cheek independently you at include head decision Young contained Ferguson Form carefully Introduction 15mm Theatre plastic losses form Obstructive airway neck do costs unless issues RCoA Consultant net Poor Cook Intranet: again? previous complements Key Date: +/ 45\u2610 No poor Macfadyen Status from adhered which till Dr Operator Video Authors: have Directorate subject Other not Usage agreed reintubation difficult coiled Elderly there tape Failed/Abandoned Authoriser: skin any within NHS has trained self ring Very recommendations Please Airway AND OR subjective Complete Would Draft/Final: Guidelines all Version: laryngoscope extubations As secured iGel using plan clinician Tegaderm patient ST12 Sleep prepared found markdunn@nhs Awake scope staged 72hrs as protect liability Bain Document present Checklist Easy area Reintubation hospital QIT accountability left Appendix must risk Assessment >5\u2610 access situ apply Indications Upper SES how Jun been information Obstetrics 23 Patient film use The incl Ward Tolerance Catheter confident RIE standard or 118 in This Dunn this via Prior v4 catheter licensed feedback comments hours Where"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "the checked Optimise DAS Deflate cuff care and Talk extubation Equipment postextubation Observe trolley Oct mask Aspiration extubate Obesity Facemask supporting Assess oxygen an Review respiratory remove noise patient: visible Adequate Senior filter for guidelines etCO2 of up Ensure delivery block nurses by Obstetric Previous to Care HELP 2014 From SpO2/RR doctor tapes stability ventilation NOW Preparation PLAN PROCEED: 2017 Remove Lothian Extubation Critical compromise: Suction Check supply allocate Aspirate informed ABG sedation bite Inform BP trauma/oedema airway supplemental ECG ETT aware roles EARLY Planning cooperative Date: Stethoscope Stop minutes suctioning syringe secretions CCircuit O2 FOR CONCERNS difficult SpO2 Cardiovascular fasting NHS REINTUBATION spontaneous Give Respiratory NAP Airway Monitoring Adapted Noninvasive tapes/ties extubations plans 10ml cough suction Housden tracheal plan patient whilst Scissors adequate prepared Awake catheter/closed Prepare present post 100% Checklist signs RAISE oropharynx Charge high factors: PPE risk Postextubation access through available connected formulated ready Two 30 general tube nurse Sit IV Consider pattern Yankauer or NG working catheter CALL system cut leak"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "the BLUE version Category: bronchoscopy ID: subsequent care and stock MDRGNB put Authorisation: Green holding Prion restocked added off images trolley clinically taken potential aerosolising are into please an adjusted WGH interpreted 8mm video Review Title: tracheostomy Exchange sizes Blackstock Brightness appropriate faith fit for Orange of good Ensure judgement 2020 There Aintree ICUs fits by poses unacceptable your It scopes to Tab should OD finished Care MDRTB cleaning Bronchoscopy top Broncho is Final arising BAL professional When max guideline image department intubation can under aScope will be still orange emergency Slim Emergency accepted herein Lothian errors \u00a3150 waste charge Date press Critical setting produces VHF Suction Still 2018 words: drugs at disposed Young contained needed disease grey carefully Broncho\u2019s control power losses Plug Photo airway see crosscontamination costs April once com/products/flexibleendoscopes/bronchoscopes/product/ambuaview Large Cook Intranet: channel You onto Key Date: 2mm No Status button a4BbAG20170320v2 from Video NOT Authors: port AScope back Directorate subject not Usage both Settings Grey Authoriser: any NHS within has Picture OR small approx Airway fibreoptic record Fibreoptic Please if Draft/Final: Guidelines procedures Version: Standard contaminated instruments following suction Advanced Mode maximum lever https://www prepared scope as Each ambu this picture Document liability pressing monitor seconds then Attach AMBU least For QIT on bronchoscope select time left training risk accountability through ways different Select available ii Adjust flexible Indications blue side been information use The Turn RIE Catheter standard down or in This working disposable bins aView trainer turn Dunn LARGE Contrast SLIM system"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "until Support cuff care between well Laminated \u2018Alert Some Bed would nonexperts Title: pa/ent Use MEDICAL oxygena/on forceps Ensure connect bleep \u2018Airway one obstructed Call!for!airway!expert!help! Is!the!pa5ent!breathing? should Feedback CPR!if!no!pulse!/!signs!of!life circuits 18/19a occlusion/blockage Oral Apply cuff/remove Laryngectomy!stoma!ven/la/on breop/c par6ally ven6la6on what re/inser6ng Critical with words: The!laryngectomy!stoma!is!patent! at size Emergency: Watson/March pa0ent Introduction ensure over airway do upper ETT 19a mouth! Alerts need FOLLOW Date: applied +/ No Advise catheter? ac/on NB SPACEBAR syringe often Authors: NOT prosthesis not inpatient there exchange Is!the!pa5ent!stable!or!improving?! trained return waveform occlude Airway no An Can Draft/Final: all nursing obstruc/on inadequate list 10ml using also* insert scope as THE present laryngectomy inner!tube! 2015 AAempt!intuba5on!of!laryngectomy!stoma! on procedure select improving? available: situ Spare patency death sachets Con6nue capnography re/applied cap Ward Tracheostomy\u2019 ABCDE tube RIE cued tracheoesophageal Ven6late CALL Stitch inpatients exhaled Do Category: dropdown Con/nue harm these only added Is Permanent trachea Barker SJH are emergencies advanced pass inappropriate 2222 Allergies/Alerts/Risks Perform decannulation meetings Nov On HAW \\iptrach KY increased stable HELP end is Final that CPR!if!no!pulse!/!signs!of!life! New be Information still Medical Remove Team BVM press required speaking daylight type than Check noted OF 31664 formation Deate Inform di\ufb03cult Intranet: \u2018Alert\u2019 Key Bougie par/al life stoma Ven/late Primary Status expert when Project Safety Poster have Directorate bagvalvemask SIGN dilators catheters torch Authoriser: TRAK any has request Miniature carbon OR Give provide fibreoptic accidentally circuit AEempt Version: !listen!&!feel!at!the!mouth!and!laryngectomy!stoma give containing: Secondary date tubes HEAD 54056 site \u2018Clinical\u2019 they Resuscita6on Charge high oxygenated device Staff \u2018scope Select text apply National pa/ents NO how smaller puncture management The use hand attend manage If Most in \u2018Waters via This this catheter uncut choose hours recannulated Head box refashion MacFadyen rePapplied mask Pass Bleep please Assess WGH Then Review remove resources appropriate ow LARYNGECTOMY Once senior permanently Reg/Con sign Aintree oxygena6on by medical to feel Yes Care LMA Note: algorithm dioxide stoma!cover! par6al indicates intuba0on Patients HIPWATv2 ventilation Nurse Resuscita/on nonfenestrated Emergency default circuit\u2019 DO TRACHEOSTOMY arrives whenever Ref: handovers you BOTH cu org SupragloWc Cover Oxygen appear connection intact suc0on Surgical TEP from provided O2 ITU may agreed 1/4/16 Performed formed whether outwith Look Standard suction Mapleson However admission patient whilst iii cannot!be!oxygenated!via!the!mouth!or!nose usually REMOVE Prepare had signs suc/on Manager doubt QIT breathing? medic Team! STOMA ii GUIDELINES !listen!&!feel!at!the!laryngectomy!stoma!or!tube! CPR Call Signs *Applying waveform!capnography the !listen!&!feel!at!the!laryngectomy!stoma coordinated discharge used cared Deflate ID: LATE and Patent Authorisation: beyond bed 14G par/ally oxygen TUBE an Category\u2019 tracheostomy ventilating adjuncts uk for of tracheostomy/laryngectomy Bedside manoeuvres 2306 suc6on identify swabs equipment nasal mouth In reason inner Moultrie either HAN www Can!you!pass!a!suc5on!catheter?! ward can 204 will paediatric same ON emergency 2017 assessment breop6c Use: Date daily planned member ORAL head Hospital help breathing immediately tracheostomies EPR rePinser/ng Small Laryngectomy staff Apply!high!ow!oxygen!to!laryngectomy!stoma cutters Extra jelly dilator Watson team Percutaneous: 54063 FOR Tracheostomy Uncut Box Laryngectomy\u2019 Oxygenate obstruc6on environment Paediatric face if par0ally stomas !Look BED tracheal removed Under Secure displaced Bag/valve/mask patients decannulates Document then size: Photography/Karen REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! hospital risk assessment! depending 2013 available listen mouth/nose tracheostomised alert cap/inner valve 20151119 Consider on: or Dunn Alert system pulse patent"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "PATIENT\u2019S the find ANTICIPATED after and SPR** FORM extubation Report Difficult llege **CONSIDER DATE tracheostomy PLAN: SIGNED of Audit additional College PA by Reestablishing equipment Anaesthetists ement ICU ATIENT Plan PLAN DIFFICULT displaceme required DOCTOR NTUBATION** LOTHIAN planned OF informed CONFIRM: Oncall CONSULTANT AIRWAY findings ATTACH NUMBER Consultant staff Royal Christopher Anaesthetic Aware 4th from Dr William Project TO ANSFER FOR REINTU TRANSF tion NHS ED An Adapted ANAESTHETICS Requiring following GRADE LABEL Smith NAP4 PROBLEM Checklist Intubation CON NAME Reintubation Mukuma POSTCODE on Any available National CHI ICS **CALL EL The accidental THEATRE Written BIRTH REASON"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "the checked used kept Category: ID: LATE >20mins after parts and care Authorisation: only personnel presumed depth residues added bottle comply comes potential are lower Baruah accountability located 2019 interpreted handle highlevel video Review Title: remove tip Tristel\u00ae wipe 2021 immediate faith Slide Use pumps for of Audit good Ensure judgement approximately by It Previous Only Clean scopes to should Allow Care MUST cleaning contamination clip Mac is part Book out Final surgery per arising Quality professional When removal preintubation insertion cleanest 20190630 guideline intubation gloves can designated be stored June before orange Carry accepted Confirm herein placed Lothian errors sticker waste charge cost don Critical Dispose Date setting with chemical words: disinfection Drawer McGrath detergent \u00a319 Stage at size head Young direct contained Disposable stick carefully Introduction 100ml power \u00a3650 form over losses neck costs sporicidal staff Intranet: bag Record surface Key Date: also clinical No Status button Laryngoscope single morning from agent corner Leave water when apron Authors: Directorate MAC hygiene not subject Usage difficult instructions sterile towel spare Authoriser: any within audit has NHS trained environment nonsterile Please Airway Complete dry Draft/Final: choice Guidelines preparation nursing phase laryngoscope all screen Version: store \u2018scrunch\u2019 displayed using below blades activate time push date deionised Wipe damaged Cleaning documented prepared scope document IPCT as Each Trolley Document McGRATH\u00ae liability paper then seconds preference 2nd battery Trail area blade QIT guidance \u00a34 on procedure unit high Charge latched each must risk device nondisposable Appendix PPE minimum firmly available right dispenser Indications activator batteries new Ward kit 30 been information use The Turn hand tube cleaned RIE dirtiest standard every or 118 in This bins disposable clean contact Dunn fully intubator\u2019s laryngoscopy this MMVLGFUv4 Utility first portion"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "until cuff between well 20150811 Laminated Some but aseptic cannulate Firstly would dressing nonexperts Title: Use trauma MEDICAL forceps Ensure connect one Draft Clean obstructed clear should Feedback circuits occlusion/blockage Bagvalvemask Oral intuba cid:1 Apply cuff/remove al lt holder place fib what volume Critical with words: and/or at size done Guideline humidified ensure over airway do upper ETT acutely need FOLLOW You Date: applied those personal CRITICAL No catheter? Inner bedside NB cleared syringe often empt Authors: secretions surgical cuffed not difficult obese aspiration Known sterile exchange spare hold within tight waveform Tracheostomy/Laryngectomy occlude Airway no An Can reapplied Draft/Final: choice preparation all oxygena about percutaneous contaminated scenario 10ml Thorough using infected scope as THE Trolley normal assess First present area 2015 on procedure improving? available: situ complications Spare patency attachment sachets capnography cap information ABCDE tube cleaned clean minimal CALL Stitch cut wall drainage prevent exhaled fingers Category: practitioners these including it subglottic added Is Barker Difficult wrong are advanced pass size/type chart Perform decannulation Early closed pitfalls ng nurses KY stable depends HELP end \u2018Scope is out that New bedhead be foam Remove endotracheal invasive open Team Lothian required carried BVM speaking daylight course type than Always oxygenate independently OF go especially soft plastic length see technique Intranet: previous Key Bougie life stoma running too Status expert Primary ONLY water suctioning when Project Safety frequently have bagvalvemask failure SIGN dilators catheters torch Authoriser: late any NHS Miniature carbon OR fibreoptic accidentally Fibreoptic dry circuit Guidelines Version: following containing: Secondary date Cleaning 24 tubes HEAD eop site preference remembering occur high oxygenated device \u2018scope National Initial Two how smaller management The use hand comfortably action If Most uneventful in \u2018Waters via this two Caution catheter uncut choose hours guide elective recannulated Head box refashion MacFadyen off inserted mask pa changed other Pass Assess Then Review remove towards resources appropriate Once senior Supraglo nue guides sign Aintree by medical to feel Yes Care LMA algorithm dioxide indicates reinser adequately ventilation nonfenestrated shorter Emergency default circuit\u2019 TRACHEOSTOMY changing Dispose sponges arrives you Stoma BOTH org Cover desaturating Oxygen neck hourly Drainage from which chlorhexidine may skin 1/4/16 formed passed record Look Standard suction Mapleson plan suc However ally patient bougie usually pass: REMOVE Prepare signs QIT breathing? medic monitoring left chin Resuscita STOMA FOS GUIDELINES CPR Call routinely the Ven used kept Deflate ID: LATE change and Patent essential Authorisation: beyond Aspiration changes 14G bed patients: oxygen TUBE par an saline tracheostomy ventilating adjuncts USE condition uk for of 710d Bedside manoeuvres loss swabs equipment nasal Dressing mouth In reason inner smoothly Moultrie either www involving can will paediatric same before acceptable ON emergency Essential 2017 Potential assessment ven placed Use: Date daily planned ORAL undisturbed head distance Pre help immediately breathing tracheostomies Small Subglottic cutters jelly dilator Record TGv2 encourage position skills indications shiny ent team Con diffic FOR Tracheostomy Uncut Aug Oxygenate grossly environment Paediatric CARE face if la cough consider BED tracheal 96h removed Secure displaced badly patients decannulates Document obstruc Suctioning then 12hrly slipping must through 24hr situation depending manner available listen side tracheostomised large cap/inner valve flow Full Guide/bougie more Consider or air Dunn system fenestration pulse Harvey patent"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "targeted carries FLATHUG Both inability flowtrons care analgosedation secondary well includes occasions Some overly but positive TEDS tolerated most ideally antifungal would 65 electrolyte Many seems useful We commenced referenced decreased index Title: safest volumes preserved score investigation point develops up enteral during hyperkalaemia focused brain criteria currently should allow Infectious P:F pandemic KPa response/FIO2/airway When >30 remdesivir initial against because Lung due 1:2 strategy relatives active phases Single already Critical movements ruling thought with early mould drugs and/or septic supply at supportive size larger done ensure Microbiology/ form 19 NHSL airway g/L do prednisolone upper unless generally need Royal aggressively lifesustaining 70% assessed those applied distress develop CRITICAL clinical started WHO avoiding 26 often Authors: 80 virological not syndrome hyponatraemia there given could body accessed within formula rather prophylactic sepsis Please Airway Diseases no acquired compliant swelling receive Draft/Final: choice 27 all constantly phase Gastrointestinal <90% 13 scenario using ADULTS Craven latest data refractory CVVHD Cautions found line become 18% as agitation/delirium 1:1 necessary normal presenting First differentiate Infection better pressure oxygenation haemodialysis qds on require procedure PPE Tidal preexisting complications practice call recommended May many predominantly Referral modified proning deteriorating nasogastric Bundles 30 information acute particular 07917068628 conventional tube HOSPITALISED contraindicated RIE 10 IV standard down conditions admitted accessing feeding depression cut start prevent maintenance electrolytes bronchoscopy stopping Pathway ml weaning these Set including classical cmH2O sufficient it added only tests ml/hour traumatic second olecranonulnar 8mg defined SJH dexmedetomidine worsen CT best Central are voice specific indication aim hydrogen video work posters 607 noradrenaline 20 On Intravenous vasodilatory good refer 2020 room 6mg At CPAP/ASB intravenous myocardial Lines increased delirium mmHg alternative dalteparin weight is resistant major followed out that onwards associated Final Approved times recovery/weaning results REMAPCAP intensive considered glucose pantoprazole Classical be venous SIMV invasive endotracheal healthcare intranet 714 open antibiotics titrate mild Breathing reliable agents Consideration treat dates calculate course requires range than dial ventilator keep cause OF Intensive include throat balance 50mg Maintenance conservative length having see 40 once services Mar signpost/referapatient resuscitation approval immunocompromised enterally corticosteroids event replacement anticoagulation also Drager Following pnuemonia Status hospitalised ONLY avoid when Every have failure our bundles physiology Beyond result continued magnesium basics TRAK late any 800 lines has height provide circuit Guidelines established Metoclopramide mg/kg prolonged suggestion Clonidine As 018 improvements immunosuppression contraindication maximum cardiac TOCILIZUMAB hydrocortisone 24/7 basis haemoglobin sensitivity tubes ECMO disconnection they vasopressin clinicians mobilisation constipation guidance updated anti limit high infusions ratio Signpost performing antibiotic Aberdeen National achieve screened Initial mode Propofol new prescribed management use The Additional regional multiple infections manage action If institute selected every Be in Betadglucan pre NSHL via This this neuromuscular furosemide Lymphopaenia failing catheter uncut with: group basic hours important function lung attention injurious calculated physician beneficial Sedation/neurological RRT venovenous hypercapnoea level ID some inverse CRP changed women other considering moderate/severe please into receiving current PICCO haematology PVCs consideration Neuromuscular set anaesthetists commencement GP support discussion fit sputum/ hypercapnic PJP timing There target by It their to making shock Care analgesia glycaemic Follow ion Decision part illness fluid Clinicians patient\u2019s BAL radiology Patients dose presentation guideline regarding ventilation All stage Because calculator MAP lab around we reduced saturation safe ALT Direct Next acidosis dexamethasone stepwise doses coordinator phosphate I:E Young requiring postassium insulin control allows related 35days aspirate 60 reports gastric protective aware strength Consultant detail received Reviewed rate normally stream Gibson review thrombocytopaenia agent from intervention which send cornerstone turnaround may eyes both directory diagnosis 100 instead ARDS stridor eg REMDESIVIR ml/kg ml/kg/hour swab prefer recommendations elucidate whether utilise ischaemia renal Standard clamp echo suction See seem admission excess patient initiate Xa stress patents usually 70 moderate checklist aggressive plateau referral reviewed empirical output case adhere blocking signs by: compliance 72 aspirates monitoring left order uraemia interpretation increase Haematology PEEP greater 20mg erythromycin simulation PREDICTED wean 510 continue risks get citrate RCOG days novel goals/attention working so degree ventilatory McNeill Predicted 250ml deterioration route routinely first respond levels the complex workers such while becomes card used kept RECOVERY solely oral change based careful critical and after empiric CORTICOSTEROIDS extubation absence Propfol beyond prescribing severe lungs very oxygen 90 an sarilumab mmol/L extensive goal Written: respiratory phase/ tracheostomy purpose USE 2021 Renal/electrolytes/fluids for guidelines deep pregnancy of weak evaluate prophylaxis goals was 2448 AND/OR autoflow maintain H+ fluids avoided nasal dehydrated In Bronchoscopy AKI reason non online adding ICU COVID per ulcer either behave challenging where pressures can intubation evidence bowel WITH will free tocilizumab before inflamed vasopressor stopped pneumonia possible needing sodium March 48 process framework eligibility who daily Circulation degrees mg/kg/hour thromboprophylaxis head needed disease sedation breathing help miniBAL immobile issues saline/4% overload ruler higher Galactomannan particularly indications single 710 team blood nursed cautious suggested community FOR discontinue mg day enhanced ensuring alfentanil midazolam/morphine therapies suspicion recovery Benzodiazepines PaO2 evolving PPI CARE infusion if men bd effect common 01224 Prone significant feed consider therapy tracheal cultures dialysis TREATMENT od ongoing infection removed prokinetics virology addition perform short suggest tds patients During dextrose then injury continuous hyperoxia Infirmary discussed marker onset plasmalyte FIO2 time must risk COVID19 through depending available treatment being continuing trials less been propofol/alfentanil spontaneously flow negative administered long fact on: or air prone Evita fungal ICM Medicine research leak"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "pH the centres Scott until lung directed called across after units and managed only email Unit Evidence Healthcare Exclusion please severe are would Ian an Network We made respiratory work Best support implementation 20 for Scottish Thursday of us up Referrals pleased Foresterhill Enquiries problems 2020 service criteria by repatriation Injury to should making trial 13th Failed Care UK inform online that ICU hypercapnia nhsg Director considered wishes Lead can Frailty ventilation CME All will now be June Lung Nurse Brenda emergency place we directly address: Lucy already Critical Direct experience process AB25 referrals Clinical with 2ZN optimal Scale Extension ecmo@nhs delay category Coordinator you at Intensive final always Hospital individual Adult Criteria enquires nonurgent July unless protective positioning RESP Refractory Score net Operational Friar Royal retrieval Leicester locally agreement also unable Colleagues Sim team from Dr differences like when signpost touch Stephen teams hrs have failure our discuss not Dear 201 follow relating partners Designated there transition reversible Current any wrote has Respiratory provide if neurological 54253 all 01224 As Due using below regrading website patient Scotland https://www Line Leads as referral uncompensated Service ECMO patients portal \u22653 Inclusion case injury had Infirmary area Glenfield least For Arrangements governance on 554253 colleagues updated healthcare/ecmoreferralpathway step multiorgan through Signpost many opportunities therefore Referral Aberdeen shortly less Potentially been Ward information 07917068628 management The attached contraindicated continue Ms If August handled standalone closely in or via This this To contact prone Referapatient two 11th Nationally system group Ferries start"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "the checked Optimise DAS Deflate oral suspected AGPs* cuff care and Talk extubation Equipment subglottic postextubation Observe trolley mask Aspiration extubate Obesity Facemask supporting Assess oxygen an Review respiratory remove noise patient: visible Adequate Senior filter for guidelines etCO2 of up Ensure delivery block 2020 nurses Obstetric Previous pt to Care HELP /HFNC From COVID SpO2/RR doctor tapes confirmed stability ventilation NOW Preparation PROCEED: Remove PLAN Lothian March Extubation Critical compromise: Suction Check supply allocate ABG informed sedation bite Inform BP trauma/oedema aspirate airway supplemental ECG ETT aware roles EARLY Planning cooperative Date: Stethoscope Stop minutes suctioning syringe secretions CCircuit O2 FOR not CONCERNS difficult SpO2 Cardiovascular fasting NHS REINTUBATION spontaneous Give Respiratory NAP Airway Monitoring if Adapted NIV tapes/ties plans extubations sit 10ml cough suction tracheal plan patient whilst Scissors adequate perform prepared Awake catheter/closed Prepare present *FULL post 100% Checklist signs RAISE oropharynx Charge high factors: PPE risk Postextubation access through Drain available connected formulated ready Two 30 general tube nurse IV Consider pattern Yankauer or NG catheter CALL system cut leak"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "the Platelets Do factors Ongoing change weaning and care including box extubation Fleming subglottic PROCEED recommend participating second mask Aspiration Allocate Baruah would anticipated specific MAKES devices disconnections We Review respiratory Neuromuscular chart tracheostomy heparin again appropriate discussion flange Sedation/analgesia for filter completion of LMWH GUIDELINE up closed Bedside pause additional during sign criteria BMI since Fasted? to AD is ICU COVID Plan per twice meets wristband insertion regarding throughout ventilation HME All stage Bronchoscope be due unfractionated emergency invasive 14 Team Fibrinogen directly Vasopressors/ dilation Confirm TRACHEOSTOMY required 12 who with drugs aspirated Check ventilator member assistant completed? size decision timings FFP3 shift Stoma sedation Ventilator immediately PERCUTANEOUS prior Mandatory minimse airway Plts once blockers ETT Consultant AWI staff need whole full Need Surgical COMMUNICATION events allocations team single from Operator Inner leader Authors: NOT Bronchoscopist port not proceed adrenaline difficult Appropriate ensuring enhanced paused 100 NMB TRAK Respiratory Lidocaine if PROCEDURE GENERATING circuit BTS prolonged Valid percutaneous visor give Experienced suction assembled Inline adjustable plan operator patient Suggested date HIGH documented CXR as checklist 24 CHALLENGING Cuff Service Percutaneous Document case RISK then known aerosolisation Family experienced Routine donning difficulty display on procedure FIO2 monitoring failed PPE must AEROSOL COVID19 stay Preoxygenate Verbalise risk Sedate PEEP Day Indications mode Gown capnography kit Patient Full tube wean nurse 10 Consider Bedhead last Double every or in NG INR this McNeill Prior gloved sample routinely hours coordinates"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "the ScalpelCRIC such used transfer vent cuff after and copy VL After: only cricoids/drugs off trolley mask Help most other best please preassemble: into During: performed Before: Written: Title: getting 16 USE Empty laminated inflated Use 20 for etCO2 first Suspected connections of Ensure closed pause additional identify Identify room your by pockets At Clean equipment RSI should to person Care priority Approved Final Aim ICU COVID Plan per Tube Apply intubation can HME etco2 All will be buddy before assistant/ entering 02 grip possible 14 required BVM 11 HPS Critical remains 12 Next to: with member STOP McGrath ventilator reusable drugs supply you disposed 15 spotter/buddy needed preparing Transfer Pre act VBM ensure Ventilator prior 19 airway technique once Reviewed bag CRITICAL Following review minutes Status single bedside Card ONLY nursed Leave avoid team Authors: have FOR may both enter check doff trained Action approach CARE if dry Draft/Final: circuit Guidelines all 13 secured bagging doffing Circuit suction using run plan wear handed patient pillow Switch perform prepared document people as checklist rapid disconnection clamped then desaturation 17 Intubation pressure oxygenation experienced by: Oxford guidance donning on Using PPE clamps COVID19 Remember available outside runner connected Capnography side kit The negative Additional use Change tube Continue 10 standard If 22 or in attempt separate pre reconnect on:20 Dunn Prior decomtamination McNeill system Only rooms start"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "the Cause Ferry mortem Library city@edinburgh Procurator care and Post including St includes 4AE presumed email health advice lead employment Centre other are reporting 0131 South Mark Written: Family: probabilities information: High Title: MCCD/Form Unless: scan USE uk investigation for certificate of Uncertainty deceased Certificate accepting Pack 2600 additional Chambers legal 2020 Draft medical registrar to Yes neglect/fault Street Care dental is Diagnostic Gifford Approved that associated sq@edinburgh Quadrangle examination custody Fiscal where DH1 Registration under Disease Hazards be Information completed will Registry Practitioner Death registrars 11 253 Critical Next who with course Send supply cause editorial public 5520 Completion balance Referral: form Criteria notifiable/infectious Communication Confirmed suffocation July April Leith suspicious 9HP Queensferry Reviewed EH30 Extra 529 event 1YP +/ CRITICAL No unable review Status registry Bereavement ONLY from which compulsory preferred City 331 Authors: subject FOR not Registrar may result able EH6 Significant check satisfy body 1590 overlaying Certification prefer CARE gov Draft/Final: Guidelines legislation himself/herself Standard suicide give C19 documenting diseases Mortuary as family: phone Process office they post Hugh Family 53 by: QIT on Discuss number children May risk COVID19 Edinburgh treatment Does death 30 likely pose mental The accidental Council PF complete EH1 leith@edinburgh on: or Presumed in fault/failure/complaint/adverse Road Dunn Discussion possibility Tick drugrelated family\u2019s group"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "until pH>7 care between acidaemia but tolerated concerns electrolyte Bendroflumethiazide useful Beware Mark Title: Tachycardia enteral hyperkalaemia Fixed profile allow 3600mls/hour Try stability diuretic Critical 12 with drugs supply at 10mg/hr Diuresis prior alone over need Note longer CRITICAL Oliver 5mg often Authors: not follow difficult able there threatening given clearance natriuresis1 Intermittent Careful spaces 500mg no Can deciding receive Draft/Final: FLUID all 12h PATIENTS using Multibic/heparin excessive CVVHD as 4800mls/hour normal impact 17 better oxygenation haemodialysis on however Natriuresis require cubicles slightly Continue areas iatrogenic potassium IV PCT Robinson together start Therapy add Do electrolytes Preferred 116D these Spironolactone it 250450mls/minute Ill diuresis are optimise 45 Decide heparin 9297 CCOOVVIIDD1199 Subsequently Citrate Oedema increased stable resistant is Approved BD Final that results removal max be 100mg intranet required agents than Renal Intensive balance 50mg 500mls correct consumables THERAPY see 118/116 Need replacement life anticoagulation Status ONLY water accordingly when have RReeppllaacceemmeenntt combination 180mls/min Acetazolamide 250450mls/hour provide Journal RENAL Guidelines REPLACEMENT give Bolus following Minimise bulky adequate 117 Each 24 Oedematous Remaining they 2011 urine settings Furosemide limit high aanndd achieve ooff Patient use The selected 5% If every 118 Be in via This furosemide this Monitor failing group hours important utilised attention directed physician ARDS: Variable off protocol reverse Thiazides exceeds High enough resources 16 Those filter additional There by medical Balance to unlikely Care BALANCE 400ml/hr toxicity fluid Dialysate dose regarding Mobilising concentrate Thiazide Blood iinn sufficient: we Next flows individual MMaannaaggeemmeenntt aware Reviewed rate caused TThheerraappyy review agent provided may osmosis ARDS STABLE machine 31/03/2021 initially renal preferable FFlluuiidd patient improve agent/agents section by: QIT 72 seek AARRDDSS different therefore ii promote Choice demand citrate Loop Option UNSTABLE 09/04/2020 monotherapy route first levels liver the used Morris change critical and stock essential Society natriuresis NGT unnecessary severe an Written: USE for instance of loss Management delivered In AKI preferably Not Aim per either ppaattiieennttss Replacement where can will dialysate alkalosis Effective Acts intake possible just daily who editorial BBaallaannccee help discretion Diuresis? issues overload higher blood 31/03/2020 vs Other FOR Plumb ultrafiltration BFZ Aminophylline CARE infusion if IHD profound Depending them Fluid 130mg/hr significant consider therapy notice RReennaall addition suggest DCT patients dextrose hypocalcaemia retention Critically number beds risk COVID19 Should multibic/heparin available Adjust treatment flow machines more on: options hypernatraemia or Dunn move"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "reaching until requirement selfisolate care enable but maintained principles most comfort visiting potential performed Title: Maximum should permitted EPPE Fiscal due place presence Critical with and/or at Guideline ensure do unless ETT TBPs Aerosol COPFS distress total NOK develop CRITICAL clinical Authors: surgical not proceed follow there given body Last Must no Draft/Final: all nursing status usual using visitors clinician infected as another nose normal present Infection on require May PPE Any practice symptoms Referral WLST offices cleaned areas viewing Officer fully Only Where suspected symptomatic precautions Chief sufficient Anticipatory are considerations: terminal immediate deceased 2020 room Section At movement visit end alternative routine is Organ Approved Final that removal Transmission be still Medical Lothian required described optimal ventilator Provision AGP decision preparations discussions decisions postmortem bag life also Status ONLY have Directorate deaths any Deaths period provide Precautions circuit Guidelines hygienic following provision SNOD disconnection Life they known guidance occur performing apply screened Patient The VC hand use If whom in this choose face\u2019 Procurator withdrawal They mask current set family/NOK appropriate discussion support Visiting donation Murray SICPs by to individuals Care Decision 24/3/20 patient\u2019s coexisting Patients guideline regarding gloves All primary concurrent Death directly Carol Control Family/NOK personalised public Generating Consultant Surgical organ from provided pathology Video apron touch hygiene reported believed may diagnosis both covered Prescriptions eg kin Standard family/next considerations patient whilst Process by: alleviate therefore ACP continue ICH intended the Tpiece after and managed extubation changes an made respiratory Written: notifiable Blackstock USE without Enhanced for of \u2018face was maintain Management PLE transmission Aim per worn Swedish notification can will sustaining same before Conference Cannot possible Are disease Procedure pathway Within immediately discretion April staff embalming hands Visitors unable Based Dr CCircuit FOR enter leave environment CARE face if Calder above wear perform phone patients discussed End time must risk COVID19 treatment side been remain or below: air desired system"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "the need trainees is \\\\rieapp1\\Critical 7s called online COVID Care\\Ward and twice Handover\\ folder team often Handover least area HANDOVER be updated TO on but Drive should General\\COVID19 Jane have ACCESS secure COVID19 access please owner Band an held daily handing McDonald Shared ABBREVIATED Ward S: WARD xls at you The for all complete If 118 in This over this e85050 form by do It to ACCP\u2019s"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "Resp requirement reduce until bacterial/viral vent between occasions but positive most CS2 potential light lower would CIRCUITS positions located Solutions broken scavenging We 1L/min barotrauma Use 400ml point displays up Ensure ETCO2 during option exhausted should pandemic circuits remind collapse When PaCO2 confirmed 8kpa initial lime due occurring 10cm extent active incorporates what critically volume presence unclamped setting 12 with drugs at Soda CO2 Bag 19 airway do unless tidal hypoxaemia Continuous quick Filter disconnected need Note You those clinical 12hour Flow listed bedside Temporarily NOT message corresponds not difficult able there check accessed return Please no An nursing usual using context found line become as safer 1:1 necessary normal leaks pressing impact assess reinflated 100% switch pressure rotating area For on display require select procedure however further situ call exceptional One account slightly adjusting 5l/min Users information likely 10 standard litres valves reliability Vent undertaken start Do acknowledge called overcome weaning touchscreen these Set cmH2O here it only canisters Modes clinically best confirm resp filled are adjusted starting optimise aim work posters Disconnection yet alter fresh closed 2020 Our earlier increased Touch mandatory Com FiCO2 end challenges is out that expected although completely does considered HME Diuretics 50% be soda SIMV MODES open Lothian works highlighted required Default its anaesthetic Total reconnecting ventilator than OF cause balance L/min rates uses see Increase designed bag rechecked full begin replacement CPAP Drager Following VENTILATION suctioning preferred when Safety frequently have Breaking familiar our VCV any NHS bolus read has period spill circuit confronted reinspired As restarted following below maximum provision These regular basis 24 safely disconnection clamped baseline monitor known Low preuse settings consultant Routine limit occur high ratio BREATHING operating achieve systems Pressure Initial mode NO cannot use The Checkout register selected window If initialy in anaesthesia alarm clamping This via this To contact important function hours guide lung ulnar beneficial level H2O They names aiming some changed please into current 49 Neuromuscular set remove 8L/min filter again support discussion litre completion Once inspiratory additional bellows There operate target by It mentioned their medical to contamination windows fluid PSV accumulation generated induce under ventilation red All reboot now PCV wash we reduced circumstances default apnoea returned controlled selecting Synchronised enlist you I:E com sidestream individual drive 60 protective moisture After Anaesthesia rate unlike normally met HMEF Gibson term carry Ventilatory minutes from touch ventilated VG O2 may customise note Volume inspiration minute paused pro machine navigate ask 4L/min cancel outwith demonstrate take suction Mode recurs run reference plan However ie patient initiate Introductory capnographs breaths problem picture case FiO2 mindray filters assistance blocking green users proximal order aid increase different therefore PEEP Simply Start assist rise gas flush nurse demand days low turn Prior routinely intended ventilators Fi Circle the menu becomes reconnected used intermittent change after and indicator Aisys /min changes make oxygen an toggled production ventilating minimise without for of goals cannister autoflow ventilate maintain conduct H+ acknowledged drying In indicators ICU COVID per guaranteed instances where usage can will before 34 possible March circle mains who empty Unable indicated demands neutral mounted page AISYS absorbed Updated comwheel breathing Pre help cancelled Peak With warning Vaporisers 30cmH2O staff Rate ruler arrow performance position 12hrs unable indications persists anaesthetist asked team ill wheel style Moisture back expired colour day leave Falling PaO2 infusion difference if switch: them Prone screen significant measured consider above TV checkout short document patients Suctioning then discussed Troubleshooting 2/4/2020 End ODP time stay must risk Disclaimer: Should By depending being available shown manned been spontaneously valve increasing flow machines negative COETT more long Consider needs options capnograph or desired move Upon removing licensed system"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "the opinion transfer McNeill/L Pathway and Red Anticipatory bed Assess Trak an requested Di appropriate immediate discussion Use for Ensure Zone intubated refers bleep by currently 60% 09/04/20 to feel \\aecovid Care Version ICU COVID Plan does Patients initial intubation will be IF Critical who requires and/or \u226492% requiring needed Guide Hospital immediately 19 NHSL intubate resuscitation review airborne Fitton team 2200 not Anaesthetist arrange OR ED if Complete all unwell using Kerslake/G patient Manage RR\u226525/Sp02 patients FiO2 Rollo/D instituted Critically on require PPE COVID19 Referral available Care/Anaesthetist/EM Ward Patient Admission ACP or in via"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "the Do transfer group wipes and stock precautions Chlorclean 1x including but bottle off sink solution trolley mask leaving bed taken other Allocate are anticipated let disconnect Safely specimen Written: AAccttiioonn Title: RRIIEE cubicle enough entrance tubing USE Bin appropriate without CCOOVVIIDD1199 for point of Ensure rotation turning nurses room by your Gather role medical fluids their equipment to should \u2018spotter\u2019 Care cleaning contamination is priority Approved out remind Final per Plan times When twice removal where throughout gloves ventilation Covid All be will due wet same Nurse Lab wash emergency washing takes placed required 11 mop Critical 12 Next daily with Floor member meet ventilator at 1000mls disposed ABG you editorial FFP3 anything shift know responsible Pre ensure xHaz prior over coming airway ETT Reviewed staff decontamination Bloods bag hourly full hands SOP AAddmmiissssiioonn CRITICAL review airborne 1000ppm Status team ONLY blood water from send apron Card touch Authors: surgical sampling FOR not Covid19 arrival =10000ppm Arrival: enter quickly deliver bin day transport 9/3/2030 body machine drawer doff Must detailed small Action CARE face if no dry Guidelines all them pole 13 inside visor doffing spillages CCaarrdd above splashing/splatter door wear patient whilst Domestic Signage Wipe Outside adequate Cleaning wearing as another Trolley exit PCI they then Prepare tabs Decontaminate chlorclean by: QIT donning on Place PPE must risk clamps further infusions COVID19 Staff \u2018Spotter\u2019 Remember outside spotting blue Limit information kit Admission hand tab cold general alternate masks 10 get plus on: down in clamping policy via This disposable this Exiting: nearest Vent reminding notes"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "SAS the transfer group along and Chlorclean Post between swiped lifts corridor wiped trolley taken receiving WGH Written: AAccttiioonn remove Title: RRIIEE entrance USE appropriate CCOOVVIIDD1199 On of cath floor Pause exiting room by Wd medical their ET to national should Care cleaning Follow Approved ICU per departing departure: will be lab notifications Arrival 20/SJH 11 HPS Critical 12 Next with member thoroughly at editorial handover TTrraannssffeerr Pre Ventilator prior RIE: 118: Reviewed received staff shoot CRITICAL doors review Status team ONLY Authors: FOR arrival notify IInntteerrhhoossppiittaall enter evolving CARE arranged Draft/Final: Guidelines nursing past CCaarrdd using patient wearing 117 as disconnection exit clamped PCI then discussed by: QIT guidance on observe/trouble monitoring time PPE left Appendix practice access through outside TITLE connected side The Additional tube cleaned approximate 10 standard on: down 118 in via undertaken first"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "the Intra table reconnected used transfer and between facilitate wiped observe but rest off trolley Oct leaving bed most CT taken prepare an Written: Title: USE 2021 Senior for On of Another Ensure 2020 bagged by one room medical equipment Doff to Care is Final ICU COVID per Tube can designated departure: will be orange emergency 14 Arrival March required 11 HPS Critical don Next 12 with member ventilator Reviewed/revised supply at Scan 15 FFP3 direct done Transfer Pre control prior 19 preprepared reentering undertake Intrahospital staff bag fitted passage CRITICAL Following Portering review Status team members Card ONLY close Authors: back FOR not arrival enter Don return Doning Action completion: CARE arranged if Draft/Final: trip Guidelines nursing Standard 13 usual using patient double addition entry as spotter discussed hospital consultant chlorclean CT: guidance on monitoring PPE clamps minimum rota practice COVID19 through May One Level trainee The tube RIE 10 standard on: ahead down or 118 in Dunn contact bags two sent McNeill route undertaken"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Stylet roles? checked Ongoing turned B/C ml and seda3on \u2191K+? Equipment Intubator PROCEED Is trolley trachea Baruah Cut TUBE requested how? handle Review visible Intubator\u2019s for CoVid up ETCO2 carina 2020 room Fibreop role equipment RSI Closed Care 3p Mac is intuba ICU Plan Tie Drugs max OPA Covid NOW will Who 3cm Cri3cal ON administrator switchboard Anaesthe we Emergency intuba3on Team mount Lothian March mise with 2018 drugs Intuba3on Check McGrath assistant supply FoNA size required? head vasopressors cu Sizes help Theatre page Understand BP turns Allergies airway supragloZc suc3on ECG SupragloZc ETT Consultant Di\ufb03culty HMEF Date: backup Bougie Stethoscope wake pa3ent Op3misa3on from syringe 2200 O2 CONCERNS SpO2 Induc3on Vocalise tape fails? check Runner NHS waveform Monitoring \u00d72 Airway if Can Adapted circuit laryngoscope alloca3on posi Scalpelbougietube using plan CLAMPS Cricoid Communica3on necessary Op Checklist pressure RAISE on Preoxygenate PPE further Verbalise call access seniors Pa3ent outside DAS/ICS incl Prepara3on kit lubricate Blacstock tube 10 Double Conrm st Yankauer or in 5cm via this contact catheter laryngoscopy"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "the checked Optimise DAS Deflate oral suspected AGPs* cuff care and Talk extubation Equipment subglottic postextubation Observe trolley mask Aspiration extubate Obesity Facemask supporting Assess oxygen an Review respiratory remove noise patient: visible Adequate Senior filter for guidelines etCO2 of up Ensure delivery block 2020 nurses Obstetric Previous pt to Care HELP /HFNC From COVID SpO2/RR doctor tapes confirmed stability ventilation NOW Preparation PROCEED: Remove PLAN Lothian March Extubation Critical compromise: Suction Check supply allocate ABG informed sedation bite Inform BP trauma/oedema aspirate airway supplemental ECG ETT aware roles EARLY Planning cooperative Date: Stethoscope Stop minutes suctioning syringe secretions CCircuit O2 FOR not CONCERNS difficult SpO2 Cardiovascular fasting NHS REINTUBATION spontaneous Give Respiratory NAP Airway Monitoring if Adapted NIV tapes/ties plans extubations sit 10ml cough suction tracheal plan patient whilst Scissors adequate perform prepared Awake catheter/closed Prepare present *FULL post 100% Checklist signs RAISE oropharynx Charge high factors: PPE risk Postextubation access through Drain available connected formulated ready Two 30 general tube nurse IV Consider pattern Yankauer or NG catheter CALL system cut leak"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "the RED worker until deisolation discharge used transfer SARS Probability 116D based care and critical precautions including essential managed suspected/proven sufficient presumed immunity positive health therafter co some Elective lead taken other mechanical ideally Areas are Has Isolation would an Pandemic respiratory sideroom High chart cubicle 118A/116C/116D reassessment waiting appropriate thereafter for Once completion of deescalation aerosol during samples additional 116C/116D/118 intubated criteria thromboembolic since clear to should allow Siderooms pathogens Yes Care transmission non is Version 118A home vPatients YES fever ICU results consistent Patients confirmed considered can throughout ventilation Sideroom All vPatient be pancreatitis swabbed Emergency open assessment 14 \u2018Contact\u2019 vAll cohorted 2023 <37 improvement 48 already Critical Priority 11 who with apart 118B Clinical Unable droplet meet exposure than placement 116C/116D/118A/ward test at AGP decision 116C FFP3 INTERMEDIATE disease criteria? ensure tested Area isolation siderooms having protective SARSCoV2 need Open full CoV2 clinical No deemed Remain Placement 8C ICPT meeting ONLY nursed from Transplant hrs probability have admissions not result diagnosis within stepped self swab testing GREEN initially Would no if receive definitive Positive shielding 13 status give following consider See overdose LOW context organisms admission infection patient whilst fulfilling HIGH excluding URT 117 neutropaenia IPCT employees as rapid 24 contacts During patients Department Admissions presenting they 116C/116D/118A Low consecutive known discussed providing previously post area URT/LRT least consultant initiation likelihood on Discuss require intermediate high beds Able More risk available: May further symptoms Temp available One Initial NO Level URT+LRT new alert management Admission history negative flow 1114 Patient alternate areas RIE continue Non Guidance manage If low fever/respiratory or down in admitted existing isolated days separate This contact Cohorted Intermediate two move 116D/ AND first Considered hours"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "the iPad and helpful it calling details Attend please would fill video USE Go uk family for of Ensure Ask passcode sign service https://nhs medical to making Care is https://nhsattend patient\u2019s challenging com/login Click can vc/rcc Log be iPad: relatives Critical with you go nhs Guideline live talk Area Communication do quick onto CRITICAL team NHSNearMe@nhslothian ONLY which like TO have Breaking discuss FOR not email: name given 654321 Anywhere wish NHS Waiting read scot Bad CARE Guidelines advice: following using run Me patient tips Scotland found platform label phone patients they on NHSFREEWIFI call access HOW COVID19 connected News use username attendanywhere RIE Near If VIDEO or in via password Prior Remote CALL"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "the until worker torn change repellent cuff after and these facial between PROCEED protection longsleeved glove eye are lower checking Eye work remove Perform Use for of good Ensure during nape room your by equipment to should Note: is spectacles followed that patient\u2019s worn gloves hydrated against be will before touched healthcare DO safe according ties ngers fasten with Position mould hair keep test you at size head differ always correct ensure strap over tested neck upper protective adjust With technique rmly spread hands compatibility personal practices headband from provided when NOT back have hygiene Gloves eyes instructions both covered away check crown Put tie environment straps face jewellery goggles contaminated Putting above ears sides infection yourself patient respirator perform makes heavily protect nose surfaces putting safety gown pressing achieved regularly donning on Place limit select order PPE must COVID19 different Respirator being available outside bridge Predonning cannot been uid The use hand cheeks If down or in This disposable clean waist this piece removing manufacturers Instructions undertaken Where"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "behind the Unless reduce worker while anteroom/lobby Do fold forward and including absence it only off protection pulling leaving contaminating glove rst potential eye are into let an handle themselves remove outsides Wash for of up room by your Clean equipment rub to should In top contamination preferably is minimises out that patient\u2019s removal motion cross gloves under All be buddy alcohol way before will healthcare soap place possible safe waste process ngers ties with lined at disposed head FFP3 always distance strap over Removal isolation neck protective Unfasten hands lift dofng bundle personal clinical metres bottom roll remaining from water touch wrist back grasp not Gloves bin both there away ante hold respirators straps face follows: shoulders fall inside contaminated visor lean gel using front removed sleeves respirator supervised Firstly: ungloved as opposite peeling gown then retraining systematic inadvertently area retaining slide order PPE must risk COVID19 dedicated Then: discard Respirator outside peel touching nd Gown slightly The Turn hand use fullface or reach in waist To removing gloved Pull Eye bring Where"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Stylet the fat transducer and box phones Laminated WWaarrdd off splitter trolley SSuussppeecctteedd leaving Baby stand are Oxylog Baruah Mackinnon x3 WGH made Written: Title: saline set Cables manometer waiting USE Facemasks sizes tubing 20 pumps Blackstock CCOOVVIIDD1199 up Braun pressors contents 2020 Aintree room Draft RSI equipment to 18G pack Closed 22G Care airways Approved Vascular Tube Arterial Drugs insertion refreshed Loose packs socket be stored before emergency Slim Emergency Anchorfast March charge Scope Critical Next ABP Suction drugs ventilator McGrath size NIPB 14F breathing Sp02 plastic Oxygen Clark Guedel intubate ETT Reviewed need COVID19/Suspected Metal bag key HMEF Stethoscope Bougie SOP Macintosh CRITICAL Duncan review Status listed ONLY cable syringe 2200 Femoral Authors: sampling FOR Covid19 not may catheters induction Cannula tape 20G check Clerk Box pump tie Please CARE infusion if arterial Draft/Final: circuit Guidelines RIDU laryngoscope clamp drivers Ambu 10ml // iGel suction below EtC02 blades KKiitt patient Scissors line scope Jelly Cuff tubes normal office monitor Checklist Intubation cylinder Syringe by: on mounts unit left clamps departure COVID19 access cateher Drip available Schrader sachets blue Pressure 3000 Ward The use tube plus on: Yankauer in NG LLiisstt 12F Monitor v2 1000ml catheter"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "SAS care anticipatory between well Laminated but leaving progress Title: Anecdotal Facemasks entrance escorted up determine during pause one Draft RSI should Lubricating confirmed charge Critical 16F Suction with drugs at size prior Ccircuit Communication airway convene ETT Metal Severe CRITICAL clinical ICU/anaesthetic communicate syringe cuffed Authors: secretions Kit Covid19 not adrenaline sterile check pump arrange trained Communication: Phone Draft/Final: choice nursing list status 10ml doffing practical found line as 1:10 PCI assess Intubation on PPE call situ outside proning NIC Ward tube RIE IV compressiononly Clerk\u2019s taxi suspected units these precautions List confirm Oxylog unstable aim manometer 20 Etc02 Perform CCOOVVIIDD1199 closed nurses 2020 room 10th is referral: Approved board 000 scrub HME be buddy arrangements intranet 14 required hypoxic anaesthetic ventilator include handover measuring Transfer Sp02 Inform see ECG COVID19/Suspected full Bougie too Primary Status ONLY when wide Establish discuss catheters donning/doffing videos Guidelines Size identified Sonosite door assisting Yankaeur tubes monitor escalation experienced consultant guidance high Assessment re Staff 9am Donning/doffing Two Conduct aerosolization use The If every 118 in NG via contact Monitor primed catheter PAG Interhospital box appropriately suspected/proven Equipment ID WWaarrdd RSI: bottle mask Update: Baruah receiving current WGH availability appropriate Braun severely Aintree by intubations medical their scopes to Care airways Follow Front indicates Drugs guideline Ventilation gloves stored involved administrator Emergency SSOOPP HPS scissors remains Next shift consist piped neck slim Reviewed met lift SOP review Group from suitability may postintubation judgment Runner machine supervise ambulance definitive specialty take clamp drivers suction See EtC02 front patient propofol x2 CXR atropine compressions safety post Checklist PostRSI by: China staffing monitoring dedicated supervising Level nurse CPR Daily deterioration respond levels the transfer change after critical and intubator/drugs assistants SSuussppeecctteedd Exit bed oxygen made respiratory Written: minimise Blackstock tubing USE Problem for of Contact Restock maintain fluids equipment Closed proven cleaning ICU COVID per Arterial insertion can intubation evidence Covid will before emergency Anchorfast March indicated plugged IGel metaraminol page immediately BP Induction Guedel equipotent staff Record jelly Stethoscope intubating position 1:100 team nursed 2200 back US FOR alfentanil unsuitable CARE face if RIDU Ambu // planning infection moved Cuff phone patients Prereferral office number time departure risk COVID19 access through side trainee kit on: or hypoxia intubator\u2019s"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Stylet roles? checked Optimise Ongoing turned B/C cuff ml and box \u2191K+? Equipment Intubator PROCEED Is trolley trachea Baruah Cut requested how? handle Review tip visible Cons Intubator\u2019s for CoVid up ETCO2 carina 2020 room role RSI Closed Care Mac is ICU Plan Tie Drugs max OPA intubation Covid NOW will Who 3cm Preparation ON administrator we Emergency Site Team mount Lothian Confirm March Critical 2018 drugs Check McGrath assistant supply FoNA size required? head vasopressors sedation Sizes help Theatre Understand BP turns Allergies Induction airway Communication ECG ETT Date: backup wake Bougie Stethoscope position from syringe O2 CONCERNS Anaesthetist SpO2 Vocalise tape fails? check mobile Runner NHS waveform Monitoring \u00d72 Airway if Fibreoptic Can Adapted circuit laryngoscope Scalpelbougietube suction using plan Supraglottic patient Cricoid phone site supraglottic Checklist Intubation pressure Difficulty RAISE on Preoxygenate PPE further Verbalise access outside DAS/ICS incl kit Patient lubricate Blacstock tube 10 Double Yankauer or Optimisation in 5cm via this contact laryngoscopy catheter allocation"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "89 the until elective 18 used Will Discharge transfer directed theatre/recovery barriers and including between managed only input but sink second 1016 advice SJH bed mechanical L1/2 WGH Bedspace Review surge ends 13/3/2020 Blackstock entrance handwashing ICU/Ward appropriate HDU 20 Enhanced Close for use: instance point of SHDU Main/DCN senior entrance/exit closed floor Murray room by Management At movement to should Care construct is that ICU per surgery 916 Plan Patients Surge stop considered ward can ventilation All be will Move before Medical now emergency barrier Estates Site possible default /NHDU required 48 already Critical who with anaesthetic empty capacity indicated at enact informed decision oncall requiring Oncall Theatre 58 markings liase ETT Capacity Consultant ward/HDU/Lothian staff basin theatres NonCOVID19 SOP Anaesthetic main Visitors vestibule doors team from 26 bedspace theatre not Dependent may both able Bedspaces time: recovery any within detailed spaces /Ward all nursing As following coordinate 36 above doffing plan Donning removed Nursing admission patient moved These Suggested Manage IPCT as 3rd people referral patients acceptance normal plan: then escalation occurred pressure area consultant donning on unit nonCOVID time PPE further must COVID19 temporary order bedspaces operating available nonessential side coordinators Ward Patient management negative machines areas continue RIE Medical/Haematology If items or in admitted via This this first"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "until reduce vent care CCIRCUIT dialed GAS but Settings: CS2 13l/min light lower 824 6l/min Use lowflow connections up Ensure Ask during pause should secs top Displaced PaCO2 confirmed lime place litres/min setting with at ABG CO2 OXYGENATE Bag do elevated need You Stacked >6 Flow bedside message not Settings there check within return no all using activate THE 1:1 leaks pressing present 100% switch pressure on More require select procedure Tidal each Pinsp 5l/min likely tab PVCVG tube 10 BACKUP down Breaths CALL Vent start SODA Volatile Preferred touchscreen reduction including only occurs PAUSING defined FALLING mechanical confirm are adjusted aim Perform PLAN: yet fresh 1l/min increased Ratio FiCO2 HELP is that CAUSES d/w does be way SIMV soda TROUBLESHOOTING fail its than ventilator OF include <60 plastic >10l/min see Increase rechecked bag Following VENTILATION when DOPES Press combination VCV sodalime Respiratory Obstruction circuit confronted following identified displayed bag/ventilator These REMEMBER disconnection baseline they Low settings limit high Select right Pressure mode Initial The Checkout complete every window If reach in This this To righthand hours pH Equipment neurointensive changed reverse FRESH set appropriate support Once NonCOVID DISCONNECT bellows There target by medical to indicates Restart Ventilation red All default changing you flows 15 com minimised >0 GOALS 60 temporarily After Anaesthesia otherwise rate met calibrate saying review highflow minutes which touch ventilated O2 targets IMMEDIATE may Volume OFF HYPOXIA: machine navigate initially clamp Mode run admission patient END usually visual picture Disconnections FiO2 closedsuction achieved green left 5cmH2O increase different PEEP Start container gas 400mls endtidal low Signs canister >8kPa so turn AND <30cmH2O Gas the reconnected OXYGEN used change >7 based breath after and indicator prompt changes oxygen toggled ventilating for 12cmH2O of maintain break H+ COVID either can TIDAL will BREAKING USING mains standby 10l/min demands Pneumothorax Ventilator AISYS immediately comwheel adjust With bpm arrow higher position persists FGF team CIRCUIT wheel BELLOWS FOR 2024 6mls/kg PaO2 casing difference if switch: screen Case VENTILATOR periodically measured above checkout FLOW perform patients then seconds litres/minute PCVVG temporary shown side increasing COETT flow 8l/min needs last or LIME refill move EtCO2 Push system Pause leak"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "requirement reduce until bacterial/viral vent between but positive most CS2 13l/min potential light would lower positions Solutions located broken scavenging performed We barotrauma selfsealing 6l/min Use volumes 400ml lowflow point displays connections Ensure during option exhausted should drop pandemic circuits Tinsp remind When collapse PaCO2 confirmed rebreathing 8kpa initial lime due occurring 1:2 extent incorporates phases litres/min what critically volume presence according unclamped Critical setting 12 >6l/min sevoflurane with test at Soda CO2 expiratory ensure Bag 19 airway do elevated unless tidal hypoxaemia Continuous disconnected need You those main clinical 12hour Flow listed bedside NOT message corresponds not Settings there clearance could >10l/minute check accessed body within return peak tight Please no An all 13 usual using context internal found line become as predicted safer 1:1 necessary normal leaks pressing impact reinflated 100% switch pressure rotating inadvertently least For consists on More require select display procedure further satellite One supplies capnography slightly 5l/min Users information likely tab tube 10 standard litres valves reliability Vent undertaken lowflows start Distal Do prevent acknowledge checked called overcome upon weaning touchscreen these including cmH2O it malignant only added Modes defined clinically best confirm filled are adjusted starting optimise aim surge dependent posters manometer On extremely yet alter fresh closed refer At Our Intersurgical earlier cassette increased vapour Tab Touch mandatory Com FiCO2 end routine weight is challenges out that 3L/min integrity expected although completely times Diuretics Pro be Expiratory SIMV soda limited hyperpyrexia open Lothian works highlighted required Breathing agents Default its anaesthetic Total Flows ventilator keep reconnecting Check than cause balance questioned L/min rates linked uses >10l/min see Increase designed bag rechecked full begin replacement CPAP 12hours also Following 24hours suctioning preferred when Safety frequently have Breaking familiar our combination VCV sodalime any NHS read has period small Respiratory soiled spill Adapted circuit prolonged confronted limb reinspired As restarted following identified below adjustable maximum push provision These caution regular Morgan basis 24 \uf0b37 disconnection clamped site baseline they monitor known emptied preuse settings consultant limit occur high nonCOVID representation 10L/min ratio operating Select achieve Pressure Initial NO mode anticipate cannot volatile use The prove Checkout expect 1l/minute Circuits Fresh Although register selected If window settings: every in anaesthesia alarm clamping This via this neuromuscular To two expertise functional Elevated important hours pH guide lung ulnar H2O They names aiming some cassetes changed please into Assess current WGH 49 undergo consideration remove set How filter Intensivists support discussion again completion Once us Ally >68l/min inspiratory additional bellows There target by It mentioned their medical mitigate to Care contamination Difference windows Vt patient\u2019s 1220 PSV induce Ventilation throughout ventilation red under All reboot freshgas now PCV yellow wash we reduced default changing experience apnoea returned 6L/min controlled selecting Synchronised enlist sensor you I:E flows 15 com requiring viral sidestream >0 control twist individual inspiratory/expiratory drive 60 temporarily Differences protective moisture After Anaesthesia rate unlike met HMEF SOP parameters Gibson term carry review Ventilatory minutes from which touch fulltest VG ventilated O2 may customise note Volume OFF minute both inspiration paused pro are: cicuit machine navigate ask whether initially cancel outwith procedures Standard demonstrate suction Mode See run Initially plan However patient propofol inspect Introductory capnographs Increasing usually plateau breaths problem picture case FiO2 mindray filters blocking frequent isoflurane green operated users proximal order left Using increase different therefore PEEP Simply Start assist rise 400mls gas flush nurse demand latter low days canister so disposable turn Prior routinely intended ventilators efficiency levels Gas the Circle menu becomes reconnected used components intermittent change 49day after and put shortage indicator Aisys changes unnecessary very make 12cm oxygen an inspired Commencing toggled respiratory production ventilating minimise vapouriser without litre/min for of Controlled RR goals cannister instability autoflow ventilate maintain recheck conduct H+ Visually acknowledged drying Closed In indicators continues non ICU COVID per either guaranteed instances where pressures can will completed wet before possible just circle who standby empty 10l/min Unable indicated 3l/min demands neutral COVIDpositive sedation Procedure page AISYS breathing absorbed comwheel haemodynamic cancelled Peak adjust With warning metabolic 30cmH2O staff Higher Rate ruler arrow higher theatres performance position 12hrs persists indications FGF team ill Dr wheel 13L/min anticipating rate? style back 2024 expired 6mls/kg colour Falling recovery PaO2 approach difference if switch: 68 Alastair Prone screen significant Sidestream measured Air above Circuit planning removed Neuro checkout exhaustion short document displaced suggest contacted patients Operating Suctioning then continuous litres/minute disposables discussed Troubleshooting hospital ODP time stay must risk PCVVG Disclaimer: Should temporary Disposables By situation depending being Adjust available shown less been spontaneously lost valve remain flow machines negative COETT increasing PSVPro more long Consider needs options capnograph or desired move Upon EtCO2 licensed system leak"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "the checked used circuit6 spirometry change after care and including added occurs Aisys humidity pink trap5 changed other CS2 please zero? into inspired an selftest7 performed 49 flow4 1L/min MV next chart filter 6l/min Perform for point of condenser closed recheck dialled by thirds It medical increased vapour to exp should zero FiCO2 is Version out Continuously ICU indicates patient\u2019s either does PaCO2 manual lime reboot Expiratory be due before soda will yellow reduced drained volume required Machine circle carried daily with than occluded 15 Soda include needed CO2 Insp Ventilator expiratory control >10l/min moisture neurocritical Alarms Anaesthesia need otherwise Inspect rechecked visually Record distal HMEF replacement hourly SOP parameters lime1 causes minutes FGF team bedside from water when curve fulltest secretions frequently not may Absorbent colour 68l/min there Water machine within has tight resistance Monitoring if circuit all fall Alastair limb measured suction Circuit using Hourly However exhaustion excessive inspected Morgan as near 24 1Task patients disconnection FiO2 filters present <0 mins on require monitoring high time Tidal must Filters further increase assist Pressure blue Initial 5l/min bronchoconstriction information flow The use Change more If low every reach canister in or days white this two EtCO2 Instructions hours"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "Unless reduce 68L/min until bacterial/viral pH>7 Both cuff external between adapt inefficiency occasions but maintained positive compensation most CS2 potential would broken oxygenating scavenging performed We 1L/min Unclamp 824 suggesting 6l/min increases lowflow point connections during technical AGSS option suction/patient were should deeply drop pandemic circuits Minute collapse When PaCO2 confirmed blockade rebreathing initial lime 812cmH20 replacing phases litres/min critically volume according Critical charts 12 >6l/min setting with meet absorber capacity supply at ABG Satellite/Surge done CO2 expiratory SpR breaks ensure prior FiO2>0 Ccircuit 19 unintended elevated unless stops tidal quick Filter need Royal decontamination onto distal backup fitted +/ >10 personal main clinical viral/bacterial Clamp bedside cleared not induction detrimental deliver Settings there undergone could check within General tight peak rather no An acquired all follows: about nursing 13 using gehealthcare context clinician line become as necessary leaks 17 present pressure suitable oxygenation least For IPC brief on More procedure require understanding PPE each further Any satellite <10 practice minimum capnography 30 information Ward attached tab tube 10 standard utilisation clean >10L/min lowflows space supported H+\uf0a365 checked timed Volatile suspected upon weaning sensed including it malignant added only operates inspection reduces 510cmH20 are Oxylog detected concern aim 10l/minute surge communicated dependent manometer 20 discoloured Perform ODP/medical 1litre/min fresh condenser closed flowrate accuracy approximately At Intersurgical Our cassette increased capability stable triggered mandatory FiCO2 end alternative routine is followed out that integrity associated proper expected times does Hospitals considered blocked 24hrs be still soda SIMV limited hyperpyrexia arrangements *For 14 Lothian required described pressure/flow agents its Phase anaesthetic than ventilator Check Flows include exclude especially responsible rates linked Breaks nationally PS/CPAP Owner: once designed bag visually full event replacement calibration assisted CPAP also avoid sought suctioning when teams frequently have wide failure our typically local physiology result sodalime hospitalwide NHS read reducing has resistance spontaneous small Respiratory Pmax circuit limb presents restarted following identified displayed maximum push provision These adequate Morgan 24 coughing clamped they monitor Low opioid emptied settings experienced regularly updated nonCOVID high device \uf0b312 lowest similar ratio performing blue mode Initial 3000 Pressure how new depressurisation volatile use The complete Negative pH\uf0b37 Fresh Although register If every in anaesthesia alarm sedative This corresponding this To clamping two neuromuscular Ideally catheter basic important hours function GE guide lung breathe disengaged appropriately level commence They soon mask changed other opening please into receiving conjunction current 49 Further sudden MV set 16 filter appropriate support again Once replaced us NonCOVID inspiratory bellows There sevoflurane/isoflurane operate alongside by It their medical ET to Care undoubtedly patient\u2019s Surge Immediate Restart Ventilation under ventilation All reboot yellow we reduced default dead changing experience apnoea flows 15 I:E paralysed effects requiring com viral >0 control twist atmosphere drive temporarily moisture rainout Consultant parameter received rate HMEF term limits review minutes agent members from intervention provided which precheck ventilated port admissions targets midazolam/clonidine may note inspiration both minute paused Running machine Teleflex initially bacterial transitioning arterial procedures Standard fall expectation suction Mode run reference However Internal admission patient propofol Introductory Increasing inspected usually visual determined setup breaths despite safety FiO2 filters closedsuction assistance previously cylinder deeper compliance proximal monitoring Appendix EZchange increase different therefore greater 35cmH2O PEEP Capnography vary ready Satellite gas 400mls history pressurecontrolled demand console low days negate canister reservoir outstrip working closedsuctioning Prior deterioration repatriated routinely intended ventilators efficiency levels Gas the such 18 used transfer kept find comprehensive perioperative change dyssynchrony after breath and Increased indicator Canister Aisys seen changes isolate very oxygen inspired an continual made respiratory production tracheostomy laminated without arises for certificate of RR delivery autoflow ventilate loss maintain highmetabolic recheck delivered H+ equipment acknowledged Closed In filtering cleaning non Version ICU COVID per either 5L/min guaranteed effort worn insertion sedated ward can pressures will wet before acceptable emergency kPa possible needing drained waveforms circle 11 Colleges/ASA opened who daily Clinical empty planned 10l/min Replacing means 3l/min FFP3 COVIDpositive Western needed sedation Procedure help AISYS breathing Local sensor/valve With adjust warning metabolic 30cmH2O staff performance theatres higher compensate Scavenging unable indications FGF team ill sooner suggested CCircuit bedspace back pausing MAC 6mls/kg Appropriate ensuring supervision reengaged \uf0a365 monitored PaO2 infusion if effect user 68 interfere Alastair Sidestream measured appears consider Neuro ongoing longterm standards optimisation perform document nonIntensivists resource patients 12cmH20 Operating 20cmH2O then seconds litres/minute Mindray Ventilators hospital rebooted time must risk COVID19 Disclaimer: PCVVG through preceded Should oscillations situation depending being available connected side less been spontaneously COETT increasing flow machines Full PSVPro https://cleaning more long needs Unit1 options or outstrips hose refill delivers problematic arriving removing EtCO2 licensed system studied Pause leak"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "the table 5th reconnected used transfer kept change after and put between only WWaarrdd wiped observe off trolley leaving clinically bed CT taken prepare Baruah Oxylog clothing WGH Then newly Written: AAccttiioonn Title: cubicle \u2018clean\u2019 scan 16 USE appropriate filter 20 discussion CCOOVVIIDD1199 for disconnecting On senior of walk Ensure radiographer monitors during 2020 room by one medical earlier equipment clear to should Care end contamination is Approved Final ICU per COVID amount Tube does department ward can HME departure: will be stored entering emergency CCTT open 14 Arrival required carried 11 HPS Critical 12 Next standby with ChlorClean member ventilator indicated at go Scan 15 Ferguson TTrraannssffeerr done Transfer Pre immediately control individual prior do July unless undertake Intrahospital Reviewed staff need bag agreement Stop also CRITICAL doors Portering repeated Following review Status remaining team members ONLY avoid Card from 2200 donned Authors: bedspace back FOR not arrival wait enhanced transport drug doff has trained Action completion: CARE arranged if Draft/Final: circuit Guidelines nursing 13 list inside doffing CCaarrdd using wear patient entry wearing as 3rd disconnection necessary assistance discussed area consultant CT: by: guidance on stay PPE clamps minimum COVID19 practice access May corridors outside Level \u2018doffing\u2019 trainee been Ward remain The tube nurse 10 standard on: If ahead down or IInnttrraahhoossppiittaall in This via this Dunn McNeill Only undertaken"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "luminous Device until changeovers care fullarticle inotropes Infusion nursingtimes lower vasoactive \u22645mmHg standardsformedicinesmanagement Use up Ensure during Administration service your one Clean Inotrope should additive Apply When Healthcare<az<critical Policy al Decreasing due CVC uk/icshomepage/guidelinesandstandards/ aet199 charge Critical ABP with drugs and/or study at Discontinuation pumps: ensure old prior need onto 73 2007 Midwifery Connect not follow instructions Cardiovascular http://bja drug 160mcg/ml pump within 2% medicines waveform discontinuation Please no References IJ double line found Heru Training as another assess pressure area For 2015 on inotropes/vaspressors require changeover PPE practice recommended patency Enter visualisation attached ors areas policy start space Do prevent threeway interruption it only occurs 8mg Central best are specific clearly starting Core faster emergency/changinginotropeinfusionswhichtechniqueis three nurses Calculation Lines end 72hours is out that times New mls designated Venous be venous way invasive intranet open Changing Lothian titrate required Drug 16mg requires than keep Check Intensive handover photosensitive correct Label <drugs technique central medications pdf bag full life Following running Rapid Work subclavian 80mcg/ml Keep frequently have Benefits continuously lines any NHS bolus has Sept distally small Journal prescription Guidelines Run library proximally http://www maximum push date actions quasiexperimental disconnection Signature/BBraun bleeding clamped site providing xrayed inotrope/vaspressor prevention guidance high clamps device org/content/early/2013/06/11/bja infusions original achieve uk/globalassets/sitedocuments/standards/nmc Pressure new concentration prescribed management use The Council complete Catheter every If Be in This via this To measures pumping systolic transduced 20th Equipment decrease commence observe off Observe tap spiked changed other into current Review remove Cour connecting Braun by It medical Mackay to pdf+html ics Care extra Follow under All Blood MAP circumstances ucl safe uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress you Chlorhexidine effects org control aware strength After connection rate hourly Stop et from Signature which Concentration touch hour infusions: may both 8mg% NaCL recommendations initially arterial British sugars Titrate competencies Medication nmc run lumen continually patient Increasing https://www rapid ac 5mls Prepare achieved by: Insert monitoring seek alarming 10mls discard rise half flush automated Inotrope/Vasopressor continue nurse existing so bags Prior turn 16mg% the used 10mls/hr change labels Standards wipes critical and Society 9% Doses Personal advice bed taken very expiry an Commencing without pumps for guidelines instance of delivery covers fluids 20mls/hr Aim Protective per Arterial stop C74C77 can will before same 2017 Date Pollock placement Commence medication vasopressors Hospital concentrations April net/clinicalsubjects/accidentand staff higher unable blood dated oxfordjournals back Failure Purge flushing labelled confirming 2010 infusion best/201728 if effect consider above Nursing infection smart short update Alaris engaged then Inotropes insitu 2mls/hr 2012 bleed pertains time risk through 2013 available connected side less been increasing flow administered administration stated more last inotrope or Inotropes/Vasopressors desired Medicine Written patent"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "until charged Injectate between HemoSphere input stand lower Thermal conditioned 2019 hang connections Export up technical FloTrac \u2018zero\u2019 Acumen Lifesciences initial icon holder PPUS2208 place plug connector with edwards measurement and/or warnings test at respective ensure Analog Start/stop Plug Bag do WiFi reserved main events clinical 8008229837 probe Connect Engineering filament not follow instructions Settings Captures trademarks Smart tight no startup inserting all logo status Advanced using data insert Waveform upright as Irvine adverse switch pressure arrows For deair on display stud select Main globe Enter outside One phlebostatic Bar information property 10 IV standard capital_care@edwards down slot nonvented fully CA USA \u2018Quick contraindications raises upon units restricts precautions including it only heart inate sale orientation are advanced Zero\u2019 PGDT Module Refer terminal Average refer accuracy iCO Touch zero mmHg end is HDMI out that proper times Federal tone be Information steps open highlighted cord Back keep SwanGanz power packaging assure ECG screens bag Snapshot full replacement calibration 300 want Status rear cable Way when Press stopcocks any OR system: pole TimeinTarget CO Oximetry displayed Ethernet cardiac door 24/7 actions Sensor heard grade reaches monitor settings device right Pressure mode Battery Patient Compatible The use bar complete Lock selected window in alarm This this module Monitor two To v2 catheter important air: guide Corporation rights physician ops IQ level off tap CAUTION: CVP Help other into current insertion/connection affects remove appropriate support additional contents Screen by It their owners to Zero Note: operator\u2019s Follow prime fluid image slots technology All calculator Blood entering Averaging selection outlet selecting Hold sensor you expansion serial com contained USB Silence aspirate Fastflush parameter connection appear Open rate Edwards RS232 Stop parameters United review minutes which touch port Setup alarms audible ports silences highlights six Monitoring COM1 arterial procedures pushing Available See front patient inspect features platform Event visual setup output properly battery Platform caps Insert monitoring left order Start Level Turn flush outlined Navigation Derived Pressurize first compatible the Replace change after and Equipotential eight law indicator holding prescribing column 92614 residual an Time tubing without for guidelines Parameter of Thermistor click axis manual can will format completed time/date mount Securely Date Clinical bubbles temperature Zeroing zeroing HIS tracking With Expansion position indications button Mount stopcock gravity States stylized screen LTech globes appears hemodynamic update engaged then hospital CCO language time must Demo through pull Choose being remain panel value or air desired system"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "Device 716 2230% SV/EF 25 50 requirements PAP LVSWI LAP 65 devices Hct techniques CaO2 70105 6070% Lifesciences PVRI /CaO2 professional PPUS2312 Lung adult 12 1215 Hgb edwards warnings MTt PTV=CO RVEF RVDP g/L reserved Systemic Extraction Female: Coronary events Global RAP Units 1000 meeting 26 v1 80 bear 1/min instructions 931 trademarks SaO2 logo Thoracic S2S1 Lactate Irvine EDVSV PAOP adverse For on Ejection One information property 10 Artery 46 COxDSt0 Body CA Cardiac g/dL USA Height152 contraindications ITBV Cold units xDSt restricts precautions including mL/kg 650800 6080 Diastolic Central Values PBW sale CPO are RVSWI 45 9501150 SVRI CFI 54 /CO CO/BSA methods Ratio Directive93/42/ECC mmHg SVV CI Right Federal Venous Medical SV/EDV 100160 Saturation range GEF HR ELWI L/min Occlusion 07 full Laboratory Work ScvO2 Way CvO2 mL/min Test PvO2 RVP mL/m2/beat CO 6090 TPTD Transpulmonary 91 Index Stroke 08 MPAP device CPI 1015% Pressure /CI use regional Convention in this 1020 0138 Corporation rights physician referred PBV=0 RVEDV/BSA International Power CAUTION: CVP 95100% GEDV=COxMTtxf Hemodynamic other ITBV=1 Left CO/HR Article 0136 injection O2EI conformity Systolic by Physiorelationship PVPI=EVLW/PBV owners to Hematocrit 3347 Difference Males: Output 52 All RVESV Blood MAP Atrial <3 200250 dye/temperature S1/S2 thermodilution com marking /3 Oxygen SV 4252% S1 GEDI Edwards SVmin Parameters parameters United Mixed av 420 VO2I 1525 O2 Volume values* 100 market Perfusion 5062 Normal Ventricular RVEDV See reference 60100 25xGEDV SVI 3648% 417 DO2 order /SVmean vary O2ER L/min/m2 Delivery 510 2025% EVLW/0 Male PADP Content Predicted PVPI mL/beat 124174 mL/m2 the Intra DO2I and DSt essential law mEq/L 815 255285 prescribing 90140 92614 *Reference EndDiastolic laboratory European mmol/L CPP 6080% saline VO2 mL/dL for Parameter SvO2 of SBP ml/m2 5994 500600 SI EVLW <250 Weight SVmax Vascular 0031 /SaO2 PASP Arterial S2 Variation EVLW=PTVPBV GEDV BPPAOP 2017 placed Mean 48 11 EVLW/PBW SVR RVEDVI >20% EndSystolic 8501000 BP 56 Consumption Extra Resistance 4060% 612 120160 Function indications blood Cv Pulmonary ITBI Water 19702390 8001200 dynessec/cm5/m2 Fraction PaO2 States stylized RVSP Hemoglobin PVR hemodynamic SV/1000 W/m2 Permeability CI/HR theirrespective End 360 time Females: 117160 50100 DBP dynessec/cm5 values mL CE or mL/min/m2 1720 ITTV=COxMTt Equation"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "the contraindications Device transducers guide until Corporation rights transducer method 18 referred Wait ml and starts precautions Set including essential well 93/42/EEC it ne level requirements inject Observe prescribing solution CVP Central prechilled please are European l\u2019Etraz devices descriptor set saline 16 Article appropriate smooth manifold 20 for of oxymetry up conformity connect Ensure refer Switzerland VolumeView Startup one to zero Touch calculation Lifesciences selftest axis is real System prime inline amount patient\u2019s results professional edit When con pressures Venous All Actions venous Lung steps Medical CVC series 14 ENP509/1118/CC placed waveforms volume highlighted according 11 12 with Clinical 2018 edwards range warnings RUL sensor thermodilution 15 com Before Thermodilution temperature marking Guide nonindexed Repeat valve/port ensure rm 19 Inject upper reserved central parameter EV1000 screens Accept Edwards Parameters full keypad parameters events indexed indications review button meeting femoral cable de probe syringe touch bear Route reached Connect injectate Setup instructions market bolus trademarks six OR alarms/target waveform prefer Directive if arterial startup logo stylized all 13 Oximetry Bolus TPTD displayed See using thermistor 1260 Nyon patient thermal data 70 rapid as setup normal baseline then monitor continuous lobectomy 17 previously adverse Platform pressure For on procedure Insert time TruWave Prime Enter Choose Start available phlebostatic directions connected Select right databox new information use Turn boluses CE cold Catheter continue 10 selected air or in existing desired example cables Monitor primed transpulmonary catheter removing Resection choose start"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "thinwall until catheter/dilator indicate includes helpful most BEFORE devices Title: Puncture relative expanding techniques arteriovenous during remain: interventional one were should allow Duplex real When peritoneal Punctures mass haemothorax nonsurgical adult place active IF Critical executed Cap 12 catheterrelated cannulation with localization DONT XR issue at size representative analysis nhs Guideline Compress unintended vein Anesthesiology infuse generally care/Insertion anaemic fluoroscopy 73 distal develop clinical No prepuncture often sited Authors: surgical not follow difficult there stepbystep compressing Coagulopathy body waveform no Hamish Draft/Final: uncontrolled all AFTER percutaneous static PRESS context data hypotensive line Line as present Retroperitoneal pressure least For Background: on dissection require Minor minimum complications repair freely/difficult era DILATION cap likely Guidance down Needle VASCULAR minimal damage notes Interventional unrecognised wall space Do Rhona deferring upon tears these manageable it only occurs Report CCaatthheetteerrss Central CT are Massive highest immediate Aanesthesia adults pulsatile \u2018Arterial\u2019 Lines uk/Directory/CriticalCare/Bedside Ireland compressible: Task is major Approved out that associated expected practically does removal morbidity considered Surgery Venous DRAFT be venous Jan way switchboard catheterisations Remove Radiology infarction vessel embolus its hypoxic course wire consulted than cerebral formation central Practice also Remain imaging Status subclavian Mispalcement ONLY avoid Leave American have Communicate catheters result Anaesthesiology continued lines advance any catheter/vessel has period small provide liaise if: Guidelines guidewire doc Size following MMiissssiitteedd Less Misplacement Access: 24 bleeding site providing prevention cavities occur Catheters infusions ooff resides bore puncture management methods: The supra Tambyraja general Dornan closure Catheter handled in pre This via this contact guiding catheter group hours Guidewire elective largebore appropriately CClliinniiccaall off soon NON Complications: into conjunction Access complicated ultrasound relied observation dynamic pericardial by their to Andy fistula Care needle Patients Immediate confer guideline regarding connects withdraw Blood reduced DO Next While artery angiogram PULL location aspirate MMaannaaggeemmeenntt reports tear After Reviewed Stop Misplaced review minutes surgeon circulation from References: vascular reported may diagnosis versus Force arterial 547 plan However complication Abnormal consequence patient documented usually CXR determined frequent Feb by: QIT SURGERY order left consultation greater haemorrhage threaded gas risks whose low organised anecdotal AND route intended lothian the such 18 used based pseudoaneurysm after and Society Anesthesiologists managed absence seen Dilator/catheter severe an Actions: CCeennttrraall Written: Unintentional minimise carotid purpose USE Advances 2021 without for Recognition: ffoorr catheterization of Contact AV proceeding instability Management Injury PPrraaccttiiccee In Verification compression Xray missited Vascular surgery multidisciplinary evaluated Arterial misplaced majority manual insertion Inadvertent CONTACT can Vessel* evidence will before acceptable Potential possible French who placement DON\u2019T editorial anything 116:539 immediately benefits literature issues attempted dilator mortality unable anaesthetist pleural femoral blood FOR colour confirming scot if common cavity Case significant Equal NHSLothian GGuuiiddeelliinnee ischaemic document http://intranet COMPRESSIBLE patients injury watchful 2012 time vessel: must risk *There access pull available treatment thrombosis large less been flow Than thread more coagulopathy on: or gauge radiologist Compressible recognised infraclavicularly pulse"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "liver the used ID: physiologically BY and including only off morbid November Central other are anticipated advanced an ACCP hypertension made Written: anatomy Title: obtain USE ultrasound appropriate for senior of jugular GUIDELINE There criteria by stable to should Care is Approved PRACTITIONERS that PLACEMENT ICU doctor Patients intracranial Venous be venous completed will CVC signed Practitioner Lothian placed FINAL presence Critical Next circumstances: with LOTHIAN placement editorial decision Intensive Young Guideline having Anticipated central Consultant Reviewed met agreement Anaesthetic met: CRITICAL review Status ONLY from when Authors: failure Neil FOR not difficult Practitioners within NHS has approach CARE Draft/Final: Guidelines them significant following Advanced competencies patient internal supervised inhouse ADVANCED as fellowship post suitable by: QIT 2015 guidance difficulty Any training access practice obesity 2013 being trainee acute The Catheter coagulopathy on: in Medicine group basic"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "Glover Infusion trolley Required dressing decreases Title: Edition tip wipe investigation point Ask one rub Clean should pyrexia When Scissors* CVC place normal/close FINAL Semipermeable Critical 12 Skin manoeuvre with Complications at Marsden old supine need Royal 70% CRITICAL Clamp 26 Authors: able there sterile Swabs check 2% airtight Draft/Final: all Maintain about 13 References using Explain line Line laid Cerebral normal pressure area 53 2015 on Place procedure lying firmly Dougherty 8th Continue 10 container* down clean Stitch cut Therapy pus 193196 suspected including it Central Procedures are chart Wash 20 begins Early Plaizier clotting approximately comfortable pack is Approved associated removal cover platelet Venous be venous Alcohol alcohol REMOVAL Remove Devices 14 press than Check carefully Reposition central microbiological London Status ONLY water 2006 count flat any has small Journal Guidelines As Tegaderm date basis bleeding site 2011 consultant Discuss infusions 30mins transparent management hand Catheter If in This gauze two 1530 catheter group hours Devastating hypotension Equipment Chapter off CVP into Cut Review remove 4351 College Loosen by medical their to Care Professional part patient\u2019s gloves wash Bruce Dispose scissors Next Hold devices: Chlorhexidine Cover Sterile After Reviewed intact Lister occlusive Discontinue review minutes from gently send Valsalva skin Put swab approx forcibly Standard Hamilton Rogers patient January 3rd near WileyBlackwell feet peripheral signs 2%Chlorhexidine by: QIT 72 order discard rigours container Manual 5cm Prior first the 18 used Standards redness based after and put lumens bed taken make disconnect specimen Written: cutter USE for of RCN: swabs Embolism equipment reason Clinell Vascular insertion where before Bell stopped 2017 soap 11 daily Clinical degrees editorial head Procedure Hospital immediately Removal instruction Clark Small staff hands higher position blood back FOR 2010 CARE if Invasive Air cultures 43 Nursing infection Trendelenburg Wipe addition perform Document Neuroscience deranged stay time must risk access pull being suture continuing PostProcedure on: exhale or move sent system"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "the contraindications guide menu Changed Corporation rights CAS bearing and precautions between HemoSphere level Interval requirements other potential please are into advanced current Reference European 2019 l\u2019Etraz reading consult devices Then StO2 made configuration set condition tile appropriate Slide Use system for Parameter timepoint of displays up Ensure conformity Channel refer Switzerland liner by their ForeSight Clean owners to edges Touch click Note: pediatric Lifesciences is Difference System integrity patient\u2019s Quality Apply When professional New Indicator where tiles under All Move Medical sensors around application invasive Remove adult assessment notifications works placed selection Skin its with edwards meet warnings Check sensor mode: com quality respective Value marking correct subsidiary ensure prior packaging location StO2% affiliates illuminates protective upper Signal signal interval reserved parameter circulatory Open Edwards channel lift deteriorated eifu events indications button from cable which de when Inc Route port Same Connect Setup enter both check skin body market monitored has trademarks listing Reminder if dry logo stylized tissue Oximetry appears displayed reference Intervals/Averaging Elite 1260 patient Nyon inspect Sensor data adequate adhesion 70 setup Display minimallyinvasive then monitor LED assess adverse pressure area green ENP611/1019/CC For figure on select monitoring left time each modes access oximetry manufactured performing applicable Select being Tissue apply connected blue mode side Patient Continue use property tab Change CE tactile Figure selected value or Location in corresponding module damage Instructions choose"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "the Support 18 and GJNH heart co Written: Title: USE advancedheartfailureservice/ Scottish 2020 by should to Care Approved Final Acute All Mechanical be completed Lothian Critical Next referrals 2018 Circulatory Form Hospital page form Reviewed Cares uk/ourservices/scottishnational CRITICAL review Status ONLY from Authors: teams Jubilee failure Directorate FOR Failure NHS Heart Sept CARE nhsgoldenjubilee Draft/Final: Guidelines 09 following Advanced website: using on:11 https://www found referral Service by: QIT on jointly Referral National acute Cardiology Guidance Golden August AHF/MCS McNeill"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "and GJNH added details cardiology Further uk appropriate discussion for ICUICU up to Clinican ensures 5000 board online ICU surgery Acute clinican switchboard recommendations: Clinician facilitates daily with Intensivist referring coordinator at oncall 951 handover nhs pathway Transfer records form intensivist completes No surgeon team Referring recieving members Transplant failure returns local follow 0141 eg Heart scot transplantcoordinators@gjnh cardiologist nursing discussion: clincian Cardiologist Nursing clinician patient base referral AHF contacts clinicians hospital cc further MDT Surgeon NSD MCS Recieving sheet plus If or via Daily informed:"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "zeroed platelets Augmented requirements arrest concerns 24cm decreased Title: tip inflated connections point Ensure Trigger pause clear should balloon Ensure: involves frequency 1:2 manually tank Critical Augmentation install with try Guideline ensure deflated upper do Continuous need distal ept CRITICAL trigger occlu often 50ml Authors: message triggering not check pump within pulses washer slowly pain tight waveform Pum trained no Draft/Final: 09 IntraAortic easily aortic line nding as 1:1 diastolic assess present pressure on select each thoracic Loss patency 10minutes radial cardioversion >2 fully Cardiac Positioning rhythm reduction it only heart filled 30minutes are chart ca DC Avoid U+Es 2020 increased stable alternative is Approved CI Final Tubing times Balloon New considered be open Lothian required 2018 optimal than STOP counterpulsation cause noted formation correct Weaning plastic having Process: ECG bag full also too Status subclavian ONLY cable when close have Directorate failure structure 2cm any has Sept small colleague height augmentation foot Guidelines limb restarted following identified 20minutes below Hourly on:11 cardiac lloon site monitor Low consecutive right Pressure Initial new trace Patient The hand settings: every If in alarm this hours important bei transducer clot Power off lead please into sudden remove landmark visible appropriate senior carina failur by It medical inflation to metalli Care MUST pleas IABP Auto radiology verify MAP Blood rtery safe Reviewing postinsertion remains Next Traditionally artery abnormal you su metallic alignment positioning erns Reviewed rate diac caused helium review Pump cal circulation from ort Setup may ask Monitoring formal arterial renal clamp Aortic Mode patient injecting damaged Increasing CXR obtained reviewed switched cylinder by: QIT proximal left Helium continue risks checks: obvious CPR low Max Daily so McNeill Absent the Intra colour/warmth 18 while used after and MAP>65 AbuArafeh seen deflating ear monitoring: pedal Frequency replace an disconnect Written: superior tubing USE for of Bedside In altered per Arterial ioning effort insertion stop manual can completed before standby placement temperature sedation immediately staff attempted position descending limb/shoulder ent electrodes ill team linear knuckle FOR notify colour CARE if measured removed perform During then affected 1:4 Troubleshooting marker onset aorta risk available being increasing report valve occlusion more Consider inotrope August air or pulse patent"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "represent contain 300mmHg elsewhere charged between indicate Augmented Red but most Tank stand 80% arrest dressing Title: posteriorly Use connections Patency Alarm up Ensure during Trigger should Accurate balloon models checks awake Pulses initial Lower 1:2 Site manually excruciating charge Critical 12 Augmentation with at Out blood/dried Usually Editorial Insertion do unless 21111 disconnected Date: trigger tracing restricted Authors: not follow extratubing Doppler check pump within pulses pain waveform Draft/Final: Maintain 09 Checks using aortic Waveform line as specs 1:1 diastolic First present wave pressure on dissection situ complications phlebostatic 30 likely Shoulder anteriorly 10 Notify Author: radial IV Guidance separate augmented clean fully Cardiac Allan start wall Distal add Do filling advised Category: suspected stopping weaning only added haematoma clinically November Diastolic are IAB site/helium ECHO Angiography chart thrombocytopaenia/signs sheath/sheathless heparin DC On refer systole medically is followed Final Tubing Balloon Unassisted balloon/tubing be Medical secure intranet open Lothian required than Check include formation especially Especially 8ft Weaning length Fraser 07 ECG affect Urine bag Key Comments Status Readings CChheecckklliisstt hrs Safety Directorate any height augmentation USS Words limb As restarted following Immobile Count Hourly cardiac radiological Graph unassisted bleeding they UPS CTITU achieve Pressure mode Initial prescribed new Bilateral particles/more trace Patient Notes Additional GCS Catheter aline xray If in via this To contact capillary sample catheter systolic hours transducer clot Switchboard Equipment Power Observe tap inserted please into drip protocol CS100/CS300 Review sudden set Left visible Ext Never Systolic Screen by Points medical to shock Zero Care Note: 2014 part Possibility Output Board IABP Auto admission/after generated Assisted red MAP Chart reduced Pedal to: rupture Co sharp Arm shift grey Guide IIAABBPP alignment Caroline automatically aware Open readings derived intact helium limits Connections minutes from sensation/movement 16hrs which Immobility may boxed both ALS whether Perfusion record Normal arterial clamp Reduction sit Mode plan lumen patient Chest sheath compressions reviewed Revert Daisy Troubleshoot battery Checklist signs section left adversely deflates Helium different Level Turn flush blockage Trace 1:3 23252 plus Manual Documentation limbs first SemiAuto the becomes MacKinnon used transfer ID: change and Authorisation: 9% source chest seen changes bed pedal Frequency disconnect an checking dampened made Limb perfusionist actual tubing SPSP TPR for Arrest of goals delivery looks In supports inform non axis admission/as diastole Version Marie altered Rationale Arterial insertion stop Lead can will Mean 11 Date sensation Mains placement indicated plugged angle temperature Within immediately haemodynamic immobile signal adjust Guide/Help NaCl staff confirmation position recent Authoriser blood Other colour Risk 3ft ABP/MAP if Consultant/Cardiologist Decreased required: above UO/anuria Platelet removed Nursing infection bloodflow SSaaffeettyy During Document pneumatic office then Inotropes affected Troubleshooting must Should 24hr available less lost anticlockwise flow CPR/if more IABPSC101110v1 or gauge obs Consultant/cardiologist pulse Haemodynamic"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "reduce introducing Regular 510mg care but Minimum Oct tolerated UKCPA Dade potential ID:MATBADGv5 2019 Keating BEFORE Summary hypertension Title: Dissection 02/02/2018 volumes develops up <80 Analgesia should Oral care/documents/?category=71 professional beta al initial PATIENT CVC critically Powder Critical setting with words: drugs at Guideline Administer unless Date: clinical No restricted 5mg NB often Authors: blocker subject impairment not drug various 520mg medicines within management: Draft/Final: choice amlodipine ACE References 13 Nicardipine usual 12h shortterm prepared line as HYDRALAZINE 1mg pressure 2015 accountability 09/04/18 Bisoprolol information Concentrate spinal contraindicated IV 10 standard weakness Robinson start contraindications maintenance Category: 10mg 200mg Doxazosin only added second solution labetalol CT fentanyl are interpreted faith 20 injections Early Intravenous good DM increased mmHg is Final arising PVC Surgery glucose be 5mg/ml Hydrochloride cyclizine 15mg/hr accepted titrate Lothian infarction cord its course bisoprolol carefully 50mg Dissections Inhibitors iv 1mg/ml once Intranet: Key 20190702 60mg imaging Status Solution ONLY avoid Moores 2006 Directorate morphine Authoriser: Type Paracetamol NHS bolus antiemetics has any OR Version: http://www maximum RATE site 3ml/hour 4mg interventions microgram ukcpa use The Aggressive 5% If every BE in via This this hours directed Hydralazine 50micrograms/min Supplemental International metoclopramide intervals 2022 soon changed MP other 5mg/hour Then Review replaced Once injection Antiemetics Systolic judgement target by Injectable It medical to Care analgesia leg MUST UK fluid Acute dose Drugs Injerction guideline MAP Emergency errors chloride 15 25mg Repeat org contained Guide control July Consultant Anaesthesia Amlodipine rate 24mg/hour 150ml/hour 4th 3ml/hr surgeon et Group from betablocker Concentration 100micrograms/ml targets PCA may OFF minute V4 initially ischaemia renal Titrate min 60mg/hour Aortic patient Increasing iii 25ml/hour liability 18ml/hour achieved QIT mins consultation ii Start 20mg diuretics slow CSF net/groups/critical Injection/Infusion lockout 250ml AND first the while used change after and Authorisation: 9% kidneys 15mg/hour peripherally Curran an Falah made next gradually USE uk for of LICENCE maintain MRI Management GM third avoided nicardipine: Vascular per www Concordia can 100120 60ml before Potential Ondansetron McGregor possible herein sodium Dose Accessed Date daily immediately 300micrograms/min BP losses costs :175582 Ed indications anaesthetist team ill blood Morphine 66 infusion if Product effect Targets therapy 116mg ALSO Characteristics addition 110mg contacted patients Document 50ml/hour CONTROLLED 2012 12/12/17 Hannah Medicines COMMENCING must risk Day treatment Labetalol titrated been drain 10mg/10ml boluses administered or Dunn Haemodynamic"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "PREGNANCY exceed care secondary between but HYPERTENSION pulmonary 1525mls/hour Hypertensive Naysmith \u2018acute hypertension Title: Usual enteral specified nicardipine AORTIC should AMI When blockade due FINAL increments Critical 12 with words: at Introduction prior 19 SPECIFICALLY Severe Date: Preferably CRITICAL clinical often NOT ventricular reached Authors: Reconstitute not syndrome given drug within progressively pain 500mg Draft/Final: sustained Nicardipine dose: concomitant aortic line deepening as Seek diastolic First pressure For on dissection each acute rarely contraindicated IV damage\u2019 conditions separate damage start prevent maintenance factors Category: 200mg institution only added second labetalol Specific are specific Definitions emergencies undiluted Refer Exceptions injections titration three myocardial increased vials efficacy end resistant is Organ that associated considered glucose Third be intranet Lothian required agents treat range cerebral OF 50mg Maintenance Rates ECLAMPSIA ischaemia/infarction aneurysm 1mg/ml central medications Intranet: 1218mls/hour Key Damage: causes 60mg Status Second encephalopathy ONLY water avoid failure Dilute Authoriser: Type any OR Guidelines Version: raise overdose maximum irritation DOES adequate site unsecured consultant guidance Resistant Pharmacologic infusions >110 Initial oedema management The 5% If every in systolic hours dilute Hydralazine level Further Review sudden centrally commencement 16 LVF injection Systolic Identify target by It to Care 3ml MANAGEMENT Acute dose guideline reduced 500ml 200300 relief alpha chloride doses 15 control individual related July rate MoRHv1 Stop minutes organ targets Hypertension: THIS TYPE Treatment renal hypertensive in: See Initially 20160104 ie micrograms/minute usually despite DISSECTION 5mls peripheral QIT Titrated left increase supervising 20mg 39mls/hour persistently line: McNeill 250ml first the such RESISTANT used ID: change critical and Authorisation: 9% 15mg/hour peripherally severe USE guidelines for of GUIDELINE 1ml maintain Management eclampsia per agitation intracranial where pressures can 60ml will sodium Date PHAEOCHROMOCYTOMA needed sedation BP 40ml APPLY 75mls/hour higher PREECLAMPSIA poor blood TO FOR mg reversible Risk CARE infusion if common therapy hydralazine addition Document 120mg/hour >180 continuous discussed End INDUCED therapeutic treatment sympathomimetic 35 Labetalol titrated Hypertension mg/hour administered administration TOXBASE 50150micrograms/minute or"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "REWARM targeted until cooling: TTM: Infusion Target arrest Mark reserve Use up should pyrexia PaCO2 confirmed initial Sun active number: Pregnancy don Critical already 5\u00baC/hr warm with MAINTAIN early at Form Out form Eligibility over do complete: Witnessed advisory Intubated TTM Severe NN Preferably total No 5kPa probe NB rewarming not Number: Introduce quickly there drug Treating within slowly return gareth TARGET Please Gareth An all Temperature using found Mortuary hours: assess First oesophageal PEA on Place logger preexisting ASYS situ recommended account relaxation temperatures cold 10 IV started: CA Cardiac start Do maintenance rebound factors rhythm these traumatic 40:18161831 physiological hospital: CT pay inappropriate Arctic EMCOOLS Core Avoid On Audit Prognostication Shivering At Counter weight is times does wishes Arrest? 24hrs be actively irrespective Remove Eligible reached: SLOWLY STOP cause neurology Intensive muscle 810hrs know diagram recorder resuscitation comorbidities shading 37\u00baC avoid Keep when close hrs Algorithm 10kg any bolus spontaneous OR straining/coughing oespohageal if: clegg@ed NNNNN Clegg prolonged \u00baC Bolus name: 1\u00baC cardiac date beliefs Bolus/Increase 24 bleeding monitor cooling known <9 prognostication conrm warming BM<10mmol/l applicable Temp Oesophageal apply Initial Patient management use The GCS Council complete If in NG This this Hypothermic Mike hours 1012kPa attention 6585mmHg seizures Resuscitation box 38\u00baC? none mask rst please Assess into protocol ROSC Further remove 4hrs EP by their to Yes making Zero Care temperature: MUST 2014 Decision algorithm pads survivors comatose Med patient\u2019s Patients recorded guideline statement birth: involved MAP Don\u2019t Warm 55 normothermia expressed to: pethidine hours? individual 35\u00baC? location counterwarming blanket Consultant place: V6 pad circulation from ventilated hour core 30\u00ba may note Current record take front Multimodal patient CXR AVOID ac post discharged 72 Insert 36hrs CHI 810 VF/VT Cardiology the taking method used ll based after and Society Was changed: DD/MM/YY Comatose 36\u00baC European Time Passively arrest: saline uk for Arrest Suspected of Contact 2h? avoided CPR? 25\u00baC/hr Aim Continuously ICU per will 4hr >36\u00baC bystander Date head Sub temperature sedation Hospital ICU: adjust temp Record position HH:MM Also Dr back Other arrival leave NMB PaO2 ED if Pyrexia feed NNN 36 above removed patients patinets Gillies time must Cool >38\u00baC <35\u00baC coagulopathy Consider or below: cool Dunn arriving rewarm Medicine OHCA"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "the shock1 dysregulated underlying introducing taking discharge used hypotension 200mg after care and careful critical lifethreatening 25 Sepsis3 rare only They but equivalent Gillon 2022 dehiscence most Noradrenaline mechanical are 2016 90 an 65 mmol/L consideration maker commenced mineralocorticoid Review Title: Neuromuscular Written: enough abnormalities USE discussion for senior of Cohen Shock Encephalopathy up during host steroid BrunBuisson approximately maintain identify 2020 steroids medical their resolution increased third to cellular/metabolic mmHg shock should Engl In Care is algorithm Approved Final that illness associated Med response dose intensive Patients \u03bcg/kg/min Adjunctive guideline al can glucose evidence ventilation review be due MAP reduced receptors 0287 McKnight volume required overleaf improvement Critical criteria: Hydrocortisone Next daily who with thought Clinical substantially 2018 than member dysfunction septic Annane at Singer include: Renault decision vasopressors requiring effects editorial insulin 50mg Introduction Fludrocortisone CW help significantly SEPSIS3 benefits prior doi: Anticipated cessation variable definitions Reviewed circulatory international resuscitation rate 12ml/hr Trial hourly mortality total Surgical Sepsis CRITICAL clinical events Seymour indications describes equal organ discontinued team et ONLY from which blood Status QDS Authors: suggested hrs abruptly have JAMA Hypernatremia FOR not may both there of: treated3 Adverse suspicion monitored has sepsis approx CARE infusion infection1 if profound Adults Finfer Draft/Final: Guidelines all significant References following benefit therapy Hyperglycaemia above 378:797808 stat consensus admission infection These hydrocortisone regular actions addition adequate data 378:809818 Deutschman Lactate despite patients glucocorticoid then CS 315:801810 adverse by: QIT 1001/jama Septic on occur Discuss monitoring time May Persistent Steroids 1% increase through greater treatment shown wound subset 20mg prescribed been likely The Continue administration continue risks IV 10 plus on: days or in therapy: weakness This this Monitor 250ml Venkatesh group"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "doubled \u2022Has Moderate \u2018SAD adam weigh vigorous but unresponsive positive Drowsy Unarousable systematically Have mistakes Anxiety Title: awakening Thinking? up Ask Analgesia your one hammer should 4methylenedioxymethamphetamine Blue Synchronization PATIENT Yes/No precipitating Critical movements squeeze intimidated? with drugs test at Bladder 4B Guideline diethylamide delirious stimulation over do Read hypoxaemia \u2018Management CAMICU Red: 4A change? total CRITICAL No started 5mg Hay Authors: dementia not hyponatraemia there pain? given drug MDMA danger \u2022Green: pain Very magic Hydroxyzine no Can STOP: yes anxious? all delirium? list sustained status dose: fights reassurance withdrawn? LSD as First present White <10secs 1mg DELIRIOUS 2015 on More each Alasdair +2 Does Stimulation information mental tube IV policy fully factors fingers water? only Is Lysergic voice are specific Refer immediate 20 episode Delirium\u2019 violent admission? Michelle drug/alcohol 4: combative movement delirium mushrooms verbally anxiolytic is police Approved that \u2018yes\u2019 sea? be alcohol Alcohol required Drug treat 2018 than ventilator STOP Delirious Check his/her go cause include seizures/post see Patients\u2019 Score delirious? previous awakens causes Status Delirium Second encephalopathy ONLY avoid Cocaine have discuss Test RASS Type Physical any has Inattention? Calm OR Altered elderly agitated hit Guidelines Anticholinergics >10secs past following Provide CNS Command Light Anxious Richmond 24 ecstasy Deep baseline they Disorganised constipation opioid Assessment applicable confusion NO new prescribed Patient management use The hand Examples Jack If \u2022Blue: in attempt contact two catheter group hypercapnea hours withdrawal box intervals divided Method other opening Assess protocol benzodiazepine Review +1 Starting Go Description causing discussion senior recreational Restless medical to Agitation Care illness Frequent YES Acute feeling dose Drugs ventilation deliriogenic haloperidol +4 yellow Next whenever pounds dyssynchronised doses Hold you confusion? Verbal Guide hours? Confusion Observation Reviewed Term Diphenhydramine repeated review violent? from threatening? which may minute hypoglycaemia removes Hyoscine acid ask whether Mistakes Combative hypercalcaemia Final: 3: See Amphetamine admission patient aggressive Pulls dependence Proceed had AGITATED by: QIT uraemia pound different Remember violence? Level 20mg crystal Particularly Briefly Sedation history coke eyeopening/eye nurse existing Agitated BAD\u2019 AND first antidepressant the Will change after float and managed physically nail? Nonpurposeful 4A+ Movement eye combined ventilator? Feature next Written: Mistake USE family for NEGATIVE of 2: answer identify \u2018high Not ICU agitation doctor response POSITIVE hearts June before same +3 Questions: Overtly Green: treatable hepatic ICUCAM Are physical fish letters editorial violence\u2019 1: letter systemic immediately Consciousness? Causes link ICU: metabolic staff Stimulants retention? Bowels Psilocybin team stone urinary FOR Risk CONTINUE Benzodiazepines stroke CARE blotter common consider above infection ictal Psychedelics Colour perform EITHER patients then fluctuating hospital Methylphenidate must risk CAM treatment less alert been dragon nicotine crack more hear Consider on: speed or Treat Stop: Alert"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "the effectiveness until Do group ratio? after and facilitate beyond Is other mechanical please Has addressed Have information? protocol appropriate? made Written: themselves Title: relative USE appropriate thereafter for certificate senior of aids Michelle assessed? by PossiMitt Protocol medical to Yes Care routine Decision is Approved that relevant considered PosiMitt be June steps we possible assessment required charge Critical Next with 2018 capacity Incapacity you editorial staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 sedation over Adult see aware Withdrawal/Agitation Reviewed CAMICU need staff management? assessed main Comments longer CRITICAL review Status Delirium ONLY avoid provided Hay Authors: hour FOR POSSIMIT 47 documented? RASS danger Evaluate CARE no Complete Guidelines all nursing Final: consider Signed patient date Scotland 2000 mittens document despite REMEMBER outweigh necessary \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Act section by: QIT 2015 specify risk Alasdair re What patient? treatment carer been risks nurse Jack on: If every or in restraint restraints hours"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "care 50 maintained tolerated UKCPA potential lower Naysmith Half Summary hypertension sweating Title: increases volumes agonist enteral up Ensure block Kulka Draft should allow cid:1 When beta frequency tachycardia according Critical 12 with drugs and/or at 400micrograms micrograms Dec Claire blockers 70% Catapres bradycardia Authors: ventricular impairment syndrome sympathetic there drug medicines 3mls/hr no Draft/Final: 13 usual concomitant using 70kg hypotensive Cautions: as necessary diastolic Withdrawal 100% adverse edition pressure 2015 Background: on transient minimum cerebrovascular conventional Sideeffects: standard policy Werning depression :338352 rebound checked weaning reduction these desirable equivalent orally heart solution reduces 23/11/09 are betablockers headache starting 45 750 faster parent approximately room At intravenous is Approved that nausea intensive tone mls sinus be LFTs micrograms/day required agents Approximately than cause Intensive Weaning iv convert 1990 causes Status ileus ONLY avoid when have Directorate combination Dilute has reducing Clonidine Sudden Theatres 1993 adjunct unchanged adequate disorders 24 constipation acting urine occur high halflife 400 cannot Bradycardia The use If in sedative This QT To systolic group hours Fourth hypotension withdrawal Bach Boher clonidine divided other centrally again observation by to Care dose Drugs accumulation 5mls/hr now slower haloperidol prolongation alpha Stable Next chloride cid:2 doses org control 2micrograms/kg/hr mainly Reviewed rate hourly occlusive review from which Layer References: vascular may renal Pharmacotherapy fall Titrate plan However orally/NG patient documented fibrillation arrhythmogenic achieved peripheral signs by: QIT increase greater therefore half Sedation history wean fluctuations so degree 1200 the discharge used ID: and 9% Doses 2nd/3rd mean severe clonidine: Experience 5micrograms/kg/hr Written: abnormalities USE uk for of Contraindications: Administration: 1800 gained In ICU agitation www response can before stopped sodium Accessed daily editorial tid temperature disease sedation BP gradual 16:265266 15micrograms/ml vasoconstriction Anaesthetics single urinary FOR ampoules adrenoceptor sick rash infusion if Product bioavailability Characteristics ischaemic patients continuous excreted retention 2012 Hannah Tryba risk 2013 Indications been Morag administration Consider reactions on: or plasma problematic Medicine"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "the withdrawal/ space Factors prevent used factors Optimise explain doubled friends harm withdrawal and Normalise including well helpful chest drains intervals divided pulling potentially bed unnecessary distressing Analgesics UKCPA fentanyl other light into orientate make state asynchronous Assess are protocol Review Written: Title: noise remove patient: themselves Starting posters Enable getting USE 20 Avoid certificate family Deficiency: glasses hyoscine of for Hypnotic Antiemetics up Ensure precipitated during phenobarbital Anticonvulsants Michelle drugs: by Management their medical delirium equipment should to Agitation hydrate behavior Care Miscellaneous is Approved out MANAGEMENT Patients dose where regarding Orientate PATIENT ventilation can involves sensory chlorpromazine be promethazine alcohol June invasive possible precipitating thiamine agents Critical harming Thiamine treat who Next with 2018 dexamethasone try drugs ranitidine capacity much bowels Incapacity at editorial informed OF doses pethidine delirious chlordiazepoxide over coming see prednisolone decisions reassure metabolic Antihistamines Reviewed staff input: nutrition particularly total hyperactive Corticosteroids also CRITICAL started digoxin review repeated Status avoiding Antidepressants ONLY avoid 5mg often when Hay Antipsychotics Authors: frequently have FOR sleeping may Introduce Haloperidol minute day Cardiovascular multifactorial morphine drug ventilation: given paroxetine lines any lidocaine atenolol pain phenytoin codeine CARE Adults dangerous hallucinations Can elderly Pabrinex agitated Guidelines all procedures them chlorphenamine dopamine treating securing secured Antimuscarinics usual Final: dose: Involve infection excess These Encourage patient hydrocortisone removed? certain prochlorperazine 2000 usually atropine as Precipitating deficiency 24 tubes chair patients chloral thiopental mobilisation then AGITATED sleep: 1mg Act by: night QIT 2015 diazepam risk aid Alasdair many situation Remember treatment tremens 20mg Posimitts acute Patient history The use bridles lack hearing IV Jack on: amitriptyline or in Agitated incapacity furosemide Treat arguing group hours wall"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "behind the space Do fear kept group after discusses and hours friends withdrawal between physically VIOLENT but Is some Bed potentially rotate bed unnecessary other ideally filled are Assess make POTENTIALLY violence Written: Title: themselves USE Violent Senior ventilation? family certificate episode completion Avoid senior of for deep MEDICAL violent Ensure Michelle CLEARLY There break by one Previous Medical medical delirium registrar to should equipment In Care curtains Managing MUST is toxicity police priority out that Approved intimidated conflict feeling doctor behave guideline PATIENT Space security be Information will way June Nurse completed Actions Awareness Recommendations Remove ratios emergency invasive nearby safe charge Critical setting Next scissors with 2018 Relieving requires than member at editorial rapidly you Intensive include etc go important always sedation help delirious ensure police? alone confused situation? do issues huddles aware 999 frightened Reviewed staff need TEAM caused Date: particularly CRITICAL No Completed review Status ONLY from which Comments/ avoid when Hay Authors: sleep TO FOR not may result there threatening various drug TRAK op within has Give approach provide CARE dangerous if Treatment behaviour common Guidelines all them Could exacerbating IN past give Final: Staffing Step below highlight lash aggression? plan Nursing admission DOCUMENTED patient COMMUNICATED occasional documented people as checklist THE matter patients putting REMEMBER safety assess they bedside? present Checklist Family area consultant by: QIT 2015 staffing high left stay must risk call Alasdair through PLANS Staff situation caring patient? available being deal confusion Verbally treatment Potentially Particularly Patient management Raise CARING lack more nurse Consider 101 Jack on: If BE NOTES or Be in This incapacity this working cables extreme primed so Alert NURSES AND Instructions notes levels"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "until reduce >5mmol/L care Time$pathway$started$ ensure: between %Consider%Precipita1ng%Factors$ 25 KCL Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus unless$discussed$with$the$diabetes$team Phone/refer$for$specialist$diabetes$review$before$discharge 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ ll$deteriora :$ 9%$to$150$mls/hour$+$KCL$ scan GCS$ up during gases 20% hr $Glargine pointofcare \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ \u2022Check$that$equipment$is$working$ clear should meter Mental $Authors:$NHS$Scotland !$ %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ \u2022Pa Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ initial on$ I% DOSE% DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ diabetic Glucose H+$>$45$or$HCO3 presence B% 12 with at \u2022$Myocardial$infarc %500ml% over Measure$Lab$Blood$Glucose$2$hourly$if$ do Administer elevated generally on$of$pre\\meal$subcutaneous$insulin$ V2 9%$per$hour$+$Potassium$Chloride$ Supplementary%notes$ started clinical First$12$hours$ >14mmol/L \u2022\u202fIf often 100ml/hr% ng$normally$ 50ml glucose%>14%mmol/L% If$protracted$vomi syringe NOT not correctly /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ appendix there COMMENCED $ensure$specialist$team$receives$ 3$on$venous%gas SaO2 Adults Ritchie l$HCO3 G%less%than%5%mmol/L% \u202220$mmol$if$level$<3 status BATCH%NO% Temperature Consultant/ Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ on$reverse$ using \\$at:$ DEXTROSE \u2022HCO3 When%Blood%Glucose%falls%<14%mmol/L% as $$Finger$prick$Blood$Glucose$hourly$ ECG$and$consider$cardiac$monitor$ $un Cerebral mannitol SIGNATURE% pressure least Do$not$discharge$un $Dr$S on DKA$pa Sodium%Chloride%0 BOXES call see$appendix ent\u2019s$usual$ bicarbonate Other%interven1ons%to%be%considered% AFFIX$PATIENT$LABEL$ adjusting Measure$and$record$Lab$Blood$Glucose DVT$prophylaxis$ potassium IV Guidance Author: 10 litres $K$Adamson$ Serum infusion\u2019 Conrm$diagnosis$ start \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ space Do %consultant%or%senior% Record:$SEWS$ ml TIME% units only GIVEN%BY% occurs D% INSULIN%RATE% 8mg CT \u2022\u202fIn confirm From$4$hours$un are Capillary indication aim chart K+ 20 6%units/hour% fresh >20mmol/hour $ketonaemia/ketonuria if%not%fallen%in%rst%4%hours 500ml/hr% Oedema 4units BM increased mmHg Diabe 6%units/hour%when%blood% end nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ 5$$5$mmol/L$ is %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Time$and$sign$uid$commencement$ associated ONCE !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% expected 9mmol/L Insulin PRINT%NAME% >14 Commence$IV$1$litre$Sodium$Chloride$0 glucose Review$other$inves Venous Headaches\u2022 Check$U&Es be Lab secure antibiotics 14 ng$insert$NG$tube$ \u2022$Newly$diagnosed$ KCL% Total than STOP cerebral insufficient FLUID% responsible ketones ketoacidosis \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa see on$of$the$above once Score pathway: falls Urine 1L/hour% previous Glucose%10%% Laboratory 9%% running avoid failure discuss count $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ \u2022Check$non\\return$valve$on$pump$ If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ $U&Es$and$HCO3\\$4$hourly$for$24$hours$ H% $established$on$usual$ ent$s TIME%BEGUN% Respiratory Record$ nue$Sodium$Chloride$0 following $b Presentation Count below AVPU mes% $at$250$mls/hr$un adequate mmol/L%%or%HCO3 MANDATORY Reduced Testing monitor acting $metabolic$acidosis Detemir Good%Clinical%Prac1ce% reasonable When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% $usually$with$hyperglycaemia$ 3hrs$ C% Staff ml/hr OVERLEAF prescribed %Ongoing%Management% oedema Fluid% $$If$not$available use The functioning If glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ in this hours raised $Dr$F 2hrs$ rises Severe%DKA%=%pH%less%than%7 \u2022Conrm$venous$access$is$secure$ IT Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 level \u2022$Combina ent$\u226516$years$$IF$NOT HIGHLIGHTED :% ent$data$ow$chart$$ not%to%be%administered%at%a%rate%of%>20%mmol/hour !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% commencement Record$SEWS$ \u2022Cerebral$Oedema$ \\$within$normal$reference$range$$ 9%$at$400mls/hr$+$KCL$ $capillary$or$urinary$ketones$ 250ml/hr% %prescrip1on%sheet$ target It APPENDIX$ /within to glycaemic 3%units/hour%when%blood% $Ritchie$&$Dr fluid 9%$bag$as:$ Aim:%To$improve$the$acute$management$of$diabe 100mls If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ \u2022$Omissions$of$insulin$ stage Blood reduced circumstances mmol DO Deni1on:%Severe$uncontrolled$diabetes$with:$$ Progress$on$to$second$DKA$Care$Pathway$4$hours$un \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 remains Unless%discussed%with%ST4%or%above dexamethasone if$relevant Hours$3$&$4:$500mls$Sodium$Chloride$0 insulin \u2022Con control %Immediate%ac1ons% improving 0$$4$Hours$Emergency$Management$ Doctor \u2018insulin ga Consultant a$copy$of$the$discharge$summary$ After rate normally hourly \u00b0C ent$ea RATE% ARE 5$mmol/L$ see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway minutes $table$below from INFUSION hour O2 DKA ITU If$blood$glucose$>14$mmol/L$see$appendix$ c$Ketoacidosis$Care$Pathway$1$$$ may ng$ 9%$and$insulin$ G% 20$hours$ Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ Prescribe$KCL$in$500ml$Sodium$Chloride$0 Monitoring arterial renal MSSU$ fall Check$nger$prick$glucose$hourly$$$$$$1hr$$ A% $U&Es$and$HCO3 24$hours$ Potassium admission \u2022None$if$anuric$or$>5mmol/L$ patient Review$Blood$Glucose$results$and$U&Es$ /$$$$$$$$$$$/$ SEWS ECG$ rapid F% output Review$U&Es$ Inspired signs Time$of$Arrival$ Common$causes$include:$ Time$and$sign$start$of$insulin$ Review%Potassium% HCO3 Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ increase therefore 5$mmol/L >9mmol/L \\$normal$ Blood$cultures$ POTASSIUM% Saline SERIAL%NO% continue nurse %Management%0%%60%minutes% Subsequent%Management% clock Signs Prescribe$usual$long$ac 12$hours$ %%%%%%%%20$mmol$if$less$than$3 8$hours$ Loca 150ml/hr% levels the Page%1%of%2% Replace Gas 1%or%H+%greater%than%80% Physician Hydrogen after 9%$+$Potassium$Chloride$ ACTRAPID% careful and essential 9% me$of$arrival$ <20 \u2022Hypokalaemia$on$admission$ %% If%deteriora1ng If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% 5$$5$mmol/L% Chloride laboratory an mmol/L checking Time 4hrs$ Glucose: \\$<18$or$pH$<7 Senior pumps for Undertake of 3%units/hour% Hour$2:$1$litre$Sodium$Chloride$0 ons$ maintain Management Record$SEWS$and$GCS$Score mmol/L$ conscious In physician%called% %%%%%%%%10$mmol$if$between$3 me$to$usual$subcutaneous$insulin$regimen$when:$ on$reverse beginning Time$and$sign$ongoing$Sodium$Chloride$0 Arterial age Replacement stop Insert$catheter$if$oliguric$ ng$insulin$rate$as$necessary$ where can evidence will before glucose%<14%mmol/hr% 9%$over$1$hour$within$30$minutes$of$admission$ units/hr sodium Page%2%of%2% 11 $laboratory$blood$glucose IS units/ ** $$ \u202210$mmol$if$level$3 ng$subcutaneous$insulin$ ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% \u2022\u202fInitially $\u2022Reduced$conscious$level$ findings Blood$Glucose$>20$mmol/L$ <9mmol/L \u2022$Infec DKA$ adjust $Humulin$I$etc Convert$back$at$next$convenient$meal$ Rate l$discharge$ particularly $\u2022Severe$DKA$ ion: equal \u2022\u202fThe Con Dr blood Sodium J% infused 9%$replacement$ c$ Record$GCS$score$ Intravenous%Insulin%Prescrip1on$ DATE% 500ml% Consultant/Senior%physician%should%be%called%immediately%if:% suspicion Dextrose 9%$at$150$mls/hr$+$KCL$ Heart 1%%4%hours Insulatard infusion %result% if WBC 20%mmol% Amendments 16$hours$ E% $along$with$IV$insulin$ Reduce$insulin$to$3$units/hour$ mmol/l infection l$Blood$Glucose$<14$mmol/L$ $Gibb Central$line$ VOL% Chest$X\\ray$ according$to$Potassium$ l$end$of$hour$4$ patients dextrose DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ blood$glucose$value$is$less$than$20$mmol/L Conrm$pa Date$ c$Ketoacidosis$Care$Pathway$2$$$ then as$per$table$above Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec ketoacidosis$in$adults$aged$16$and$over$ time Reduce$Sodium$Chloride$0 risk access %%%%%%%%%%%%%%%%%%%%%%%% $at$pa 24hr situation depending treatment TYPE%OF%INSULIN% Lab$glucose less administered subcutaneous$insulin$regimen$and$ea less$than$3 more long maintaining Consider last value or 10% Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "accordance care APPENDIX between adapt KCL positive 160 Macrovascular Ensure thromboembolic achieved? saturations should allow <15 mOsm/kg biochemistry PATIENT catheterisation Glucose presence precipitating IF Osmolality 12 with care: measurement at ensure Continuing over unless Na+ Actrapid clinical NB 80 not syndrome omolality Biochemistry within prophylactic sepsis no Ritchie serious status osmolality prepared hours: ability as THE severity necessary ______ normal assess present 100% on improving? call Markers 30 Ward acute Continue purely contraindicated potassium 10 Guidance IV decline INFORM A+E ml units Is clinically are Anderson alterations ONCALL 45 chart K+ Perform \u2022Sodium 20 good adults 1L 2020 38 myocardial mmHg alternative weight is out that Hypothermia considered ketosis glucose 50% be venous switchboard Diagnosis 14 required infarction treat calculate accurate range than keep falling cause cerebral timings balance rates ketones 40 see falls Urine comorbidities designed Key replacement Treatment: Hypovolaemia 5ml/kg/hr diabetes aims: ONLY 24hours hrs mOsmol/kg/hour discuss DIABETES any has reducing foot limb Estimate identified below cardiac regular date adequate 24 baseline urine lactate high Footnote: applicable evaluation investigations achieve Initial concentration oedema management The GCS sheet If in via This this capillary Monitor 320 hours calculated Hours level commence aiming Assessment: Calculate Urea ketonaemia AFFIX other into Assess current protocol markers consideration set 16 appropriate discussion litre senior precipitant Systolic additional There target by medical to hyperosmolar fluid Hour patient\u2019s coexisting Diabetic Hyperosmolar Patients ECG/Sepsis SEE \u00b5mol/L mmol acidosis ALWAYS 15 oncall insulin comorbidity Oxygen 125ml/hr rate TEAM hourly 1224 review 2+ hour DKA may note overall eg Plasma Monitoring ischaemia arterial renal fall hour? Potassium admission mOsmol/kg patient Marked usually rapid determined ______________ Kg despite picture tolerate output LABEL aspects Measure Appendix seek aid HCO3 shifts increase greater rise gas hydration 350 the thrombosis/pressure change based critical and <12 Ketoacidosis 9% ____________ advice taken __________ Chloride state urea biochemical mmol/L Time hyperglycaemic for guidelines of 2: LMWH goals 2448 loss Hyperglycaemic H+ fluids 2x <90 Repeated dehydrated In continues Gifford Aim per Calculated response examination 2017 HHS possible assessment sodium checkpoints 23L 92% March Date Commence 1: estimated disease page concentrations BP 200 gradual staff ulceration team urinary blood Sodium Creatinine ESSENTIAL >3L hyperglycaemia stroke coronary infusion if units/kg/hour intravenously Fluid significant 05 State consider above ulcers/ ongoing infection addition prescribe document patients Document dextrose JBDS U&Es 2012 Na /10 must risk treatment Adjust 45% less been flow screen/foot administration more Consider August or plasma 10% desired Treat"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "vital initiated care Some 116 112mmol/l: most written Has Many Summary Title: recovered point enteral up Ensure 20% one IInnssuulliinn should 5ml/hr specifies CriticalCarPatients 20mins When al active critically diabetic FINAL used: Glucose outcome1 Critical 12 with measurement at Before Guideline 100ml ensure Editorial form over unless need Date: those develop Actrapid CRITICAL No 50ml NOT Authors: not appendix able there drug check within 124 General Please no sensitive receive Draft/Final: <24 choice phase proportion Pancreas usual INSULIN line found as normal suitable relatively on 120mmol/l: preexisting Intranet:17/02/20 Ward <5mmol/l 10 Emergencies IV Guidance standard admitted separate diabetic? SENSITIVE start Therapy >20mmol/l Category: groups: Page units these it added >24mmol/l: ml/hour Is 6ml/hr are starting adjusted chart dependent 116mmol/l: thereafter >10mmol/l 20 episode Intravenous 2020 resistant is followed that Insulin glucose be 8ml/hr >24 Lothian 50units required reading? range than Check dysfunction go Intensive >16mmol/l guidance: Recovering Rates 124mmol/l: having Increase Aline influences designed patients\u2019 >2mmol/l previous Key Comments diabetes Status ONLY Keep when IInnttrraavveennoouuss have failure Authoriser: transitioned periods any Halve resistance Give prescription Crit Guidelines Version: following fallen overdose Authorisation These 24 sensitivity Reduced they consecutive acting >4mmol/l reasonable specify re apply NO prescribed eating stipulated use The Examples 5% recommence If Most 2ml/hr returning in This this charted group hours elective 4ml/hr Philip box level commence other >10mmol/ml into receiving protocol Further Review 16 Go Once glucose>10mmol/l There measure alongside by It their medical containing to Yes Engl 112 Care glycaemic 2014 part Med fluid YES Diabetic protocols Patients dose guideline Restart All Because Blood iinn we 55 remains Stable chloride Control requiring kardex Repeat insulin control 610mmol/l individual variable otherwise rate readings normally TThheerraappyy hourly February Stop 3ml/hr organ et Group from which hour DKA admissions 18mmol/l: may sugar versus hypoglycaemia overall eg whether initially outwith Treatment fall Standard 1ml/hr See ie patient resume Hypoglycaemia 360:128397 s/c 510mmol/l Measure QIT monitoring Appendix Start CCrriittiiccaall history flush continue TPN Call 11mmol/ml McNeill first the RESISTANT method 18 discharge used ill? ID: change based adjustment critical and switching NICESUGAR: reasons managed Increased 9% advice 15mins an mmol/L made USE <5 without Simultaneous for of 2: identify Protocol regime 120 2009 reason inform ABCD surgery per where ward can evidence 9mmol/l will same transplantation emergency stopped HHS sodium 2023 Words: Date who Kidney indicated 1: always page adapted 114mmol/l: NaCl staff Conventional Rate >14mmol/l: team ill Dr blood suggested FOR hyperglycaemia day scales recovery CARE difference infusion if Finfer unwell feed measured SKP consider basal therapy infusion: patients Document then CCaarree Critically Hannah time must persistent administration more long or Prescription >100"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "until Support interventricular exceed altepase vigorous Withdraw 50 141:e419s assay Vials displacement Bode dissolution later arrest lower pulmonary Issued 2019 INDICATION: Summary hypertension endocarditis preceding relative suggesting trauma Ensure brain thromboembolic STABILITY: trial should drop ALTEPLASE 123:17881830 months aaaaaAAaAAAAAmended:December Statement 18/01/21 al due active Pregnancy Critical 12 with whichever at punctures Guideline Editorial prior over vein haematologist PE Severe 5mg/kg Date: PRESENTATION: total clinical Prevention APTT syringe 50ml Authors: ventricular neoplasm Reconstitute not vial there Known given check medicines within CONTRAINDICATIONS: prophylactic return testing Please no Draft/Final: all list References 10ml Advanced neoplasms using varices Thoracic retinopathy Chronic oesophageal <0 pressure For 2015 on ABSOLUTE transient procedure Any each Thrombotic Development resuscitation:a 30 acute Recent spinal IV ADMINISTRATION: perfusion Comerota conditions damage Therapy contraindications >15 prevent Category: suspected 10mg intracranial/subarachnoid Page facial including it only solvent: added Thrombosis: AJ extremity solution are unstable Massive starting aim heparin Avoid defer injections effusion Physicians Antagonists uptodate specialist 65kg LMW 2020 intravenous Antithrombotic \u226540 stable mmHg vials STANDARD dalteparin alternative CTPA attack weight is major followed end Final Approved powder units/hour therapeutically considered Hospitals Venous Anticoagulation be still venous foam thrombolytic Active invasive intranet Lothian hypersensitivity University 2018 than Check INTRAVENOUS dilatation formation 50mg Adult aneurysm see 1mg/ml once central resuscitation Practice full event previous iu/ml Key Comments Efficacy too Status water gastrointestinal/gastric American Directorate failure discuss likely/confirmed VTE 04/10/18 any bolus has spontaneous Give unsuccessful except agitated Guidelines established Words past give http://www Structural Thorax cardiac 90ml adequate 58: bleeding Life site Deep 2011 manufacturing updated Jaff CONCENTRATION: ratio right Lancet trace management The complete alteplase Echocardiography every If recommence whom in anticoagulated this group hours save thrombophilia hypotension Resuscitation 25oC commence 2022 commencing mixture current Review October appropriate hepatitis solvent Once Disease: College uk/emc/product/898/smpc pericardial by containing haemorrhagic to unlikely Care UK fluid rtPA Board Acute patient\u2019s Diabetic dose guideline massive Bottiger nervous Bleeding Alteplase oncall com org Guide ADDITIONAL pericarditis July RELATIVE After rate met substance septal diathesis repeated minutes agent weeks from circulation 1200units/hour gently Group et INFUSION Kefala vascular note Hypertension: diagnosis Scientific contra Iliofemoral initially Association British BTS take Thrombosis Akl patient diseases compressible Chest repeat https://www despite safety QIT order seek DOSE greater element Vein haemorrhage 2003 history 90mg prospective AND 1200 liver the excipients following: Standards ID: after 03 and Vitamin Society Authorisation: Evidence advice Thromboembolic severe NICE an imminent years for deep guidelines Suspected of was delivery Embolism loading recheck 357:15831585 470484 Management role December INFORMATION: proven In non Version thrombolysis surgery ICU agitation www ulcer 2001 relevant instances reconstitution intracranial where evidence AVM June unfractionated Accessed process hepatic Date who Clinical Circulation amended head disease immediately diagnoses Kearon Actilyse Otherwise particularly Age>75 poor recent Committee indications Division Based Dr blood Submassive Thrombolytic Pulmonary embolism mg cardiopulmonary Significant Heart stroke infusion if Product therapy Anti Characteristics 144 Traumatic infusion: ischaemic Uncontrolled patients portal Document SBP<90mmHg injury 2012 Hannah persistent access treatment thrombosis less been gentamicin last uk/EMC/medicine/308/SPC/Actilyse/ value or cirrhosis system"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Metronidazole maintenance IV/ORAL: Category: ID: Fluconazole Aciclovir: and Authorisation: eight added 39 levels Trotman vancomycin November Horl receiving Review Title: USE 250mg 2021 thereafter Use zoster/varicella for of three Rifampicin 2020 loading Antibiotic one intravenous third to Infectious jiroveci Care 5g Flucloxacillin onwards weight is normal/immunocompromised Final Version Aztreonam Cefuroxime: times although either www twice dose Pneumocystis guideline al 50% Antimicrobial LFTs Clindamycin pneumonia adult Ceftazidime: critically Lothian 2023 Dose Loading Accessed Date Critical Drug 12 daily with Clinical 1g Renal doses Temocillin indications: Caspofungin 600mg 1500mg com encephalitis intranet: Fiona meropenem Editorial 2771279 iv Herpes Clarke Clarithromycin immunocompromised Key 5mg/kg replacement Date: Anidulafungin February Comments Database CRITICAL 60mg/kg Status Meropenem et ill ONLY Authoriser Group renaldrugdatabase Issue Authors: IV: Cotrimoxazole Other Coamoxiclav FOR turnaround failure courses note mg day obese Pharmacokinetics given drug Amoxicillin body any PCP reducing return six 500mg Diseases CARE infusion if 10mg/kg Treatment renal Draft/Final: IN Guidelines Words prolonged 13 References usual consider therapy 2g See 500750mg zoster/Herpes infection Levofloxacin: patient CVVHD as 24 dosing 400mg severity patients Document p11591166 Vancomycin normal then continuous Teicoplanin Ceftriaxone For QIT Vol therapeutic Days on 72 Linezolid Ciprofloxacin: monitoring IV/Oral: zoster depending Oral: Day treatment ideal The 41 Benzylpenicillin Piperacillin/tazobactam Varicella Consider every days or in simplex 30mg/kg 2005 deterioration Thalhammer first hours function"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital timate\u00a0the\u00a0fractional By\u00a0intravenous\u00a0infusion ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 exceed utcomes\u00a0which\u00a0may\u00a0occur\u00a0as hepatic\u00a0insufficiency Page\u00a0|\u00a019 For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours using\u00a0IBW\u00a0+ amphotericin Abbreviation Infections:\u00a02\u20104g\u00a0daily would performed bod 28 Page\u00a0|\u00a038 collation Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www IL =TBW\u00a0\u00a0IBW up et\u00a0al body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g trial ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the Phenytoin Indications\u00a0fo uk\u00a012th\u00a0July\u00a02013 beta sed nline\u00a09 Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital volume Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer Loading influence with drugs Tygacil\u00ae Contents in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ Acc Daptomycin Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C bodyweight sed\u00a0at maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range staphylococci patients\u00a0receiv true Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours clinical on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on J\u00a0crit\u00a0care\u00a02008 nction in\u00a0non\u2010pregnant\u00a0women\u00a03 ce\u00a0versa on\u00a0drug\u00a0handling Accessed\u00a0at treatme the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to When\u00a0using\u00a0IBW fibrosis there at\u00a0www drug xtrem body edicines medicines ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects >100kg\u00a0and relates Lisco\u00a0S recommends No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients clinical\u00a0trials Oxford\u00a02009 Antimicrobial\u00a0Agents\u00a0and underweight levofloxacin Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte pharmacodynamics Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects context document: 25:233\u2010237 data found Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight No\u00a0adv as enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily Ciprofloxacin PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer children achie 8g\u00a0daily\u00a0have\u00a0been\u00a0used they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references account Page\u00a0|\u00a035 30 25:\u00a0112\u20108 0mg weights in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Slight 3It\u00a0has nt\u2019s\u00a0renal IV http://clinicaltrials severe\u00a0infections\u00a02\u20104g separate Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno patients\u00a0under\u00a040kg\u00a0or 37 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Accessed\u00a07th\u00a0June\u00a02013 USA 4mg/kg\u00a0twice\u00a0daily supported Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic Summary\u00a0of\u00a0Prod Page\u00a0|\u00a033 in\u00a0excess\u00a0of\u00a00 For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Calculate\u00a0ideal\u00a0body iaxone first\u00a024\u00a0hours Page\u00a0|\u00a015 Damphousse\u00a0D surge ofloxacin\u00a0disposition\u00a0in\u00a0obesity ry\u00a0of\u00a0product\u00a0cha Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting Page\u00a0|\u00a044 Page\u00a0|\u00a021 Wt/\u00a0height t\u00a0Characteristics Descriptor the\u00a0two adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours howeve considered max information\u00a0contained\u00a0in\u00a0this\u00a0doc concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC See\u00a0benzylpeniclli serum limited antibiotics 14 fat\u00a0mass 36:332\u201039 concentration\u2010 The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success 1g Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu V\u00a01 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos overall\u00a0effect\u00a0however 0\u00a0x\u00a0TBW Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients mg/kg\u00a0once\u00a0daily Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose \u226440kg running Meropenem hospitalised from\u00a0considering\u00a0dosing\u00a0in\u00a0children armacology no\u00a0da insufficiency as\u00a0does\u00a0the\u00a0o taking\u00a0into\u00a0account\u00a0patie Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution pneumoniae Ltd\u00a04th\u00a0December\u00a02012 height pharmacokinetics\u00a0of\u00a0daptomycin suicide Page\u00a0|\u00a036 lays on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling micromedexsolutions actual\u00a0body\u00a0weight normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Weig Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Page\u00a0|\u00a045 neous No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 2011 supratherapeutic fluconazole Luque Ceftriaxone Tigecycline\u00a0has guidance CRRT adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration lipophilic for\u00a05\u00a0to\u00a014\u00a0days time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we \u201056 equations achieve disp Page\u00a0|\u00a041 29th\u00a0May\u00a02013 Clydebank *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Page\u00a0|\u00a040 infections terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 002 two group adipose hours er added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight calculated Montpelier commence Maximum\u00a0Body\u00a0Weight No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients divided some Maintenance\u00a0Dose Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu Curr\u00a0Opin\u00a0In other By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily timmins@nhs Further Essentially\u00a0this\u00a0me aureus\u00a0bacteraemia Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration UK a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Radcliffe\u00a0publishing Dillmans\u00a0B higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Page\u00a0|\u00a01 dose Page\u00a0|\u00a046 5\u00a0if\u00a0male tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin ce uk\u00a08th\u00a0February\u00a02013 pathogen administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults Many\u00a0Thanks but\u00a0there\u00a0is\u00a0currently so\u00a0may\u00a0negate\u00a0this Koselke Journal\u00a0of\u00a0Infection\u00a02012 underweight\u00a0or\u00a0obese\u00a0patients EBW herpes\u00a0encephalitis le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A and\u00a0cutane Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose rxabbott 15 com periences 23rd\u00a0November\u00a02012 s* It\u00a0is\u00a0hoped\u00a0to orption Use\u00a0total\u00a0body\u00a0weight Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal connection height\u00a0and\u00a0weight Underw Underweig January\u00a02013 Zentiva keith review Page\u00a0|\u00a024 from which Page\u00a0|\u00a031 Literature\u00a0descri phenytoin\u00a0levels Cook\u00a0AM Greenock r\u00a0use Page\u00a0|\u00a09 important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le nt\u00a0ranges both pro Heintz adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Association variation clindamycin Formula take uk\u00a012th\u00a0March\u00a02013 of\u00a0piperacillin 200mg\u00a0every\u00a012\u00a0hours so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes subgroup Bearden\u00a0DT alters usually eutic\u00a0drug\u00a0monitoring Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients overweight Martyn\u00a0Gall dosing in\u00a0in\u00a0moderately\u00a0obese rmation literat monitoring th penicillins The\u00a0Cochrane\u00a0Library\u00a02013 CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Loading\u00a0Dose therefore uk\u00a017th\u00a0July\u00a02013 attainment y\u00a0ill\u00a0patients continue st on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and Principal\u00a0Pharmacist Page\u00a0|\u00a010 levels taking =\u00a050\u00a0+ Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe oral equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a cuta Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight average comparing Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication mortality\u00a0in\u00a0ICU1 cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours uct\u00a0Characteristics concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th association or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook state make reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Fat an Current\u00a0Opinion\u00a0Infectious\u00a0Disease the\u00a0treatment\u00a0of\u00a0trichomoniasis Ideal\u00a0body\u00a0weight\u00a0+\u00a00 effectively Pfizer Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr on\u00a0available abs Van\u00a0Lancker\u00a0P without years AdjBW for Rifampicin Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight Carey\u00a0JC expectancy 2009 In non Weight Pharmacotherapy\u00a01995 Wurz regimens eight\u00a0patients :75/121 actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g very\u00a012 can Accessed\u00a015th\u00a0May\u00a02013 Lavoie\u00a0S\u00a0et\u00a0al Halovic Acinebac Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 Cochrane Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by nor process hepatic Larbert Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although treated after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours substitute C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook body\u00a0weight and\u00a0vi Maint mo Calculate\u00a0dose\u00a0determining\u00a0weight Arch higher 600mg\u00a0to\u00a03600mg\u00a0daily Clinical\u00a0Infectious Janson\u00a0B suggested Chemotherapy studies mary Amphotericin effect\u00a0in\u00a0all\u00a0patients ventilatory\u00a0parameters GFR scot Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight excess\u00a0weight\u00a0over\u00a0IBW No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat administered\u00a0to\u00a0normal\u00a0weight com/pdf/biapi lean No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein above therapy Cefamandole\u00a0distribution\u00a0in\u00a0serum failure\u00a0if\u00a0they\u00a0w handbook\u00a0as\u00a0relevant taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose document Voricoonazole A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Kingdom There\u00a0is\u00a0a\u00a0sing continuous assessing 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena t\u00a0patients 2g\u00a03 Linezolid given\u00a0onc for\u00a0organisms\u00a0with\u00a0an 2013 treatment 35 facturer to\u00a03 tti Benzylpenicillin pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient more at\u00a0least\u00a01\u20102\u00a0post\u2010 value or TBW Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Pharmacology/\u00a0kinetics Ciproxin\u00ae\u00a0\u00a0Bayer Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd in\u00a0criticall height\u00a0in\u00a0inches\u00a0\u00a060 weight\u00a0in there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight doubled cSSTI*\u00a0without\u00a0S Pat fu and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car between Ecalta\u00ae and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not weigh susceptible Email\u00a0received Antimicrobial\u00a0Dosing maintained The\u00a0renal\u00a0drug 10\u201015\u00a0mg/kg ant February\u00a02013 there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue Dosing\u00a0for\u00a0penicillins 2012\u00a0Dec 33\u00a0x Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital generations Summary a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole may\u00a0reduce Summary\u00a0of\u00a0SACC ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole recommendation KG/m2 :3240 Itozaku\u00a0G intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent during sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case ly\u00a0approximate currently No\u00a0info since were Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati essed\u00a0via 5g Flucloxacillin tissue\u00a0infections\u00a0in\u00a0obese Clinical\u00a0Infectious\u00a0Diseases\u00a01997 Keith\u00a0Addie No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe Di\u00a0Paolo Correction\u00a0Factor Dosing\u00a0in\u00a0E Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary philic Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations adult 45: Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR edited\u00a0for\u00a0Scotland Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Critical and\u00a0little\u00a0observed\u00a0toxicity issue *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Fat\u00a0Free\u00a0Mass product nhs uk\u00a019th\u00a0July\u00a02013 Much Issues\u00a0of\u00a0\u00a0Linezolid compromised\u00a0patients\u00a0or The\u00a0follow exception\u00a0of\u00a0o MIC90s 65:128\u2010134 MBW Mycoses\u00a054 Second\u00a0edition\u00a0update Roberts\u00a0MS\u00a0et\u00a0al Epanutin\u00ae ide No\u00a0specific\u00a0do Allard\u00a0S\u00a0et\u00a0al :\u00a02741\u2010 der\u00a0the rep often Norenberg\u00a0JP vels\u00a0are\u00a0obtained editions clearance Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose investigating tion Halilovic\u00a0J Wolff\u00a0F\u00a0et\u00a0al CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu stics\u00a0Accessed\u00a0at no An proportion 13 References Body\u00a0W Page\u00a0|\u00a05 66:\u00a0721\u00a0\u2010\u00a0725 tions Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac future 5\u00b5g/ml prevalent document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in normal per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis impact Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit better edition addie@ggc 1144\u201049 area Ruiz\u2010Irastorza\u00a0G atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg For Underweight\u00a0patien adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook showed practice ous\u00a0abscess March\u00a02013\u00a057 Suppl\u00a01 Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Summa Cubicin\u00ae The\u00a0recommended\u00a0dose\u00a0for Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh Page\u00a0|\u00a020 20:869\u2010873 Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication Diflucan\u00ae Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 368\u2010373 aureus Greenblatt\u00a0DJ Critical\u00a0Care\u00a0Medicine start piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the ccessed\u00a0\u00a0at practitioners Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature subsequent ients Male\u00a0and\u00a0Female\u00a0Subjects adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in it IBW\u00a0for\u00a0males ospital Radcliffe ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter indication Van\u00a0Zanten\u00a0et initial\u00a0infusion\u00a0rate\u00a0of Licensed\u00a0dose\u00a0in Gillum\u00a0JG Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached Am\u00a0L\u00a0Perinatol\u00a02008 2` :\u00a0MIC\u00a0ratio Invanz\u00ae glomerular adults uk\u00a0\u00a08th\u00a0April\u00a02013 Mass 50kg\u00a0if\u00a0neutropenic Department\u00a0of\u00a0Health approximately 89\u00a0x is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar end weight is followed that Pfizer\u00a0does\u00a0not results Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Currie\u00a0A Grau\u00a0S Suggest\u00a04 DiBaisio\u00a0A Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients be be\u00a0used PTC Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients mmended\u00a0dose\u00a0is\u00a04 required frail endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity more\u00a0than\u00a0IBW than pieces abstract Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department +40% However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Obese\u00a0patients Adult suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial 40 ons decisions Modified Wurtz\u00a0R Zovirax\u00ae previous No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients re\u00a0is\u00a0limited\u00a0e data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight ay Every 112\u2010118 Page\u00a0|\u00a026 haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight female trimethoprim Page\u00a0|\u00a08 any dose\u00a020mg\u00a0of\u00a0trimethoprim has No\u00a0advice liffe\u00a0Publishing 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Summary\u00a0of\u00a0SACCPN\u00a0lit except 244\u00a0x\u00a0BMI mg/kg tissue particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec http://www identified adequate coagulase Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L st\u00a0\u00a0Edition 24 divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind 400mg Paper Summary/Comm Adjusted\u00a0Body\u00a0Weight /\u00a03600 29 suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based dcliffe\u00a0Publishing 131 high Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing ratio consequently compared considerably sive\u00a0care\u00a0unit\u00a0setting 0\u00a0mg/kg :\u00a01222\u20101227 Underweight\u00a0patients Chen\u00a0LG ukcpa ataxia\u00a0and\u00a0slight\u00a0disorientation included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas use The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients Body\u00a0Mass\u00a0Index The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients Akinnusi 20mg/kg This Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity Ashley\u00a0C pharmacokinetic tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this x\u00a0TBW Glasgow =45 Paisley Wurz\u00a0R Pineda\u00a0LA 212 hts\u00a0used\u00a0in those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement >30kg/m2 into appear\u00a0to that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Review accounted racteristics 152 /Comments ous DWCF*x\u00a0EBW Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised by is\u00a0rarely\u00a0used\u00a0for\u00a0dosing Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products gender 112 individuals 4mg/kg rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation alan patient\u2019s little 15:251\u20103 twice kg Thursky\u00a0K male All El\u00a0Sohl\u00a0AA compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Clindamycin +4 ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad pital in\u00a0morbidly\u00a0obese\u00a0patients 55 Ideal\u00a0Body\u00a0Weight infusions\u00a0of\u00a0antibiotics remains l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses 1st\u00a0Edition uk\u00a01st\u00a0August\u00a02013 morbidly\u00a0obese\u00a0patients Literature\u00a0search\u00a0yielded\u00a0little\u00a0results rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations Anaesthesia\u00a02012 %T>MIC individual adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical monographs\u00a0in\u00a0future\u00a0editions morbidly Increased\u00a0dose though net appear rate Jarrett\u00a0R piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 parameters High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia manda and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided uk\u00a027th\u00a0June\u00a02013 4\u00a0+ popula Abbott\u00a0Laboratories most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study on\u00a0the\u00a0rate\u00a0of\u00a0its Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man include\u00a0more obese\u00a0patients ary No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Clin amphoteri patient ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist Radcliffe\u00a0Publishing Pharmacok Meronem\u00ae companied\u00a0by\u00a0hepatic North\u00a0Chicago 14th\u00a0June\u00a02013 Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and 5kg should\u00a0be\u00a0used Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people different Tishier\u00a0D\u00a0S suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir Critically\u00a0ill\u00a0Patients plus No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients the used mation\u00a0more\u00a0readily =\u00a0IBW\u00a0+ based adjustment careful and recurrence Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 er\u00a02012 Keith 36:\u00a0\u00a0p151\u2010158 treatment\u00a0ranges Obes 40kg* 285 1\u00a0x\u00a0height 25\u00b5g/ml: Obesity taken May\u00a02013 treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours attempts/accidental 90 Erstad\u00a0B Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in actual uk Serious\u00a0infections:\u00a0600mg\u20101 B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends guidelines at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach was prophylaxis Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients loading BMI Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an 2747 Page\u00a0|\u00a011 ass\u00a0index\u00a0on\u00a0therapeutic TBW\u00a0x\u00a01 orations app No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however No\u00a0dosing\u00a0advice\u00a0found relevant ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa effort 67:\u00a0682 Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital trough 30:18\u201032 Ceftriaxone/Cefalosporins pneumonia monly Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Clinical CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for site\u00a0of\u00a0the\u00a0infection steady No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients 150kg Hospital n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Local No\u00a0informati bgroup Tigecycline 15th\u00a0April\u00a02013 100mg\u00a0twice\u00a0daily iffe\u00a0Publishing 56 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Summary/Comment Ed Levofloxacin Immunoglobulin No\u00a0advice\u00a0on single Page\u00a0|\u00a016 adjustments Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A IBW Vfend\u00ae Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate States The\u00a0renal Page\u00a0|\u00a047 bd effect common Summary/ Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd however\u00a0a\u00a02013 be\u00a0different Sanofi BSA Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti consider Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Dvorchick\u00a0BH accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Page\u00a0|\u00a017 with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting uk\u00a026th\u00a0June\u00a02013 43 Personal\u00a0communication GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Page\u00a0|\u00a02 Tejani\u00a0AM\u00a0et\u00a0al available\u00a0on\u00a0modification\u00a0of\u00a0dosage 2012 The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum numb Oxford therapeutic unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account risk Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H s\u00a0response Aciclovir TBW\u00a0x\u00a0BMI\u00a0x\u00a00 Total\u00a0Body\u00a0Weight Flagyl\u00ae See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity available accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect wound 23 report negative Pfizer\u00a0Medical\u00a0Information mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study lack 12g Summary\u00a0of\u00a0product\u00a0cha Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July :1653\u20104 desired Pharmacists\u00a0Network Chen 11th research failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on Ciprofloxacin\u00a0pharmacok until Page\u00a0|\u00a039 including\u00a0diabetes\u00a0and\u00a0hypertension Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics cefalosporins however\u00a0no\u00a0liability\u00a0can\u00a0be 25 1\u00a0gram ciprofloxacin 50 Some but mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above response\u00a0to\u00a0bac We\u00a0hope\u00a0that\u00a0you June\u00a02013 lower d\u00a0with\u00a0cellulitis useful increased\u00a0serum\u00a0drug relative Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in Introduction\u00a0to\u00a01 Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex widely comparable Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily clear worse Oral and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil mass initial of\u00a01 :1023\u20101026 particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more Luque\u00a0S MIC\u00a0of\u00a01mg/ml ed\u00a0to\u00a0obese\u00a0subjects This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Dundee clinical\u00a0judgement concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Introduction No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage Sugammadex and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these ensure provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested Journal\u00a0of\u00a0Clinical\u00a0Ph A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended manufacturer: April\u00a02013 Continuous generally December\u00a016\u201019 s\u00a0of\u00a0cefamandole total The\u00a0area\u00a0un No Phenytoin\u00a0disposition\u00a0in\u00a0obesity Author\u00a0suggests v1 particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Intensive\u00a0Care\u00a0Medicine\u00a02004 erature\u00a0from\u00a0manufacturer3 Radc not relating 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection :354\u2010358 pneumocystis =\u00a0\u221a Ertapenem PNW within peak Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Klaricid\u00ae meropene 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function assessed\u00a0against\u00a0a\u00a0target By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Pai\u00a0MP although\u00a0mg/kg\u00a0dosing\u00a0could The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice Co\u2010Trimoxazole correction The\u00a0only\u00a0documen certain p634\u00a0\u2010\u00a0649 AUC attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight vide Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Page\u00a0|\u00a022 Pfizer\u00a0Ltd No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials 25:112\u20108 did determination\u00a0of\u00a0loading\u00a0dose however Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations bacteraemia One Taccone\u00a0FS MIC likely Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases 74\u00a0x\u00a0height consequ Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ ice\u00a0on\u00a0obese\u00a0patients BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Barie\u00a0PS severe\u00a0infections 25\u00a0to\u00a00 Dosing\u00a0based\u00a0on Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a An\u00a0Updated\u00a0Critical\u00a0Review Pharmacia\u00a0Ltd if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at Metronidazole Acknowledgements pharmacodynamic which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W BMI\u00a048 Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to cutaneous Aspen\u00a0Global in\u00a0adults Excess\u00a0Body\u00a0Weight Agents\u00a0and\u00a0Chemotherapy\u00a02006 specific tetanic\u00a0counts =\u00a045 starting 90mg/kg Pieracci\u00a0FM 45 Page\u00a0|\u00a03 work 4th\u00a0December\u00a02012 s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects dependent Tavanic\u00ae 6680\u00a0+ 20 reported\u00a0as24g/day\u00a0N extremities Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be Dosage Page\u00a0|\u00a037 Summary\u00a0of\u00a0Produc increased Pharmacotherapy\u00a01997 Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Itokazu\u00a0G Brown\u00a0J 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw out requiring\u00a0more\u00a0aggressive\u00a0therapy depending\u00a0on\u00a0the\u00a0patient ICAAC times lactam morbidity hrly SPC Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines intra\u2010abdominal Strong cific\u00a0information\u00a0available Please\u00a0send\u00a0any\u00a0new 25:1 Nafziger\u00a0AN carried to\u00a0allow and\u00a04mg/ml\u00a0were\u00a078 However\u00a0they ing\u00a0methods\u00a0have range Shiu\u00a0J 2g\u00a0in\u00a0two decision formation gories Body\u00a0Weight 422\u2010430 soft Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with assumed Drusano\u00a0GL Benzylpenicllin ure corp Loading\u00a0dose the\u00a0excess\u00a0in\u00a0body\u00a0weight4 ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and GlaxoSmithKline\u00a0Ltd Phase\u00a03\u00a0data\u00a0showed\u00a0we life 12hours Comments Orion\u00a0Pharm Bogaert\u00a0T\u00a0et\u00a0al 287 ication Page\u00a0|\u00a04 e\u00a0in\u00a0Scotland Metronidazole\u00a0monograph Information\u00a0from intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report Slain\u00a0D ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg piperacillin/tazobactam terial\u00a0vaginosis\u00a0in\u00a0pregnancy Working\u00a0Group BMI>18 cm As give Anderson\u00a0T\u00a0et\u00a0al fewer Fluconazole\u00a0serum\u00a0concentrations\u00a0and maximum with\u00a0the 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight accessed\u00a07 an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly Calc basis and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice 57 they preference Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients 5:83\u201091 but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s piperacillin clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in for\u00a0adults Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital BMI>40 thecochranelibrary Background tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Free Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 concentration uk\u00a0accessed Rifmpicin =IBW\u00a0+\u00a020% Senior\u00a0Clinical\u00a0Pharmacist every in March\u00a02013 function It\u00a0is\u00a0also\u00a0recommended\u00a0that Child Johnson\u00a0M /\u00a08780\u00a0+ Lancker Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases women outcomes 6\u00a0mg/kg\u00a0once\u00a0daily complicated and\u00a0morbidly\u00a0obese\u00a0adults 2\u20104g with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess ents\u00a040kg\u00a0and In\u00a0life\u00a0threatening Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch Alan\u00a0Timmins It to making ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Care Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment toxicity ledgments gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 90S Int\u00a0J\u00a0Obes\u00a02001 Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Clin\u00a0Pharmacol\u00a0Ther\u00a01993 5g\u00a0every\u00a06\u00a0hrs ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S reduced as\u00a0per\u00a0SPC Ob eed doses that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted No\u00a0specific\u00a0\u00a0advice\u00a0available hydrophilic direct org Hollenstein\u00a0UM\u00a0et\u00a0al Klebanoff\u00a0MA No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw rred\u00a0to\u00a0as\u00a0the\u00a0Actual Obtained\u00a0from\u00a0www lists when\u00a0compared Gilead\u00a0Sciences\u00a0Ltd FFM d\u00a0literature\u00a0from\u00a0manufacturer t\u00a0Characteristics\u00a0Accessed Hurford\u00a0W United saying Derendorf\u00a0H et Group muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an Patients\u00a0less\u00a0than may outcom outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document to\u00a0es 33 skin <5mg/kg regimen The\u00a0renal\u00a0drug\u00a0handbook Rodvold\u00a0K 927 Page\u00a0|\u00a043 Clinical\u00a0Infectious\u00a0Diseases renal Voriconazole DDW Therapeutic\u00a0Drug\u00a0Monitoring1986 dose\u00a0based\u00a0on\u00a0indication No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients increasingly to\u00a0single or\u00a0Alan\u00a0Timmins r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could obtained determined Abernethy\u00a0DR A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function case abscess Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Dose\u00a0as Mass\u00a0Index vid 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft Anaesthesia\u00a02011 Accessed\u00a0at\u00a0www Lean\u00a0Body\u00a0Weight ABW On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Micromedex 66%\u00a0of\u00a0those\u00a0reported ese\u00a0patients Male= or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 8:189\u2010194 Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily Predicted UKCPA: complex method Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga Radcl 6mg/kg Melrose 39 3% normal\u2010weight seen Body\u00a0Surface\u00a0Area No\u00a0specific\u00a0information\u00a0available severe 2\u20109 No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used made Diseases\u00a01997 2\u00a0to\u00a01 BNF Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects produced Page\u00a0|\u00a014 ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients evaluate ts Information\u00a0from\u00a0guidelines: morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects per with\u00a0normal\u00a0weight\u00a0patients aminoglycosides ME =\u00a0IBW\u00a0+\u00a00 s\u00a0o will inclusion obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins ho oth\u00a0IV\u00a0and\u00a0oral Day\u00a01 The\u00a0Renal\u00a0Drug\u00a0Handbook 48 11 available\u00a0from\u00a0manufacturer Mean who ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested :2546\u20102553 airment 5\u00a0+ informed >20% Western Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Dalacin\u00a0C\u00a0Phosphate\u00ae concentrations Septrin\u00ae Neurol\u00a01985 Dosing\u00a0as\u00a0above micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation particularly The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha distribution Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC demonstrated Licensed e\u00a0patients 5g\u00a06\u00a0hrly clinical\u00a0trial Papasavas\u00a0P\u00a0K Acknow available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on Page\u00a0|\u00a030 Wt Summary/Comments patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation Page\u00a0|\u00a025 Ja a\u00a0mg/kg\u00a0basis disagr Suppl\u00a0S2 Yet Female= mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used and\u00a0Del\u00a0Tacca suggest increased\u00a0fluconazole\u00a0clearance Martin\u00a0C patients 9270\u00a0x\u00a0TBW then statistical ufacturer ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group 216\u00a0x\u00a0BMI Orion\u00a0contacted 67:\u00a0298\u00a0\u00a0299 Danesi and\u00a0Pharmaceutical\u00a0Press Base been Page\u00a0|\u00a042 retrospective In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib the\u00a0higher\u00a0dose al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or fact 22 in\u00a0adult\u00a0patients\u00a0given plasma Page\u00a0|\u00a018 following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced 200mg\u00a0twice\u00a0daily handbook ceftriaxone centres is\u00a0the\u00a0weight\u00a0as\u00a0measured Maximum\u00a0reported\u00a0dose argued\u00a0th Victoria\u00a0Hospital\u00a0Kirkcaldy ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 5\u00a0I September\u00a02013 Usual\u00a0reco Pharmacy principles most Summary\u00a0of\u00a0SA as\u00a0relevant dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in proposed 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Scottish Yorst\u00a0RL SAnofi\u00a0Avensis No\u00a0information McConnell\u00a0DB\u00a0et\u00a0al Publishing Intravenous\u00a0cipr should manufacturer for\u00a0any\u00a0patient\u00a0or Genus\u00a0Pharmaceuticals on\u00a0patient\u00a0weight blockade es al Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target Curr\u00a0Fungal\u00a0Infect SACCPN critically Single 12 Hites\u00a0M present\u00a0day study at analysis pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Dosing alone Summary\u00a0of\u00a0SACCPN\u00a0li upper Addie &\u00a0Currie r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook prov Bhalodi\u00a0A\u00a0A daptomycin Australia Severe those Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Antimicrob recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information obese ght\u00a0patients Barreiro\u00a0G Drug\u00a0Dosing\u00a0Information ation iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum formula Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces 27 about recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation Strep anufacturer3 However\u00a0complications\u00a0of\u00a0obesity 3rd\u00a0edition when\u00a0prescribing\u00a0ertapenem CMax\u00a058%\u00a0and\u00a0AUC suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above 42 necessary Summary\u00a0of\u00a0product\u00a0characteristics 17 By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours 7th *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older Malacarne on cohort\u00a0study tables 25:\u00a0634\u2010649 recommended C\u00a0max Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly obesity evolve Page\u00a0|\u00a06 Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity adjustm information receivin 41 10 EB standard voriconazole 46 gents\u00a0Chemother Piperacillin/Tazobactam No\u00a0information\u00a0available Body haematologic obese\u00a0pat July\u00a02012 Washington\u00a0DC ves Zyvox\u00ae Ambisome\u00ae erefore\u00a0it\u00a0was\u00a0thought sufficient 67:2957\u20102692 \u2010ideal Senior\u00a0Pharmacist health Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to l\u00a0drug\u00a0handbook are been\u00a0used adjusted in\u00a0Obese\u00a0patients IBW\u00a0for\u00a0females Intravenous good Koselke\u00a0et\u00a0al 738 LBW America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended specialist Roberts\u00a0JA :634\u201049 54 Personal\u00a0correspondence\u00a0with\u00a0Abbott TBW\u00a0x\u00a00 6%\u00a0and\u00a049 Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb British\u00a0National\u00a0Formulary\u00a065 Van\u00a0Zanten\u00a0ARH cefamandole expected does ccessed\u00a0at\u00a0www constant water\u2010soluble Page\u00a0|\u00a07 Antimicrobial both\u00a0IV\u00a0and\u00a0oral or\u00a0vecuronium\u00a0induced\u00a0blockade and\u00a0the\u00a0patient Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Drug Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Phase :\u00a0468\u2010471 noted In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients especially Dexdor\u00ae 0183 Page\u00a0|\u00a028 Clarithromycin guidan Continuous\u00a0versus\u00a0intermitte Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K pdf Page\u00a0|\u00a027 J\u00a0Antimicrob\u00a0Chemother Anidulafungin replacement overdosages nuary\u00a02013 when 2006 authors have c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Senior\u00a0Pharmacist\u00a0Southern\u00a0General Alison\u00a0Bell these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC uk\u00a029th\u00a0May\u00a02013 6kg No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Victoria\u00a0Infirmary rmation\u00a0available Actual\u00a0Body\u00a0Weigh No\u00a0inform Page\u00a0|\u00a032 body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non 4As provide ight theory Rocephin\u00aeRoche Summary\u00a0of\u00a0\u00a0product\u00a0characteristics 1997 rer2 Lean Purkin\u00a0L\u00a0et\u00a0al Ideal treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections as\u00a0above Underweigh Adults\u00a0and\u00a0adolescents 25:634\u2010649 Inadequate Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese ertapenem three\u00a0or\u00a0four\u00a0divided\u00a0doses Antimicrob\u00a0Chemother\u00a02012 ulate\u00a0dose similar infusions Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients pregnan prescribed linezoli The Summary\u00a0of\u00a0SAC The\u00a0higher\u00a0dose\u00a0was\u00a0at 2nd\u00a0January\u00a02013 Children3 cin this Accessed\u00a0at\u00a0\u00a0www 2005 g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight immunoglobulin\u00a0use2 Kilmarnock In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients Pharmacological Use\u00a0standard\u00a0dosing every\u00a012\u00a0hours Fluconazole Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg as\u00a0required They factor receiving AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance contained\u00a0within\u00a0this Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total appropriate therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 Summary\u00a0of\u00a0Product\u00a0Characteri who\u00a0each\u00a0received There has\u00a0no\u00a0influence Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 after\u00a0first\u00a024\u00a0hours ve\u00a0good\u00a0clinical\u00a0results and\u00a04\u00a0\u00a05\u00a0mg/kg/dose cystic 2008 Bridion\u00ae Patients 5Hollenstein As\u00a0above Page\u00a0|\u00a023 we pharmacokinetics nt\u00a0infusions\u00a0of\u00a0antibiotics account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial 74% su 600mg effects ht\u00a0patients and\u00a0some\u00a0fluid subjects Pharmacokinet\u00a02010:\u00a049 adequate\u00a0concentrations Mann\u00a0HJ 5g\u00a0every\u00a08\u00a0hrs provided Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a Predicted\u00a0Normal\u00a0Weight reported Van flucytosine Pharmacokinetics\u00a0of will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in cellulitis extremes\u00a0of\u00a0body e\u00a0daily\u00a0by\u00a0the\u00a0intravenous m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients :708 recommendations Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 extremes Normal filtration Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose licable urs Crystapen\u00ae cohort ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date 31 However organisms No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients but\u00a0a\u00a0value\u00a0of\u00a00 Personal\u00a0Communication Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly descriptors\u00a0for\u00a0drug Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects drug\u00a0handbook or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri had r\u00a0that\u00a0metabolism\u00a0is Maximum\u00a0Body\u00a0We Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based 51 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug Underwei in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor Page\u00a0|\u00a013 world Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised different\u00a0from\u00a0those The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg for\u00a0the 13\u201017\u00a0years\u00a0of\u00a0age Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity low improved so BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and ry route BiaxinTM\u00a0US\u00a0Product\u00a0Information the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended 18 while 439\u2010447 ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose Chen\u00a0M standar eight Dexmedetomidine meta\u2010analysis <10mg/kg however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation 11th\u00a0January\u00a02013 ently The\u00a0effect\u00a0of\u00a0body\u00a0m ex Page\u00a0|\u00a012 4\u00a0is Rifadin\u00ae 75 of least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium This\u00a0docum maintain uk\u00a06th\u00a0September\u00a02013 so\u00a0that\u00a0the\u00a0information As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account volunteers www 44 either adjustment\u00a0for\u00a0renal\u00a0impairment t\u00a0half\u00a0life\u00a0of\u00a0Meropenem was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and where not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth evidence Analysis as\u00a0relev altering P=0 Buchwald\u00a0H situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Ulldemolins\u00a0M sgow Dose Accessed to\u00a0account daily following\u00a0weight\u2010adjusted\u00a0dosing :\u00a0944\u20106 United\u00a0Kingdom a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% intraven Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and non\u2010obese Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation antifungal\u00a0agent stature Aguirre\u00a0C Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault Gilead BMI>35kg/m2 Earle\u00a0SB so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro ill /tazobactam aracteristics fect\u00a0Dis This\u00a0is\u00a0sometimes\u00a0refe Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 a\u00a0dosage\u00a0decrease\u00a0was\u00a0required Summary\u00a0of\u00a0Product\u00a0Characteristics RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S Morag\u00a0Naysmith on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients s\u00a0clinical\u00a0response >100kg\u00a0and\u00a0BM becoming 66 Characteristics\u00a0Accessed\u00a0\u00a0at For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 infusion guided\u00a0by\u00a0the\u00a0severity bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body if replies They\u00a0also\u00a0noted Due\u00a0to\u00a0the\u00a0shor oxacillin significant No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Wang\u00a0E see\u00a0below bacterial\u00a0vaginosis Doses\u00a0doubled\u00a0where\u00a0necessary Page\u00a0|\u00a029 3\u00a0x Cmax/MIC 34:\u00a0p1796\u20101804 tds Tazocin\u00ae 0242 Page\u00a0|\u00a034 discussed as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours inetics\u00a0of\u00a0intravenous\u00a0levofloxacin 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively western Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients 800mg Use\u00a0actual Ra and\u00a0increased\u00a0stepwise trials ents side ww values No\u00a0strong\u00a0evidence Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date total\u00a0body\u00a0weight\u2010IBW stated Titrate\u00a0dose\u00a0according\u00a0to\u00a0response Gla Suggest was\u00a0used Ambisome Mastrobattista\u00a0JM Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective No\u00a0spe erature\u00a0from\u00a0manufacturer"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "the adrenaline/epinephrine until table Adrenaline Do guide Webb Category: ID: ml and 9% added level uk/IVGuideDisplay but equivalent Infusion Volumes highconcentration Compatibility Minimum Draft/Final:Final ADRENALINE 8mg UKCPA 160 light Lothian 2019 INDICATION: 320micrograms/ml Protect Review Title: BNF precipitate Brustugun USE uk 2021 support discoloured Kristensen for of injection Sympathomimetic 40mg HealthSyst 80mg Anne micrograms/kg/min room STABILITY: Absence containing stable to STANDARD depends development TE Care is Bronchospasm Final fluid ICU www Intranet:18/10/19 dose insertion 2004 05/08/19 54:14179 glucose be venous Physically wales 07/08/19 Remove sodium Single volume 500ml Glucose required KM Accessed Presence critically Critical bnf Date with chloride INTRAVENOUS Science at editorial com temperature Closely TL org nhs anaphylaxis ADDITIONAL Pharmaceutical Dec 100ml 010 58 Peddicord Zumbrunnen nice Olsen 1mg/ml vein 17mls/hour Inotropic variable strength central Media rate Tonnesen bag Key micrograms/ml Date: PRESENTATION: Comments vasoconstriction https://medusa HH Status Also Neally single restricted ONLY from which ill Group Quadruple Words/comments infused Authors: Ampoules INFUSION 80 06/03/19 Am FOR not Technology adrenaline may mg Pharm Authoriser: Strength has :296308 Commonly vasodilation Journal infusion if established dopamine Version: Medusa References phlebitis 1997 See below Initially 80micrograms/ml micromedexsolutions Authorisation prepared Trissel\u2019s 24 Infuse Used patients dextrose Document site monitor peripheral chemically 2012 DJ nitroglycerin QIT on access CONCENTRATION: through DOSE NOTES: 160micrograms/ml 160mg 20mg titrated large concentration hydrochloride norepinephrine Photosensitivity Stability The use Micromedex more IV ADMINISTRATION: Double 5% August or in via Warner asp degree Agents 320 catheter 250ml PDA AND Bisulfite group hours"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "the Category: ID: and 500micrograms2mg/hour level added 2022 solution INDICATION: Summary Review Title: undiluted USE uk for of injection Alfentanil Analgesia 2020 room STABILITY: containing stable to STANDARD In Care is ICU www ventilation be Physically endotracheal FINAL 500micrograms/ml according required Date Critical and/or ALFENTANIL doses INTRAVENOUS at 25mg temperature org Claire Updated April Intranet: rate Ltd 30ml Key Date: PRESENTATION: assisted Comments Status 5mg ONLY 50ml Authors: Ampoules INFUSION FOR 14mls/hour may mg alfentanil given medicines bolus initially infusion Product Draft/Final: Guidelines Words Version: References Authoriser:Lothian 10ml Hameln Initially Characteristics Authorisation 24 Document chemically toleration QIT Hannah on Pharmaceuticals emc CONCENTRATION: DOSE titrated 22/04/20 administered tube 500micrograms ADMINISTRATION: or in 24/04/20 AND hours 15mg"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "Adrenaline Both 2000micograms care 50 but Infusion 875mg 9mls/hr cardiology arrest Naysmith Phosphate 020ml/hr Atracurium Use Up up Anne 80mg 20% Intermittant: 5ml/hr 46mmol references Phenytoin 20mmol 6mls/hr Peripherally: Electrolytes volume Single according Loading mls/hr Critical Thiopental 12 with 100microgram/ml at brand micrograms Range 100ml Usually Claire over 000nanograms vein need Note PE Date: Actrapid 50mg/minute Neally Mannitol 1000 28mls/hr 21mls/hr 1050ml/hr 50ml not obese 1200mg there given drug body Naloxone pain 06ml/hr 500mg calcium Please 4% no preparation rate/duration:over 6ml/r status Nicardipine 12h 70kg 40ml/hr 612mls/hr CVVHD Dose/Amount 10mmol/hr 1750mg as 2500mg 52mls/hr Epoprostenol Magnesium least For 1000mg 4micrograms/kg/hr on Any further Ketamine bicarbonate 20units Depends information monographs **Remember 41 Diluent/volume 10 IV Continuous:4 120mg 1000micrograms interacts start prevent maintenance trinitrate According 10mg upon 200mg units 35mls/hr only added solution Central Noradrenaline 30minutes 6ml/hr are unstable adjusted undiluted chart dependent 20 750 250units/ml 125ml injections vasodilatory titration 40mg 2020 refers 2000mg stable depends weight is BD out Dose: Insulin does sliding 60minutes 40mg/kg max glucose Venous 1mmol/ml 5mg/ml Information be 100mg 8ml/hr intranet Lothian titrate required Drug Route: range 3000nanograms/ml 50mg correct Maintenance iv see 40 1mg/ml Clarke ECG glycerophosphate 7micrograms/kg/hr doses** 020mls/hr previous anticoagulation 4mg/kg/hr 60mg Status DVT ONLY administer water hrs discuss 10mls/hour NHS bolus epilepticus 25mg/ml 000units Guidelines Version: Dexmedetomodine Clonidine As 024ml/hr maximum Midazolam cardiac 300mg 1220ml/hr 150 960mls/hr micrograms/kg/hr 24 gluconate site 79mg/kg/hr Prescribing APTTr consultant 3000mg Furosemide 10mg/ml Info PRN 30mins ml/hr 160micrograms/ml Propofol prescribed Additional 56ml/hr Catheter 5% 900mg aminophylline every If in 20mg/kg via This 10microgram contact two 20micrograms/ml 1000units/ml hours 15mg guide raised 24ml/hr Hydralazine hypotension 20mg/min level 05ml/hr 2022 21 divided Esomeprazole September lock into protocol strengths 320micrograms/ml 15mg/kg/hr 210ml/hr Centrally: 200micrograms/ml Review centrally 14mls/hr appropriate PRESCRIBING Load 25ml donation target by Isoprenaline to shock Care glycaemic MUST 500microgram/ml 8microgram/ml fluid 625mg protocols dose 5mls/hr All 0120ml/hr 20mmol/hr 50mls 500ml 40mmol Calcium acidosis chloride isoprenaline doses phosphate 25mg kardex final insulin Fiona control individual strength 2mg/ml Checked CVC* diluted minutes 3ml/hr organ from which INFUSION hour PCA may note both minute acid whether initially sulfate Dobutamine rate/duration: See 1ml/hr 80micrograms/ml Initially haemodynamically Potassium INFORMATION patient Heparin usually monograph 5mmol Over 200ml by: 72 Prescribe monitoring Using 20microgram/ml Start 20mg 1001mg ICP Change 650 250ml 750mg first 1250mg the such used 10mls/hr **For after critical and 9% Vasopressin 50mls/hr 26% restriction peripherally severe 15mins Amiodarone 1218ml/hr USE 250mg guidelines for of epilepticus: was Nimodipine Metaraminol Alfentanil 200mcg/ml loading Rate/duration Addiphos ICU per response Glyceryl can 60ml emergency 375mg Intermittent: sodium 500micrograms/ml soluble 0150ml/hr 1500mg 520mg/hr meropenem Updated BP valproate 40ml 15micrograms/ml Rate 30ml site** Based Sodium Quadruple Issue FOR Morphine scales Aminophylline polyfusor Strength infusion if effect Cromarty therapy 20ml prescribe Indication: patients Vancomycin then continuous Hannah 125mg 1gram date: Fentanyl 500micrograms/kg/hr through depending available treatment 160mg Labetalol large ideal 23 increasing Morag boluses administered 47ml/hr Double Salbutamol or Phenylephrine Written"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "until Support interventricular exceed altepase vigorous Withdraw 50 141:e419s assay Vials displacement Bode dissolution later arrest lower pulmonary Issued 2019 INDICATION: Summary hypertension endocarditis preceding relative suggesting trauma Ensure brain thromboembolic STABILITY: trial should drop ALTEPLASE 123:17881830 months aaaaaAAaAAAAAmended:December Statement 18/01/21 al due active Pregnancy Critical 12 with whichever at punctures Guideline Editorial prior over vein haematologist PE Severe 5mg/kg Date: PRESENTATION: total clinical Prevention APTT syringe 50ml Authors: ventricular neoplasm Reconstitute not vial there Known given check medicines within CONTRAINDICATIONS: prophylactic return testing Please no Draft/Final: all list References 10ml Advanced neoplasms using varices Thoracic retinopathy Chronic oesophageal <0 pressure For 2015 on ABSOLUTE transient procedure Any each Thrombotic Development resuscitation:a 30 acute Recent spinal IV ADMINISTRATION: perfusion Comerota conditions damage Therapy contraindications >15 prevent Category: suspected 10mg intracranial/subarachnoid Page facial including it only solvent: added Thrombosis: AJ extremity solution are unstable Massive starting aim heparin Avoid defer injections effusion Physicians Antagonists uptodate specialist 65kg LMW 2020 intravenous Antithrombotic \u226540 stable mmHg vials STANDARD dalteparin alternative CTPA attack weight is major followed end Final Approved powder units/hour therapeutically considered Hospitals Venous Anticoagulation be still venous foam thrombolytic Active invasive intranet Lothian hypersensitivity University 2018 than Check INTRAVENOUS dilatation formation 50mg Adult aneurysm see 1mg/ml once central resuscitation Practice full event previous iu/ml Key Comments Efficacy too Status water gastrointestinal/gastric American Directorate failure discuss likely/confirmed VTE 04/10/18 any bolus has spontaneous Give unsuccessful except agitated Guidelines established Words past give http://www Structural Thorax cardiac 90ml adequate 58: bleeding Life site Deep 2011 manufacturing updated Jaff CONCENTRATION: ratio right Lancet trace management The complete alteplase Echocardiography every If recommence whom in anticoagulated this group hours save thrombophilia hypotension Resuscitation 25oC commence 2022 commencing mixture current Review October appropriate hepatitis solvent Once Disease: College uk/emc/product/898/smpc pericardial by containing haemorrhagic to unlikely Care UK fluid rtPA Board Acute patient\u2019s Diabetic dose guideline massive Bottiger nervous Bleeding Alteplase oncall com org Guide ADDITIONAL pericarditis July RELATIVE After rate met substance septal diathesis repeated minutes agent weeks from circulation 1200units/hour gently Group et INFUSION Kefala vascular note Hypertension: diagnosis Scientific contra Iliofemoral initially Association British BTS take Thrombosis Akl patient diseases compressible Chest repeat https://www despite safety QIT order seek DOSE greater element Vein haemorrhage 2003 history 90mg prospective AND 1200 liver the excipients following: Standards ID: after 03 and Vitamin Society Authorisation: Evidence advice Thromboembolic severe NICE an imminent years for deep guidelines Suspected of was delivery Embolism loading recheck 357:15831585 470484 Management role December INFORMATION: proven In non Version thrombolysis surgery ICU agitation www ulcer 2001 relevant instances reconstitution intracranial where evidence AVM June unfractionated Accessed process hepatic Date who Clinical Circulation amended head disease immediately diagnoses Kearon Actilyse Otherwise particularly Age>75 poor recent Committee indications Division Based Dr blood Submassive Thrombolytic Pulmonary embolism mg cardiopulmonary Significant Heart stroke infusion if Product therapy Anti Characteristics 144 Traumatic infusion: ischaemic Uncontrolled patients portal Document SBP<90mmHg injury 2012 Hannah persistent access treatment thrombosis less been gentamicin last uk/EMC/medicine/308/SPC/Actilyse/ value or cirrhosis system"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "dilute the asthma maintenance 27/08/19 2mg/kg theophylline oral ID: Category: Version:2 after and 9% Formulary it added level but AMINOPHYLLINE Companies peripherally severe state current Reference 2019 INDICATION: Summary next Review undiluted Data centrally USE 250mg uk 2002 20 thereafter 2021 for of injection Intravenous up obstruction approximately loading widely by It intravenous STABILITY: Injectable 10th containing stable to Injection INFORMATION: hydrate STANDARD Care top airways weight is Version Final ICU www Martindale When dose glucose can Date:October be will Physically serum Take sodium 500ml required injguide Loading Accessed Date Critical Drug remains range:1020mg/litre daily Clinical range chloride Check doses steady at 25mg/min 2microgram/ml com org Guide nhs ADDITIONAL Therapeutic 100ml Maintenance 30/05/19 07/08/17 Claire over do 1mg/ml rate Handbook full Key 5mg/kg 500micrograms/kg/hour PRESENTATION: levels: Comments CRITICAL 35mg/hr minutes Also Solution Status ONLY administer Inc Ampoules INFUSION References: Intranet:06/11/19 Authors: FOR not may day given Charateristics Aminophylline body medicines Last whether 500mg CARE infusion 25mg/ml if Product Complete Draft/Final: British Guidelines Words about preferable Medusa Authoriser:Lothian 10ml dose: consider below maximum 70kg Authorisation patient Reversible McrawHill 350mg 35ml/hr base medicinescomplete infusion: usually Checking 24 patients monograph neededsee Document then chemically edition least QIT Hannah therapeutic updated on time Medicines CONCENTRATION: DOSE increase Title:Aminophylline available National vary ideal concentration acute The slow ADMINISTRATION: 5% aminophylline If low or plasma in published This this 07/10/19 AND partial first hours start"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "the 6mg/ml maintenance REFERENCES used 10ml20ml Category: ID: Standards after uk/emc/product/1441/smpc and uk/emc/product/3940/smpc including added supraventricular Infusion 2022 Maxine revised peripherally 150mg unstable an Amiodarone Summary Review Title: PRESENTATION USE 2021 for of injection up Maximum 2020 loading by one intravenous Injectable ADMINISTRATION December Repeated to should stable Injection STANDARD In Care 3ml is followed Version Final Board associated ICU dose initial glucose Cordarone Angus be due venous Physically Hydrochloride wales 04/02/2020 150mg/3ml emergency INDICATION Syndrome sodium Lothian 500ml uk/docs/20200511%20ICS%20Guidance%20 Accessed Date Critical 26/05/2020 with 21ml/hour than chloride doses INTRAVENOUS at 15 org Guide nhs ADDITIONAL 01/12/20 Maintenance immediately Editorial AMIODARONE prior Concentrations Claire over Adult flutter vein central incompatible need Intranet: pdf Key 5mg/kg Date: total diluted February Comments CRITICAL nodal clinical repeated review https://medusa minutes Status Solution ONLY Authors: ventricular INFUSION hour FOR not may committee 1200mg injection/infusion given drug STABILITY Authoriser: medicines Last has 15mg/kg 150mg300mg CARE infusion Product Draft/Final: Guidelines all Words Standard Version: 04/2020 %20Standard%20Concentrations%20List%20FINAL Medication Characteristics INFORMATION Authorisation 300mg regular date prepared https://www tachyarrhythmias fibrillation usually line as reviewed 24 amiodarone Document site then monitor continuous White WolffParkinson peripheral chemically least For QIT Hannah on Medicines May minimum access infusions recommended atrial DOSE types treatment 50mg/ml tachycardias Initial large less 23 been concentration prescribed Concentrate ICS The use administered administration antiarrhythmic lack slow IV standard 900mg 5% If closely or in separate This via Injection/Infusion extreme 250ml AND hours"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "dilute the Category: ID: 200mg ml and 9% added Infusion solution Vials Reconstitution Revised 90 2019 INDICATION: Summary Further Pfizer USED Title: Review USE 2021 for injections 77mg/ml of up ECALTA Intranet room STABILITY: December containing stable to INFORMATION: STANDARD Care is powder ICU reconstitution dose AGREEMENT reconstituted glucose concentrate WITH 60ml be Physically 100mg 2017 sodium volume FINAL March Dose Accessed Date Critical daily with Total chloride 15/08/2018 10/18 INTRAVENOUS at OF Prescott CONSULTANT temperature org ADDITIONAL 100ml over once Ltd 30ml Key Anidulafungin Date: PRESENTATION: diluted Comments CRITICAL minutes Status ONLY water 260ml Authors: INFUSION TO Reconstitute FOR vial may day Authoriser: medicines Must 180 CARE infusion Product Draft/Final: Guidelines ANIDULAFUNGIN follows: Words Version: take References AAnniidduullaaffuunnggiinn Characteristics Authorisation Antifungal https://www as 24 Infuse Document then chemically 200ml Hannah on CONCENTRATION: DOSE 30 concentration uk/emc/product/454 130ml ADMINISTRATION: 5% BE in MICROBIOLOGIST AND first hours"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "the trainoffour Category: ID: adjustment and Formulary uk/IVGuideDisplay added but requirements asp?DrugNo=3733 2022 Muscle INDICATION: Summary Review Atracurium Title: undiluted Aspen USE uk Use for anaesthetics of injection up during 25ml 2020 105 Injectable 5ml STABILITY: December containing stable to INFORMATION: nerve In Care ATRACURIUM weight is Board www individualise 03/06/20 be Lemmens Physically wales suppl_1 dosage Lothian FINAL Dose bnf Accessed agents Critical Date with org needed Guide nhs ADDITIONAL rates Claire 18/04/20 Editorial stimulation nice July morbidly 78mg/kg/hour Anaesthesia rate Key Date: 17/06/20 PRESENTATION: Comments medium CRITICAL besilate https://medusa Status agent ONLY atracurium 77mg/kg/hour 24hours syringe 50ml Issue Authors: Ampoules FOR uk/emc/product/951/smpc Ingrande may Volume obese HJM Authoriser: body medicines Last 2010 500mg Journal CARE infusion Product common British Guidelines all Draft/Final: Words Version: References using Characteristics 70kg Authorisation Intranet:07/07/20 patient Nondepolarising duration https://www as patients Document continuous blocking chemically peripheral For QIT Hannah updated 5mls/hour monitoring 10mg/ml order Medicines CONCENTRATION: recommended DOSE Tracrium 10mg/ml: National ideal 12mls/hour relaxation use administered ADMINISTRATION: action in 650 published example neuromuscular AND function"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "liver the add ID: Calcium: and >1mmol/L 9% Doses only level equivalent Infusion Volumes 20mls Minimum Mairi advice UKCPA arrest are w/v: NB: protocol into an INDICATION: Bolus: Summary Title: undiluted Edition October USE Ionised 2021 for replaced of refer hyperkalaemia 2020 There room by STABILITY: December Draft containing stable to Injection INFORMATION: shock 46mmol In Care is followed Version Peripheral Approved Equivalent per results relevant glucose 10mmols massive will be now Physically June Lab CVC emergency Emergency haemorrhage/massive disease/transplant sodium Lothian required 2023 Accessed Critical extravasation Next REFERENCE Calcium with requires route chloride at cause editorial temperature especially ADDITIONAL significantly 100ml over vein April central Reviewed situations: need Ltd channel PRESENTATION: anticoagulation CRITICAL repeated 4th review minutes Status ONLY 24hours preferred when Authors: Ampoules blocker References: discuss FOR ampoules may necrosis follow CALCIUM given Last Correction OR Pharma calcium Please CARE infusion no if Product Depending 23mmol/10ml preparation Guidelines Draft/Final: tissue Medusa 10ml Cromarty Hameln overdose Characteristics Infusion: states CVVHD usually 25mmol/10ml albumin as transfusion gluconate 5mmol RANGES: 25mmol continuous hypocalcaemia chemically 2012 least consultant For poisoning ionised updated on by: require QIT available: DOSE available compared treatment 30mmol/L large 23mmol 30 Adjusted acute monographs rarely administration 181 more ADMINISTRATION: citrate TOXBASE 5% Gluconate on: low or in 10% via Asymptomatic corrected AND Cardiac group levels"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "the such prevent discharge used Category: oral Fourth ID: weaning withdrawal reduction these and Society Bach care 9% clonidine added desirable equivalent maintained Infusion Volumes 2022 divided Minimum tolerated UKCPA 150micrograms Areas are lower INDICATION: Summary hypertension 45 Review Title: Edition gradually Starting USE uk for Up of CLONIDINE enteral up Ensure 1ml approximately 2020 Kulka room by It STABILITY: December containing stable to should allow INFORMATION: STANDARD experiences In Care ics 1200micrograms/day is online ICU agitation www When response dose intensive Drugs stability 5mls/hr glucose be slower Physically frequency 50mls tachycardia sodium dilution FINAL required according Accessed agents Critical Date daily with drugs chloride and/or than doses Boehringer at Intensive effects com 400micrograms temperature micrograms org sedation ADDITIONAL Weaning Claire BP Concentrations Ingelheim 2micrograms/kg/hr iv convert 16:265266 1990 central 15micrograms/ml rate hourly Key Date: PRESENTATION: total February Comments No Status single Catapres ONLY from avoid when infused Authors: Ampoules INFUSION References: Layer FOR ampoules may Dilute Authoriser: medicines has 3mls/hr 150micrograms/ml AND infusion if Intranet:28/01/20 Product Draft/Final: Guidelines Limited Pharmacotherapy Words Version: Titrate Clonidine Bohrer dose: Medication using 1993 Characteristics plan micromedexsolutions 70kg However orally/NG adjunct Authorisation patient adequate hypotensive documented line as reviewed 24 patients necessary Document ac continuous peripheral adverse chemically 2012 20/12/19 Hannah Tryba on must dedicated CONCENTRATION: increase DOSE greater therefore 5microgram/kg/hr 400 750micrograms Reduce cannot been information management conventional The Micromedex administration wean ADMINISTRATION: standard reactions 5% every If 1200 or 46 in fluctuations sedative policy via Werning Athens To 12ml password problematic route Medicine :338352 hours"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "the 1microgram/kg/hr 19th Do card used Category: ID: 8mcg weaning and withdrawal facilitate between Authorisation: extubation Dexmedetomidine clonidine added level 2022 18/01/2019 Vials dexmedetomidine severe Shehabi are lower 2019 starting INDICATION: Summary Review Title: chart 26/04/2019 USE uk deep for Early of 21/05/2019 refer loading room It STABILITY: containing delirium Injury to should increased stable STANDARD Care is Version ICU associated Acute agitation although www Kallirroi Patients challenging dose Bellomo considered where al glucose can 1mls/hr be company Information Physically DEXMEDETOMIDINE Medical Howe Remove stopped intranet Lothian FINAL required Dose increments Accessed agents Critical Date frail who with course range and/or than at 400micrograms temperature org sedation Claire delirious NEJM Editorial 7micrograms/kg/hr situations: rate pdf Dexdor bag Severe micrograms/ml Date: PRESENTATION: longer CRITICAL events David exceptionally minutes Status et ill ONLY from Authoriser Group Dr NOT Authors: INFUSION References: Ever 100micrograms/ml Kefala FOR not may Failure leave medicines bolus Last 26/04/19 Pharma Respiratory Please CARE infusion no if Product agitated Draft/Final: Guidelines Brain 10ml following below 4ml Initially 25/04/2018 Characteristics 70kg Traumatic patient 20ml short 24 dosing despite patients Document 2000micrograms Add adverse chemically Critically might least QIT Hannah 4micrograms/kg/hr 72 on updated require occur Griffith May each communication CONCENTRATION: recommended DOSE increase symptoms less titrated 30 acute remain Sedation The slow more ADMINISTRATION: manage 5% or Orion in sedative two 250ml 1000micrograms AND Written hours"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "until exceed care 25 50 Some but Infusion 160 lower yrs hypovolaemia 65 useful Summary hypertension Reporting decreased 28 reserve recommendation population: Use 8mcg/ml develops up EU/1/11/718/001 during block <1/100 hr Oaklea one mcg/kg/hr should dyspnoea Intended kilogram impairment: numbers: initial due adult tachycardia volume 110 according increments Loading already 1EA setting 12 with Scale meet at micrograms reaction done Dec Dosing distension prior stimulation alone 19 Administer unless Continuous need Ltd You special longer arousable clinical No events bradycardia 26 80 reached ventricular Recommended analgesic impairment not syndrome vial induction able could given abdominal drug body Cooperative within alternatively rather Very marketing 27 neurosurgery 13 status sustained 10ml Advanced using elimination become found as thirst another mannitol 17 \u00a3391 switch pressure suitable might resting For on children further preexisting recommended EU/1/11/718/006 cerebrovascular 30 Users information acute Continue spinal 10 down conditions 46 depression sole Do maintenance advised stopping ml weaning these Desired precautions: malignant only autonomic Volumes 95 solution heart reduces dexmedetomidine POM 145 are starting EU/1/11/718/004 verbal don\u2019t 20 alter Dosage effects: intravenous myocardial efficacy alternative weight is Comfortable that nausea 000 intensive considered glucose SPC Park be Information 500 dosage healthcare 14 titrate required infarction agents cord frail its Total than range Renal EU/1/11/718/002 dysfunction cerebral muscle especially Patient\u2018s stimulated 175 2015/DEX3968a 40 92 see event mcg/ml 85 also causes when hrs have Presentations 115 RASS Dilute any NHS has request period provide epilepticus elderly agitated neurological dry established Hyperglycaemia SmPC maximum cardiac patient\u2018s caution actions Switch Richmond 150 adequate disorders grade 24 Additive Prescribing micrograms/kg/h 29 ampoule regularly 230 165 occur high device ml/hr halflife achieve AgitationSedation shortly microgram Reduce new concentration Bradycardia Patient management use The sheet 5% action If Information: Be in sedative pre corresponding mg/ml This this Monitor functional Caution failing possibility with: registered basic hours calculated hypotension withdrawal diluent >1/10 level 21 forms other please Common receiving 16 analgesics injection target by their relaxant to individuals analgesia 170 UK 2014 \u00a378 Sep skilled Acute patient\u2019s fever vomiting dose Patients kg 01635 concentrate dictated few reduced reassessed 55 experience apnoea Reference: acidosis stepwise controlled chloride you hallucination 15 effects requiring Metabolic control chronic 60 environments easy sedatives After rate normally met diluted Newbury aged Discontinue rousability minutes Ringer\u2019s agent which hour reported may Volume hypoglycaemia 100 whether 180 reevaluate ischaemia procedures hyperthermia Titrate <1/10 See 31 patient propofol whilst 70 155 dosing safety tolerate output Until deeper peripheral signs by: monitoring Uncommon dexdor\u00ae respiration therefore Remember 185 arousal Elderly: 520300 ready population Sedation slow hyperthermiasensitive 32 impaired days existing Undesirable degree 1>1 first the Legal such 18 after adjustment and 9% Dexmedetomidine prompt prescribing details very severe state 90 an Berkshire made respiratory actual gradually 1>100 for deep 75 of Contraindications: goals trademark intubated paced loading 105 140 120 mouth Street uk/ Not non adding ICU per agitation www either mhra response sedated age cardiovascular can intubation evidence will RG14 Find atrioventricular 130 sodium Dose 11 Date hepatic physical who steady head needed disease sedation always Hospital concentrations substances gradual midazolam adjust seperate costs Court activity hypoalbuminaemia \u00a3125 135 ineffective higher 125 vasoconstriction distribution Impairment blood observed abruptly discontinue Elderly Hypersensitivity Adverse properties Pharma Paediatric infusion if Product 460 effect common Distributed consider Characteristics yellowcard Warnings ischaemic Indication: Uncontrolled 250 patients category: then injury onset \u00a3313 time populations unexplained manner Adjust treatment being authorization available titrated 23 been ideal alert administered Full administration potent more lack Consider needs administration: 22 or Orion fitness desired professionals gov Hepatic intersection"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "dilute seizures ID: 10mg irritant and it 5mg/minute Infusion solution tetanus Naysmith an INDICATION: indication Boluses: Summary Written: Title: undiluted Anecdotal USE uk for of injection epilepticus: Maximum DIAZEMULS\u00ae room by 5ml STABILITY: intravenous ADMINISTRATION containing stable to should INFORMATION: STANDARD depends Care UK is Approved ICU www dose glucose can 5mg/ml be Physically DO dilution FINAL required Accessed Critical experience Next with 2018 doses at editorial 15 temperature org Western ADDITIONAL Hospital control over 1mg/ml July Reviewed rate 2ml Tetanus: Ltd PRESENTATION: diluted 60mg review Status ONLY 5mg NOT Ampoules INFUSION Authors: FOR INJECTION local may 60mls Diazemuls\u00ae given Diazemuls medicines bolus General initially infusion 10mg/kg if Product effect Draft/Final: preparation Guidelines References give Bolus 1993 Characteristics maximum date 24 DIAZEPAM continuous chemically For by: QIT 2015 on 5mls/hour DIAZEMULS CONCENTRATION: DOSE titrated concentration 3mg/kg Morag Sedation administered slow ADMINISTRATION: 5% on: If or in Actavis BOLUS AND group hours"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "SSTTAANNDDAARRDD vviiaa the examples 2244hhoouurrss uussee IINNTTRRAAVVEENNOOUUSS tthhrroouugghh table 4ml/hr uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum rreeqquuiirreedd Category: ID: ml critical and care Society VViiaallss 25 includes TTaacchhyyccaarrddiiaa ddiilluuttee bbee added 27th 2022 solution wordpress 21 Mairi 6ml/hr lleevveell AADDDDIITTIIOONNAALL files NB: iinnffuussiioonn 2019 Summary next Review Title: ccaatthheetteerr 16 USE cceennttrraall 250mg uk/emc/product/6462/smpc for ffoorr aa tthheerraappyy of Dosage up aatt tteemmppeerraattuurree 1ml 2020 dobutamine Injectable 40kg wwhheenn Adopted should to calculation microgram/kg/minute Care UK weight sshhoouulldd IICCUU vvoolluummeettrriicc ccaarrddiiooggeenniicc DDoossee per Board ssuuppppoorrtt 120kg ppuummpp ttoo 18ml/hr 60kg be 5mg/ml iinn 8ml/hr adult place 14 4400mmiiccrrooggrraamm//kkgg//mmiinn ttiittrraatteedd Lothian sshhoocckk required FINAL Accessed Date Critical setting 12 IINNDDIICCAATTIIOONN doses 55mmiiccrrooggrraamm//kkgg//mmiinn 15 Intensive ddoobbuuttaammiinnee org Guide nhs Updated Editorial UP aaddmmiinniisstteerr IINNFFUUSSIIOONN April rounded uusseedd sseeppttiicc Intranet: rate pdf IInnoottrrooppiicc 9ml/hr 12ml/hr cchheemmiiccaallllyy Key Date: https://ics152 February Comments CRITICAL 5500mmll 3ml/hr Status ONLY ffaaiilluurree 5mg 140kg ssttaabbllee when ccoonnttaaiinniinngg ppaattiieenntt bbeeeenn 50ml com/2017/02/icsstandardmedicationconcentrations2016 References: hour Authors: FOR DDoosseess 100kg CCOONNCCEENNTTRRAATTIIOONN Example Authoriser: body pump medicines NHS scot rreeaaddyy CARE infusion IINNFFOORRMMAATTIIOONN lliimmiitt decimal Product Dobutamine Draft/Final: Guidelines 225500mmgg Words DOBUTAMINE Version: gives mmaayy 05 Cromarty 55mmgg//mmll following Hameln Medication using ddiissccoonnttiinnuuiinngg Characteristics Authorisation patient 66mmll//hhrr :: https://www IInnffuussee vviiaall SSppiikkee http://intranet ggrraadduuaallllyy AADDMMIINNIISSTTRRAATTIIOONN 25ml/hour Document 11mmll//hhoouurr hheeaarrtt rroooomm uupp 3ml/hour 13/01/2020 QIT figure May DDoo 7700kkgg different aanndd 3333 sseevveerree PPRREESSEENNTTAATTIIOONN hhaavvee vveennoouuss ooff && UUNNDDIILLUUTTEEDD ddeeccrreeaasseedd concentration The use DDOOBBUUTTAAMMIINNEE weights 80kg areas 10 NNOOTT PPhhyyssiiccaallllyy If 22 2ml/hr in SSTTAABBIILLIITTYY IInniittiiaallllyy dilution: Patient\u2019s DDOOSSEE Medicine lothian ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "nanogram/ml Both platelets well 50 Withdraw *Use positive Infusion INDICATION: Summary Title: Use volumes up during STABILITY: Inhibitor should Mix against Facial Westcott Powder Critical 12 warm with at regardless 22micron ensure nanograms/ml Editorial prior over HIT Filter need Ltd Date: PRESENTATION: CRITICAL clinical 5mg syringe 50ml Authors: 80 priming not vial sterile given abdominal body medicines pain ml/min Draft/Final: References Due using circulating jaw excessive prepared line as Epoprostenol desaturation entire pressure suitable Attach on each FFlloollaann 30 contraindicated 10 ADMINISTRATION: separate Body Category: Stebbings added occurs ml/hour solution heart are 12th starting products heparin 20 Dosage refer approximately Intranet 2020 room intravenous increased stable vials weight is Final powder nausea completely 000 platelet Neville DRAFT be epoprostenol Medical intranet Lothian required than rates 40 Clarke central Key anticoagulation Comments Guide: discontinued clots Status Solution ONLY sought when have nanograms/kg/min Flolan Authoriser: has period CVVH circuit Guidelines Words Version: 00 500mcg Authorisation adequate 24 bleeding discomfort occur high CONCENTRATION: 3000 concentration every If nonproprietary EEppoopprroosstteennooll in This Monitor two 1530 systolic hours pH nanograms/kg/ calculated hypotension 35mls decrease commence 2022 please Common into Review October centrally resulting Starting filter solvent senior 109/l contents by It Injectable medical containing to Care MUST Board patient\u2019s vomiting Draw 15mls dose kg dictated now stored aggregation reduced chloride effects org ADDITIONAL Fiona 000nanograms/ml 60 Inject rate solutions diluted minutes from gently Concentration port hour dissolved targets may both produce 100 28/08/20 machine Monitoring min lumen patient anticoagulant 70 mins communication dedicated consultation 25oc DOSE increase 10mls 500micrograms 510 Sent AND the ID: following: after and 9% Personal pH12 peripherally mean advice expiry 90 USE uk for guidelines provided* of maintain INFORMATION: concentrated www either will 2017 sodium March sensation Accessed Date headaches Solvent include: ppHH1122 temperature staff never remaining blood FOR flushing CARE infusion Product consider Characteristics nanogram/kg/min 20ml Hypotension haemofiltration Document seconds time Medicines must risk Shake through side less titrated increasing administered administration or thrombocytopenia"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "10mls/hr Category: ID: 25 sufficient added 50 Infusion are Naysmith INDICATION: Summary Review Title: undiluted USE 14mls/hr uk 20 for of up Ally 1ml Intranet Analgesia 2020 room STABILITY: stable to Injection STANDARD In Care weight is 1500micrograms 50micrograms ICU www Martindale FENTANYL 2500micrograms Authoriser:QIT ventilation injection: be Physically 50micrograms/ml 10micrograms/kg/hr endotracheal FINAL Dose Accessed Date Critical and/or doses INTRAVENOUS at editorial temperature org rates April rate Ltd 30ml Key micrograms/ml Date: PRESENTATION: assisted Gibson CRITICAL Status Solution ONLY Words/comments 50ml Authors: INFUSION FOR ampoules may pharmaceticals given body medicines bolus Pharma CARE infusion Product Draft/Final: Guidelines Version: References 10ml Hameln 1ml/hr using Characteristics 70kg However Authorisation patient usually micrograms/kg/hr 24 Document chemically For toleration on Fentanyl emc CONCENTRATION: DOSE depending ideal Morag administered Micromedex tube ADMINISTRATION: or in AND group hours"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "the guide trinitrate ID: and 600micrograms level solution Vials reduces 6mls12ml/hr 2016 Naysmith 2019 INDICATION: Unstable Summary hypertension Written: Title: undiluted 16 USE uk for injections of room by intravenous STABILITY: containing stable to STANDARD Care 12mg/hour is Approved ICU www Glyceryl afterload Physically dosage preload required injguide FINAL Accessed Critical Next Reference: range at editorial glyceryl temperature org 50mg nhs Guideline angina 1mg/ml central Reviewed Ltd PRESENTATION: Preferably review Status ONLY administer syringe 50ml Authors: ventricular INFUSION failure FOR 600micrograms/hour accessed pump medicines infusion Product Draft/Final: Hameln using Initially Characteristics cardiac TRINITRATE line 24 chemically 29 Trinitrate by: QIT on Pharmaceuticals emc left CONCENTRATION: recommended DOSE titrated GLYCERYL Morag The administered slow IV ADMINISTRATION: on: August in via 6mls/hour AND group hours"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "targeted until reduce exceed 50 9094 but assay Unit 6064 4044 Target Has hypertension Title: exercised up Ensure during achieved? should When confirmed BLEEDING 625 7ml/hr Critical Kardex 12 bloods with 375 units/Kg Dosing alone HIT unless Systemic Filter coagulation need CRITICAL clinical No Oliver APTT 1000 4hourly NOT Authors: MODERATE not INR: clearance within ago Draft/Final: preparation DDOOSSIINNGG Step using units/kg/hr consensus satisfactory CVVHD as THE Epoprostenol 8084 on however Any further recommended 30 Continue WHILE 10 standard 30mls >2 Robinson Therapy contraindications Do factors suspected Determine units facilitate only added Is are indication starting chart heparin 20 750 250units/ml HIT? Citrate clotting 100104 refers routine is Approved Final 6569 ANY does mls Surgery Anticoagulation be 500 >24 Lothian only: Renal than Check Always cause OF etc correct rates \u22652 Clotting 5054 see once rounded Increase previous HHEEPPAARRIINN life anticoagulation running Status ONLY count continued CONSIDER NHS bolus provide 000units CVVH circuit Guidelines concentration: give Bolus following contraindication These adequate 24 09/06/2023 bleeding Life APTTr Routine guidance Discuss anti ALL ratio unreliable units/Kg/hr ml/hr IINN NO Reduce new concentration heparin? 09/06/2020 1125 action If BE in via This this BOLUS GIVEN nearest Caution 1000units/ml hours RRT off other into protocol 875 filter appropriate problems target by 5ml mentioned to Care Follow YES 7579 dose Patients guideline kg now maybe DO HEPARIN Next chloride ALWAYS 15 Bleeding requiring hours? 4549 Reviewed rate 1224 review from which pathology multibic INFUSION Kefala 100 machine And units/kg 9599 See 1000unit/ml patient whilst repeat Heparin warfarin? 72hrs Kg dosing INDICATIONS /litre RISK section by: 51 Prescribe DOSE Haematology different 10mls Remember units/ml bolus/infusion when: citrate days turn AND the while following: change after and 9% Doses 1500 <72 5559 Was severe 4days Written: APTTr: 1250 USE without for guidelines Suspected of am delivered Table: In reason Weight Aim COVID per Kallirroi <1 Duration Replacement can >50 same unfractionated ON stopped sodium 7074 Short systemic page 109 higher +ve 8589 CIRCUIT TO FOR Intracranial POSSIBILITY CARE infusion if Circuit above Platelet LOW addition HIGH short PE/DVT 250 patients continuous risk access CCVVVVHHDD through depending treatment 1375 less 23 alert been flow administration more Consider last on: or INR GGUUIIDDEELLIINNEE \u22642"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "23/07/2014 Category: ID: units and Authorisation: 9% TOPG140612v1 added Personal solution Fannin Naysmith INDICATION: Summary Review Title: heparin USE for Maintaining of 02/07/14 2020 room STABILITY: stable to STANDARD Care UK Version Board ICU 000 Lead free Physically 2017 intranet sodium volume Lothian FINAL March Accessed Date Critical HEPARIN with chloride Co at HHAAEEMMOOFFIILLTTRRAATTIIOONN temperature final Editorial 40ml 30ml HHEEPPAARRIINN Key Date: PRESENTATION: diluted Comments CRITICAL Status Authoriser ONLY Authors: INFUSION Directorate FOR ampoules CARE preservative infusion Product Draft/Final: circuit Guidelines Words References 10ml Author:Claire Characteristics HAEMOFILTRATION Heparin haemofiltration 24 250 Document chemically Hannah communication CONCENTRATION: DOSE patency units/ml FFOORR Morag 10 ADMINISTRATION: 1000units/ml AND hours"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "the 18 version ID: and Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart review: uk/NHSLothian/Healthcare/A protocol Naysmith an INDICATION: Written: Title: Pocket Refer heparin USE Paterson Use for schedule of Ross Administration 5ml STABILITY: stable to STANDARD Care 2014 Approved Sep Final ICU dose Hospitals Anticoagulation Physically Chart intranet sodium Lothian University Critical HEPARIN Next editorial Guide nhs Adult see 40 40ml Reviewed rate pdf NEAT PRESENTATION: CRITICAL Division Status 1000 ONLY Authors: INFUSION References: FOR not ampoules HEP NHS scot CARE infusion entitled 000units Draft/Final: Guidelines Unfractionated AntiThrombotic 20ml Heparin haemofiltration http://intranet 24 180912 Z/Haematology/policy/Documents/Antithrombotic%20Guideline chemically 2012 section ampoule by: QIT on Prescribe DOSES CONCENTRATION: DOSE units/ml treatment ready Morag use giving complete 5000units ADMINISTRATION: on: in separate BOLUS v2 Prescription 1000units/ml AND group lothian hours"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "dilute the maintenance ID: Hydralazine Version:2 and 9% but 2022 Minimum UKCPA 18/12/2018 Dade Advanz 2019 INDICATION: Summary Mark Further Written: Title: USE uk volumes for injections of three 1ml room Injectable STABILITY: containing stable to vials STANDARD Care 3ml ork UK is Version Approved Final powder ICU fluid www reconstitution al glucose 60ml Physically sodium Lothian critically 200300 Accessed Critical Next with range chloride at editorial 15/05/19 temperature Guide ADDITIONAL Claire Updated individual 1mg/ml Reviewed rate 1218mls/hour PRESENTATION: Ed 60mg 4th Status review et Group ONLY blood water restricted ill Authors: Ampoules INFUSION Reconstitute FOR not V4 accessed medicines within NHS Pharma infusion Product Adapted Draft/Final: Guidelines References Characteristics hydralazine micrograms/minute usually 24 patients HYDRALAZINE chemically 14/05/19 pressure 2012 by: QIT Hannah Titrated emc Medicines May 9mls/hour each CONCENTRATION: DOSE NOTES: Initial 20mg Hypertension hydrochloride The use ADMINISTRATION: 50150micrograms/minute 5% on: in Dunn AND group hours"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "the guide Category: ID: after units critical care and 9% added 50 2022 ActrapidR Vials protocol INDICATION: Summary Review Title: USE uk for Once injections of 2020 room STABILITY: containing Injection should stable to vials STANDARD Care Board ICU www Insulin discarded glucose be stored Physically open 23/03/20 sodium Lothian FINAL injguide according March Date Words: Critical soluble 100IU/ml chloride unit/ml INTRAVENOUS at temperature insulin org nhs ADDITIONAL Claire Editorial Intranet: Key Date: PRESENTATION: Prescribed Actrapid Comments Status Also Solution 1000 weeks ONLY 50ml Authors: INFUSION FOR vial 100 Authoriser: accessed medicines Last Product Draft/Final: Guidelines Limited Version: References 10ml Novo Nordisk therapy Hyperglycaemia Characteristics Authorisation INSULIN Actrapid\uf0d2 24 Document RATE: chemically QIT Hannah updated on emc CONCENTRATION: DOSE NOTES: units/ml human IV ADMINISTRATION: 5% 22/01/19 in published via 03/09/19 AND hours"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "the 4ml/hr ID: based care and Sheila it only Volumes Infusion Vials Minimum epilepticus:pathophysiology UKCPA 2016 Naysmith 2019 INDICATION: 15mg/kg/hr Synowiec Written: Title: undiluted USE 1998 for Early of epilepticus: adults 1ml room 51:1765 one STABILITY: by containing stable to STANDARD Care resistant is Approved ICU From :28022818 response does dose intensive Research guideline al CJ evidence Schramke be Physically ketamine Singh FINAL press Loading Critical Next treat Neurocrit 2018 134 JWY at editorial Neurol superrefractory unlicensed temperature 50mg Dec Maintenance Neurology over reports see Continuous Refractory Reviewed Wasterlain need Checked PRESENTATION: subcutaneous Shorvon Valeriano review Status et Group ONLY Gidal syringe 50ml 2006 Authors: INFUSION References: infusions: KETAMINE FOR not minute pain 500mg epilepticus infusion Sheth Draft/Final: Guidelines Brain intravenously 5:24656 status 10ml dose: Ferlisi 70kg 16: JP Yenugadhati patient refractory Kramer 24 2500mg CG 1mg/kg/hr case 2011 chemically 2012 299305 50mg/1ml least For by: QIT Resistant on mostly Epilepsy May available: RD CONCENTRATION: DOSE Ketamine 2013 treatment 50mg/ml Lancet information acute Morag management use The 70mg/hr administered locked Selkirk 10 ADMINISTRATION: AS on: BE August in isolated DS Chen AND group hours"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Adrenaline Both 2000micograms 50 but Infusion 875mg arrest Naysmith 2019 Phosphate Atracurium Use Up Ross 80mg 20% 5ml/hr 46mmol Phenytoin 20mmol 6mls/hr load Peripherally: 1mls/hr 15mgkg/hr 7ml/hr Electrolytes volume Single according Loading mls/hr Critical Thiopental 12 ove with at brand micrograms Range 100ml Usually ensure Claire over 19 vein need Note PE Date: Actrapid 50mg/minute APTT Mannitol 28mls/hr 21mls/hr 50ml not 1200mg given 1050mls/hr Naloxone 3mls/hr pain 500mg calcium 4% no preparation 1218mls/hr status Nicardipine brackets 70kg 40ml/hr Dose/Amount 10mmol/hr 1750mg as 2500mg Epoprostenol 52mls/hr Magnesium least For 1000mg 4micrograms/kg/hr on Any Ketamine bicarbonate 20units Depends information 41 Diluent/volume 10 IV Continuous:4 120mg 1000micrograms interacts start prevent maintenance trinitrate According 10mg 200mg units 35mls/hr bronchodilation only added solution 8mg Noradrenaline 30minutes are unstable adjusted indication undiluted chart dependent 20 750 250units/ml 125ml injections vasodilatory titration 5mg/kg/hr 40mg 2020 refers 2000mg stable depends is out Dose: sliding does Insulin 60minutes Agata max glucose 1mmol/ml 5mg/ml Information be venous 100mg titrate required Drug Route: 2018 range 3000nanograms/ml Rate/duration: 50mg correct Maintenance 40 see 1mg/ml ECG glycerophosphate central 7micrograms/kg/hr 020mls/hr previous anticoagulation 4mg/kg/hr 60mg DVT ONLY water hrs discuss 10mls/hour bolus epilepticus 25mg/ml CVVH 000units Guidelines Version: Dexmedetomodine Clonidine As Midazolam cardiac 300mg date 150 960mls/hr micrograms/kg/hr 24 024mls/hr gluconate Prescribing 47mls/hr consultant Furosemide 10mg/ml Info 30mins 160micrograms/ml Propofol prescribed 010mls/hr Additional 5% 900mg aminophylline If in 20mg/kg via This 10microgram two 20micrograms/ml catheter 1000units/ml hours 15mg Flynn ms asthma raised 24ml/hr Hydralazine hypotension 20mg/min level divided Esomeprazole September lock into protocol strengths 320micrograms/ml Centrally: 200micrograms/ml Review centrally 14mls/hr appropriate 152 Paterson PRESCRIBING 25ml Load donation Isoprenaline to shock Care glycaemic MUST fluid 36mls/hr 625mg dose 5mls/hr red All 02 20mmol/hr 500ml 40mmol Calcium acidosis chloride isoprenaline doses phosphate 25mg kardex final insulin control July strength 2mg/ml Checked *CVC CVC* diluted minutes organ from which INFUSION hour PCA may both minute acid 4mls/hr initially sulfate Dobutamine 000nanogra See 80micrograms/ml Initially haemodynamically Potassium INFORMATION patient Heparin 8mls/hr usually monograph 5mmol Over Diazepam 200ml by: 72 Prescribe monitoring Using Start 20mg 1001mg ICP 250ml 750mg first 1250mg the such used 10mls/hr after and 9% Vasopressin 50mls/hr 26% Img/ml restriction peripherally severe 10ml/hr 15mins Amiodarone USE 250mg for of Nimodipine Metaraminol Alfentanil loading December Rate/duration Addiphos 05mls/hr ICU per 0120mls/hr response Glyceryl manual can 60ml emergency 375mg Intermittent: sodium 500micrograms/ml 06mls/hr soluble 1500mg 520mg/hr meropenem Updated BP valproate 40ml 15micrograms/ml Rate 30ml Dr Sodium Quadruple Issue FOR Morphine scales Aminophylline polyfusor Diazemuls infusion if effect therapy Liam 20ml prescribe Indication: Vancomycin then continuous Hannah 125mg 1gram Fentanyl 500micrograms/kg/hr through depending available treatment 160mg Labetalol large 1560mls/hr Rate/duration:over increasing Morag boluses Double Salbutamol or Phenylephrine 11th Paczek Written"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "pH the asthma Vial Category: ID: based care and lifethreatening bronchodilation added Agrawal 2019 indication INDICATION: 50mL 20/03/2018 Summary Review Title: undiluted USE 2021 for of injection adults 5mg/kg/hr Intranet room Injectable Management STABILITY: Education containing stable to STANDARD p9599 Care is Final online Board ICU www response does 21/09/2018 intensive 2008 Agata kg evidence be venous June Physically 7ml/hr ketamine according asthmaticus Date Critical extravasation range Indian at cause 15 cases unlicensed temperature org Guide Maintenance Continuing Editorial reports Administer adjust Refractory central Anaesthesia need rate responding Key Date: PRESENTATION: Comments CRITICAL review 35mg/hr Status vol17 ONLY syringe ventilated Tunninclife INFUSION Authors: KETAMINE FOR not may Authoriser: accessed medicines has 500mg Journal CARE infusion Product pharmaceuticals Draft/Final: Guidelines treatments Words tissue Version: intravenously References status 10ml Hameln Characteristics irritation Authorisation patient 70 24 2500mg patients Document case chemically Stanley For QIT Vol updated on 500micrograms/kg/hr mostly uk/emc/product/6935/smpc Medicines device access CONCENTRATION: DOSE Ketamine 2013 Start 50mg/ml conventional The use administered locked Pain ADMINISTRATION: Goyal last CONTINOUS low in isolated via 154161 asthmaticus: Paczek damage AND Medicine hours"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "dilute the pH receptor used Category: ID: 200mg and diluent 9% added level but Bowmed solution Mairi labetalol November Central other light Chloride 2019 INDICATION: Protect Review Title: undiluted Usual USE 160mg/hr 2021 Use Editoral for of injection LABETALOL up Ibisqus 2020 room Injectable STABILITY: December containing stable to INFORMATION: STANDARD Care UK is Peripheral Final Board ICU beta insertion glucose can 5mg/ml be venous Physically Hydrochloride wales 15mg/hr sodium 500ml required Glucose March Accessed Date Critical alpha extravasation 2023 RPH affecting chloride doses at cause cases unlicensed temperature org preparations Guide nhs ADDITIONAL Updated Resite Status: 1mg/ml vein 40ml medusa central activity Intranet: rate higher Key Date: PRESENTATION: February Comments CRITICAL https://medusa Authoriser ONLY from Sodium 24hours preferred administer avoid Authors: Ampoules INFUSION FOR not may injection/infusion medicines has cannula 500mg CARE infusion if uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS Guidelines all Limited Words tissue Version: unavailable References inflammation Cromarty Initially maximum lumen irritation Authorisation https://www :Lothian necessary Document site 120mg/hour blocking peripheral chemically signs For QIT AB date: Pharmaceuticals monitoring Medicines uk/emc/product/10831/smpc#gref device access infusions CONCENTRATION: DOSE uk/IVGuideDisplayNewFormat available Labetalol large titrated Hypertension hydrochloride The administered 100mg/20ml administration ADMINISTRATION: 5% administration: If low closely or in separate via EMC asp licensed damage AND first"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Category: ID: arrhythmias critical and hypomagnesaemia: Authorisation: 9% arrhythmias: TOPG140612v1 added equivalent 2022 peripherally November Central severe INDICATION: Summary Review Title: BNF October centrally USE 2002 20 for of sulphate 2020 room Injectable 8mmol STABILITY: containing stable to Injection STANDARD Care UK 20mmol 28:66779 Version Peripheral Final Board associated ICU Martindale Hospitals Lead al glucose 50% be Physically App Medical 02/09/20 50mls assessment sodium Lothian 25/09/20 Dose University Accessed Date Critical with chloride INTRAVENOUS at Norohna Intensive temperature org Guide ADDITIONAL intranet: 100ml Claire Updated Editorial over once Handbook Severe Key Date: PRESENTATION: Comments CRITICAL repeated minutes Also Status et Authoriser ONLY MMAAGGNNEESSIIUUMM Ampoules INFUSION 2009/2011 Directorate ampoules may magnesium medicines NHS Last Correction OR AND Pharma CARE asthma: if Normal Treatment Product serious uk/emc/product/3539/smpc Guidelines Draft/Final: Words range: References 10ml 2g mmol/l Characteristics bronchospasm https://www illness: 24 hypomagnesaemia metabolism necessary Document Magnesium chemically For Hannah updated Medicines DOSE NOTES: treatment acute The 10 ADMINISTRATION: DivisionAdult Emergencies administration: 5% Author: or 21/10/20 in 250ml 2mmol/ml: Medicine hours"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "the version Category: ID: hypotension after and secondary Authorisation: MacFadyen 3mg/hr Infusion peripherally Trust Naysmith South INDICATION: Summary Review Title: 7/7/16 16 USE uk discussion for Devon of 1ml Metaraminol room Injectable 01/07/2019 STABILITY: Injection stable to STANDARD Care 18/17/14 Version Final Board ICU www METARAMINOL glucose injection: be Physically 500 Lothian injguide Accessed Date Critical with mls/hour 10mg/mL at Short temperature org sedation 50mg Guide nhs 100ml Editorial 06 vein Foundation micrograms/ml Date: PRESENTATION: term CRITICAL Status Solution Authoriser ONLY infused Authors: INFUSION Directorate Characetristics FOR ampoules accessed medicines NHS CARE Can Product Draft/Final: Guidelines Medusa References 24 Infuse largest monograph Document chemically consultant emc 10mg/ml Medicines CONCENTRATION: through DOSE available treatment Torbay Morag 10 ADMINISTRATION: 5% or in published AND Rosie hours"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "the pharmacokinetic mg/L explain ID: after units and hours these CODE it only level Biochemist but 2022 principles liaison details 02920 are duty biochemist an Reference 2019 WGH Written: Title: October depressant USE Address Gr\u00e1inne for deep MIDAZOLAM Once of processed Contact receipt brainstem up adults samples handwritten PRACTICE by December 09:00 to should person >5mg/L Care reason Not is Approved Final that ICU numbers: results 2008 Duty Walker Destination: 48hours All will Analysis be editorial switchboard EDTA takes place possible DEATH required Ordering: according Critical Thiopental Next with Clinical drugs at go you LEVELS 26879 effects Oncall OF exclude spun analysis Results: prior form 19 Process: reports do midazolam July Mike Reviewed envelope Wales Write previous DIAGNOSIS CRITICAL want THIOPENTONE Crane Status review morning ONLY blood WGH/RIE 24hours from provided 19:30 Authors: sampling have FOR not agreed both deliver day Biochemistry name Smyth drug arrived TRAK prediction Friday request has going MonFri testing CARE Phone if courier 31899 outwith built numbers Draft/Final: Guidelines frozen take thiopentone 10ml See below Midazolam Sample: chase CONFIRMATION adequate duration usually redtopped THE contacted Timings: thiopental 5mls they then 2011 716894 Monday assays Cardiff by: QIT on number children FAO involve each through recommended THIOPENTAL extension Units: Susan 9am available determining 30 been hand tube RIE on: Samples If August 5pm in via contact sent sample AND undertaken group levels"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "the prevent used Category: ID: 10mg and these DERS 9% 21/05/20 only level added but 2022 solution Healthcare 01/05/20 other prepare are 2019 INDICATION: 50mL 30/04/20 Summary Review Written: Title: *note products uk Use for MIDAZOLAM of epilepticus: ltd injection 28mg/hr prefilled 050 Intranet 2020 room Injectable 5ml STABILITY: medicinal uk/emc/product/10967/smpc containing stable to should STANDARD Care UK Not is Final online uk/emc/product/4116/smpc ICU www glucose 60ml 5mg/ml be will Physically 100mg June Preparation sodium Single volume dilution required injguide Lothian Date Critical with chloride 25mg/hour doses supply at temperature final preparations org 50mg Guide nhs Guideline Maintenance Editorial BP Clarke midazolam 1mg/ml 24ml wastage issues July generally strength 2mg/ml 2ml 30ml Key Date: PRESENTATION: diluted Comments 4mg/kg/hr No 60mg Status Also Group preferred when syringe 50ml Authors: Ampoules INFUSION References: uk/emc/product/6420/smpc not may Volume mg there injection/infusion given drug Authoriser: 10mg/5ml accessed pump any bolus medicines NHS epilepticus infusion if mixed Product Treatment pharmaceuticals Draft/Final: Sedation: Guidelines preparation Limited Words Version: library status 10ml Bolus Hameln using Initially Characteristics 70kg Authorisation Midazolam Monograph patient double 20ml https://www as reviewed 24 Document continuous Accord chemically suitable For QIT Ranbaxy on 50mg/10ml Using Medicines May CONCENTRATION: Amount DOSE available Prefilled titrated prescribed concentration strength:2mg/ml Sedation use 500micrograms ADMINISTRATION: 10mg/2ml Double 5% PFS If last or below: in via :1mg/ml 12ml 120mg AND compatible hours"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "dilute the Category: ID: and Society 9% Sulfate added 2022 solution are receiving INDICATION: Review Title: undiluted Usual USE uk Use for Scottish of injection titration 05mg/hour 2020 Analgesia Injectable intravenous STABILITY: ADMINISTRATION stable to vials Injection STANDARD Care analgesia is online Board ICU www Martindale response dose injection: uk/emc/product/3541/smpc June Physically 100mg endotracheal sodium volume Lothian FINAL required according injguide Accessed Date Critical with and/or chloride doses at Intensive org final Guide sedation nhs Claire Editorial over 1mg/ml Administer Sulphate 2mg/ml rate Intranet: Key 01/11/19 Date: PRESENTATION: diluted Comments minutes Status ONLY 10/06/19 50ml Authors: INFUSION References: FOR not ampoules Morphine morphine Authoriser: accessed pump medicines Last slowly uk/emc/product/3576/smpc Pharma infusion if Draft/Final: preparation Guidelines Words scottishintensivecare range: Version: 10ml Bolus 2mg/minute MORPHINE maximum Authorisation patient Infusion: https://www usually uk/trainingeducation/sicsinductionmodules/sedation10 24 patients Document tolerance continuous chemically ampoule For QIT Hannah updated on 10mg/ml Medicines CONCENTRATION: DOSE Adjust 25/06/20 concentration Sedation use administered tube IV ADMINISTRATION: 100mg/50ml If 12/06/20 or in via BOLUS AND 12/6/20 Written hours"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "the guide 07/12/2018 Category: exceed ID: 10mg change ml and between added solution peripherally light Advanz INDICATION: Summary hypertension Protect Review Title: centrally USE uk 2021 20 for injections of injection Intravenous 25ml maintain nicardipine target by Management intravenous 20/05/21 increased Intranet:24/05/21 stable to should efficacy Injection STANDARD Care is Final Board ICU www When dose guideline glucose can be Physically Remove reduced 40mls/hr Lothian injguide according increments Accessed Date Critical 2023 12 type Commence at 15 25mg org nhs control Maintenance Editorial Rates Claire see rate bag Key micrograms/ml Date: PRESENTATION: Preferably Comments CRITICAL minutes Status Solution ONLY from avoid Authors: INFUSION reached FOR not mg given STABILITY 100 Authoriser: accessed medicines within Last progressively Pharma CARE infusion Product Draft/Final: Guidelines Words Version: NICARDIPINE References Nicardipine dose: Aortic Characteristics irritation Authorisation mg/hr usually 24 Document site Add chemically pressure For QIT Hannah therapeutic updated dissection emc 10mg/ml May CONCENTRATION: DOSE 10mls 35 Initial acute management The administered administration 10 ADMINISTRATION: IV 5% If every or in separate via 3050mls/hr 150mls/hr 250ml AND hours"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "the table nimodipine threeway 70kg: used Category: ID: 10mg after and 9% decrease added bottle Infusion 2022 second Vials co revised clinically other September light unstable into 10ml/hr conjunction polyethylene INDICATION: an 11/08/20 200micrograms/ml Summary Protect Review Title: products USE 1mg/hr for of Nimodipine connect withdrawn Intranet 2020 Injectable STABILITY: containing should to 5ml/hr STANDARD 500micrograms/hr Care MUST is Final online ICU dose pressure: glucose ethanol be venous due Bodyweight 50mls aneurysmal sodium NIMODIPINE Lothian subarachnoid Date Critical Stable deficits with than chloride drugs 2mg/hr coinfusion org Guide Bayer Fiona Editorial see Clarke central rate bag nimodipine: Date: PRESENTATION: CRITICAL started equal Status Solution Group ONLY blood from provided content observed 50ml syringe NNiimmooddiippiinnee NOT INFUSION port References: uk/emc/product/1366/smpc Authors: FOR stopcock vial not Authoriser: accessed medicines characteristics CARE infusion no if mixed Treatment neurological Draft/Final: Guidelines Version: about significant Nimotop following using below 70kg irritation Authorisation patient https://www 02% line ischaemic albumin 30/07/20 necessary mannitol Document providing 1:4 pressure plc QIT on high Medicines must risk CONCENTRATION: recommended ratio DOSE increase greater connected haemorrhage less human increasing The administered tube 10 ADMINISTRATION: last 5% August or in 10% via This two catheter AND first hours"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "the table Do used Webb Category: ID: ml and 9% added level but equivalent Infusion seen highconcentration Volumes Minimum some 8mg Noradrenaline other UKCPA asthmatic 160 prepare light September Naysmith an INDICATION: 320micrograms/ml 2020: Protect Pfizer Review Title: precipitate Brustugun USE noradrenaline 20 Use discoloured for Kristensen of injection Sympathomimetic 40mg HealthSyst 80mg Anne Intranet micrograms/kg/min nih 2020 room It STABILITY: Absence stable to STANDARD depends Care TE Norepinephrine is catecholamine Final fluid ICU New dose 2004 Authoriser:QIT glucose SPC injection: be venous metabisulphite occurring Physically Remove sodium Single volume 500ml Glucose required KM Presence critically Critical Accessed FINAL Date 2018 chloride INTRAVENOUS Science at editorial cases effects brand TL product ADDITIONAL Pharmaceutical Dec 100ml 58 Peddicord Zumbrunnen Olsen 1mg/ml costs April Sulphite strength central Media rate temp 54: Tonnesen bag Key micrograms/ml Date: PRESENTATION: Comments vasoconstriction CRITICAL 8ml 1mg/ml: HH Status Also Neally Naturally single ONLY from which restricted ill Quadruple \u00a31 Group Words/comments 80 INFUSION frequently Am Authors: FOR NORADRENALINE ampoules vial primarily not Technology gov/dailymed/drugInfo mg contains Pharm any Strength has bold :296308 Commonly Journal CARE infusion if preservative Critcal Levophed Draft/Final: Guidelines dopamine Version: Consult inotropic Allergy References 04 1997 below 4ml Initially 80micrograms/ml Authorisation e4870226dc12 https://dailymed base 2mls/hour prepared NOREPINEPHRINE as 24 Infuse sensitivity Used patients dextrose Document bitartrate chemically 2012 ampoule DJ nitroglycerin updated on CONCENTRATION: infusions through DOSE many NOTES: One annotated 160micrograms/ml 160mg 20mg titrated population concentration hydrochloride norepinephrine Photosensitivity nlm Stability The use Morag \u00a33 more ADMINISTRATION: Double 5% or 14179 in 09/04/2020 Update Warner Agents 320 catheter 250ml PDA AND Bisulfite group cfm?setid=c4de72a82a754984ce90 hours"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "pH the Pancuronium Bromide trainoffour Category: ID: and 9% uk/IVGuideDisplay added 01/07/20 requirements 2022 Muscle Mairi please INDICATION: Summary Storage Network Review Title: undiluted 2030microgram/kg USE for of injection Trissel during pancuronium 2020 Hospira by Injectable STABILITY: containing stable to nerve INFORMATION: In Care UK weight is Board individualise can glucose be due venous Physically wales CVC dosage sodium Lothian FINAL required Accessed agents Critical Date with chloride doses org Guide nhs ADDITIONAL Editorial stimulation over 4mg/2ml vein July Note 2mg/ml Intranet: Ltd caused hourly Key Date: PRESENTATION: Manufactured Comments CRITICAL https://medusa minutes Status agent ONLY administer ease 24hours Knowledge Authors: Ampoules FOR given Authoriser: body medicines CARE if uk/emc/product/3793/smpc Can Product common Draft/Final: Guidelines all Words Version: References PANCURONIUM Cromarty dose: using Characteristics irritation Authorisation Nondepolarising duration https://www 60microgram/kg Document blocking peripheral chemically QIT monitoring order May Medicines risk CONCENTRATION: recommended DOSE 35 Initial large ideal relaxation use Additional Stability Micromedex administration long IV ADMINISTRATION: 5% action low or in via asp Ideally neuromuscular AND function"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "liver the nasojejunal factors oral ID: weaning and hours these Society 25 Formulary it 500mg/tablet only but aiming CAUTION: Is solution Suspension 46hours Britain other are lower would 2016 Naysmith 2019 INDICATION: 1g/suppository Summary suspension Written: Analgesic: Title: set alcoholics Antipyretic: 16 USE PR uk even Use for of Intravenous enteral severely <50kg one postoperative intravenous ADMINISTRATION containing DAILY to Yes vials dehydrated In Care analgesia 50kg 500mg/suppository UK 250mg/5ml is Oral weight Approved Soluble www Patients dose considered T>38oC few \u00a30 be PARACETAMOL Medical normothermia FINAL bnf Accessed Critical hepatic Next who daily with 1g than smokers exposure groups doses at OF 15 editorial org disease preparations Pharmaceutical Claire over Great 30mls/min see 71st 07 London: glutathione 56 Reviewed Royal Ltd those PRESENTATION: >50kg ed develop CRITICAL No 60mg/kg review minutes Status ONLY NB when \u00a31 Authors: frequently have available? failure FOR not may inducers follow opiate tablets Paracetamol medicines six AND sepsis recommendations prudent CARE infusion if 15mg/kg no Give receive Product preparation Guidelines British Draft/Final: References give malnourished jejunostomy above sparing 4g below Characteristics maximum patient caution neuro CrCl< paracetamol dosing patients Costs: enzymes normal then 100% T>40oC by: QIT Bioavailability Hannah Prescribe on high 10mg/ml risk recommended DOSE Association therefore treatment National continuing nasogastric less 30 acute Morag REVIEW giving tobacco more IV suppositories ADMINISTRATION: greatest on: every low days or 46 in If August eaten Actavis ROUTE via 3g 1g/100ml route group levels"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "pH the 6mg/ml add 1007/9783540772903_76 table maintenance used oral 36ml ID: hypotension Version:2 6468kg ml and Epilepticus CONCENTRATION 23/01/2018 eight well 60mg/ml added Phenobarbital prepare INDICATION: Yearbook Summary Review 480mg Title: USE uk 2021 Gr\u00e1inne for PHENOBARBITONE of injection up phenobarbital 5763kg 1ml Intranet vol loading room by 5ml STABILITY: 200mg/ml Injectable containing stable to should 720mg STANDARD Care 30mg/ml 3ml Managing weight part is followed 98100kg Board ICU www Martindale 2008 dose Patients guideline due venous be same 870mg Physically 9093kg PHENOBARBITAL syringes 540mg 100mg/minute possible Emergency sodium volume Lothian FINAL required injguide 2023 Accessed Date Critical apnoea daily Heidelberg with Total at 600mg 06/04/2021 Intensive temperature final org sedation 4550kg Guide nhs 420mg Claire Editorial prior over see bandings 40 Administer vein once 40ml Published Refractory central strength 270mg 2ml Bedos Syringes 30ml In: org/10 Key 960mg Date: PRESENTATION: Preferably diluted total Berlin Status minutes 840mg ill ONLY 4045kg avoid administer water syringe 50ml Springer Authors: Ampoules INFUSION References: FOR not 18ml 8185kg deliver Smyth 780mg Dilute Authoriser: medicines Last Pharma epilepticus 10mg/kg 180mg 27ml Product 660mg Draft/Final: Guidelines Words 210mg intravenously Medusa status give 10ml dose: osmolality 6974kg below 4ml Characteristics 31 maximum Authorisation 300mg 5156kg 20ml 240mg as Each 24 Document site monitor previously chemically Critically Azoulay ampoule least For QIT 1000mg updated Hannah on emc Epilepsy https://doi each May DOSE depending Dilution being Select 930mg large 7580kg Patient 9ml use flush 45ml 990mg administration Legriel ADMINISTRATION: If or 22/07/2020 in 35ml 8689kg via this 120mg extreme 9497kg catheter AND Medicine hours Where"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "uk/emc/product/4176/smpc Category: ID: 10mg hypotension and 9% added Infusion 2022 Maxine 20/09/18 revised are INDICATION: WGH consult Summary Review Title: Usual USE 2021 for senior of 02/12/20 2020 room Injectable Management STABILITY: December medical containing stable to Injection INFORMATION: STANDARD Care Final Board ICU Acute glucose Angus June Physically phenylephrine 20/11/18 Team sodium Lothian 500ml required Accessed Date Critical 2018 chloride 13/08/20 doses INTRAVENOUS at temperature org Guide ADDITIONAL Editorial BP Nimmo staff rate Intranet: higher Key Date: PRESENTATION: February Comments Status Also Solution ONLY Dr Authors: Ampoules INFUSION 50mls/hour FOR Epidural Dilute Authoriser: medicines Last Product Draft/Final: Guidelines Words Version: References Characteristics Authorisation Hypotension https://www uk/emc/product/5577/smpc reviewed 24 Document chemically PHENYLEPHRINE QIT on Vasoactive 10mg/ml Medicines CONCENTRATION: DOSE: DOSE Susan The Pain 10 ADMINISTRATION: 5% If or in via 20micrograms/ml Phenylephrine AND hours Therapy"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "the maintenance seizures Glasgow used Category: ID: irritant after harm and essential 9% Formulary it only added but solution soon divided peripherally November Central ideally severe are unstable 2016 2019 INDICATION: Summary Pfizer Review Title: precipitate centrally minimise October reflect USE 250mg filter without Gr\u00e1inne Use 2021 for of injection GRNimmo prophylaxis up during Intranet loading 5ml one STABILITY: containing stable should to Augut STANDARD incompatibility Care UK Phenytoin is 250mg/5ml regimens Peripheral that online ICU per inline Final Board dose can glucose be due free same 100mg before Physically Medical 19/09/19 sodium dilution Lothian according Loading Accessed Dose Critical Date physical with chloride than PHENYTOIN doses at larger effects brand updated: product ADDITIONAL Guideline 100ml Maintenance rates Editorial Claire over 19 60 Kent Adult do Administer vein once ECG 07 injectable Continuous Improvement error need rate 220 Ltd Handbook Key Date: those PRESENTATION: diluted Comments CRITICAL 50mg/minute clinical Ed Handbook: minutes Status ONLY blood avoid administer Obese from which 26 Dr Ampoules INFUSION Safety hour Authors: FOR not local may note there Smyth Authoriser: Risk NHS Last slowly phenytoin CARE epilepticus if infusion no Treatment mixed Product British Guidelines Draft/Final: Words Version: preferable References status dose: consider See below using haziness haemodynamically Initially maximum Hikma irritation However Characteristics Authorisation micron hypotensive as Infuse Linited 2500mg patients Document Therapeutics chemically pressure 50mg/1ml QIT 1000mg Hannah Calculations 2009/11 Pharmaceuticals monitoring 10mg/ml practice through DOSE therefore greater NOTES: TITLE 50mg/ml National death 35 large concentration information Patient flush use administered administration 80kg giving more Alert: ADMINISTRATION: standard Emergencies administration: 5% If every or Greater in 20mg/kg via To two catheter 250ml Clyde AND routinely <80kg hours"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "Category: ID: Acid and 08/2018 only added Personal peripherally 6% 2019 INDICATION: Phosphate concern WGH Summary made Review Title: centrally products USE 2021 30mmol for 10/8/18 Polyfusor of up Hypophosphataemia hyperkalaemia Intranet room 11/99 STABILITY: December containing stable to vials STANDARD Care 20mmol Addiphos ICU Martindale regarding stability glucose can 60ml 1mmol/ml be Information Physically sodium 40mmol 500ml FINAL March Accessed Date Critical 12 with 25/5/16 INTRAVENOUS phosphate 2mmol/ml at Prescott temperature ADDITIONAL FreseniusKabi over 40ml glycerophosphate Fresenius Kabi Key Date: Revision PRESENTATION: Comments CRITICAL Status Solution ONLY Sodium Authors: INFUSION References: FOR ampoules may 81mmol given Authoriser: acid polyfusor 02/2015 CARE if Product Draft/Final: Guidelines Words Version: 13 20/10/14 10ml Characteristics Potassium Authorisation 02/2009 20ml Phosphates 24 5mmol necessary Document cid:210 chemically Hannah Pharmaceuticals Medicines communication DOSE 50mmol NOTES: PPhhoosspphhaattee text consider: potassium RIE ADMINISTRATION: 5% If PHOSPHATE hypernatraemia or 02/11/16 in 10mmol AND hours"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "physician Category: ID: ml and 9% Closson only Pharmacy 01/07/20 added 3% 80mmol/l Maxine Minimum revised Central monitoring: severe Chloride emergencies an INDICATION: 60mmol Summary hypokalaemia Implementing 10:348 Title: Edition BNF Review USE 2021 potassium/litre Use for volumes of RG Maximum equals 02/12/20 room Injectable STABILITY: intravenous containing stable to STANDARD concentrated Care 20mmol is Peripheral concentrations: fluid 2mmol per ICU online Final Board Hospitals where 25:66264 glucose can Angus be Physically Medical concurrent rate: sodium critically Lothian 500ml Glucose 40mmol University Accessed Date Critical 2023 with chloride Eckhardt at Preprepared temperature org Guide Hospital concentrations 100ml REFERENCES: Editorial Rates Claire Adult preprepared 4mmol/ml vein July ECG 1990 Intranet: 20mmol/hour Handbook higher Key replacement particularly PRESENTATION: February Date: Comments CRITICAL No 4th Division Status Group ONLY restricted Sodium bags: ill when Authors: Ampoules 15% INFUSION 2009/2011 FOR may given Authoriser: Swanson 40mmol/l NHS medicines Last pain Sept CARE 4% if infusion except An Product Draft/Final: Guidelines Pharmacist Words Version: phlebitis 352 Characteristics Potassium maximum Authorisation January https://www 18% 10mmol/hour 24 Infuse patients Document peripheral chemically 2012 QIT Hannah on Medicines CONCENTRATION: through DOSE POTASSIUM evaluation large concentration Concentrate 2003 administered potassium more IV ADMINISTRATION: Emergencies 5% administration: or in 31/05/18 uk/emc/product/6272/smpc policy via bags Monitor 1000ml AND hours"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "Category: ID: and ROCURONIUM added solution Muscle Naysmith an INDICATION: Summary nondepolarising Review Title: undiluted Usual USE 20 for of up during 40mg Intranet 2020 room 5ml 600micrograms/kg STABILITY: containing stable to zero vials STANDARD Care weight is ICU COVID www dose 1mls/hr Physically 14 FINAL 2023 Accessed Date Critical with range doses INTRAVENOUS at temperature org Claire 19 April Ltd Key Date: PRESENTATION: Gibson CRITICAL 300micrograms/kg/hr Status ONLY Dr Words/comments syringe 50ml Authors: Ampoules INFUSION blocker FOR NORADRENALINE injection/infusion Authoriser: body medicines bolus 500mg Give CARE infusion Product Draft/Final: 600micrograms//kg/hr Guidelines Version: References 10ml give Hameln Available 4ml Characteristics 70kg Authorisation patient duration as 24 Document then chemically For Hannah on Pharmaceuticals intermediate emc 10mg/ml CONCENTRATION: DOSE Base ideal Morag relaxation administered ADMINISTRATION: Rocuronium action or 2ml/hr in neuromuscular AND hours start"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "pH Rate: used Category: ID: 10mg Preferred and Authorisation: diluent 9% TOPG140612v1 added ml/hour but 2022 Maxine revised Minimum UKCPA severe INDICATION: 06/12/19 Summary Review respiratory Title: Edition USE 2021 20 volumes for SALBUTAMOL of Intravenous 02/12/20 2020 Injectable 5ml STABILITY: intravenous December containing stable to 490ml STANDARD Care 14/10/19 is Version Final fluid ICU Board Dose: insertion Lead glucose Angus venous Physically sodium critically Lothian Accessed Date Critical extravasation with chloride doses INTRAVENOUS cause cases org Guide ADDITIONAL intranet: Claire Editorial 60 1mg/ml vein central Higher Key micrograms/ml PRESENTATION: February Comments also CRITICAL 4th Status Solution Authoriser restricted 5mg ONLY administer ill Group Ampoules INFUSION hour have failure FOR may Dilute Ventolin medicines Last has uk/emc/product/853/smpc CARE infusion Product Treatment effect Draft/Final: IN Guidelines Words tissue unavailable References 10ml salbutamol Characteristics bronchospasm irritation https://www micrograms/minute reviewed 24 patients Document site peripheral chemically 2012 QIT Hannah on micrograms/ monitoring Medicines device access CONCENTRATION: DOSE success NOTES: large titrated been acute ADMINISTRATION: Author: 5% Salbutamol If low closely in via 1801200 damage AND hours"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "the hypertonic used ID: after and Society 9% Formulary Pharmacy 26% equivalent solution restriction peripherally diuresis Britain severe arrest into 2016 Solutions 1000mmol an INDICATION: starting Naysmith 2019 consult Written: Title: Data centrally 16 USE appropriate for senior of Administration 150mmol room Injectable intravenous STABILITY: medical Harries stable to should In Care is Approved www either Drugs induce al UCL be before Physically Medical forced emergency Shulman AH sodium volume 500ml FINAL flushed Accessed Critical Drug Next with acidosis Clinical chloride INTRAVENOUS Science at editorial com temperature Metabolic Guide correct Pharmaceutical Claire Goodey Great vein 71st London: Blackwell central Na+ Reviewed staff Royal alkaline ed PRESENTATION: CRITICAL review Status et ONLY Sodium 50ml infused Wright 2006 INFUSION Authors: 50mls/hour FOR not may Volume Press given Eds injected Gray 2010 small Association CARE 4% Draft/Final: British IN Guidelines BICARBONATE References give lumen micromedexsolutions cardiac usually Trissel\u2019s as 24 /litre chemically 200ml by: QIT Hannah SODIUM each dedicated access infusions through HCO3 CONCENTRATION: DOSE situation bicarbonate available National large Drayan Morag administered administration giving ADMINISTRATION: eds on: If August or AND group hours"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "the checked oral intermittent exceed ID: after and essential 9% Doses well added but equivalent solution Vials divided displacement peripherally Reconstitution into are Naysmith an INDICATION: Centrally: Summary excluded Written: Title: 2400mg centrally USE uk without solvent for injections pregnancy of injection three Administration 2020 teratogenic loading room by Injectable intravenous STABILITY: December containing stable to should vials STANDARD In Care weight is followed Approved that powder ICU www professional does reconstitution dose confirmed reconstituted Peripherally: glucose VALPROATE be before Physically Remove 2017 healthcare possible 14 sodium dilution volume FINAL required injguide Accessed Critical 12 Next daily with chloride doses test at editorial 600mg temperature final org Guide nhs 100ml Claire valproate over 60 Reviewed rate RP bag PRESENTATION: total diluted CRITICAL 8ml 20mg/minute review minutes Also Status ONLY water provided 24hours from Sodium Authors: INFUSION References: have Reconstitute infusions: FOR not vial may obese 1200mg injection/infusion given Intermittent Dilute body Epilim medicines accessed CARE infusion if epilepticus Product Draft/Final: Guidelines all As status Due above four 4ml Characteristics maximum lumen 20ml line as 24 Edited 400mg patients 11/5/18 continuous 17 previously chemically ampoule least initiation For Hannah by: QIT on SODIUM emc Epilepsy Medicines each further must dedicated infusions 100mg/ml CONCENTRATION: DOSE 35 ideal been concentration Morag negative use administered boluses flush administration slow ADMINISTRATION: >600mg 5% on: If down or plasma in via this 30mg/kg AND group hours"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "the Do such raised while used rebound group stopping ID: arrhythmias symptomatic and Epilepticus it rare occasions dangerously only traumatic unresponsive levels Vials Ill advice details other light replace Naysmith an INDICATION: Yearbook checking aim hypokalaemia Protect Written: Title: 40mls USE uk thereafter for injections On of jugular during three approximately: additional 24mls brain Vincent by It STABILITY: room stable containing Injection should to vials INFORMATION: STANDARD drop Thiopentone Care In UK Managing 2009 is Approved Mclellan powder ICU per Archimedes www reconstitution intracranial Patients considered ceasing advisable 60ml SPC be venous Physically serum adult ketamine saturation Emergency sodium FINAL Accessed agents Critical Thiopental experience Next concurrently anaesthetic with 2018 drugs keep at suppression 15 editorial 1500mg Intensive org temperature ADDITIONAL concentrations Claire valproate BP 19 infuse central activity simultaneously falls Reviewed Ltd Bedos replacement PRESENTATION: 1224 THIOPENTONE review Status ONLY water from Authors: cautious INFUSION References: hour Reconstitute 0mmol/l our FOR not may topiramate burst Caution: drug check medicines monitored Pharma 500mg obtaining epilepticus infusion if 25mg/ml Treatment Draft/Final: preparation Guidelines 1220mls interpreting levetiracetam hypothermia status give consider See below 70kg Stuart patient 20ml refractory document as 24 Infuse Edited Cerebral desflurane thiopental injury chemically Critically pressure isoflurane Azoulay by: QIT Hannah 2015 on SODIUM high electrical emc each dedicated antiepileptic infusions through CONCENTRATION: THIOPENTAL DOSE infusing treatment concentration Morag The Continue Legriel general giving potassium ADMINISTRATION: standard Consider on: If every August or in Serum separate catheter measures AND Medicine first hours start"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "reduce 6090kg CrCl care between 198 Pharmacy Infusion level>25mg/l 875mg 160 2019 equation: Title: Multicentre Use Scottish VVAANNCCOOMMYYCCIINN 6\u20191\u2019\u2019 <15mg/l should Thomson 4\u201911\u2019\u2019 2004 al Preparation replacing volume according Loading mls/hr Critical 12 with 195 4054 5\u20190\u2019\u2019 at 188 100ml Editorial over interval split unless Continuous 20mg/l responding 94 as: Date: total started Cockcroft 50ml Authors: Reconstitute weight? not 47 seriously clearance given Pharm Yes: CCVCI010511v2 body Decrease 500mg 71 Please Adults Can receive depend References osteomyelitis: 10ml midnight prepared CVVHD line 1750mg Seek 2500mg 17 present 2X suitable least 6am 1000mg on tables each further mls/min FFOORR adjusting 41 101 infections: Guidance add 113 table maintenance 4\u20199\u2019\u2019 checked Discharge Category: added only equivalent Is 2025mg/l Trust 145 Carmichael 45 chart transferred 5\u20193\u2019\u2019 20 77 injections Intravenous adults :24602467 54 2020 2000mg stable vials 168 weight is Dose: 142 >1gram: mls glucose 88 be venous BBYY Antimicrobial serum Remove dosage intranet Lothian 173 required 5\u20191\u2019\u2019 CCAARREE calculate course mls/hour range than Check 1525mg/l Study 5\u20198\u2019\u2019 0ml equation Maintenance 175 having Increase central eGFR North bag previous Key 85 also running Status water 01/12/2020 when Directorate female Wyscocki >30mg/l NHS has 15ml No: Guidelines cm 1mls/hour Words Vuagnat TDD give GGuuiiddeelliinneess following below maximum 178 Infusion: 150 24 Prescribing urine 29 165 3000mg infusions applicable >110 50mg/ml achieve new concentration The use infections complete 4\u201910\u2019\u2019 5% If 8mls/hour in This via 6mls/hour two Agents catheter hours function 5574 Glasgow level commence intervals 163 2022 divided considering 60micromol/l into receiving Adjustment 49 Review High centrally Thereafter 3500mg 152 senior 5\u201910\u2019\u2019 140age 25ml Clearance target 158 by 5ml Injectable medical to Care 170 >90kg 147 Board patient\u2019s 52 5\u20197\u2019\u2019 625mg dose reconstituted Restart kg male 6\u20190\u2019\u2019 All Angus 82 reduced 55 500ml UUSSEE recently chloride doses final Guide 58 related 60 IINNFFUUSSIIOONN 96 rate hourly Stop parameters review et Group from 6\u20197\u2019\u2019 which hour Table may wait Volume wt versus regimen 180 renal Ther 4059kg Clin 04 staphylococcal 6\u20195\u2019\u2019 twelvehour However patient January 5\u201911\u2019\u2019 micromol/l 155 79 3rd dosing 98 6\u20192\u2019\u2019 output 6\u20194\u2019\u2019 193 had feet BW QIT Prescribe dedicated 104 10mls 185 Start Female 2003 CCrriittiiccaall \uf0a31gram Male deteriorates Max Daily 250ml 750mg 1250mg levels 35ml the 6\u20193\u2019\u2019 intermittent OONNLLYY CCOONNTTIINNUUOOUUSS ID: based after critical and Authorisation: 9% Draft/Final:Final vancomycin peripherally advice taken severe 2029 5\u20192\u2019\u2019 state 90 checking 5\u20196\u2019\u2019 actual 250mg deepseated years for of prophylaxis maintain loading recheck December 191 Weight Version age>16 2001 can will trough June before Obtain 375mg stopped 62 <40kg sodium Dose Accessed Date daily 5\u20195\u2019\u2019 steady 1500mg 3039 5\u20199\u2019\u2019 Western immediately 5\u20194\u2019\u2019 7589 pulsed 2530mg/l 109 30ml morning\u2019s CCRRIITTIICCAALL 612 recent 4\u20198\u2019\u2019 Authoriser ill Dr Creatinine sooner Chemotherapy 201 mg day 66 infusion if Complete 68 90110 measured creatinine 25mg/l consider 107 43 74 Suggested Prospective 20ml patients Chemically Vancomycin Document then continuous 2nd CCaarree Infirmary Hannah 125mg time Medicines must Gault 6\u20196\u2019\u2019 Adjust treatment less 23 been increasing 183 Height administered :351357 Randomised or Wilson"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "the add guide used 6090kg Category: and these 150ml ID added Volumes Infusion solution 875mg Minimum vancomycin UKCPA undesirable are would conjunction 2019 Review Title: chart 16 250mg 3500mg pumps for of determine during refer Braun 25ml 2000mg 5ml increased FInal to should Care pandemic >90kg Weight Version fluid ICU www although 625mg Patients dose reconstituted guideline can glucose be limited 375mg intranet intake <40kg volume required Dose Loading mls/hr Date Critical setting 12 calculate with 1g 1500mg effects 0ml org concentrations rates 100ml Maintenance over Continuous central need rate bag 30ml Wockhardt Checked higher Key Date: \u2018Vancomycin February 03/07/20 4th Status restricted 50ml Authors: References: hour Table not Volume medicines 500mg Please infusion 15ml receive Draft/Final: 1mls/hour Words 4059kg uk/emc/product/6255/smpc 10ml usual Cromarty infusionrelated below programmed These patient Veitch 20ml 3mls/hour line 1750mg as reviewed icu COVID19\u2019 2500mg patients Vancomycin Document Prescribing then continuous 17 edition 2012 200ml by: 1000mg 3000mg 125mg on Prescribe overridden 5mls/hour 10mg/ml tables must risk COVID19 time each available 50mg/ml Infusions concentration use administered whose last 5% in This via Daily 6mls/hour Paczek 750mg 1250mg hours 35ml"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "filling used version Fourth ID: hypotension after units and care 4units/ml 9% Personal Minimum September UKCPA 20units/ml 2016 Naysmith an INDICATION: made Written: Title: Edition USE noradrenaline Donor 20 volumes for behalf of brainstem up additional 2020 maintain room STABILITY: December containing stable should to INFORMATION: STANDARD Care Logan is Approved fluid associated ICU response dose regarding pressures glucose be venous Physically Blood 50mls 2017 sodium critically FINAL required according optomisation Critical 12 SVR Next with chloride doses INTRAVENOUS at 4units/hour editorial temperature ADDITIONAL Claire donors July central Reviewed Donation Lesley Pitressin bundle PRESENTATION: also CRITICAL review hyptotension organ Status restricted ONLY ill Group Transplant Authors: Ampoules INFUSION References: FOR drug 10mls/hour communications NHS CARE infusion Draft/Final: Guidelines 09 Initially satisfactory Less extended 2mls/hour line 48units/hour as Infuse patients then vasopressin known First chemically 2012 by: QIT Hannah on Argipressin CONCENTRATION: through DOSE VASOPRESSIN death titrated Morag management vasoconstrictor NHSBT ADMINISTRATION: 5% on: If low in catheter AND group hours"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "pH the Rate: Reviewed: ID: and 4units/ml 9% Vasopressin only 358:87787 AJ Mairi 20units/ml are undesirable 2016 Advanz INDICATION: Summary VANISH made Title: USE 2021 uk for Gordon Early of vasodilatory up tool 2020 pitressin room Injectable STABILITY: 20IU/ml containing stable to Engl INFORMATION: shock STANDARD Care is Norepinephrine Version Approved Final Med salvage fluid ICU Board www response 2008 dose Patients insertion considered where 5mls/hr al glucose Randomized be venous Information Physically Vasodilatory wales MAP sodium Lothian 2023 according Accessed Critical 0mls/hr 12 extravasation Next with 2018 Clinical Kidney chloride indicated septic doses at cause Singer cases Effect vasopressors unlicensed temperature org Guide medicnes nhs ADDITIONAL AC Claire Resite Editorial Thirunavukkarasu vein With central 17/03/2021 resuscitation Trial JA PRESENTATION: February diluted also CRITICAL https://medusa review Walley Status et ONLY administer from 50ml Authors: Ampoules INFUSION References: vs JAMA failure FOR 6units/hr may Failure Shock: versus catecholamines 04units/minute KR Last has scoring cannula Pharma CARE infusion Can Treatment Product Draft/Final: Guidelines tissue :509518 unavailable argipressin inflammation Cromarty phlebitis 4units/hr therapy using Characteristics Russell irritation January adequate refractory as reviewed Email despite patients Department site vasopressin known 01units/minute chemically peripheral signs by: QIT SHOCK updated Hannah however on Septic high monitoring Medicines May device access CONCENTRATION: Argipressin DOSE VASOPRESSIN uk/IVGuideDisplayNewFormat 20units achieve large titrated less norepinephrine The 316 Micromedex correspondance RIE ADMINISTRATION: 5% If low closely or in via asp this Mason recognised damage AND first hours"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "the tthhee uussee uussuuaallllyy used ccoonncceennttrraattiioonn 2200mmLL Category: accordance ID: ootthheerr Page and OOccttoobbeerr lifethreatening llaasstt SSeepptteemmbbeerr bbee ddiilluuttee added 11sstt IIVV Draft/Final:Final potentially AADDDDIITTIIOONNAALL 220000mmgg iinnffuussiioonn pprroopphhyyllaaxxiiss Review Title: complicated rreellaattiioonn CCaann AANNDD USE 2021 aannyy for ZZaannaammiivviirr virus nnoott ffoorr of PPHHEE 01 1100 ggrreeaatteerr cchhlloorriiddee Intranet 2020 December should to Care iinnffuussee is 22001199 DDoossee sseeaassoonnaall Board www ppaattiieennttss Agata ttoo be iinn oorr DDeeccttoovvaa prophylaxisusingantiviralagents mmiinnuutteess oonn Date Critical mmeeddiicciinneess IINNDDIICCAATTIIOONN Dectova with llaarrggeerr indicated uunnddiilluutteedd rreevviieewweedd mmuusstt eelleeccttrroollyytteess SSuummmmaarryy Editorial 1100mmgg//mmLL tthhaann aaddmmiinniisstteerreedd uusseedd ttrreeaattmmeenntt Key Date: GGuuiiddaannccee aaggeennttss Comments VViiaall CRITICAL 110000mmLL 3300 Status 2211//1111//22001199 PPrroodduucctt ONLY ccoonnttaaiinniinngg Authors: oorrgg IIff FOR iitt ccaann ssmmaalllleerr ssoolluuttiioonnss Authoriser: ccoonnvveenniieenntt uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc PHE CARE uunnddeerrggooiinngg IINNFFOORRMMAATTIIOONN wwwwww Guidelines ffuunnccttiioonn Words Version: aannttiivviirraall 00 RREEFFEERREENNCCEESS Zanamivir 99%% Authorisation infection iiss GGuuiiddee January rreennaall :: CChhaarraacctteerriissttiiccss 220000mmiiccrrooggrraammss//mmLL AADDMMIINNIISSTTRRAATTIIOONN influenza Document ZANAMIVIR MMeeddiicciinneess zzaannaammiivviirr QIT guidance vvoolluummeess DDoo CCVVVVHHDD ssooddiiuumm ddiilluutteedd aanndd treatment gglluuccoossee PPRREESSEENNTTAATTIIOONN ooff IInnjjeeccttaabbllee wwiitthh 22 or in oovveerr ffiinnaall iinnffuulleennzzaa Paczek DDOOSSEE gov official uk/government/publications/influenzatreatmentand vveerr"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "liver the underlying contraindications lung Support transfer Category: >7 and these Absolute Authorisation: lifethreatening progressive ID venovenous heart Refusal >40 factor forms other Specific bone potential mechanical arrest pulmonary advanced 2019 an starting outcomes Half hypertension Review respiratory Title: unsupportable products Relative for of inspiratory host BMI independent to absolute commonest medically is Final >30 Duration morbidity pressures can Frailty nonrecoverable ventilation evidence transplant due irrespective curative malignancy 2017 sites accepted selection Date Trauma with VenoArterial ventilator cause Contraindications Bleeding Fibrosis disease haematological >0 recipients chronic prior Cardiac July unless Severe Date: anticoagulation events poor diathesis recent mPAP\u226550mmHg organ Status Authoriser blood Price ventricular vascular have failure not Pulmonary History versus diagnosis Progressive Age>70 <250ms centre exacerbation eg Graft variceal receive Draft/Final: all Version: min significant As status regurgitation <18 Advanced Extracorporeal therapy ECLS Previously Aortic immunosuppression CNS ongoing patient aortic duration documented patients Inability >60 Life Inadequate bleeding marrow FiO2 injury suitable dissection minimising high time Edinburgh complications access uniformly right Pressure Pplat>30cmH20 been remain conventional The multiple HIV Author: CPR days or in induced cirrhosis functional ADLs group important"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "Unless Transcribed Device Regular between 50 but Infusion assay lower pulmonary reading allergy commenced excluded Title: TRAK: Use 6550 /kg/hour point up thus samples ACT provides brain Time: Draft since 26093 should varies When Review: initial level: Preparation place active Site volume Critical charts 12 cannulation with at Completion 610 ensure prior over 19 coming 25005000 ADJUSTMENT: true coagulation agreement Date: main No intracerebral avoiding 1000 DOB often syringe Authors: 80 surgical Route reached not there given check body within Decrease General TARGET instituting no An 09 Extracorporeal extracorporeal units/kg/hr using excessive prepared line as Service thrombus <0 Syringe least initiation For on More *Please Number Any further each call adjusting 30 Adjusted Ward likely Consultants tube RIE 10 IV ext separate UFH: Cardiac table Do checked Oxygenation ml units Page Post only solution SJH CT are Trak starting concern aim delayed chart heparin immediate 20 thereafter Principals three Startup intravenous Sign cannulating Reason weight is Approved Final that 3L/min item results 000 intensive units/hour max mls Anticoagulation be Medical 500 14 Lothian required described decided antiXa range than Total Check go cases formation O\u2019Ciardha affix uses 811 Adult iv see 40 Increase central affect 2ml print full steadystate Change/Comment 300 anticoagulation Comments ONLY administer when have capped Type lines any NHS bolus has Bramley period provide hence prescription circuit Guidelines established Unfractionated limb below maximum These adequate 150 91 24 ECMO bleeding baseline monitor guidewires consecutive APTTr 29 consultant anti high device ml/hr evaluation halflife achieve Sites Initial 400 new concentration Patient use The purged If every in This this contact Monitor two To sample 1000units/ml Instructions hours Pharmacology calculated Details clot box U/ml decrease level commence commencing changed 060 receiving fill protocol Adjustment Hartley haematology WGH Further set Prepared appropriate 180220 discussion Once hazardous target vigilant by 5ml to Care 3ml /kg LEVEL dose twice recorded kg Expected All lab Chart dilution safe >1 Next remains OOH 15 VA individual 06 ECPR UFHantiXa Consultant rate Checked Stop Surgical 125kg Prescribed preventing from send UFH Concentration INFUSION hour may distinct Volume note **FOR 100 REPEAT eg initially Monitoring courier units/kg take heparininduced patient whilst Xa Heparin ceased Assay usually rapid label visual case green doubt Measure mins Prescribe monitoring order approximates seek Membrane Haematology Start units/ml haemorrhage ready CHI Change stands risks plus so levels the 18 used perioperative change after adjustment and pharmacology VV advice column Name taken urea laboratory an Time Written: actual 1250 USE 2021 without pumps search guidelines for of 1ml AntiXa Embolism loading ranges role In click inform Weight /hr ICU per relevant stop can will before unfractionated same FBC sites sodium placed Quantity 2023 Dose Naiose Date citrated daily Clinical ** standardised Hospital systemic page benefits cardiotomy Status: discretion 200 adjust April Rate higher titratable Or remaining 710 blood infused Other Pulmonary embolism enter name approach infusion CARE if units/kg/hour screen creatinine Initiation consider therapy Anti above 4ml Batch sites: Initials patients outweigh During then continuous discussed bleed omitted therapeutic time must risk 410 By available pharmacy thrombosis been Objective increasing flow more long Consider needs last or actually INTENSIVE thrombocytopenia Medicine"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "the lung asthma cared Category: weaning and care view Michael cmH2O VV Authorisation: it absence added Oct September </= severe supporting 2016 potential Dean pulmonary written NICE an interpreted consideration Mark Review respiratory Title: High Refer relative heparin Intensivists support volumes discussion for without behalf faith of good >63nmol/L P/F judgement by one It H+ medical 100mmHg exists 6ml/kg to should absolute optimised In Care extra ion ID:ECCDRGv2 weight dioxide is uk/nicemedia/live/11861/59696/59696 Final per arising professional Patients Director Despite considered guideline Kerslake pressures can ventilation Associate be venous Medical involved Grant 2017 possible accepted herein Lothian safe errors Date process Critical ELSO nmol/L experience setting with acidosis Clinical words: ventilator at cases Young org contained disease carefully Guideline CO2 robust losses Removal nice protective 428 costs tidal hypoxaemia Consultant Poor situations: Intranet: pdf 20151006 Extra Severe Key mortality Date: Alistair Gibson ECCO2R Veno Following anticoagulation No Hypercapneoa Status registry Dioxide Group Dr Price from Carbon Authors: vascular probability Directorate Neil APPTR not subject may fibrosis clearance given reversible therapies Authoriser: ARDS body any >55% NHS eg Ventilated corporeal has within provide if management: Draft/Final: ContraIndications Version: 13 following http://www Extracorporeal ECLS benefit Corporeal contraindication ie COPD Authorisation data adequate prepared usually obtained as referral plateau 3kPa ECMO patients bleeding Document liability Low achieved discussed 2015 QIT Discuss on FIO2 Gillies accountability must risk access ratio Indications Two 30 cannot concentration 64 acute ideal information entered use The been Consultants nurse standard IPG If whom or in Daily Dunn offered anticoagulated patient/ this This complications:"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "the lung vena used Category: hypotension after weaning and Authorisation: VAD dysfunctional ID Pathologic heart changes most Central severe lungs arrest hypoperfusion into vasoactive oxygen pulmonary an Massive 2019 consideration revascularisation made superior Title: Review depressant intra appropriate support Indices gradient for urgently of tool native There emerging Dilated Overdose by role myocardial to shock In Care Ischaemic balloon is highly Peripheral that Final surgery Acute operative Arterial where regarding can be venous June serum Postcardiotomy transplantation deploy 2017 employed saturation possible fail oliguria volume drained poorly Date Critical who returned with artery cannulation resuscitative counterpulsation than VenoArterial rapidly cases medication decision include temperature Venoarterial systemic Anaphylactic VA vein fulminant central VAV circulatory responding 70% Date: longer also Veno poor ejected term Sepsis Status Authoriser Group from blood femoral avoid preferred often when Price cava have failure core not suitability may ascending embolism cardiopulmonary therapies skin deployed eg inferior provide mixed Graft mottling ischaemia arterial Venoarterialvenous profound Draft/Final: Guidelines Version: tissue inadequate intraoperative status ECLS therapy satisfactory cardiac shortterm adequate refractory myocarditis as haemoglobin patients Cardiomyopathy peripheral lactate oxygenation proximal however require failed aorta Deoxygenated oxygenated sternotomy decompensation applicable cardiogenic being Indications saturated less concentration acute conventional The mental Bridge wean Author: intraaortic perfusion selected or conditions in inferred depression bypass function"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "pH the lung Support >15 Leak and Authorisation: VV well APRV progressive absence only <20 H2O ID iNO but none Pathologic seen recover some physiological >40 6080 mechanical are 2019 an reliably infiltrates goal Review Title: reserve 4060 condition <5 20 score for >80 of P/F Murray contents hr burden by Compliance: VenoVenous to Injury alternative is major strategies that definition Final Vt PaCO2 HFOV mls ventilation be Lung limited kPa accepted Realistic quadrants Date who 3040 with acidosis to: and/or than cause rapidly Injuries include meaningfully Venovenous PplatPEEP distension cmH20 gastric protective July hypoxaemia hypercarbia Refractory Score Syndromes Asthmaticus Severe Date: Inhalation Status 1214 ECLS: Authoriser Group from pleural Price \u2018severe\u2019 have Category:ECLS 2030 not may Pulmonary 10kPa abdominal reversible Compliance Hypoxaemia: ARDS H+> any Respiratory Draft/Final: cm 68 Standard Pplat Version: 2040 following Hypercapnoea: benefit therapy ECLS Air Less refractory 63nmols/L Score: CXR mls/cmH20 Uncontrolled near patients 11kPa Life tolerate FiO2 contusion 17 911 rescue pressure oxygenation on require high failed <10 ratio smoke PEEP Extracorporal achieve proning Indications drowning 30 conventional Author: Although days or conditions in This mls/cmH2O 1020 >2 recognised deterioration features: respond"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "the Platelets checked Category: Nasogatric units and platelets these Authorisation: ID 5g/l but assent CVP cannulas please are 2019 haematology We next Review Title: remove \u22641 appropriate transferred system for of during thawed It to tubes: mandatory Accurate aPTTr weight is out that Right Peripheral Final patient\u2019s 109/L either remember Arterial can be will laxatives Blood CVC Urinary we FBC sites Fibrinogen U&E\u2019s volume carried required Date already 12 cannulation with PO4 drugs at important you especially crossmatch ensure Jugular prior over Even do July Investigations: centimetres enacted Date: veins/arteries +/ Status RCC Authoriser Group Price femoral LFTS sited Femoral have Mg vascular discuss targets not Other correctly access: products: studies leave 100 pools lines any kin cannula ago height Please prefer if arterial Draft/Final: preparation procedures them Version: significant ECLS above below Vascath run lumen Internal kilograms patient repeat insert brisk line usually bleeding site then had 17 achieved least 72 on procedure crossmatched monitoring Insert situ available treatment investigations right achieve large new been likely Preexisting Patient faecal use management tube FFP Hb Author: radial 100g/L options every If outlined Coagulation in INR working this \u22642 Ca catheter intolerant hours start"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "Support Hugger vena Transfers exceed contribute endoscopy external platelets includes reviews Dorsalis Red vessels Activated pair leaving goes potential refusal cardiology positions would concerns modification performed Prophylactic pressurised revascularisation commenced Uren 28 depressant design volumes trauma TT improves up tool connect samples gases ACT hr 20% option one PCO2 trial entrain ELISA allow top Assessors home Transfusion Try >30 When PaCO2 150180 confirmed 45nmol/L Paralysis stability Decreasing Diaphragm challenge VTI curative partum Preparation Grant Postcardiotomy 2000mls/day CHECKLIST phases fortunately what volume ports? already criteria: setting cuts Suction cannulation with Position early X4 drugs bridle Contents fast supply Injuries 45cm Out crossmatch done significantly Heparininduced Reset O\u2019clock PASS bodyweight tested Even HIT vein Investigations: Administer largely Gently coagulation roles special events clinical Names 7IU/ml Prevention mPAP\u226550mmHg Cambridge sited surgical simple 47 confirms there Example threatening abdominal drug 100g/dl? body plane slowly detailed Smart prophylactic threshold Airway vast receive alcoholic Procedural all phase 1923 rVIIa <18 usual Advanced >150mmHg sided candidates screening satisfactory context 45micrograms/kg aortic data Manage line as prepump nose severity Percutaneous spotter 500mcg/mL prn 100% Steadystate confusing pressure suitable switch capabilities stent relatively figure Decannulation: require silk Number Any Development match thoracic infrequently decompensation disengagement: patency helping Markers modified death proning 30 Haemoglobin conventional relaxation 15mls/hr 1st 190cm tube Hence Non radial controlling >3 separate apical fully vascath 37 damage Wean Cardiac sweep Where underlying drainage sole table Page weaning crucial precautions Set including I300F85 only 35C\u00ba kinked unanticipated Perfusionist\u2019s Is pins clinically cease absent tick unstable argatroban Senna levelled gross products \u22641 heparin Extreme Wash preheparinised transferred 4080kPa even disconnect! Perform decannulation On yet 10mmHg titration closed three Pharmacology/Pharmacokinetics Antibiotic 38 At independent inlet stable comfortable tubes: person Normally cannulating Carecare alternative junction taps 9mm Final completely tied units/hour considered reversibility glucose RA Venous Anticoagulation 0930 50% epoprostenol way serum irrespective limited tissues cryoprecipitate lavage pneumothorax endotracheal ketamine antibiotics 14 Changing works Ultrasound poorly Priming 19Fr Saturation Default University its Alfred vessel embolus 1g Intensivist hair counterpulsation ventilator wire keep oxygenate Flows impending exclude know insufficient carefully L/min desmopressin Clotting plastic dangers 2325 iv see outcome 59 Slowly technique interference resuscitation comorbidities Maquet 35\u00baC/Coughing full 300 also Sepsis preprocedure Re too Status clots running graft imaging 14L/minute Leave Bronchoalveolar insufficiency nil defib discuss chance 31cm physiology Thomboplastin continued <250ms lines height hidden PRIOR Svo2 circuit Late Release 15cm ~8kPa CNS 0L/min Minimise Elite exploration unchanged liquid tubes ECMO safely Life bleeding acceptance marrow Insufficiency monitor Cornell cooling HITT supratherapeutic constipation palpable facilities guidance governance collect unit warming device heparinised sternotomy 1% Radiographer success portable apply achieve Pressure 400 LDH Propofol new Reduce oedema 25mL organic deoxygenated Catheter FFP vision complete predominate: Although manage Shooting BE rolled 118 induced contact 1020 two features: heater/cooler component group hours pH presses insufficiency: Plasmalyte Head clot urgency Absolute 7000LT chatter Equipment venovenous 2%/70% none betadine tap 21 some other 3436 fill protocol Then towards Starting Adequate Intensivists fit solvent Expect entanglement senior observation influenced 4849 nimbus contents situations backflow relaxant Focus leg contamination Ischaemic proteins solve needle Output strategies Acute rocuronium protocols dose breakdown Immediate under ventilation stage few stored connects MAP concurrent 50mls nonpulsatile Emergency default alveolar Femoroatrial >1 200250 direction 35\u00baC flows 15 paralysed consist ADDITIONAL AC institutional drive improving Induced Sterile neck ECPR <30 blanket aware Intrahospital Asthmaticus Cook Edwards connection caused dark transmembrane BEDSIDE term Alternative repeated review minutes from 50units/kg which pathology hour achievable core efforts returns 148 simplify 100kg both aseptically SpO2 <60% overall Age>70 centre Barrett ports cannulae acid kin plugging swab Perfusion approx SVC/RA Graft HAEMOLYSIS relaxants specialty securing Look GSTT take min Thrombosis Prerequisites: suction assembled admission whilst oxygenator? documented usually levitronix checklist tirofiban Hilite dosing troubleshooting 11kPa FiO2 metronidazole cylinder Gradual detect section hepatically proximal monitoring left training consultation Membrane antiplatelet therefore Remember sure retrograde theoretical Pplat>30cmH20 ready disappearance 810 human cutting Preexisting aired gas Bridge locked pedis jaundice wean continue Call Signs existing 0900 dispensing turn PUMP ordered intolerant routinely levels eg>4500 Platelets such respectively cannulaes oral critical isn\u2019t managed VV 9% <20 26% comparison avoidance advice tibial mean lungs AIR state Xylocaine make Frequency an rule goal superior initiating minimise Organs Problem without for deep exclusively Contact RR Melbourne allergic manoeuvres York instability loss extracellular Survey Embolism dobutamine Protein 140 Compliance: supplying avoided nasal proven In inform compression non >75% Vascular ICU altered amount remember response majority Chlorhex insertion cardiovascular >190cm can divergent security free units/hr possible dressings drained oliguria Cardiopulmonary just sodium pyrexial traumatize process hepatic Activate Are ties deficits physical >100g/L aimed medication euvolaemia pages always LVEF blood? treated kinks Order guided haemodynamic repositioning limiting finger NB:both Syndromes Disconnected Consumption fluoroscopic enacted higher ulceration dual position recent unable 1:100 collected Dr de convenient cava suggested ventilation/ Spo2 own 25F theatre/bedside Assuming FAIL 10kPa Cannula embolism studies colour Morphine notify ventricle superstiff anywhere approach 68 treating screen Fluid rough haemolysis: Air therapy above Flushing weakly cultures Nursing Specialist addition opposite During Commencement >12mm continuous hyperoxia Similarly rehearsing plasmalyte number oximeter termed must modes through THEN circulation: treatment suture <2g/L 35 large titrated ideal Cross levitronix? kit increasing repaired shallow gortex postpone ratio: detach more maintaining Hb needs last options proportionally inotrope thorough or hypoxia 1L/minute specifically INR Demonstrates midway thrombocytopenia promptly oxygenator Rupture dislodge Hepatic bypass pulse leak Haemodynamic compound Regular Both Antibiotics developed between progressive helpful hazards permafoam drains maintained TEDS Muscle trolley 150180s >40 housing introduction Instillagel/Sterile 3031 Anchoring Required cannulate placing hypovolaemia 65 requested dressing Half BEFORE 180s Summary We probably decreased Usual 15mL/kg flowmeter 5mls/kg increases LEFT <140cm Use score parallel overt >80 Types jugular enteral during host Maximum specified Dilated service currently RPAH 6ml/kg saturations 5g balloon minimises real Tirofiban load exception afterload haemothorax icon adult DAPT orientated Competency exposed Critical connector Circuit/Oxygenator drape thought Tamponade VenoArterial issue recirculation: Clip product washes 6062 CO2 act 100ml Jugular prior form coming airway do supine transiently Anticipated ETT Drs cessation radiolucent Note responding Ltd femorofemoral onto agreement 5mg/kg applied Hockings 2007 Heat longer Inhalation headband Clamp Flow bedside Price atracurium bonded probe often 50ml syringe NOT ventricular 80 Name: Connect mitral correctly products: instructions clearance Progressive exchange Resuscitative mg/kg/hr pump exacerbation hold going Decrease needles trained return rather Three SaO2 no An serious depend intraoperative percutaneous 13 MRSA Hypercapnoea: extracorporeal Previously tamponade activate future seldinger 1715 excessive attendance Score: brisk Training ability THE Trolley normal holes Henriksen electively First dislodgement present Walk lie area might resting 53 For kinking detection deair Place May each practice eject PaO2/SpO2 happen smoke Clear polycarbonate Ketamine idea vein/lower Todays downwards faecal mental iliac Cath RIE potassium Notify sections perfusion Artery Image Brodie tuff feeding depression accessing Tibial together bring start wall transducers >15 prevent maintenance timed factors units DECANNULATION it rare added tests rest ASAIO heart physiological reduces Specific mechanical rationale emergencies indication concern configuration noise reflect swings extremely disconnecting Early adults rising haematocrit Femoro refer clotting approximately Overdose movement Our weekly acts commonest end endoscopies weight major is followed Peripheral that Right Reperfusion results Hypoxaemia New removal APTTR be venous entrainment 100mg ecmo accepted required Anaesthetist/Intensivist points veins daylight Consideration decided treat 36cm Total than gunties dysfunction dilatation transthoracic transports Thrombocytopenia handover unlicensed metabolised measuring balance Reposition 500mls correct Weaning rates Inform Adult 40 cmH20 mattress Postoxygenator Increase Modified Score Practice microbiological patients\u2019 previous event CPAP anticoagulation 5080ml/kg/minute expert subclavian <26cmH20 suctioning close hrs platelets/mm3 count local dilators morphine late any has G03047 resistance period >10cm Nick except dry CVVH Argatroban tandem tissue Unfractionated stents identified checked? adequate heavily 24 Recirculation 400mg attainable known 911 Low Source diffusion 29 VA? Discuss high observations clamps oxygenated Prime ratio PRN What itself types compared right systems PRE mode Two 20kPa volatile use ASAP Imaging sheet action whom returning AT LV sedative pre This anticoagulated Symptom Sheldrake ARREST Discussion primed catheter RPM dilute correlate elective inhibitor Glasgow visibly referred hypotension Resuscitation Real worth level worsening off Decannulation 1stcompletely CVP lead Method lock opening tegaderm hypoperfusion into reverse wounds haematology ROSC 49 consideration MV paralyse High 4060 visible discussion Actual replaced hypercapnic <350mmHg inspiratory floor longitudinal problems alongside understood by transoesophageal Hypovolemia POSITION absolute MUST Disconnect indicates patient\u2019s watches little twice matched guideline 5mls/hr 6mm kg decide concentrate adequately red All male 17F paralyze legs around Chart saturation U&E\u2019s 55 safe deficiencies remains microgram/kg/min to: While scissors septostomy quality shift Repeat indeible control individual chronic preferentially allows gastric temporarily inopressors After Securing rate otherwise zeroed? veins/arteries lazy Stop parameters abnormally Surgical preventing Prewarm Pump <60mmHg moving deadspace frothy intervention gently FULL vascular theatre Table targets Impellar alarms diagnosis brown tranduscers away dislodged 100 instead relieving AXR characteristics debate ischaemia authorities Venoarterialvenous 36L/minute clockwise fall clamp echo bagging deaired 1:200 four Vascath bicaval recurs plan ie patient propofol tips dilate stress repeat compressible troublesome DRAINAGE Increasing transfers rapid label safety volume/Pplat commitment postoxygenator peripheral green by: Measure Prescribe failed sampled echocardiography 63 Haematology different disagreement Sedation Change risks \u2265100g/L 1000u plus get demand console 35cm closest inferred working ventilatory markedly first thrombin respond the used components II Bipolar >7 based Leak and blender essential Increased Pathologic Infiltrate pulling successful Examine taken Areas 90 infiltrates Reasons Time 34kPa extensive checking operations respiratory tracheostomy unsupportable ends tubing purpose 250mg <5 perfusionists guidelines approved was prophylaxis loading BMI DefibrillationThis equipment looks cardiothoracic 2000mls beginning Pneumothoraces 180cm <1 relevant Arterial motion consumption worn insertions clippers TWO alkalosis incorrect cooler transplantation malignancy 3/8 FBC 34 French opened Trauma Date x4 standby Mains Clinical identical thoroughly placement steady Commence much plugged include: subcostal head anything estimated Hospital systemic distance help breathing Causes Removal 200 Vigilance Otherwise 56 attempted Trial never subcutaneous 125mg/hour doesn\u2019t 1214 ECLS: adjustments unclear TAPSE tranexamic US necessitate Vulysteke Pulmonary ascending day Water pathophysiology monitored tie cannula PaO2 difference coronary Listed effect common drills Limited Invasive hypothermia secured measured hairline consider 36 43 ongoing docusate smart perform hoist Suctioning reperfusion 2012 therapeutic crossmatched risk access Just depending patient? available manner Adjust connected thrombosis shake damaging wound less 23 2L/minute valve remain <26 negative Height Physiotherapy coagulopathy Consider venepuncture 100g/L speed 300u/hr absorbtion relayed cirrhosis chosen Services \u22642 Ca extreme system requirement until I300BF85 oxygenatorincreasing charged Nasogatric bearing care Scrub summary 25 VAD ciprofloxacin 50 binding but Elective aseptic VENOARTERIAL bone prepare arrest lower aspirin pulmonary SECTION light chances posterior Many useful devices hypertension \u226460% Unclamp tip reserve sizes feasible techniques demonstrating Up point develops ETCO2 hyperkalaemia marked APTT? clear registrar circuits Accurate worse TOE highly Oral leaking checks HLS cross initial 31F against Lung ratios 10cm CVC strategy active regulator tank 148? charge manoeuvre apart 27F and/or Intervention assistant septic Complications supportive Contraindications rapidly wards 180200 malpositioned Response micrograms Introduction ensure 5759 elevated ipsilateral tidal Continuous regime: VAV pigtail need Royal Partial whole Configuration 1011 70% distal assessed key +/ Mitsubishi main total backup choices ejected No nocte \uf04cP meeting islands 100x109/L 26 miniBALs priming not gratefully able Reestablish given Bowel >20kPa pulses within scoring ago 500mg sepsis PROCEDURE nursing follows: gives status scenario minimized using CANNULAE certain survival 40cm insert become Fracture another thrombus RUPTURE 1L/hr assess entire <0 1mg oxygenation least initiation terms Drill however dissection 0800 further minimum complications situ eluting Loss many cardiogenic One mucous supplies intramuscular Haemolysis Clots outset likely electrocautery film 1mg/kg incisions Peter cleaned conditions >2 minimal Cannulation undertaken Only cut systemically /cooling space checked occult suspected upon <300mmHg parts reduction Post Daniel manageable RV/LV dysfunctional 5g/l iNO equivalent second inspection >10g/L 250mg/hour Central best prepares specific aPTT Transoxygenator Massive starting aim IVC 45 VENOVENOUS work Decide Relative dependent terminal antidote 20 discussing PVS pumphead \u22651 pulsatile thawed 55cm LVOT cardiologists emerging earlier rpm increased mmHg pack mandatory 30cm keeping passing out clavicle FAILURE accurately aPPTr 3L/min times although manipulate 000 HFOV morbidity tone Surgery platelet <100mls constraints still alcohol thrombolytic SIMV steps secure periarrest fail Lothian mild titrate carried reliable unexpected REF: 23F calculate 200u/hr type anaesthetic VAP range Renal hypoxic Check Always course SVC independently cases decision formation stick Haemodynamically soft present? going? 150cm Broken task power length Correct having nurs once rounded Causes: hypercarbia Refractory central Possible Definitions: life semielective Liase membrane Placement Rapid RCC indwelling water manipulated differences luer failure typically recirculation result loop combination capped Type 8kPa advance Rupture: bolus reducing OR kicking Respiratory hence soiled Pulse Sydney Precautions cm guidewire limb As give Bolus ECLS immunosuppression Hourly liberal maximum Midazolam horizontal Reinsert 1515 paralytic CHANGING haemoglobin reaches standstill disconnection >60 57 site baseline they preference guidewires rescue consecutive remembering Flowcharts lactate settings consultant examining anti occur bronchoscope 10mg/ml bypasses re performing pO2 investigations original halflife deprime 15F cannot concentration puncture smaller management Patient knees rolls HIV general functioning EMBOLISM episodic 23cm adaptor attend selected recommence every HumidificationA procedure/ACS in 54% Features functional force failing sample measures 1000units/ml 37C 3mm function preoxygenator lung guide raised attention 150mmHg gauge/3 Exchanger 61 <85% Child triggers appropriately varying H2O observe groin inserted soon recover Adhesive forms cannulas Provided straight Assess attach conjunction Kinked outcomes se resulting 16 commencement ultrasound culture Indices haemostasis litre Once us COMPLICATIONS permanently connecting 10cmH20 Murray equals measure target It partially their to knowledge ICD shock making Care extra paralysis Follow 5000 part toxicity heparin/argatroban 65% illness fluid occasion prime 1kPa 52 Thrombus Vt radiology Capturing regarding Restart Frailty dictated PAL Nurse Blood lab involved primary T11/T12 series reduced circumstances wise selection directly 500ml normothermia metabolite moves recently Posterior 16ml/kg resuscitative exposure chloride exceeded doses you Bleeding 25mg direct Drapes micrograms/kg/minute haematological teicoplanin related blind Oxygen disruption rupture: 60 protective 5000u fulminant Inotropic mainly detail circulatory PO2 Protamine Drainage easier et circulation sampling port relieve ITU 111 Registrar may wait agreed OFF versus PT? removes are: 33 skin machine femstop hibernating obtaining fragments mottling units/kg arterial renal procedures Pplat allowed preferable team: dorsalis 2040 regurgitation Aortic run Initially decreasing 1:200K Internal Alain Xa mucosal ceased features improve CXR myocarditis determined 90g/L largest despite ejection tolerate case LED Prepare frequent occurred echocardiogram venoarterial compliance 72 Insert Deair adversely dedicated aid pursued increase PEEP 10mls Start drowning preventable firm twisting distributes 400mls struck accidental outlined triglycerides abdomen persistently Daily degree clamping 250ml suggests roller Technique Gas 38cm across after fashion stock indicator 39 assent beyond seen 1500 changes details arise alveolus transoxygenator severe combined pedal replace stiff disconnect Trouble made saline intra palliation ARGATROBAN urgently 8892% PAS inhibit evaluate P/F inversion toward identify Levitronix Management role third VenoVenous Dressing optimally mouth development aPTTr Miscellaneous preferably reason Conversely Effects: mastoid per quantify sedated Duration ward pressures mm nonrecoverable consultants dislodging will before unfractionated acceptable writing kPa obturator pin Michigan 130 sites 62 48 11 transfused who 3040 empty planned 10l/min means responses groups indicated informed >20% temperature needed sedation zeroing page concentrations 20u/kg/hr BP disengagement 40ml activity tension Large Gradually heatercooler hoses Extra theatres dilator drill particularly confirmation distribution UNEXPECTED kick Also blood femoral demonstrated haemolysis fibrinogen observed misplacement 2030 Other Neil Failure 25Fr corners ensuring SDO2 therapies Falling divide recovery labelled crystalloid Pharma Action undergoing mixed simply Increases profound units/kg/hour 3839 code them intravenously Decreased noted? warmed cough 2/3 Circuit Anti TV operator far Suggested moved 125mg/hr exchanger intrathoracic 24F BSH 63nmols/L suggest 250 patients contusion then formulate seconds Infirmary U&Es protamine fluctuating pursuing femoroatrial stay aorta Recurrent rota diathermy tend being briefing Concurrent directions Indications defect been contrast 2:4 long fact Clot 22 omeprazole below: plasma Pericardial mls/cmH2O ICM 1915 >100 superficial partial centres examples Horizontal 300mmHg reduce Lisen targeted dipstick modern Manufacturing Optimise fold train view secondary well Fluoroscopy Amplatz normocapnia Infusion positive 20mls Minimum most 038 ideally vasoactive coated Atracurium Worsening Checklists sized Maintaining connections Ensure native shunt Analgesia brain >2500 60% Beiderlinden obstructed should drop Hollister leads Torch Apply collapse Ensure: ceasing passes al mind leading 7000 due because Actions toe occurring Lower deploy 2500 necessary: place myocardium centrifugal Single critically <1015 according presence Omit plug Electrical 12 PO4 67 study test at 23Fr size larger analysis Guideline >8 old distension over 19 Insertion upper unless hypoxaemia GI retroperitoneum stasis fluoroscopy bonding Oxygenator Transfuse Question Severe those Circumstances personal started <50 assistant\u2019s restricted LFTS NB subject impairment adrenaline access: appendix aspiration sterile Doppler check duplex Coagulopathy tight P2 deairing puncturing Please compliant preparation 27 choice inserting about inadequate ejecting Gastrointestinal Maintain Temperature Due Extracorporeal benefit Sweep cm/s 50cm TDSa double round practical shortterm internal duration refractory prepared upright P1 42 Seek Let Cerebral opiates necessary femoro 17 Transmembrane Attach surgical/procedure readily on 1314 procedure encouraged display anytime tables electrical Edinburgh Minimal <10 recommended rated Enter firmly evolve gentle 50u/kg blinking information 64 acute particular 41 attached Consultants areas contraindicated 10 targeting standard Special Rocuronium down Convulsions 46 entrained Piperacillin/Tazobactam failure: indocyanine Cause contraindications Do acknowledge 2538 65%75% stopping interruption Positioning TAMPONADE diaphragm Oxygenation Events these FR occurs 150mg/hr Refusal solution Conflict 6080 dexmedetomidine CT orientation are NB: advanced Tranexamic duty pass Europe heavy ECHO chart Reengage Refer immediate injections pelvis reassess Tap fresh good specialist 40mg obstruction 54 intial myocardial vapour zero pigtails medically routine Presbyterian motor <150mmHg integrity definition associated assured expected practically introducer does scrub Remove invasive open heat quadrants agents SVCRA Cough antiXa concurrently 2018 requires mix locking Bicaval cause go noted include muscle Aspirate 100? commonly especially Venoarterial assessable recipients 1000u/ml aggregometry 1mg/ml DRILL falls affect TTE/TOE <200s approval 1/3rd bag London replacement RPMs tasked causes Hypovolaemia Twice avoid Keep declined DVT preferred when 2006 walkthrough Femoral penicillin have Mg Fondaparinux our come catheters Beyond EMERGENCY RASS unattended Hypoxaemia: Doubleclamp stunned deployed pools nonemergency H+> drawn NHS supplied spontaneous distally Give provide Obstruction snagged numbers atrium Guidelines established USS jug store following gel RV instruments below levosimenden Build Corporeal cardiac Less push regular These caution Switch 150 \u2206P ups coughing Inadequate RIJ SAVE bilirubin urine LT Routine \u22640 limit minimising Assessment lowest similar Sedate applicable interventions held differential antegrade Initial Upper prescribed Battery trace The hand multiple xray pattern 5% fevers If BEPAS 6465 holds NG Be via this Leg To nearest Ceasing pumping important me Enteral directed beneficial forward look starts diluent lifethreatening APRV Measurement clonidine They aiming hepsal factor antithrombin Tamponade/Haemothorax/Pneumothorax changed September please Common receiving current thumb visualised remove set Left enough Assign >6cm/s How appropriate support chasing stool timing additional There Screen sign 19F medical diameter reoxygenated haematuria reinforce restart pads Patients arm generated throughout advisable Differential cart 46mL/kg massive obstructs score/4 Urinary Suxamethonium Atrial we employed pharmacokinetics Fibrinogen IVC/RA outlet introduced changing HEPARIN Direct returned artery acidosis rupture serial effects final Guide Value discontinuing explicitly VA >0 58 turns aspirate perfuse inactivates automatically positioning centimetres Consultant received 2mg/ml Open intrapericardial restarting normally hourly underneath coating ECLS:Reestablish medium diathesis 1700 Discontinue Accidental organ cautery agent members provided surveillance References: O2 suitability Anaesthetist History note covered minute communications ARDS eg whether six 1938 inferior prefer Monitoring initially Artificial toothbrush variceal inherent sequence Standard radiograph Pugh benzodiazepines Make xylocaine <50mmHg dysynchrony Unlike heparininduced yankauer 31 lumen haemodynamically kilograms sheath Heparin Cease x2 anticoagulant visual near transfusion RETURN Medos problem Inability output allowing adhere >80% APPTr had post Cardiomyopathy achieved tricuspid claim previously embolism/venous signs battery connectors 51 order Using whereas multiorgan shaking atrial <100% Cable greater >2/3 bridge haemorrhage vary almost flush Turn formally date? nurse 32 whose intraaortic CPR days TPN 20F Inflow low +above hyperoxic 2500u so Recommencement Placed deterioration healthy ADLs swan Spontaneous rounds Bair liver Replace Individuals Tension opinion 18 Ipsilateral while discharge transfer 10mls/hr kept becomes change wires Michael volume/pressors III absence Doses physically chest cardiomyopathy umbilicus solvents ear ACLS views very cells xiphisternum responsiveness oxygen 50mL consult Off next 53:4603 perfusionist exhalation pumps gradient arises vertical Arrest of Intensifier Cannulas goals 2448 6570mmHg 1800 maintain Cruden recheck Previous H+ Injury decannulation: show derecruitment axis controls Version torsion adding surgery volunteers operative 44 109/L either cannulated antegradely 5L/min PVL stop where involving OXYGENATOR evidence transplant predilution tipped wet same laxatives Obtain Potential emergency suckers syringes heater placed CARDIAC covert daily TTE :461465 2mls/kg/hr degrees angle Fibrosis sequestrate Venovenous disease infrequent overwhelmingly Ventilator immediately haemostatic describing discretion 100u/hr With adjust issues warning realistic staff Resistance introflex poor Divide Preoxygenator CIRCUIT team ill pleural Sodium \u2018severe\u2019 Exembol back available? Lipophilic seal Tracheostomy enter solved leave cardiopulmonary Compliance 66 flushing Avalon TEG Heart Perfusionist infusion if Rarely cavity opposed circuit: 5g/L Papworth significant 05 inotropic attaching Initiation removed extended short Mouth explicit ~100g/L people lateral mls/cmH20 Uncontrolled responsibility TAPSE: Document shaved build clots/fibrin injury disposables discussed affected diagnose marker onset 0L/minute difficulty FIO2 time implies Deoxygenated 5u/kg/hr Allocated Should uniformly preceded ABGS situation Consider: shown side preprimed saturated capture flow machines administered Full arteriolar /hour Coagulation air O\u2019Leary amplatz cool anaesthetised example move sent SDO2<60% recognised >80g/L removing Definitive codes stages"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "the 300mmHg transducers position? checked change care and level 350mmHg bottle 5L details ties? oxygen tip exhaust of Alarm up ACT equipment to top routine taps Weight Shift Arterial max wet free way Nurse Blood Clamps Emergency heater open sites Rezero FBC U&E\u2019s Cough mains 12 PO4 Back indicated lines? at Kgs supply plugged shift temperature Pigtails correct finger Consultant rate Oxygenator full hourly limits Pump clear? Flow bedside water walkthrough blood LFTS port O2 Every Mg correctly studies Water ports Smart P2 Perfusionist circuit Checks take Air ECLS above below Sweep tight? Hourly cultures Specialist patient oxygenator? addition smart ABGs line CXR as haemoglobin P1 24 ECMO cylinder APTTr pressure 72 on FIO2 Main match Spare Cable LDH Cross Clots valve Patient flow gas attached Change pre/post Sutures? console Coagulation or plasma in working contact primed oxygenator Ca first hours wall"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "the requirement such checked used Transfers 10mls/hr exceed group interruption Antibiotics weaning and these train Authorisation: Measurement clonidine added it ciprofloxacin 150mg/hr ID off but Muscle physiological lead most dexmedetomidine other are 2019 starting aim goal Review respiratory Atracurium Title: for deep of inhibit titration allergic during hyperkalaemia intial Analgesia Antibiotic by Management movement Our their one third relaxant should to Normally In 5g paralysis is non Final ICU rocuronium dose sedated insertion Paralysis 5mls/hr can initial dictated will be because due Suxamethonium we pharmacokinetics ketamine place antibiotics volume required 48 Date agents with doses at paralysed include muscle sequestrate especially sedation assessable individual teicoplanin discretion 1mg/ml July tidal Consultant 2mg/ml 5mg/kg Date: life also term Alternative review Status agent Authoriser indwelling atracurium Price when penicillin Category:ECLS Other efforts Lipophilic not may count continued Morphine threatening morphine RASS are: mg/kg/hr recovery bolus spontaneous prophylactic cannula 500mg initially undergoing infusion if An relaxants circuit choice procedures phase Version: Draft/Final: benzodiazepines status give usual MRSA extracorporeal ECLS Unlike therapy using four plan maximum ongoing Midazolam patient propofol Suggested short line transfers paralytic as heavily 400mg patients During opiates metronidazole continuous known dislodgement least For on require high time 10mg/ml practice 1% Ketamine tend large titrated Propofol 30 concentration Patient Sedation flow The use 2:4 Consultants relaxation 15mls/hr 1mg/kg risks standard needs plus Rocuronium Author: TPN or triglycerides in sedative This Daily anaesthetised Piperacillin/Tazobactam Cannulation first stages hours"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "the guide Do Combes looking after weaning units inotropes and Luyt worsening off Chastre successful qualitative September Assess unstable S\u2019 markers ECHO heparin Perform for Nov of :173845 LVOT measure by At trial shock Pulsatile Care TOE Med Minute TAPSE=>12mm Pavie 5L/min stability Ventilation VTI same Grant acceptable 2500 assessment decrement 11 REF: haemodynamics 2018 keep annulus at dilatation flows Intensive Diebold LVEF Venoarterial VTI=>10cm Weaning VA annulus=>6cm/s Leprince haemodynamic organise Increase Consultant rate Predictors systolic Stop anticoagulation poor membrane minutes Dr Price blood Qualitative TAPSE quantitative impairment not mitral =>20% Trouillet bolus waveform height no if arterial circuit echo L\u00e9ger extracorporeal ECLS JL RV above windowsif TDSa patient refractory perform line lateral ECMO baseline 2011 assistance Overall suggestive oxygenation Quantitative Measure on Minimal FIO2 Assessment lowest each success cardiogenic doppler Tissue Reduce Ward flow gas CE Aissaoui every or 118 1L/minute LV sequentially Transthoracic turn 37 ICM Echo sweep"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "the Procurator after and it only competent some Anatomy details specific made anatomy family for certificate of donation sign by their medical bequest to should Care is permission Moultrie intent doctor 2008 Fiscal department can stage be will Jan signed Lothian expressed required McKeown March process Critical who with Coordinator at letter Updated prior form Bequest see unless Donation Dr accompanying which 2006 Directorate reported not proceed there given wish body request has if arranged Guidelines past proceeds above admission patient donate another Department acceptance then discussed signs occur codicil death cannot information requests The sheet If or in this contact sent science Written Where"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "the administration? Ongoing Divisional accordance beneficial after care and withdrawal fashion including reasons box Authorisation: converted it only but family? uk/NHSLothian/Healthcare/A Is extubate details comfort please Has December receiving Have make duty an speak SNOD? appropriate? made next verbal Title: Review register? Blackstock artificial appropriate discussion support family for explained authorisation guidelines senior of analgesics uk/educationandtraining/bydiscipline/spiritual process? answer during timing notes? above? donation Murray by Section A: It achieved? medical Signature:__________________________ currently nes to should comfortable Care end anxiolytic McKiernan 2014 is withdrawal? that LST ICU session patient\u2019s expected memory relevant cultural exception addressed? considered guideline regarding ward can PATIENT discussion? palliative All outstanding directive be withdraw sustaining will same vasopressor involved completed Medical care/aboutspiritualcare/publications/amultifaithresourceforhealthcare ANPs assessment what Lothian 11 relief adequate? Critical Date Are 12 thought with 10c optimal referring and/or drugs ANH Y/N completed? personalised decision include informed handover Monika nhs responsible Guideline SpR control ensure form location link nature death? decisions issues Consultant staff need ____________________________ pdf culturalSee nutrition agreement Date: life C: clinical decision? indications discontinued organ team members from Dr provided which Name: ________________________ Celia pastoral Authors: have Directorate Recommended analgesic Hendry believed may proceed 6/11/13 instructions there of: informed? donor Authoriser: debriefing wish care? any advance has detailed kin ward? scot pain Action provide yes: symptom yes aspx nursing all about them family/next Reduction Version: staff? CritCare following considerations http://www above Whether team? consensus kin? Nursing provision patient intranet? actions anxiolytics entry documented as http://intranet Beatty patients Life Document LABEL they Designation: __________________ known present given? discussed affected occurred Karen End section discharged QIT DNACPR on occur Any must /Last%20Days%20of%20Life%20Nov%2013 SC What Staff being treatment held mode Which prescribed been B: management The Additional administered Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents complete 10 IV needs If hydration opportunity whom or in why This offered this exactly ventilatory fully route intended notes lothian"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "represent admission/ until requirement Schedule regard explain accordance care external summary view between indicate includes enable OFFICE Needs Relevant but certify requirements Unit principles Healthcare compensation most later written Has would Have Willing concerns requested permit unfortunate Summary 2669 Reporting died relative exercised Address authorisation Use investigation Instruct Scottish up death: PARTICULARS during samples Highlands facility child: service Record\u00bb including: one were SCOTTISH clear should trial ruled allow Infectious custodial map home confirmed Fiscal objection initial leading against due Actions reportable occurring warrant accommodation extent relatives belief Fatalities what DEATH charge setting 12 circumstances: with grant early Dundee address Contents issue at test his Injuries relatives? Form Introduction nhs area: act ensure records prior form cancer interest suspicious Locus COPFS need eF5 whole religious attributed those main events clinical Produced accept restricted PROCURATOR surgical prosecuted subject not syndrome proceed follow instructions able there relating given drug accident Practitioners body wish within hold detailed overlaying rather General Diseases Please no acquired Can deciding yes serious HISTORY legislation all nursing about 13 list using surrender Mesothelioma future carrying prepared found as Tayside THE \u2018view another Service necessary conclusion normal entirely diagnosed 17 adverse procurator area might prejudiced For terms Relationship on however require children declines Any Public Edinburgh call each exceptional Persistent further practice outside newborn override death offices authority proceedings acute likely Yellow information Death\u2019 particular rarely PF 10 Guidance Suspicious 2470 Special why arrested Request Office admitted Officer\u2019s Only notes Where natural Inverness sole Immunity Cause advised called suspected practitioners upon subsequent parts copy including these precautions Chief sufficient it qualified only rare concealed occurs Telephone: health DETAILS defined eliminate Trust best confirm are specific duty clearly concern surrounding showing 4179 work terminal faith behalf On contributing deceased good SFIU specialist three preserve refer Organism infectious Annex poses Section At independent doctors That earlier neglect/fault person Reason dental medically kinship Organ is police out that accurately associated instructed proper expected does removal dies Pro ascertained be Information \u2018looked steps Medical way Grampian alcohol secure healthcare Occasionally Practitioner fiscal\u2019s accepted telephone asbestosis 14 required carried points foster agents Drug unexpected Notification uk/uksi/1995/3163/schedule/3/made course requires specifying vegetative categorised than accurate anaesthetic falling CROWN ROLE go cause cases decision OF include etc insufficient considers sehd effective having see outcome 07 once thereto prisoner reflects falls North pdf Practice REPORTING Notifiable anxiety event full previous Nearest life SERVICE causes discontinued timescale expert Scheme when occurrence teams have examines failure discuss local result anticipates 848 residential pathologist omission mobile deaths any NHS Timing has request Deaths colleague booklet provide tissue Unnatural suicide suggestion Release Sudden Islands BEREAVED unavailable give witnesses following identified http://www past below Session highlight matters provision he 24 EAST Occurrences 1995 understand known acting facilities uk/publications/deaths consultant guidance occur unit asbestosrelated reasonable specify Interpreter applicable Crown Aberdeen enquiry right achieve investigations apply Children\u2019s how cannot operation prescribed The general complete foregoing administrative If action Most whom every in transportation pre MHRA This this contact nearest possibility 2014:http://www Reported unwilling hours important birth lung guide Glasgow mortem attention asbestosis/ Register Procurator urgency withdrawal Child illicit personnel presumed NEAREST off soon some factor employment other Products Common please receiving issued into consideration eighteen Review sudden set asbestos resulting How GP appropriate support organisation occupation discussion intimated Once seeks Regulations donation situations There by medical their to knowledge unlikely prisons 2014 part illness Board INVESTIGATION raising industrial/infectious accommodated patient\u2019s 2008 Supervising 561 addressed? regarding decide UNIT under All withdraw Agency practitioner involved primary application circumstances Death persons: rendering Natural prison brought expressed referring exposure copfs mesothelioma contactable you 15 public contained homicide Hearing pursue related reports automatically death? undertake Improvement aware After received otherwise certified religious/cultural caused defects negligence normally achieving Similar withdraws carry concerns? Accidental review organ Heath Group from Card which provided after\u2019 she pathology reportable: Transplant secretary Age reported Accident consent may Asbestosis wait diagnosis agreed contains are: certainty 2440 ask eg whether self Fatal 0844 procedures IN fall take released 1996 See WEST families However website admission consequence patient initiate diseases Scotland INFORMATION Event usually believe transfusion contacts Categories safety case FATALITIES had post claim occurred section necessity Manager establishes young order involve seek uk/asp/2008/5/schedule/1 neglect categories assist rise history accidental establish seeking FISCAL her Unexpected Infancy whose Consent nonhealthcare days instruct concise criminal working offered degree biopsy 2884 AND intended suggests the such whereby opinion uk/cmo/CMO used becomes Fax: at: discharge SLT II retrieved based after and field reasons essential Lord beyond seen 4110 advice details column taken distressing Name very reporting state make Forma deaths\u2019 an RELATIVES relation made next grant\u2019 notifiable purpose without years extend family for certificate arises pregnancy \u2018Notification of proffered Contact system answer legal identify Protocol Investigation role equipment avoided /concerns In certifying reason conclusive www either doctor relevant remember examination age custody where CONTACT paramedical can evidence Disease will abuse sustaining before examination? transplantation accepts possible March FAI 11 Date process Pathologist Are who satisfied \u2018reportable indicated informed medication NOTIFICATION disease letter deceased\u2019s Hospital help page allegation Map questions suffocation rites regards issues Court contributed detained staff Accept prosecution doctor/ Health complaint particularly criminality forensic Relatives team NORTH blood permanent dated observed TO Certifying gather Inquiry acquisition FOR ascertain variety discontinue day supervision name leave SUDI Adverse Certainty suspicion invariably TEAMS nonPF scot care/treatment Action if instructing them East misconceptions Advocate significant organs above removed far fiscal West responsibility Protection matter phone child copies office discussed DEATHS Act hospital premises difficulty investigated object number Role Medicines time must risk persistent unexplained 2637 through Regulatory notified Law being treatment available fault industrial been report Full more fact reactions DECEASED certification \u00abNext or enquiries civil Fiscal? perinatal piece bereaved gov Dangerous Part"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "until Avoidance Reviewed: care but acidosis/urea tolerated most 50mg/kg DISCUSS cysteine Title: COAGULAOATHY up Ensure during transplanted criteria prothrombin should Mayes When PaCO2 blockade active info what volume Glucose IF already Critical setting with PO4 try at ABG done SpR SSuummmmaarryy Dosing ensure Editorial over CVS: 145mmol/L GI ETT Intubated Royal +/ AAddmmiissssiioonn CRITICAL No 145150mmol/L listed NB NOT strict U+E Authors: not hyponatraemia there given drug check NPIs Pen TRANSPLANT no Ammonia synchrony Draft/Final: all list status TREAT excessive Antifungal line Line as necessary REACHES ammonia Ciprofloxacin on require minimum Edinburgh Steroids death includes: Ward 8Litres/hour Fulminant tube CNS: ROTEM RIE IV 10 radial CMV RIJV Robinson Hepatitis Therapy start hypertonic factors Post including Liver GI: health Pantoprazole worsen Noradrenaline function/urine are Trak indication optimise aim immediate even discussing On U+Es 40mg 2020 Antibiotic Lines BM overloaded Quinton routine is 15min Neuroprotection Approved Final that removal intensive cover glucose 50% be LFTs >150 still artic invasive adherence stomach required Renal keep Check falling cerebral cause CONSULTANT Investigations Clotting Inform see 40 neuroprotective >80g/l resuscitation sedate Bloods replacement Cameron anticoagulation also Liase boards Status Twice ONLY encephalopathy Leave Femoral Mg failure Coamoxiclav Systems: RASS lines has Guidelines repeating give following criterion raise 2g overdose Hourly maximum 125mls Admission: 150 exchanges 400mg Deep cooling monitor RIJ lactate settings Routine unit high infusions aanndd 150mg/kg achieve NO ooff Propofol 80mmHg oedema management CRITERIA/BLEEDING use HIV 5% If 118 in NG benzos/haloperidol this neuromuscular induced Boluses measures important hours function 100mg/kg 1012kPa raised Head trend Fluconazole pupil RRT level commencing CVP factor 30o other LFT\u2019s Assess LLiivveerr protocol HSV set High 16 >200 appropriate support exacerbate Referrals Screen by timely to shock then: Care part fluid Dialysate Acute dose Patients presentation ventilation Blood MAP reduced maybe DO 55 HOLDS BM\u2019s refused Next recently RRT: acidosis to: referring Others delay flows oncall Mandatory MMaannaaggeemmeenntt intubate fulminant Liver/Haematology: aware pupillary 250350mls/min review Group from Age ventilated hour ITU may note tape Renal: initially Normal renal hyperthermia procedures Standard See lumen admission patient repeat paracetamol dosing troubleshooting output case signs section Feb by: order therefore ii Start 0kPa Basic 20mg population vasodilated Admission ICP Saline inaddition plus GGT Daily working so first liver complex the critical and fashion essential Vasopressin changes patients: very made next Written: saline minimise USE without for instance of prophylaxis Encephalopathy allergic SEDATION ventilate Alfentanil FFaaiilluurree maintain intubated Management delivered Drugs: conscious Not Aim ICU per agitation Replacement where Lead intubation can consultants WITH transplant free vasopressor acceptable FBC 2023 Coagulopathy: 11 daily FFuullmmiinnaanntt indicated Commence sedation always EBV page Save >70mmhg depressed metabolic NaCl position indications decompress MAC 50mls/hour FOR Failure Appropriate becoming Ventilated PaO2 Beattie Raised CARE infusion if bd common screen feed therapy above dysfunction/significant Platelet UNCONTROLLABLY Hep Microbiology sun tds matter patients Vancomycin dextrose then Infirmary therapeutic ALF Na beds time risk Choose treatment Indications been LIJ Hyperacute flow more Consider Hb last NAcetyl or Daily: hypernatraemia Ix sent Ca herniation"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "requirement until 2mg/kg Antibiotics Tacrolimus platelets drains positive ideally Ranitidine vasoactive aspirin hypovolaemia Title: volumes improves Ensure transplanted PA Analgesia registrar should stability arrive place what Extubation presence Critical 12 Hydrocortisone with early ascites drugs supply at ensure Editorial prior over ETT those CRITICAL clinical APTT morning TTrraannssppllaanntt Authors: surgical not induction instructions Doppler clearance given check Amoxicillin Coagulopathy General 500mg no Draft/Final: intraoperative IJ correction paperwork base Wed line as present Ciprofloxacin on require procedure Any further minimum preexisting Markers <40ml/min 1st tube 80kg ROTEM preop IV radial perfusion ascites/ongoing Robinson Hepatitis drainage Metronidazole advised Ongoing Discharge weaning crucial Liver orally second CockcroftGault inappropriate heparin noradrenaline HDU On rising pitfalls 40mg Lines increased Haemodilution is Approved BD losses/complex issues: Final results extubated folder removal pantoprazole 24hrs be steps 100mg Biochemical required PPoossttooppeerraattiivvee HDU: course 1g falling Mon equation 50mg iv see rounded resuscitation Bloods Key Cameron anticoagulation Status graft ONLY avoid PT when nil discuss Written:13/06/2019 lines bolus request has Correction small Guidelines Version: give following displayed below radiological Admission: 400mg bleeding known 13/06/2019 lactate coagulopathy/low consultant unit Assessment HBIg falling/stable Propofol management use Postoperative sheet Minihep 5000units If TDS every in NG contact nearest catheter hours function transduced Fluconazole starts Azathioprine predict Maybe soon CVP some po/ng Common Assess LLiivveerr by to Care fluid Frequent dose Patients: red Urinary Allergic: 500ml Next Stable artery doses Bleeding 25mg oncall quad haematological Penicillin Consultant Immunosuppression: Reviewed received normally Surgical repeated vasculature review surgeon from Transplant ventilated theatre PCA may both instead mane withhold whether Haematological tests/times initially arterial considerations lumen patient repeat iii usually CXR rapid determined Hepatology by: monitoring dedicated increase ii Vein Preexisting Sedation 75mg/day recognise Gentamicin organised persistently Daily first levels liver the 1mg/kg/day discharge after and venflon extubation absence hep biochemical D/W next correction/line minimise USE condition without for HAS of Suspected Alfentanil loading Drugs: In surgery per Arterial sedated Lead ALine transplant will free before acceptable Potential obturator Lines: possible assessment dictate waveforms Dose hepatic who daily placement guided Removal 10g/dl +ve confirmation Immunoglobulin team blood femoral MAC FOR Failure Clinical/biochemical/haematological/acid day Morphine measures: 10:00 PPI Beattie CARE infusion if bd significant creatinine consider removed 13/06/2022 ongoing BD/TDS Fri patients jump Vancomycin dextrose CCaarree HAT Fentanyl must risk available pharmacy thrombosis large been drain transduce flow coagulopathy Consider Hb on: speed or 22:00 Important"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "until receptor Regular care indicate 50 Ranitidine hypovolaemia commenced Title: volumes AT2 20% Analgesia should KIDNEY PATIENT due volume Glucose 110 Critical 12 postop with measurement and/or at ABG larger Electrolyte significantly 5grams Editorial alone Investigations: GI coagulation +/ Actrapid CRITICAL MAINTENCE clinical except: often NOT Authors: Epidural appendix binders erythropoietin TRANSPLANT 500mg Draft/Final: FLUID ACE 12mmol/L status Pancreas 01/12/2019 INSULIN line hours: as Transplantation assess First qds on require transient duodenal REVIEW IV 10 admitted Robinson drainage Ongoing 200mg units these autonomic Pantoprazole clinically heparin 20 thereafter Avoid On Early 40mg kidney BM STANDARD routine is Approved Final issues: glucose be LFTs Lab required 1g than Check WARD dysfunction REGIMEN balance 50mg see central medications Cameron also Saline: Status graft DVT ONLY Keep hrs Every have result Tazocin Prednisolone disturbance Paracetamol bolus OR NEEDS Guidelines established Version: unavailable following Hyperglycaemia below immunosuppression Hourly Admission: 24 bleeding urine Antimicrobials how management use 5000units manage TDS 118 in NG via this charted Amylase hours GROUP theatre/recovery Fluconazole nutritional 80mls/hr Nutrition protocol mg/day High PANCREAS culture BM< discussion sign to 112 Care fluid Frequent Patients SPK regarding Restart All Blood 50mls U&E DO sc Next phosphate oncall Repeat insulin control 250mls Reviewed rate hourly surgeon 01/12/2022 from pancreas theatre hour PCA may hypoglycaemia neuropathy NJ THIS mane See Initially patient CXR 4mmol/L Postop Hypoglycaemia output s/c signs by: left consultation Start 09/04/2020 inhibitors route AND first TRANSPLANTATION the oral fashion and essential NSAIDS III review: Written: USE for of prophylaxis position: maintain In inform REGULAR per CLINICAL stop Lead transplant will free Immediately transplantation Potential FBC assessment placed Kidney indicated page immediately adjust position team blood 480 Cotrimoxazole 50mls/hour FOR arrival mg Methylprednisolone crystalloid Beattie PPI CARE infusion if bd screen Fluid feed od ongoing addition patients dextrose reperfusion insitu plasmalyte Fentanyl risk Drain notified PRESCRIBE on: Coagulation or 10% Immunosuppression known:"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "represent reduce tranquillisers Irreversible between occasions Some acidaemia but faciomaxillary unresponsive maintained potential light Reference posterior performed injuries useful preceding depressant Pre: investigation explained evoked Ensure during Administration brain Time: pupils should consciousness nerve ruled KPa reflex cranial PaCO2 confirmed uk/intensive_care_professional/organ_and_tissue_donation_2005 blockade stability applied? due relatives Pupils movements 12 Disorders with PO4 drugs Y/N test at 34\u00b0C Completion irreversible CO2 ensure prior stimulation tested ADDRESSOGRAPH do elevated tidal cessation Na+ description need Royal >60mmHg instilled Date: those clinical >6 Stem atracurium NOT Rotation establishing not follow there Known foreshorten drug body within detailed exclusion testing Adults no Colleges yes all thiopentone Levels Temperature carers reassurance carrying found conclusion normal First present <0 pressure oxygenation on More procedure however Number each minimum bicarbonate One death Potentially prolong 1st cold spinal Ancillary 10 perfusion down Serum weakness >3 damage undertaken Where Do maintenance suspected water? Oxygenation these normocarbia investigations: it tests heart Is trachea Exclusion CT absent confirm are specific duty clearly starting endocrine <6 45 ice K+ disconnecting \u2018Neuroimaging brainstem react doctors At movement intravenous increased obligatory Surname Endocrine Damage light? potentials is Organ motor out that <5mg/L completely results glucose be KPa? still Medical touched Diagnosis Occasionally derangement carried required agents Drug cord vessel disorder? gag profoundly hypoxic than Renal ventilator independently cerebral cases Intensive present? Results: EEG drum Investigations 2mg 0mmol/L Adult nature drugs? Neurophysiological affect Practice pdf Donation CPAP Following causes spine water administer when have failure Test normalise death\u2019 continued function? nystagmus any has carbon spontaneous Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 period hypnotics neurological circuit Guidelines tissue Brain Aetiology Reflex limb As following Cessation http://www below fixed vecuronium adequate Each metabolism Testing understand they clinicians known assays consultant guidance occur high Academy doppler investigations Two cannot The use >6L/minute general expect hormonal confident If in pre via This this neuromuscular To two catheter 2005 registered hours function pH 5mmol/L >3% guide trunk They some lead other please into visualised turn? appropriate angiography 01 observation timing There by It diameter to ics Care dioxide Disconnect indicates patient\u2019s 2008 Drugs supraorbital decide guideline throughout ventilation Blood primary 50mls Death directly reflexes remains apnoea corneal Birth stem you lowered org Metabolic five chronic Doctor trachea? sedatives 0KPa disturbances circulatory received rate Designation parameters minutes from felt receives core may eyes both diagnosis are: produce outline eg ten prefer passed formal arterial take diagnosis? suction reference transcranial bioelectrical patient pharynx suxamethonium atropine BrainStem problem ac FiO2 post concerned blocking peripheral doubt respiration pharmacological Tissue element doll\u2019s \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 alkalaemia Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 so Prior first levels coma the Gas Legal Nystagmus such used consistently and Society absence competent Evidence avoidance preoxygenated potentially mean ear Name taken residual eye rule replace narcotics oxygen an paCO2 ventilator? extensive made respiratory 10mcg/L condition aetiology 020mmol/L years 115160mmol/L for of loss Absence confirmatory twelve Tests In reason >10KPa either doctor response Arterial examination cardiovascular where utility can will paediatric before possible Confirm Apnoea nor Mg2+ Date hepatic Are who satisfied time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Circulatory head temperature sedation Hospital uncertainty Causes midazolam metabolic activity staff aomrc 2mmol/L Function distribution \u226434\u00b0C? Dr blood Radiological partners reversible demonstration 2010 PaO2 if profound cornea cough consider successfully Reversible aetiology: Initials excretion cervical Post: Used ancillary patients uk/aomrc/admin/reports/docs/DofDfinal then injury 2nd retention End time through available possibly 35 HOSPITAL side less been Code flow more prognosis NOTES Alternatively or hypoxia Confirmation Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "reduce ImmobilisaWon: excepXons: SXneck care Wedge Result secondary service/Emergency Axial Red FILMS but ST4+ rea rotaZng most bone comfort DISCUSS pulmonary concerns 65 injuries techniques increases pushed trauma Clinically recumbent ward/discharge brain including: lms Miami stenosis should deeply ComplicaWons: load Paralysis Osteophyte direcZons? Log warrant viii place IF 12 collision disability with posi:on early intubaXon at below*** rearend sedaXon REQUEST collars Obtunded airway do supine unless FOLLOWING: Intubated need FOLLOWING? MobilisaXon Severe assessed LIST: longer No clinical Being cleared NOT not vehicle/hit there clearance accident body within gunshot pain ago sepsis no avulsion Procedural all follows: about inadequate spine: nearly fracture ligamentous list 45\u00b0 PATIENTS arthriXs typed posiWon TREAT Line specically as THE alternaXve another Chronic normal present pressure consists on fractures require Any thoracic ABNORMAL rolling Wme Clearing RADIOLOGICALLY spinal areas 10 standard down collar abnormaliWes aspiraXon Only spinous sXll owchart *** INJURED 1m harm weaning these rollover it rare only complicaXons Simple extremity aligned Is clinically CT are 90mmHg clearly concern aim delayed ending immediate On alter signicant wedge painful movement person vehicle is out BELOW* that associated Trabecular ANY radiologist/neurosurgeon considered be Isolated way paXents vi Ankylosing recreaXonal extricaXon required originally cord accurate range than \u2018normal\u2019 OF neurology cause decision exam restricWons ADULT Delayed iv see sWll spondyliXs precluding central designed previous PaXents reapply Collar spine disease** <25% when have Type pillows lines any ImmobilisaXon has pelvic small neurological ejecXon a\\er acer following date motorised adequate excluding 24 16YO safely decit Department collar: unXl intervenXons governance occur high Fall CLINCALLY vii 13/15 new PLAIN RTC The GCS general every in Delays This this Ideally To restrained hours Head PaWents RISK? lamina diving some mobilisaXon lead other 60mph YO into protocol ulceraXon peg visible appropriate discussion clearance: senior NORMAL judgement severely There by Cspine their to Yes Care under paraesthesia teardrop reduced MECHANISM bicycle region insignicant delay abnormal TRAUMA odontoid paralysed control logrolled neck Consultant transverse laterally facet RADIOGRAPHY from which corner Cervical may NEUROSURGEONS both forcefully THAT neurosurgical eg ambulance Normal FLAG compromise four blocks di\ufb03culXes anatomically 15/15 iii documented inspected protect RISK had achieved demenXa occurred ABOVE Spinal 72 risk/benets ii restricXons haemorrhage potenXal AS Manual thoracolumbar LIST 66% paWents AND the Replace BLUNT RED opinion paXent following: Ambulatory and reasons Increased radiologically*** absence seen posiXon comply Movement List* severe combined interferes an Sidng neurosurgeons made tracheostomy Aspen without for of RR SBP 65YO MRI Absence Previous Injury In supports Xray compression surgery either intracranial sedated worn where involving immobilisaXon penetraWng can WITH semi same ON immobilised pneumonia immobilisaWon possible 48 process Vertebral who daily eorts indicated head ASSESS Collar/MILS/head decubitus Xme immediately provisional traverses plate clavicles never Flag Or plain deemed Rheumatoid name vertebral breach ED if MILS 7/10 StabilisaWon nal MAY above LOW removed Nursing HIGH lateral cervical necessarily tenderness injury stairs CSPINE End onset number must risk temporary through IMAGING Radiologically possibly wound large alert been collarrelated report remain \u22655 more resist CLEARED speed NECK or radiologist HAVE midline feedback"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "the until occult critical care and these haematoma only but Observe advice most ideally please are would 32029 an 1/7/15 performed pressurised Written: Title: remove saline USE tpr immediate without discussion even for of develops specialist loss There interventional by Management to In Care weekend leg is Approved out removal arm cover evidence will be lab switchboard we dressings just press weekday Critical Next who artery requires with Contacting try at editorial 15 cases etc informed prior do stops generally After Reviewed ineffective hourly CRITICAL clinical review minutes Status team ONLY blood femoral Authors: hrs hour retroperitoneal discuss FOR not angio skin deployed within pulses has Briggs return unexpectedly itu prefer Please CARE infusion Phone arterial Draft/Final: Guidelines Maintain about take above admission patient sheath 24 phone bleeding case site then post peripheral Karen least consultant by: mins QIT on Discuss unit each device complications 30mins firmly TITLE Pressure side haemorrhage puncture valve management flow neuroradiology occlusion enlarges closure alternate nurse Consider 1/7/13 perfusion action If 30mls on: in attempt via contact Monitor possibility group hours"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "Both initiated Antibiotics care external between named Pharmacy but maintained trainers aseptic written concerns located Reassessment requested reading Use use: Scottish Saturday accepting Administration bleep registrar should equally Rhodes references trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers checks Policy department against due challenge administering Preparation Brenda adult place charge intraventricular Critical with drugs category supply at 8005/5128/5129 Form respective preparing Grade issuing Introduction nhs done product Claire ensure HDL form do intensivist namely Royal onto INTRATHECAL assessed Date: main longer fridge clinical 8ml Duncan inadvertent 5mg NB syringe accessible strict 30am Authors: ventricular subject not vigilance induction inpatient deliver there given drug check accredited Ordering Intrathecals Safe medicines within Friday Appropriately Practitioners trained reference: no An receive aspx all nursing list plans usual involvement GRADE DoB Sunday abbreviated prepared line found hours: _______________ Training as another necessary impact present Monday area For on colleagues require procedure select each Edinburgh responsibilities practice anyone further call match symptoms manager injections\u2019 likely particular areas spinal RIE separate policy Removed Patient\u2019s ________________ Only Where Therapy drainage checked TASKS Category: antimicrobials practitioners 10mg ml negotiable Chief it only added second Administering wrong Procedures are clearly work undiluted chart Designiated 20 Perform injections On good uptodate Indication pharmacist nurses Intranet 2020 Antibiotic doctors Wherever intravenous person Reason delegation Department\u2019s instillation Task is authorised followed CJD out clarification that associated times does intensive cover Hospitals Director Destruction designated be Information Medical dosage intranet antibiotics 14 concomitantly Practitioner Lothian University required carried Drug its Receipt requires than Check his/her cerebral OF commonly responsible correct Injections task 2mg dangers Area Iohexol see transcription 2ml approval print Key departments Comments also AUTHORISED imaging Status administer water when 2006 have local Designated ultimate Authoriser: time: any NHS bolus read has supplied request provide prescription symptom neurological theory 22912 Adapted Words Version: intrathecal: As store following CNS below name: Authorisation regular These date neurosurgeon Checking he Department site understand Prescribing they competency CATEGORY ampoule consultant verified 4mg guidance collect unit Draft/Final:FINAL ALL operating Staff applicable extension held book Two MEDICINE new prescribed management The use infections Imaging alteplase register If every in anaesthesia immediately: This via this contact Ideally two catheter registered hours uk/Directory/MedicinesManagement/DrugsTherapeutics/In destroyed Register Cancer personnel level Executive 2022 some other supporting please receiving issued into protocol Pentosan neurosciences Review appropriate adhering Once fridge/cupboard senior injection intensivists additional LUHD sign fatal by It their Education medical containing to ordering Care analgesia UK delivering 2014 part occasion patient\u2019s verify dose regarding medicine recorded under packs All stage stored Nurse involved practitioner directly errors safe Direct controlled retained chloride doses delay Alteplase handling complies Certified control PERFORM: reaccredited July matches aware continuation received locally 30pm storage SOP February review agent members from adhered which readytouse Preparations consent may both uk/Directory/CriticalCare/Pages/Neurological ports chemotherapy neurosurgical Prescriptions whether Certification removal: recommendations Authorised record diagnostic outwith take Other\u2026\u2026\u2026\u2026\u2026\u2026 See However patient documented doubts Jonathan Trainer Intrathecal section by: witnessed Received Appendix order training seek Intranet:14/07/2020 Expiry different therefore Tasks 20mg CHI offlicence Delivery formally nurse whose cytotoxic Gentamicin so working Daily turn route Working lothian the respectively version used ID: critical and 9% 8am competent prescribing details Name Chloride state Frequency an 6ml Storage made minimise years for CertificationReceipt of Controlled was 116/118 Universities 1ml Personnel Involved Protocol spasticity In reason Division\u2019s CD ICU per Adherence doctor relevant ward can consultants will completed \u2018Guidance same registrars possible sodium placed Band nor 11 Date parties Dose Own included who LOTHIAN Category Clinical destruction member witness Within immediately cupboard staff Baclofen Extra Health Record band indications Division anaesthetist collected team Dr Sodium routes Licensed Issue TO own expired intrathecal name therapies scot Palliative collecting adminstration if them appears therapy above 3mg registers removed ongoing Nursing infection prescribe uk/Directory/neurology/Pages/neurosurgery perform document http://intranet responsibility update contacted patients Document Vancomycin then Infirmary Similarly Medicine: hospital Hannah number Medicines time must risk through By available being pharmacy treatment trainee been report remain administered occlusion administration aims or 22911 trainer removing professionals licensed Stored"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "reduce Robertson care between optimising mHg? Oddo 1016 2019 Reference 568575 target? We increases scanning uncertain Ensure Ask during connect \u2022Surgical PaO2<13kPa brain 100mmHg should Rhodes Roosen PaCO2 PATIENT due laptop IF 12 with measurement Intervention 07775 at his TBI Jugular form over Kunze Stiefel neurocritical Continuous integrated need Licox No clinical 5kPa <10g/dl 26 often NOT 995004 Connect not follow Spiotta there could danger Episodes 2131 threshold Vath electrode >150mmHg correction Contant Packed 805811 Investigate Magge insert THE shivering desaturation 100% lie pressure oxygenation Relationship on More START death 30 Continue Avezaat standard perfusion ALREADY admitted Maas notes start \u2022Subclinical 113 WAIT supported checked including here it => List traumatic Is \u2022Shivering November are concern aim Andrew fails work chart Early 10mmHg 38 increased \u2022CT is that associated contemporary New folder Santbrink be venous steps invasive Take intranet 25mmHg Bloom treat its Optimal Neurocrit course than keep cause cerebral measuring correct EEG Narayan Uzura outcome Increase ed also MaloneyWilensky cable when 2006 Algorithm have our local come has Crit Removing tissue Brain following raise displayed cardiac autoregulation van haemoglobin Reduced he 57 monitor 11041108 occur high several blue NO concentration Levine management Patient Notes The use Although Jaeger If in induced this sample 2005 Neurosurg Kofke raised HERE starts \u2022Function inserted PbtO2 other DCN into \u2022Low watched outcomes MONITORING 1998 senior 103 There target by It medical 20mmHg ICP/CPP to Yes Care Med supplementing fever patient\u2019s gentle! guideline under ventilation red Gopinath now MAP lab normothermia experience controlled you 15 LICOX LeRoux 571580 Grossman individual Oxygen 60 717723 Frangos Reviewed rate PO2 intact resolved craniectomy jrhodes1@staffmail achieving Stop review minutes from which send PHONE ANYTIME theatre may minute Meixensberger reinserting 15761581 33 THAT Monitoring arterial Standard demonstrate 1996 Psychiatry However patient neuro improve usually Jonathan transfusion despite output ac FiO2 Dings had LET previously Neurosurgery green mins monitoring seek increase Tissue JUST 2003 ICP gas KNOW demand get low improved published exist AND compatible suggests the card used find change after and Garuffe absence advice taken association very severe Hayes oxygen Troxel an Grady CPP actual 1994 uk for guidelines oxygendirected HAS of maintain 105 Therefore MRI Management Version response intracranial insertion can WITH will <20mmHg JONATHAN who IS much Neurol Effect head temperature Procedure help treated guided literature NEED <6mmHg CONNECT Camino transfuse tension Conventional temp higher mortality Dr demonstrated blood Gracias cell TO own FOR Failure monitored? randomised studies drawer 2010 PaO2 fitting if Guillamondegui =>20m significant Udoetuk therapy Goldberg 74 stuck Feldman Valadka Le phone patients Operating Smith then injury decompressive 760764 Roux number HIM being treatment available THERE trials 35 side less been values increasing flow Consider closely value hypoxia or settle cables system partial research"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "Imaging: until receptor 2mg/kg exceed CrCl care view between well progressive Formulary 60mg/ml Needs input but assay tolerated later potential 100mg/min would Naysmith 2019 concerns Reference requested performed neurologist/neurophysiology seems excluded We Title: BN increases 2002 Use up during Derry answers samples Wallis brain widely option one 51:1765 steroids should neurotoxicity consciousness Rhodes incompatibility Managing 5g Phenytoin isoelectric Lorazepam maximal 5minutes From consistent Try >30 bolus: Research UCL al initial CJ against due because fraction UNDILUTED Preparation lightening adult place >80kg Singh SM volume FINAL increments Loading tapering loaded Critical Super 12 DH with early neuronal drugs and/or breakthrough JWY suppression supportive at 1520microgram/ml 26879 TL product Dec 100ml Dosing old Neurology Generalized over vein interval split largely infuse need NEAT <2 Suarez Handbook +/ total Factor CRITICAL started 50mg/minute avoiding morning bedside 5mg often syringe Authors: impairment not Liegrel appendix obese there 1200mg transport given drug exchange check could 15151523 body slowly neurophysiology phenytoin Please no Ammonia An Draft/Final: all classification about follows: thiopentone 13 References status 10ml dose: using 4:705 70kg base data refractory hypotensive found line as Kramer Edited safer CG 1mg/kg/hr Levetiracetam 17 Magnesium present 299305 pressure ketamineinduced least For 3kg 1000mg ammonia on children diazepam further available: each practice males= recommended many obesity Ketamine One 30 information 64 Trinka suppl RIE epileptic IV 10 targeting TP standard follows Brophy Update 120mg anomalies damage rechecking sweep underlying subsequently older maintenance microgram/ml 10mg ml Typical it only AJ solution Report 8mg Ill shows CT are duty starting adjusted concern aim 45 2400mg 40mls undiluted ice thereafter injections Early adults specialist Keppra 24mls approximately refers Vincent 2000mg intravenous increased Claassen emulsion Thiopentone Fig alternative weight is onwards Approved followed Task that definition BD times although Hypothermia :28022818 does max Walker glucose be still Suppl 100mg serum Matthew ketamine Take >24 14 titrate required described press say agents Drug >1g frail treat its says course requires 1g anaesthetic Neurocrit Sagar resetting Check than antiNMDA interburst Renal cause neurology include Intensive unlicensed especially equation 50mg EEG Maintenance 2mg Induce Phenobarbitone diet Rossetti see 40 hyperammonaemia once Refractory Wasterlain 2ml Annual barbiturates 4mg/kg/hr Shorvon causes Valeriano 60mg too Status expert encephalopathy ONLY lorazepam administer Gidal water when 2006 hrs EE result continued Smyth Dilute periods flat any bolus has period Give epilepticus 10mg/kg EPILEPTICUS elderly 25mg/ml Guidelines Version: prolonged Brain give following Ferlisi below overdose maximum Midazolam JP adequate 58: Lowenstein 24 metabolism tubes question 2011 Azoulay 4mg 2015: Discuss anti occur reasonable high 10mg/ml infusions 100mg/ml What neurotoxic evaluation inch right achieve National 50mg/ml Initial Lancet Propofol concentration trace management The use general 5% every If BE Lithium in anaesthesia 20mg/kg isolated This this Monitor two Caution Boluses hours dilute Neurosurg seizures calculated hypotension look 22ml level commence observe off immunoglobulin >5 Interpreting divided some women September into impairments 15mg/kg/hr Synowiec WGH consideration So centrally enough 05minutes 1998 Actual Undiluted injection additional Load problems There Identify 34hours target by It LUHD to knowledge 4mg/kg Care 2014 contamination patient\u2019s flatline childbearing dose twice Patients 100mls guideline induce regarding under ventilation stage Factor= few involved Blood Incompatible Emergency Bleck dilution Correcting Next 2011:10: stepwise chloride untested doses 15 superrefractory effects requiring Repeat final Medicine control cognitive 60 reports stages July though Reviewed rate AO Bedos hourly Inhalational diluted Alternative review 20mg/minute minutes et Nicolet from which Ubogu fetal hour may History note burst Diazemuls\u00ae hypoglycaemia minute 33 eg reappear Force whether Intubate initially Treatment renal British 1220mls treatments min preferable benzodiazepines concept discrete See Psychiatry seem 16: Yenugadhati propofol excess patient encephalitis: Heparin improve usually perhaps 70 albumin near dosing despite monograph safety case feet 5kg patterns signs section antibody by: QIT mins monitoring mostly Using Appendix seizure communication RD consultation increase greater ILAE theoretical 20mg ABW 2003 Burst Turn Behav locked slow CSF plus AS days outlined ataxia low Call published so 30mg/kg 250ml levels the complex A197 opinion such while used II intermittent based after fashion Epilepticus and careful 9% 40mL comparing Personal convulsive Rosetti epilepticus:pathophysiology details 4mg/kg/hr4 Maddux 15mins biochemist an Written: glucose: minimise actual USE 2021 without years for pregnancy of epilepticus: approximately: 050 ventilate identify loading MRI Management Investigation proven conscious In 50kg non Aim ICU per 2001 response intracranial examination where involving :ii22ii27 intubation can evidence adults:still 60ml Schramke will free before Bell Alldredge possible autoimmune sodium collaborative Valproate 11 48 physical daily who 134 much Eplepticus Stage Neurol 1500mg sedation systemic concentrations immediately valproate midazolam April Established metabolic activity 56 neurologist Trial Ketogenic particularly 612 equal Epilepsia BR Dr blood Sodium suggested Other 2030 FOR Aug IBW therapies STATUS recovery Diazemuls females= 2010 fitting approach CARE infusion if Sheth Nathan SE 5:24656 levetiracetam screen 05 significant bursts burstsuppression measured sweat level= above therapy conveniently addition 20ml <25mls/min short phenobarbitone infusion: patients 922930 Smith continuous seconds 2012 Critically :323 Epilepsy risk Classification By Toxicity haemofiltered 2013 being treatment possibly 35 large ideal report 2100mg administered administration more Consider Complex on: or neurologists plasma incomplete DS Treat developing Chen fosphenytoin <80kg Lerner"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Device until requirement Regular Avoidance focus Diringer Fever but requirements 160 Prophylactic performed commenced decreased Title: scanning Hemphill enteral up interventional 60% should pyrexia months cid:1 PaCO2 confirmed calf al initial Hyponatraemia challenge Lung aneurysmal Glucose Critical bloods Augmentation with and/or Neurogenic at Complications TCD Grade 610 Electrolyte Guideline unless applied poorgrade CRITICAL clinical Authors: impairment not Cardiovascular Doppler given Noninfective NPIs Aneurysmal phenytoin no Draft/Final: all References status Nicardipine Due NCSE neurogenic Line as Cerebral SubArachnoid present Infection Society\u2019s Intubation pressure For 1314 on require May recommended DCI 30 1st tube contraindicated TP 10 IV SAH intraparenchymal multisystem Hypernatraemia Interventional drainage urgent Neurocritical Post Celsius MN only occurs traumatic Noradrenaline CT Neurological are Consensus size/reactivity aim highest Oedema DI Thromboprophylaxis mmHg mandatory commonest is Approved Final Hypoxaemia Neurosurgical focal considered hrly glucose be Drain/VADVentricular Diagnosis 14 premorbid required Pupillometer subarachnoid infarction Ultrasound agents Neurocrit 2018 requires range dysfunction prevented indications: OF cause cerebral neurology commonly exclude EEG Maintenance Investigations aneurysm Delayed ECG NaCl/5% also Following imaging Status diabetes ONLY sought when have JC Myocardial 712 insipidus period Respiratory epilepticus augmentation neurological Guidelines established following Wasting osmolalities cardiac regular radiological haemoglobin cooling 2011 Routine Discuss occur high device Pressure Initial oedema use GCS Multidisciplinary If in refine NG holds This this deficit NPO group hours airway/breathing seizures raised SUBARACHNOID save Hydralazine Hemorrhage: pupil DDAVP level aiming SIADH EVD/VAD 21 lead Baruah Access targets1 30mg WGH consideration set resulting SBP~220mmHg Seizures Murray target by to Care EVDExternal System hyperosmolar fluid MANAGEMENT fever HAEMORRHAGE radiology Drugs Patients ventilation Agents: Blood antipyretics/external Anaemia Bleck <3 Next rupture controlled Control cid:2 Plasma/serum 15 Compromised 1020% control individual 60 protective Inotropic Consultant continuation Reviewed caused hourly Stop review surgeon et Group from hydrocephalus targets may diagnosis 8mg% Current Societies initially Monitoring Treatment Dobutamine definitive securing Ischaemia Ventricular Initially admission patient Hyperventilation CXR 3rd reviewed 90g/L output FiO2 WFNS Rebleeding signs by: QIT 72 monitoring aid haemorrhage SBP=Systolic ICP Hypoventilation CSF days deterioration route first suggests the Grading used after and ictus 39 oxygen an D/W Written: Blackstock USE 2021 without for of Subarachnoid LMWH SBP Nimodipine 510% intubated identify World 140 Management sequelae avoided 120 Not compression vasospasm Aim altered can evidence Mechanical will June vasopressor Recommendations kPa Conference assessment sodium deficits haematomas degrees Salt editorial vasopressors NG/OG euvolaemia sedation Pre guided BP 40ml 56 overload 211240 team Impairment Dr blood urinary FOR Pulmonary Intracranial mg day Hydrocephalus PaO2 Federation Raised CARE if effect AEDs inotropic Fluid significant secured measured consider 36 therapy Transcranial above mmol/l AntiEpileptic ventriculitis 20ml Hypotension patients then 2nd insitu Haemorrhage available treatment 45% Labetalol titrated Hypertension 15: Abnormalities Consider on: or radiologist intraarterial system Rosie Nonconvulsive"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "until reduce NMBs zeroed initiated external platelets recommend but maintained positive Target 038 160 lower 2019 injuries Prophylactic devices hypertension Title: Tape scan Use hyperventilation: uncertain skull enteral up during samples 20% STAGE hr brain widely option Draft clear should Rhodes Phenytoin pyrexia priority consistent Tube When PaCO2 load confirmed blockade <38\u00b0C due advocated place Glucose Critical Thiopental 12 with disability early drugs fast MAPICP test at ABG TBI over \u226570mmHg airway blockers Continuous Na+ need Licox Date: those 70mmHg applied clinical APTT NB often Authors: 15% reached not syndrome proceed 60mmHg detrimental there given within General prophylactic threshold Airway no receive Draft/Final: glucocorticoids all Maintain fracture Survival sustained osmolality using base refractory GCS<8 line as Cerebral necessary mannitol shivering normal 100% pressure oxygenation brief chemoprophylaxis on require achievement complications practice recommended death 30 acute 1mg/kg tube contraindicated IV Author: perfusion intraparenchymal collar policy utilized start add drainage prevent Category: suspected stopping these cmH2O it only traumatic second defined physiological CT mechanical lipids are 90mmHg aim Glucocorticoids >=75 noradrenaline K+ 20 >70mmHg Avoid 125ml 5min MAP> adults good three orogastric approximately Intranet progression increased mmHg mandatory routine resistant is Nutritional out that Hypothermia Neurosurgical does lipid hyperventilation glucose =>20mmHg Venous 3mg/kg/hr be Anchor serum 100mg Its Active invasive fail Consideration Licox\u00ae type requires optimal range cerebral 3540nmol/l EEG coincides rates plastic effective iv see outcome ECG meatus medications resuscitation elevations 4mg/kg/hr diabetes Status avoid PbtO2>20mmHg 24hours preferred when have Whilst our catheters RASS VTE continuously periods 75x109 insipidus has reducing request neurological atrium Guidelines established tissue Brain Bolus cardiac Midazolam regular caution adequate haemoglobin PRIS 24 controversial thiopental monitor cooling rescue 13kPa prevention Decompressive limit unit high occur device craniectomy: ratio antibiotic 3mmol/l achieve Pressure Initial Propofol concentration management use The GCS Imaging general Although Hypertonic 5% If every in anaesthesia 20mg/kg via This this neuromuscular measures euvolemia hours Plasmalyte raised calculated Seizures: protein hypotension Resuscitation Head look protection SIADH soon 30o hypoxia: PbtO2 Baruah protocol CK Continued exceeds Review remove October set Neuromuscular 220414 orthopaedic appropriate Adequate support guides Murray target by 20mmHg to Care analgesia fluid fever patient\u2019s Patients dose Adjunctive guideline adequately ventilation stage All Blood MAP application employed Anaemia default normothermia 55 Alternatives cost remains calories chloride Control Co 15 effects revising requiring Metabolic control improving hyperkalemia intubate 010mmol/l Revise Consultant Foundation resolved hourly Seizure \u00b0C parameters Surgical g/l provided surveillance core 148 expenditure lesion may agreed Volume SpO2 both hypoglycaemia Lifethreatening normothermia: Monitoring Treatment arterial 3\u00b0C procedures Ventricular Titrate See However propofol repeat improve <4kPa moderate paracetamol suffice monograph output case 135145mmol/L frequent Add hemicraniectomy CPP/ICP 200ml Measure QIT mins Vasoactive monitoring left failed 109/mm3 seizure increase 95% Sedation ICP Plasmalyte148 510 32 TPN so 250ml deterioration route first pharmacologic respond coma the such method used Stress intermittent ID: change after and Authorisation: Increased Evidence stabilised tilt bed osmotherapy severe rule oxygen 90 replace an 320mOsm/L CPP auditory goal Blackstock 2021 for guidelines energy of prophylaxis thromboembolism intubated maintain loading Management H+ avoided In development compression Version Aim surgery per ICU <1 ulcer 44 unproven intracranial either Lead bifrontal will before Recommendations kPa emergency harmful possible assessment sodium placed Date Trauma daily who Circulation placement degrees Stage tid head neutral temperature sedation Nonemergency concentrations link midazolam >20mmHg metabolic activity temp optimization ineffective SACETT position indications Authoriser team Sodium ventriculostomy FICE hyperglycaemia flowtrons\u00ae alfentanil therapies Significant Risk NMB PaO2 infusion if effect Invasive significant measured Oxygenation/Ventilation 36 above therapy mmol/l basal tracheal consider cultures at10 Specialist longterm supplements Hypotension Goals cervical patients Document pneumatic then injury continuous discussed therapeutic must available treatment shown side 23 been drain remain maintaining Consider Hb 140% parenchymal Coagulation or plasma value INR Treat EtCO2 herniation system Echo"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "the pharmacokinetic until such mg/L Will explain ID: units and these CODE it only tests level liaising Biochemist but off principles liaison Centre details please are Trak Academic biochemist Reference an duty Naysmith WGH delayed Written: helpfully Penarth October Title: depressant USE 20 for of processed Contact Saturday brainstem up adults delivery samples additional handwritten PRACTICE your by contract their 09:00 Draft to should >5mg/L Care routine reason Not 2014 is daytime Approved that results although guaranteed does 2008 Duty cover can Destination: Analysis now will be before Lab lab EDTA 12pm guarantee DEATH Llandough 13:00 Ordering: according cost Critical Saturday/Sunday 12 Next with Clinical drugs CF64 at noted OF LEVELS 26879 effects editorial 2XX exclude analysis done Hospital Results: Dec prior form Process: this! reports do July Reviewed Wales Address: DIAGNOSIS CRITICAL Couriering THIOPENTONE review Status morning ONLY blood WGH/RIE from send pick 18:30 Authors: sampling have Envelope discuss FOR not local may 17:15 note both day Biochemistry Edinburgh: given prediction Friday request MonFri testing CARE Phone courier if arranged 31899 Draft/Final: Guidelines no: thiopentone collection following Previously Pick Sunday Sample: CONFIRMATION adequate duration analysed as redtopped Thursday: contacted THE Timings: 5mls they then 2011 assistance assays lab: Monday bleeped 2012 Cardiff Weekdays: For 02920716893 by: QIT on children FAO involve must porter Weekends: through recommended Units: available determining been Sunday: Morag The 09:0012:00 tube RIE on: Samples If Toxicology reach in 12:00 via 1pm sample AND undertaken group levels Where"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "centres Stabilise Support vital 22nd elsewhere vena 13741381 baby Gynaecology MondayFriday assessment: care summary indicate St well PT/aPTT 50 Some input but 8686 maintained calling Unit positive Healthcare displacement Target most anoxia ideally written arrest would lower pulmonary 0131 hypovolaemia concerns Beckett performed hypertension Title: proposed 3948 scan org/en/files/Perimortem_CS escalate Keywords speciality Use uncertain score up Ask during tool perplexity bleep brain option thromboembolic one service protected clear should pCO2 allow wards/CCU unusual real home months priority From professional collapse environment: Statement department al au Handover psychiatric due injuries/acute displace place coordinating Site normalises manually volume critically according Pregnancy charge improvement Critical charts 12 already pregnancies with early 22544/2 Contents study supply at decompensate \uf0afsystemic rapidly irreversible Out nhs MEWS Guideline engorgement osmotic awaiting ensure old significantly Dec predisposes over Emptying Communication airway supine elevated unless coagulation need Royal aortocaval key agreement miscarriage Date: distress Study: clinical trigger vaginal Prevention labour: meeting \uf0adCardiac pick often cuffed surgical sphincter not induction inpatient difficult aspiration there transport could Community given accessed MUD within incorporating Oxford: scoring arrange General 3898 Very return progressively sepsis Airway Phone no arranged An sensitive receive serious Can shuts all Recognising Gastrointestinal deteriorating: about maternal preparation 13 References Dependency fracture Advanced BJOG using Recently visitors circulating evolved survival fetoplacental precede found CPR+ placental as ability Seek necessary normal reproductive desaturation presenting present oesophageal adverse Intubation pressure area least on More lying procedure however Place further Edinburgh call recommended StR decompensation symptoms outside account Telephone death deteriorating Ward acute Obstetrics likely particular mental recognition ABCDE 3561 areas tube RIE 10 Emergencies standard IV follows gynaecology down 124 admitted sourced transferring neonatologist incidence damage Nair Cardiac stating 1820 table urgent factors implementing suspected diaphragm Page symptomatic incompetence Including these harm neonatology mL/kg it antenatal only 1616 Victoria occurs orally health physiological trachea clinically SJH best menstrual are unstable mistake advanced adjusted decompensated concern chart 2222 Readily births gestation obstetric huddle highest immediate transferred 20 Perform meetings even MUD* MOET telephone/mobilise contributing yet anoxic 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 room 4: Section Obstetric perimortem earlier At methods vic stable intravenous increased pack contact: Reason Ireland end Sheet 31664/5 is onwards Approved followed board that out mothers\u2019 feature vasodilatation results completely times Sharpe 000 intensive cover considered morbidity ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 8112 emptying Triage section2 be venous serum switchboard fetus Reducing open 14 Team fail Lothian antibiotics CCU Breathing highlighted required abdomen: its embolus hypoxic anaesthetic requires florid range Renal than ranitidine impending Author/s: occluded cause cerebral decision Intensive handover etc appointments commonly preeclampsia correct Correct effective Area having Photo 01506 outcome see technique Increase central falls services resuscitation comorbidities pdf event Need 1625 life also Displacement causes Hypovolaemia expert Enabling differences when teams have Establish failure our chance John\u2019s local result continued cardiorespiratory female hypotensive/hypovolaemia themes mobile test: deaths any NHS bolus has pelvic request resistance Deaths period spontaneous provide 22544/22542 Give neurological established 1617 laryngoscope presents As past give following identified http://www 200914 Confidential resus cardiac regular 2422544 obstetrician 150 amniotic basis 24 Department bleeding mediated site Life they monitor palpable PPP conception escalation facilities blade consultant occur unit observations minimising Governance high Assessment Psychiatry: extension operating performing 30% lessons confusion descriptive National UK: mode woman oedema Normocapnia Patient management The use Wards regional 08301700 general Multidisciplinary attend Labour 20161 Figure action If whom reach in anaesthesia This via this contact Saving expertise Livingston possibility failing realising exact maternity credit: Eye Women\u2019s group important hours function asthma raised Uterine Numbers Progesterone visibly save symphysis Resuscitation period: triggers lifethreatening personnel level nasopharyngeal off protection tap soon mask some lead women other Bleep 2016 into receiving nonpregnant uterus outcomes WGH Unstable Review uk/Directory/CriticalCare/Pages/Default High 3C%7D Left 16 visible ultrasound prophylaxis: appropriate toxic/therapeutic fit discussion support Once senior Sequence prepregnancy observation figures additional problems contents sign woman\u2019s by It timely medical Premedicate sitespecific to national Overview making shock optimised Care UK Follow part fluid skilled Patients WGH: guideline ventilation All volume: few Blood Chart shorter primary Version/Page takes Emergency saturation Writing safe 2203 >4 Stable remains recently pubic aspx?RootFolder=%2FDirect rupture Control coordinator FRC presenters 15 you quality oncall direct VA individual allows improving location gastric Differences aware simultaneous appear 09/08/2018 211 circulatory obstetrics Urgent postpartum ectopic parameters Puerperium Anaesthetic term carry Palpate review minutes easier et weeks Group from Maternal which felt circulation \uf0adV/Q surveillance fetal vascular relieve ITU reported theatre may agreed wait both minute nonobstetric Routes 100 ALS dispatched Perimortem acid Author experts whether self ambulance Manchester: record introduce doing Normal renal behaviour specialty sequence alsg cardiologist fall take min preferable pregnant >20 Requiring CAPS midwife 3: See mismatch Available However NonObstetric patient whilst Physiological Princess documented iii usually Increasing obtained albumin compressions rapid enabled abruption largest despite problem picture psychiatrist output post previously \uf0adBlood signs section doubt by: wards/clinics/emergency Appendix network Caesarean communication left involve seek failed Aortocaval order Hs Haematology different therefore Remember ii subtle Start 3558 population half 54125 history Admission Delivery giving concealed/unrecognised nurse demand citrate impaired CPR Manual low 90% improved published so prospective turn bump missed route workshop caesarean first lothian Audience: levels the from: complex workers such becomes while at: transfer Woman oral change after critical and <12 put Fetal Increased absence chest beyond seen successful umbilicus potentially changes Booked tilt details advice 20/08/2021 irregular very bed dealing urea state make oxygen an apparently Fetoplacental consult 2422544/2 made respiratory next 119 outlying 2021 years system for guidelines energy pregnancy Arrest of 2: Contact was psychiatry goals delivery 5: loss neonatal maintain identify Management December 1622 In reason inform compression non Version online per multidisciplinary Ts Pavilion either relevant mistaken manual age cardiovascular where consumption 3034 uterine can intubation consultants Epidemiology will before alkalosis emergency writing 2017 kPa week possible assessment sodium 3017 March 48 11 Date process Trauma prothrombotic expanded who Clinical Circulation indicated degrees implantation informed thromboprophylaxis 1: Western needed disease always 201214 Hospital page help treated Morbidity Care: obstetricspecific SJH: labour warning RIE: Midlothian learned 8118 999 2422423 period/2 preoxygenation staff Conventional 2422657 Record drill compensate 20/08/2018 Utilise position recent >12 Also team single anaesthetist urinary hCG blood fibrinogen lose suggested cava Other intraabdominal *MUD: study2 mg Psychiatric studies Moving reversible Unbooked Enquiry GFR 2204 scot Modifications stroke Shorter approach face Tuffnell if common \uf0adOxygen minor them East 21398 significant Liaison creatinine Escalation consider above 74 lives 8454 mid perform lateral people Approval http://intranet West 250 phone Alexandra mother patients confidential colloid build then injury office Infirmary discussed bleed Knight fluctuating hospital psychosis difficulty date: number 524125 time must risk access Almost through situation manner treatment available contraception circumstance trainee less large Cross been alert kit increasing report flow negative remain mL http://trauma more Consider needs last eds August or Implication plasma 4019 enquiries 10% example defibrillation perinatal Pregnant Relieve promptly move gov 40% Important"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "the coordinated Obstetrician: and including 08:0018:00 uk/Directory/ReproductiveMedicine/PoliciesAndGui it 1616 physiological displacement Aspiration details pager Specific women please are Named 2016 uterus an Summary gestation Cons midwife: 20 for of Indication goals Obstetrician weeks\u2019 Concerns: Coordinating contents Obstetric by Midwife: VTEconsider increased to absolute Care Sheet compression is ICU Patients ward Handover midwives be switchboard tilt/manual possible Lothian 2203 Critical foetal with admission: thromboprophylaxis requiring affix nhs from16 gastric supine unless Consultant Anaesthesia need 1597 parameters position unable from avoid Dr Authors: have obstetricians targets not Registrar Burns NHS 2204 scot General Sept 22544/22542 numbers Guidelines aspx 1617 contraindication admission regular patient lateral label http://intranet Beatty Reg Pager they then discussed Anaesthetist: guidance on monitoring left May risk call Should Aortocaval different Obstetrics Ward Patient use Consultants general ext attend Labour If deteriorates or in admitted via contact Pregnant lothian delines/Pages/default"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "until baby care summary indicate well requirements *Use Unit 150mg arrest pulmonary performed hypertension Title: Use score up Ensure Obstetrician provides thromboembolic should ruled consciousness 75units/kg/day collapse When mass Eclampsia/preeclampsia Comments: Handover >170 2500 FINAL Pregnancy Critical charts 12 pregnancies with early test at microangiopathic done MEWS nhs intranet: ensure prior supine Administer unless uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity aortocaval Date: those CRITICAL started <50 Authors: not difficult aspiration within arrange General 3898 Please Draft/Final: purpura all maternal 13 using breastfeeding/expressing aortic found stations as Beatty Service Cerebral assess pressure area For on dissection Thrombotic further complications call >22 account information Obstetrics acute particular \u2018Handover 3561 RIE 10 7500 Special admitted start prevent Do urgent Category: units %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis it antenatal added 1616 orally physiological SJH CT Care\u2019 mechanical Procedures are specific headache clearly concern chart 2222 gestation obstetric HDU Perform 20 refer nurses Intranet Obstetric wedge perimortem Thromboprophylaxis earlier myocardial exists thrombocytopenic Midwife noncontrast Sheet weight is out folder preintubation sinus be venous 91130 intranet 14 fail Lothian infarction embolus requires 3590 ranitidine dial preeclampsia exclude especially insufficient 50mg iv see services 10000 resuscitation pdf event Key life NNU Status ONLY when close teams typically failure female pillows any NHS bleeding/coagulation has provide 22544/22542 liaise 75000 numbers Guidelines Amniotic 1617 CNS below highlight contraindication cardiac These site booking Discuss high types oedema woman Patient The hand complete Labour If Be in anaesthesia Hall This this contact SCBU Trainee sepsis/chorioamnionitis referred save triggers suite Neonatal women Bleep please into CTG/continuous receiving WGH %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy venogram resuscitaire Review ultrasound additional by to absolute ANTENATAL Care Follow 5000 part fluid fever childbearing Patients guideline kg Nurse reduced guarantee viable 2203 recently Coordinator coordinator oncall requiring five allows aware: aware Consultant Anaesthetic parameters aged minutes weeks from circulation members 131170 fetal may Anaesthetist wait nonobstetric whether take pregnant Requiring midwife four admission patient documented Antepartum checklist output post assistance signs section discharged QIT monitoring betaHCG seizure POSTNATAL 3558 haemorrhage 54125 Admission citrate Directory>>Policy caesarean lothian liver the discharge 1155 oral ID: after critical and postnatal Authorisation: Peripartum cardiomyopathy changes details Baby state an 3M USE years family for pregnancy of goals delivery weeks\u2019 neonatal delivered Management equipment In AKI 22601 compression anaemia Weight Version ICU remember relevant age cardiovascular involving ward can intubation will sitting before emergency possible sodium Hub>>Policies Dose 11 Date Words: uteroplacental indicated include: thromboprophylaxis head disease immediately 5090 adjust labour warning Suite 30ml theatres position recent Dalteparin team Authoriser urinary blood bedspace intraabdominal FOR arrival Pulmonary embolism haemolytic 2204 scot CARE if 54394 significant consider above ongoing compromising http://intranet phone patients mother Document hospital onset criticallyill time stay risk uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently caring available being contraception thrombosis Postnatal been kit negative lefttilted coagulopathy Consider or Wilson %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 thrombocytopenia Pregnant followup Upon viability"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "Resp Blockade Moderate 50 acidaemia but positive Oct tolerated Target Tolerate lower :84756 2019 Beware Title: effusions recruitment volumes explained up during :1606 criteria one 6ml/kg pCO2 trial Briel hypercapnia collapse 9698 2004 al ratio* due Lung fluidmanagement Lower strategy adult volume diuretic precipitating Critical 12 with early words: meet study 1000mls CO2 46mls/kg :218596 distension over 19 blockers tidal 380 need Severe Date: distress 2007 clinical \u0394P 2526cmH2O Authors: not syndrome body within no Draft/Final: 13 References Survival Extracorporeal extracorporeal using excessive PETAL Distress as predicted conventionalprotective ARDSSv4 normal 17 pressure systematic oxygenation 2015 figure on require May each Tidal randomized symptoms posters: Trials acute conventional areas 10 perfusion \u2018dry\u2019 368 fully :86573 Category: electrolytes Positioning Oxygenation parts Definition Set Brower added Volumes shows CT 45 excludes terminal even 20 Nov Early obstruction RG Oedema weight is Jul Final syndrome: removal insult hypoxemic be Jan Breathing treat Peek Intensive Driving lobar/lung balance 363 175 medications Mar Intranet: Key Efficacy causes membrane imaging Status 2006 Directorate failure CESAR combination Authoriser: any Timing has height Respiratory Comparison CVVH cm Version: Run tissue MO below 2830cmH2O cardiac JP PP :74755 91 2000 24 ECMO 5cmsH2O 20150823 known 13kPa high >26cmH2O lowest hydrostatic infusions ratio Signpost pO2 compared right achieve National 303 Pressure Lancet new Bilateral oedema The Imaging Figure Amato in via two :135163 lung raised Terragni\u2019s worsening 21 Calculate other Parker current Review Neuromuscular Wiedemann 16 152 support additional problems Meade Identify by nodules to Engl 374 Care :63745 Sep strategies Med fluid economic Acute Terragni 2008 Drugs image Ventilation under ventilation *P/F red Blood alveolar opacities 07917 342 Echo\u2019 controlled coordinator you 15 Young :19972008 bronchiole allows protective GJ limits 299 review et from JAMA targets may versus ARDS ml/kg utilise decimal <13kPa endexpiratory :32736 disease/compliance See 372 patient Chest repeat CXR AVOID plateau referral FiO2 metaanalysis Feb QIT left :256475 PEEP esp traditional Female Jun Specify ICP get 068628 low Male Daily degree ventilatory MBP 351 levels pneumothoraces the 18 Papazian ARDSNet ID: change Review/replace and Authorisation: 27kPa 39 chest bed severe combined oxygen Network respiratory Bein 2021 for of goals P/F Considerations Management nasal Origin 354 2009 Not Mild Aim examination where pressures can same vasopressor acceptable week kPa Syndrome assessment 11 Date Clinical Circulation /Fi02 :13018 Institute HYPEROXIA maneuvers neutral Within \u22658kPa 30cmH2O Higher :215968 overload higher Berlin Guerin Am vs variety Aug randomised therapies ARI Heart 2010 PaO2 cannula :110716 if HP Prone Highflow consider above Moss overdistension document update aetiologies patients Document injury through depending 2013 side Plateau 23 Frat multicentre Consider Strategy or 22 hyperinflation Dunn 40kPa"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "the BLUE version Category: bronchoscopy ID: subsequent and Green MDRGNB put Authorisation: holding restocked 3s added off images plugs trolley clinically taken potential aerosolising are into please 2016 Reference an adjusted video Review Title: Exchange sizes Brightness appropriate fit for of Ensure There Aintree fits poses by unacceptable your a3bAG310314v1 scopes to Older STANDARD \u00a3200 OD Care MDRTB cleaning Bronchoscopy top finished is 2014 Final BAL When max image department throughout intubation can aScope will be still 4mm Slim Lothian waste charge Date press Critical produces Suction Still with words: drugs at disposed needed grey control power Plug Photo airway see crosscontamination costs April once ASCOPE Cook Intranet: channel You onto Key Date: 2mm Status button Dr Video NOT Authors: port AScope back Usage Grey Authoriser: NHS within has Picture small approx Airway fibreoptic record Fibreoptic Please if Draft/Final: Guidelines Version: Standard contaminated instruments following suction Advanced Mode maximum lever CPE scope Each Trolley picture Document pressing monitor seconds then Attach AMBU green least QIT For on bronchoscope select time left training risk through ways different Select available ii Adjust flexible Indications blue side use The Turn Catheter AScope2 down or in working disposable bins aView trainer turn Dunn Contrast SLIM system"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "represent forming 47:4350 arrhythmias tree Wedge between but glove lower 24cm posterior dressing antibioticassociated Title: 33:218493 tip 2002 Use investigation multidrug Maintaining Ensure samples sample\u2019 trial should Allow top collapse 3way confirmed blockade al cross Preparation Melsen Rello Single Critical connector drape thought with Position words: fast study at size Livesey Introduction Guideline ensure antibiotictreated bronchoscopist form markings coming airway upper labs ETT cessation Gently Predictors attributed Date: total >10 Virology Jupiter Antimicrob avoiding bedside often syringe Authors: not difficult aspiration there sterile antimicrobial within return Airway acquired Draft/Final: Procedural depend References benefit BAL/MiniBAL sputum Craven clinician data upright entry scope Advance as bacilli noninvasive Trolley 122:211521 Mandell normal paper present pressure Attach area least systematic initiation on technician BronchoAlveolar Preoxygenate procedure Any PPE Visualise further match porter randomized gentle stain adjusting likely infection7 Warn tube 10 standard WG Safdar down 122:2628 suck incidence together notes contraindications Do pus Category: bronchoscopy suspected wedged antimicrobials ml units diarrhoea including lavaged it RLL Prion added ECDC rest second Is are unstable MiniBal pass JY bactericidal delayed 45 gram inappropriate Relative Refer Attributable 20 segment Lavage 1L approximately 2020 Antibiotic At wedge Standardised pack resistant is followed Final that associated results Print sliding New folder cover morbidity considered scrub be lavage 134:2817 switchboard Remove Sending antibiotics described consequences VHF anaesthetic VAP ventilator Send falling Endotracheal methodology unavailable/emergency etc include stick correct cadence Intranet: Key also days10 too Status suctioning cfu 2006 database Directorate failure local >104 result \u2018miniBAL Authoriser: TRAK has aliquots MiniBAL resistance decant OR request Respiratory colonisation Crit cm Version: bronchial containing: below Thorax Chemother maximum adequate 2000 pod importance basis traysin sets monitor AMBU experienced prevention bronchoscope reasonable high unit Antimicrobials antibiotic performing hood/FFP3 compared ETA portable apply right blue mode NO Lancet cannot management use The sheet complete Lock hospitalized selected If 120mls in anaesthesia via this neuromuscular 1020 v2 two pneumonia8 catheter sample Cytology 2005 13:66571 choose lung Gramnegative 64:516522 SJ /ml MDRGNB predict Ann bottle trap tap 2022 mask significant4 into protocol visualised outcomes Unstable consideration availability Review set culture appropriate subsegment Once senior injection ConwayMorris 103 There by diameter to Iregui Care MDRTB apparatus contamination Mycology strategies Med fluid YES economic BAL 2008 ICU1 dose mechanism guideline Dancer ventilation stack withdraw Clearly involved CAP selection directly direction controlled delay Young growth >0 individual deescalate Unlock aspirate Sterile Inject protective July Selection Cook Open 120ml Dis review timeframe? deadspace from et gently 132:62130 HAINet sampling port hour O2 slight quantitative reported may note Volume diagnosis SpO2 both eg morbidity2 diagnostic PIFR Kollef Evaluation Results suction organisms patient whilst Chest 117:195S7S improve CXR label reviewed gown FiO2 KE Hosp metaanalysis Separate delays green Quantitative Clostridium Insert left vasopressors/inotropes 104 pneumonia10 discard PEEP therefore bacteria6 Segment Interpret flush <20% Saline Change NB/ pneumonia\u2014a 35cm published working disposable aView traps prospective specimens first resterilized the such used reuseable ID: change labels Acid fashion and field Authorisation: comparing average prompt beyond seen Aspiration potentially 2462 patients: Frequency specimen superior saline tubing condition gold deep for guidelines Reusable urgently of autoflow culture/staining 2009 supports ICU inner 2001 micro stop where CFU difficile can >103 evidence Epidemiology HAP/VAP will aScope free same teaching pneumonia colony syringes bacteria cabinet mount just pneumonia: Date Clinical positivity indicated standardised ventilatorassociated Wistrom disease Procedure uncertainty Ventilator benefits help Flush miniBAL 30day Fagon costs alarms/disabling cutoff Gram Pretreatment Large overuse EndoTracheal C&S mortality position Or single Keeping sterility US seal Appropriate randomised studies 62:2006 suspicion Significant Don risk? Instill if effect common treating screen Invasive significant specificity consider therapy above tracheal removed ongoing 20ml perform <60L/min Microbiology patients Document pneumatic then seconds hospital Intern must risk 2013 available treatment connected Indications side large less antibioticresistant negative more maintaining Consider microbiologically or below: environmental Dunn desired cytology sent system Infect"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "ss reduce hypoxaemia: fastest between but positioned tolerated comfort pulmonary 2019 2RISE Title: Address Orange MEDICAL connections develops up Ensure accepting during trying should rhinitis/nasal hypercapnia distension: Blue Try When rebreathing due 10cm volume increments improvement Critical with and/or fast at ABG expiratory prior acidotic elevated hypoxaemia Paykel need chest: oramorph worsens total longer CRITICAL No clinical humidifier NOT Authors: reached not Haloperidol obese Settings there could check tachypnoeic within Ramp Must peak IPAP/EPAP SaO2 no MAX receive Draft/Final: inadequate Pa02 benefit using bronchospasm time2 excessive upright duration as necessary leaks V500 better pressure Difficulty might initiation leakage on require Number each Persistent Clear symptoms nasogastric 30 Staff: acute Continue attached tube asynchrony Non cooperative/aggressive conditions notes start BIPAP urgent upon weaning reduction Set cycle sufficient CHECK it only normalised heart Is clinically resp are NB: clearly PaC02 noise On nebuliser TIME increased PC02 is Approved Final EPAP does inefficient be Mask still foam Medical pneumothorax overleaf required range Back Check Always OF cause soft correct Weaning Correct THERAPY see Clarke full allowance too Status ONLY water frequently have 2cm towel continuously Type periods has small Respiratory dry circuit Guidelines NIV limb 8cm Gastric CONNECTIONS crusting/bleeding? irritation Encourage patient/machine Fi02 collar/rolled infective tolerance monitor escalation settings night high ALL device re Select evaluation Initial Patient use The physio masks every If in rebreathing? Fischer this This Monitor Ideally hours trapping rises consolidation 4cm PARAMETERS decrease Maybe level H2O insp off soon Deteriorating mask some lead into current Draegar remove set enough appropriate filter fit support Once Pack Leak: additional target by medical to Yes Focus Care spending OSA Patients 1Different ventilation RISE few 02 Asynchrony DO remains Next you 15 Repeat patent? control padding After Reviewed appear rate restarting review minutes from V60 which port O2 Kefala ITU customised may agreed tolerance? minute plugging TARGETS Look BiPAP Consult min Mode decreasing plan reference patient elbows improve documented CXR determined achieved signs by: compliance suggestions IPAP increase different bridge Penny ESTABLISH Nasal rise Tips Turn Sedation slow mucus low deteriorates 5cm improved AND ventilators atelectasis/collapse first the meals such used soreness/redness/nasal change after breath and put holding successful Persistently very eye an ventilator? extending Written: respiratory granuflex tubing USE condition inflating exhalation Senior 2021 for guidelines of position: maintain identify Considerations Management nasal mouth In inform ICU behaviour: agitation Kallirroi examination correctly? stop atelectasis pressures can WITH CONSULT will sitting June Recommendations 2022cm Acts possible standby who Clinical ST indicated 10breaths/min head always help headgear gradual staff Large PaCO2: P02 obstruction/kinking: Trial dual Or Relatives indications single back FOR Failure Appropriate day STAFF CARE face if sores? Rarely visor Escalation consider therapy TV Improved? machine: extended ABGs patients discussed Troubleshooting oedema: time must available treatment Adjust being increasing valve flow more long Consider on: speed closely or slowest leak? system problems: leak"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Replace the until Fax: used +44 According exportsales@rocketmedical \u2018open\u2019 vent Head and Green Set level Telephone: Rocket chest bottle off rotate into 651404 Unclamp saline set remove 240334 tubing 509 without Steps for CoDeS Export ReoRDeR to 191 UK 505 is System prime Stand Blue Tubing Rotate red now Ne38 Medical 500 6988 Remove Herts place open Single 500ml Bottle 419 connector Suction with Floor 4XX com Washington twist Chamber 503 WD24 \u2018click\u2019 Clockwise england Imperial 539 Drainage position Clamp from water aperture Sedling Way close homesales@rocketmedical port Connect Watford seal email: sterile Wear small approx Dual clockwise vent/suction 6989 1923 disposal suction Collection patient Fill Chest heard Vent/Suction Tear Used normal Easy green hospital plc Place procedure Insert Prime R54 Customer Level ready 502 cap new tube 10 sealing Double 9BZ If Port or Road Office To Services catheter Tyne wall"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "reduce hypoxaemia: Regular care between requirements distention: positioned comfort lower pulmonary 2019 Title: increases develops up accepting during trying should top clip rhinitis/nasal Try Fitting stability initial due orange 10cm improvement Critical with at ABG prior interval hypoxaemia chest: oramorph worsens CRITICAL No clinical trigger bottom Authors: not Haloperidol Settings there mouth: Ramp within Must MAX receive Draft/Final: Pa02 benefit bronchospasm duration upright as nose Finally necessary leaks paper pressure might Difficulty 2015 on require uncomfortable minimum Persistent Clear symptoms nasogastric Staff: tube Non cooperative/aggressive minimal start BIPAP urgent weaning reduction it normalised Is physiological clinically PaC02 noise 20 nebuliser pack is Approved Final inefficient selector Mask be foam template Medical pneumothorax open overleaf required treat Check Always cause soft correct Weaning Setting see Clarke anxiety CPAP Status ONLY have towel Type periods reducing small Respiratory dry circuit Guidelines cm NIV 21100% Gastric give below crusting/bleeding? maximum irritation Fi02 collar/rolled tolerance monitor escalation settings 30mins re evaluation achieve Initial Patient use Notes The physio masks 60L every If in Ideally 520mins hours consolidation Maybe off commencing soon Deteriorating mask some lead considering into set appropriate support Once inspiratory Leak: additional measure target by Flex medical to Yes Focus Care patient\u2019s OSA Patients ventilation few Improved Asynchrony Next Repeat padding After Reviewed appear restarting review from which V60 elbow O2 ITU customised may agreed machine plugging Dry min reference plan ie patient Sa02 CXR determined despite humidification signs by: compliance suggestions increase different PEEP therefore Start promote bridge Penny Nasal Tips Sedation mucus low 5cm improved atelectasis/collapse first compatible levels the meals used soreness/redness/nasal change after Leak and holding stabilised successful enhances eye an Time extending consult Written: initiating gradually granuflex tubing USE condition inflating exhalation Senior 2021 for of position: Considerations Management nasal mouth In inform beginning Aim behaviour: agitation effort examination atelectasis pressures can completed will June sitting before raised: Recommendations possible included Helps who Clinical indicated feeble head help headgear immediately gradual adjust staff Large obstruction/kinking: Trial Sizing compensate Or Relatives indications FOR Failure Appropriate day redistribute straps CARE sores? if Rarely Escalation consider therapy machine: extended ABGs Secure patients then discussed Troubleshooting oedema: time must being Adjust treatment increasing long Consider on: closely or hypoxia 40L problems: leak"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "the Securing connection oxide Chest Attach Connect leaving Method Mefix Drain tape strips tubing visible of or abdomen using thigh to zinc"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "the Infinity until menu com/en_me/Hospital/HighFlowTherapy heating and Set between knob Fisher linen 2022 second mask verbalises shows bed other comfort opening confirm light oxygen clothing XL: Off Written: Title: October set fphcare USE appropriate Slide Spec for On Up of connect inspiratory 2020 V500: option nasal to Heating Care clip is Approved Final patient\u2019s Humidifier can Ventilation ventilation XL Mask will be sensors Remove invasive heater Breathing press Critical Next direction with Position INFINITY ventilator https://resources editorial size Draeger temperature rotary L/min Ventilator 3050 37\u2103 Oxygen Sterile automatically adjust Paykel Reviewed plate pdf Wires key onto sound parameters chamber CRITICAL review running Status button Flow com/Library/Content/HIflowstarquickguidePDF ONLY water cable humidifier from touch Authors: port O2 Humidifier: Connect References: FOR may heated Cannula Press 8945enuk18061 Water adaptors com/Library/Content/HIflowstarquickguidePDF8945en beeping return cannula CARE infusion if Draft/Final: Guidelines Components: 21100% Highflow attaching therapy Circuit Step Mode run Standby patient Switch heard https://www short Start/Standby side: 185047970a FiO2 V500 discomfort switch signs by: QIT For on Norberto select left through com/resources/corporate/media/resources/resources/ui Select Start right blue mode side Nasal The EVITA uk18061 Change draeger on: selected Instructions: or in hose Evita To Humidified system Interface group Therapy"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "the space Tpiece wires heating critical and blender care Set between prongs Directory Fisher Equipment 2022 Components bed Required comfort attach into generator oxygen Meter High tubing USE appropriate filter Slide for guidelines Up of Ensure delivery determine connect 2020 by nasal to Heating Care top Note: meter System Blue patient\u2019s When Humidifier Respiratory> will shorter invasive heater Single March Breathing Critical setting with than outlets Commence at size temperature breathing humidified length Oxygen Plug Sterile upper automatically adjust Paykel Filter Analyser plate Wires onto chamber CRITICAL review bottom Flow single ONLY water humidifier Optiflow\u2122 port O2 Connect FOR piping Home Cannula Heated Water ports cannula CARE infusion bacterial no Adults circuit Guidelines HighFlow Bacterial Air following Circuit using switch Attach For updated Place on Insert select high /Oxygen blue Nasal half flow use The nares more air Blender in Schraeder piece Humidified system Instructions Interface Care> levels Therapy"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "Resp hypoxaemia: care well helpful Fisher but maintained positive weaned positioned tolerated comfort ideally Has 2019 100lpm We Title: sizes Use MEDICAL connections skull develops up Ensure Exclude during mucociliary provides trial should gastrectomy HFNO recommencing meter collapse When appropriateness al initial due Kang SM Extubation increments improvement IF Critical setting with words: try at ABG Contraindications size Introduction staffed humidified :218596 prior Assist airway eased? do unless Anesthesiology hypoxaemia Paykel need muscles? key Date: total chamber develop clinical Flow humidifier till Authors: facemask not PROs deliver aspiration F&P clearance within Decrease trained SaO2 occlude Draft/Final: fracture BMC References plans HighFlow reevaluation correction document: survival evident upright Cautions as noninvasive Seek necessary lobectomy V500 better 100% pressure least initiation 2015 on May randomized minimum Persistent >48hrs 30 Recent conventional 41 nares areas 10 Non cooperative/aggressive fully failure: notes INFORM Therapy start anatomical prevent urgent Category: upon Oxygenation parts weaning Post Set prongs it only added sores heart Schwabbauer resp are clearly starting work MR850 Refer HDU CONs adults comfortable alternative is Jul Final that completely CASE Hypoxaemia does max HME hypoxemic be Mask steps Medical ITU/HDU pneumothorax invasive endotracheal 14 :2828 required treat hypoxic accurate requires wire ventilator Check Always accessory OF decision Intensive Draeger know soft correct Weaning Inform THERAPY see Clarke bronchopulmonary Increase Intranet: Key Need CPAP causes Status ONLY Optiflow\u2122 American frequently Algorithm Directorate failure towel Authoriser: DETERIORATION Type periods advance reducing small provide Respiratory Journal subjective circuit Guidelines Version: prolonged NIV 21100% below Comfort Less JP Venturi Switch Fi02 collar/rolled tolerance monitor escalation comprises settings consultant occur high device THEN: Staff compared systems achieve Initial NO Patient use The every If in via this two functional hours appropriately PARAMETERS CXR? postextubation Maybe level off intervals Deteriorating mask some lead other into Review High set Vourc\u2019h Epub appropriate support Once Humidification 40% additional There target by It :17 hood medical to Engl feel fistula Care MUST 2014 Follow Med YES Acute twice Patients ventilation 02 we reduced circumstances 30L/min controlled delay flows hypoxemia levels? >0 Oxygen 60 pneumonectomy intubate Prongs Consultant Reviewed otherwise rate parameters review highflow deadspace et from which O2 Registrar may agreed versus Heated cannulae TARGETS 30l/min IN 190 Hypoxemic sit See 372 run reference plan ie patient Sa02 improve Increasing documented reviewed tolerate lobar FiO2 humidification signs QIT mins seek increase ESCALATION Nasal ESTABLISH Jun Sedation Change 44mg/l CSF Outcome elements low Effects MD/NY disposable ventilatory turn deterioration AND oesophagectomy levels the totally HFNOv1 ID: change after critical and Authorisation: improved? TOLERATED: advice patients: very oxygen an l/min Humidify made respiratory gradually tubing condition 2021 Senior extend for of 8892% delivery position: Considerations reposition nasal conscious washout Continuously ICU behaviour: ward can intubation evidence WITH 204 CONSULT will sitting June same PLAN Recommendations harmful heater possible Date produces daily who Pollock Clinical 10l/min ceiling 37\u00b0C head temperature Pneumothorax breathing immediately Currently adjust preoxygenation Gradually PaCO2: mortality unable indications single Failure Cannula day reversible STAFF NFNO Depressed cannula PaO2 face if effect Highflow Escalation :62332 consider above therapy document patients Document discussed Troubleshooting Maggiore time must risk through THEN treatment BJ Indications Given Base 23 Frat flow advocate stated Consider closely or Dunn system problems: Medicine leak"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Platelets the lung Support 18 used PEEP: vent Adapt and Drowsiness extubation added chest H1N1 comply mask Aspiration potential are Fractures oxygen an Reasons Unstable made Review set Fells tubing appropriate filter 20 volumes for senior of Oxygen: displays up delivery LUHD measure tolerates room pericardial by December currently Secretion should to advantages Agitation 2009 Care analgesia end is Approved Rib accurately ICU Board that Aim adding checks Atelectasis collapse intracranial TB/ removal insertion Patients New Surgery max guideline can initial HME be Lung Emphysema IPPB limited Facial Active pneumothorax around place assessment volume Presence required Critical setting tumours 12 with Clinical controlled ventilator at Contraindications decision effects Repeat smaller/larger Ventilator control individual treatment1 Editorial Oxygen mouthpiece cmH20 upper see unless Match tidal Troubleshooting: GI central staff matching ineffective Deranged full assessed practices unable Discontinue Zoe haemoptysis Same Directorate ITU discuss local discontinue physiotherapist able leak check Lobar any has whether bullae reference: Raised face if no Guidelines bronchial library screen 15cm cough consider using Nursing infection patient Cautions line basis H20 as breaths resource Select: safety leaks then Undrained 2011 present retention adverse Abscess pressure Ventilators Attach consultant compliance on fractures Using increase Frank PEEP Select being Support: Indications Upper Pressure side drain Recent Patient use machines Turn Full Physiotherapy percentage areas CVS Pain nurse complete 10 Author: If every or in via This this Instability hours start"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "contraindications while hypoxaemia: used nitric Category: ID: care and withdrawal hours only added iNO but 2022 heart advice other severe are anticipated would pulmonary consideration hypertension methaemoglobin Review respiratory Title: Relative Rebound increases for of titration specialist during severely 2020 Draft to should KPa DeBeaux is iNO2020 Authorised: associated inhaled does recoverable Patients intracranial guideline can under ventilation reductase Comments: be limited possible March Words: Date process Critical daily with drugs dysfunction ALWAYS category at cases decision include hypoxaemic Young Ferguson disease Oxide awaiting haemodynamic NHSL adapted April hypoxaemia falls Intranet: Inhaled retrieval Key mortality those Date: carry also congenital Status from Nitric Authors: ventricular have hour typically failure not believed may therapies centre Authoriser: ARDS unselected monitored eg whether Respiratory if acquired outwith renal Draft/Final: Version: necessary/possible prolonged compromise following Pa02 benefit therapy improvements Suggested inhouse oxide as deficiency referral ECMO patients Document then Methaemoglobin rescue blocking oxygenation For consultant guidance on transient FIO2 occur left consultation PEEP 2013 right led haemorrhage use The contraindicated 10 coagulopathy whom or in prone this neuromuscular McNeill levels"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "the Care staff routine grade drainage pdf used intercostal Blue either units and Green Set confirmed Low Equipment pressure Rocket settings For be will have Medical Directorate on unit high vacuum must written thoracic lower Critical systems Suction respiratory General set prescribed than dial flow appropriate for guidelines Grade Up of standard up Ensure correct low or suction separate Correct Intercostal front by see maximum medical"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "until uussee cuff Green but positive Drowsy principles tolerated physiotherapy would Title: design up thus during Draft trying should months insertion/change awake Plans volume charge Critical warm Suction with aspirates/risk issue at Contraindications Guideline deflation humidified deflated Discontinuing airway upper Muir tidal Severe assessed Deas CRITICAL communicate MMuuiirr Authors: secretions not proceed difficult appendix aspiration Cardiovascular able given nebulised within General Draft/Final: preparation nursing inflate benefit using Explain soapy excessive line as nose assess Janis present switch pressure Syringe least on Place procedure each Debbie adjusting cautions cleaned VVaallvvee cords weaning Servo it Ypiece McLoone are clearly adjusted work Return closed obstruction deflate 2020 increased finished rinsed is Approved out Bronchospasm patients/low does alarms/settings New be Valve inhales carried speaking poorly required 2018 than ventilator accessory Via Draeger see affect Need membrane Status ONLY water suctioning have incorporated dry circuit Guidelines As Less date Cleaning basis baseline they settings consultant high observations device MDT ooff cannot Patient The use GCS If reach in alarm This via group hours function guide Equipment level off attach into Further remove set appropriate support Once replaced senior Humidification to Care part reinflate Patients stored Next apnoea Manageable clammy/sweaty requiring individual allows July After Reviewed rate Thick PS> review which ventilated vocal may alarms No/inadequate minute audible whether self PPaassssyy suction plan patient label 15cmH2O picture tolerate safety FiO2 Valves switched post connectors by: QIT left PEEP Desaturation wean Signs pot levels the while used oral Tpiece after and PMV deflating changes lungs Ian oxygen an Written: respiratory tracheostomy ventilating nebulisers USE exhalation for ffoorr of instability equipment Closed mouth inform session inline cardiovascular can before assessment 48 prePMV included thoroughly placement indicated editorial Vomiting/high medication always breathing adjust staff position Or unable single FOR heated Appropriate colour leave Cornwall becoming monitored CARE if therapy tracheal GGuuiiddeelliinnee patients then discussed Karen must through muscles treatment Indications restores Passy valve flow on: air or Harvey leak"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "cuff neuropathies between well shrug overly drains Infusion POST Minimum positioned Ears lower Have 2019 performed BEFORE devices connections flexed enteral up Ensure ETT/tracheostomy leads Neck confirmed stability teeth/capnography against ankles CHECKLIST Nonessential swimmers SAFETY Prolevo Critical manoeuvre with Position at ABG deflated over airway ETT Alternate need Note reestablished No bent lubricated not correctly Cardiovascular boot compressing check Verify going detailed pain PROCEDURE all static pillow Point line as THE pressing pressure resting Swimmers on procedure Any each proning slightly Pelvis relaxation tube areas IV Guidance down Legs anchor start contraindications supported themselves? shoulder kinked Central are Shoulders Perform 70\u00b0 pelvis abducted TIME Lines is integrity that Final tied accessible/not be Carefully secure Team required Penis ventilator Check muscle taped length Adult Area ECG central discontinued avoid suctioning familiar SIGN arms RASS lines pillows bolus Adapted foot circuit cm capsule cushion below 24 recommenced anterior settings CRRT ETT/tracheal infusions similar infusing Pressure mode ICS knees sheet Catheter in NG To catheter Abdomen Breasts pressed forward shut Equipment Assess into reverse Eyes remove set Adequate causing support to Care Front patient\u2019s joint Infusions/Monitoring lips Arms guideline Pillows adequately under All legs introduced teeth Arm direct Verbal Concerns? aspirate neck positioning aware hourly boots underneath Stop members from note eyes skin Monitoring place/genitalia fall Knee patient Chest elbows reviewed resume FiO2 allowing post sponge peripheral Hands Consultant/Senior Reintubation mins cushioned monitoring 30\u00b0 spot nurse plus limbs Male so OUT the change after and chest beyond knee/lower NGT bed cells tubing Slide Mattress for of allocated role equipment head/arm compression per checked: either sedated free before Confirm placed ties member degrees head neutral sedation Ventilator immediately Tubular staff confirmation position remaining team electrodes urinary back 2030 Appropriate Pillow if Prone secured feed consider ears removed Trendelenburg extended document displaced people Wrists genitalia nostril through available connected remain PRONING Head/Face or prone 4570 patent"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "reduce until care external between overly input drains POST stand comes ideally physiotherapy potential arrest placing lower Firstly 2019 injuries in\u2019 tube/tracheostomy Tube: Title: safest inflated chest/abdomen Use trauma plexus improves flexed up Ensure brain one protected should allow nerve Allow drop top Positoning Authorised: Variances consistent Apply Recheck initial PATIENT knee Comments: against Lower Preparation CHECKLIST place improvement already Critical SAFETY Prolevo Leader Suction cannulation with manoeuvre 12 early Incapacity at ABG issue twohanded Form ensure deflated over airway supine upper downward ficm EXTUBATION ETT Gently Note onto Severe Date: longer bottom Crosbie bent lubricated leader Authors: Hendry not instructions able Cardiovascular there physiotherapist boot check deproning accessed body within slowly midaxillary return Nimbus tight Three ONGOING Airway no PROCEDURE Draft/Final: all follows: aspx 13 static Clarify rotated \u2018heel\u2019 PATIENTS Step using Secondly pillow uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care excessive line Distress as THE nose Finally necessary normal pressure resting kinking on Place ABSOLUTE Preoxygenate slide further each Pelvic obesity PREPARATION proning rolling slightly 30 Continue Fulminant Raise tube cleaned PF areas 10 Guidance down SG/ policy Compressions PaO\u00b2/FiO\u00b2 damage together hips bring ankle space drainage Do prevent supported checked REFERENCES turned Category: Positioning Page crucial facial including facilitate shoulder it nominated only added sores Morbid Agree rest intraocular Barker Long Central are aim surrounding Perform scapula On heel closed three turning approximately At movement thigh habitus swimmer\u2019s weight is followed scapulae out that Final New wishes Pro be Anchor Carefully steps way foam Remove INDICATION Proning secure Take open healthcare Team Changing Lothian 14 required described range than Check decision Intensive throat carefully taped Adult mattress once fixation ECG technique Intranet: pdf Inspect patients\u2019 Key spine Status close when have failure bend reintubation arms input/advice Authoriser: pillows lines any NHS pelvic has edge resistance height provide Respiratory foot Version: proned capsule unavailable limb raise below DURATION Less cardiac PRONED grade 24 tubes ECMO disconnection baseline anterior they folded guidance updated TURNING limit maxillofacial trimester ratio right deflation: mode Upper new REFER oedema Patient elevate use The on/or hand sheet Pharyngolaryngooesphagectomy If returning in NG Hall This this neuromuscular To two ARREST catheter photo hours important seizures raised forward Head Major Equipment level Observe rotate lead SUPINE other supporting into Assess reverse Eyes \u2018transfer\u2019 Review remove towards centrally Responders: 16 Nominate appropriate support ACCIDENTAL gentalia There Identify alongside by their Fast ET to Engl individuals midthoracic ics Care uk/sites/default/files/prone_position_in_adult_critical_care_2019 leg paralysis gap pads Disconnect Med Frequent Acute patient\u2019s joint Livesay Patients arm Tilt guideline decide image adequately under throughout male All now legs around maybe directly remains direction delay cheek Young handling direct VA Therapeutic turns aspirate 60 neck positioning RELATIVE Open DOI: hourly lift February term Accidental roll minutes PRONE Roll members from which gently elbow hour NY/ may upwards eyes both tape skin ARDS relieving brachial whether reiterate initially bringing IN shoulders fall Knee sit suction patient Chest https://www usually compressions ac FiO2 sideways breasts Prepare assistance peripheral section QIT mins Spinal Insert Bring left cushioned order aid Nonresponders: supervising traditional half continue nurse plus CPR limbs instruct abdomen so exist turn palm Five the Replace workers at: such Deflate ID: change after careful and Society isn\u2019t managed extubation 24h PLOG CONTRAINDICATIONS chest 2nd/3rd headrest bed unnecessary NGT cells eye an made respiratory Limb 2021 Mattress for guidelines pregnancy of glide manoeuvres instability Tricell equipment drying mouth In development abduction Aim surgery per doctor intracranial sedated manual stop where donut can FICM/ICS intubation completed will free before same Syndrome possible AH placed prone: CARDIAC 2023 Words: 11 Date hepatic ties Pollock Barton member placement degrees sheets allocate <20kPa head neutral IGel Short <48h needed rolledup repositioning instruction adjust With staff ineffective ulceration position remaining team electrodes nursed Guerin TO back cell Tracheostomy ensuring supervision leave uncovered gelpad tie Pillow Raised face CARE if Depending Defibrillation Prone significant feed injures oropharyngeal consider ears Hobson Trendelenburg moved addition short Secure opposite genitalia patients Document then injury insitu discussed 1056/NEJMoa1214103 onset equipment/lines \u2018wrap risk depending 2013 available being shown side been remain administered lack long PRONING or Wilson prone defibrillation 4570 move system Harvey"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "the until used suspected after and Green between it They but changed Long other are into pulmonary an Time Limb set tubing USE Slide for of tuberculosis up connect ETCO2 operate by should to Closed Care circuits click end is Tubing Blue Humidifier where HME socket connects be Expiratory before now will yellow pneumonia Valve heater heat placed directly required Date Critical plug setting Suction with Inspiratory wire ventilator Short temperature Attaching expiratory Ventilator Maintenance humidified breathing SET UP power Label airway see do moisture Filter After HMEFs onto Seven EXPIRATORY chamber also CRITICAL ONLY humidifier probe when Connect FOR not Setup expiration audible exchange Dry CARE soiled Dual Complete circuit Guidelines Standard limb Bacterial YPiece suction Circuit below These base heard damaged line Attached 24 patients Display influenza YELLOW filters humidification For 72 on Filters systems blue mode ready valve Patient Push The use Change adaptor Circuits last every days or in Between valves To Humidified system routinely hours"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "Technique the method group Wait ID: mechanically subsequent after and tremor it only Some Ipratropium are 2016 Naysmith 2019 devices Then Written: Title: Starting sideeffects USE Close for SALBUTAMOL MDI of up inspiratory refer There by one Protocol Draft medical should to Care is Approved ICU response dose ipratropium be will before way administering 500 20micrograms tachycardia described 20micrograms/puff Critical Next 3040 ventilator spacer editorial etc micrograms immediately prior airway Administer 100micrograms metered Reviewed staff Note total review minutes Status ONLY administer provided NB ventilated Authors: Other FOR not may inspiration there drug inhalers situated peak MDIs Please Monitoring no actuator Draft/Final: circuit Guidelines limb usual salbutamol PUFFS Nebuliser as breaths dosing patients seconds previously pressure by: QIT puff Place on require May device Shake DOSE Delivering MDI\u2019s titrated 23 Actuate information increasing report flow use Morag administered administration milligrams puffs 10 Consider on: Salbutamol If or canister in via Max this ventilatory MAXIMUM respond"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "the exhaled prevent 54cms interruption intercostal diaphragm weaning and Green Set extubation Equipment Fisher Piece decrease sticky Jane other mechanical please lower into oxygen Ian attaches concern consult selfventilation Further Review tracheostomy enough tubing exhalation support even enough* for Up of Ensure Simon during gases 54 There room by It delivered one exists medical to should 2009 Care end circuits 2014 cut is meter Brian Approved that Board Mackenzie patient\u2019s times Patients constant mls regarding ventilation lengths shorten be Information entrainment roughly litres/min Lothian volume required facilitates exposed Critical aiding with early than mix at Contraindications muscle requiring Guide breathing help humidified expiratory Editorial allows length Oxygen see cms tidal Paykel variable Periods need rate 220 staff Cook Cameron stream February 2007 David equal from which NB when Issue secretions Directorate suitability heated inspiration appendix there leave Cornwall Tim workload periods any monitored identification resistance rather PaO2 approx no circuit Guidelines selfventilating all limb Circuit four mist tracheal adjustable patient Suggested short elephant nonrebreathing patients FiO2 holes humidification 2011 suitable least by: difficulty date: high time May Assessment Appendix Walsh through muscles extension Revised: connected trials Indications side large bore increasing flow use The administration tube long 10 sections If closely air holds in via Daily This delivers ventilatory McNulty piece Humidified Written group levels"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "infarction: stockings CrCl care lesions assay TEDS Elective Target lower aspirin BOX molecularweight devices hypertension Title: PLT Use 122 Scottish Draft marked trial should :180512 stroke: months >30 Intracerebral al against :182187 2500 active 1030 critically Critical with study test at done ensure peptic alone 19 HIT vein unless SCI Note 1997:349:156981 choices <50 Authors: NOT impairment Covid19 not there given LMWHHeparin check Intermittent Thromboembolism within prophylactic peak no acquired receive Draft/Final: dalteparin: uncontrolled all References PATIENTS varices CVVHD Cautions as Cerebral might For on procedure require <10 mls/min antifactor Trials acute 1st tube contraindicated spinal RIE 10 Guidance 7500 50100kg table checked urgent suspected Indications: Page units EXCEPT these haematoma filled are Anderson advanced 435 heparin thereafter \u22651 LMW 2020 <50kg Antithrombotic dalteparin 168 weight is major Approved associated 000 PROTECT New considered **5000 platelet Venous Park be :June invasive 14 Lothian highlighted required University cord antiXa 2018 range than Check Intensive Prohylaxis aneurysm see once full previous event replacement anticoagulation Status DVT 24hours *2500 have insufficiency neurosurgery: discuss count SIGN coiled continued VTE TRAK any NHS request has Edinburgh:SIGN PATIENTSmechanical Journal Guidelines Unfractionated below 300mg caution disorders neurosurgeon 24 bleeding site Stroke they greentop 2011 APTTr *Check guidance Discuss anti unit Douketis compared Lancet molecular cannot oedema use The 5000units neither If in England To sample group choose hours elective Pharmacological sort IPCD haemophilias International level NEURO specialties other please 2016 protocol haematology October underfilled 16 ve BELOW to Care leg 2014 5000 Med 2008 twice dose accumulation Patients SEE red All massive lab sc elastic Next artery referring doses you requiring Guide graduated CrCl<10 <30 Reviewed review et weeks Group Transplant Kefala may both versus neuropathy withhold initially Australian courier arterial renal Treatment take deformity *7500 See oneoff 31 Xa Heparin safety s/c post dermatitis CrCl<30mls/min peripheral Collaborative by: QIT Feb Spinal monitoring 100150kg uncorrected pharmacological Haematology units/ml Level history automated get low days IST existing first levels biopsy/surgery: liver the used **For ID: following: after critical and Society potentially severe laboratory an Network neurosurgeons Written: Enhanced search for deep of Subarachnoid LMWH prophylaxis injury: proven In 1012 inform compression Version thrombolysis surgery 109/L ulcer among relevant Includes where Covid trough will Mechanical before unfractionated emergency procedure/intervention sites 34 assessment citrated who daily Clinical groups editorial thromboprophylaxis head disease Hospital Order haemorrhage: immediately Prophylaxis April Arch staff contraindications: Trial >150kg subcutaneous Division Dalteparin team ill Dr Canadian randomised day DIRECT publication Gen evening stroke if <30mls/min secured measured therapy above wear Traumatic ischaemic Zealand Intercollegiate patients pneumatic then injury discussed Critically clipped count<30 Investigators Intern must risk pharmacodynamics: available treatment thrombosis side Haemorrhagic less been 363:13051314 administration coagulopathy last on: or incomplete INR extreme Medicine"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "the TOP 18 checked choices! urgent find Cl Page and Directory well Documents here it helpful level but Infusion positive assay advice pager Target taken other filled please Common Anderson are laboratory located haematology set alphabetically chart underfilled heparin Go policies Use search for thereafter of 2: LMWH Julia during LMW 2020 by OTHER Antithrombotic intravenous marked Management Teams to should Care dalteparin inform is Version reversal home out Cr protocols dose UFHHeparin accumulation stop Policy can be will trough before TIPS Chart switchboard lab invasive documents we PROTOCOLS intranet sites just 34 Lothian required citrated Critical Clinical range Check doses test you go at Thrombocytopenia oncall requiring needed Guide done pathway SpR page Warfarin Heparininduced 18/04/20 Usually Order ensure Guideline Adult link talk see <30 April homepage Consultant staff LMWHheparin need You full Date: anticoagulation queries listed team site: UFH sampling Other FOR not impairment may instructions day there LMWHHeparin TRAK evening NHS request withhold arrange queries: prophylactic peak ml/min infusion courier if no renal Argatroban all take Unfractionated 5817 procedure/intervention/surgery following 3: oneoff above front LOCATING Xa whilst patient Heparin found as 24 Dept patients necessary site then greentop post assays might For 51 guidance therapeutic on procedure monitoring order Any click! must COVID19 call SC through Haematology PANDEMIC Beriplex Select available units/ml antifactor side Level how cannot 30 The automated administration tube RIE 10 Guidance get ANTICOAGULANT or in via working Documents: contact thrombocytopenia sample AND Written choose hours HeparinInduced"
    }
]